_Imputation_,SUBJID,NAIVE,AGE,SEX,BMI,TTDIAG1,PSAYN,BL_PASISCORE,BL_DLQISCORE,SMOKSTAT,FAMHIST,PRNONBIO,PRPHOTHR,ANYCM,CURTRT5,CURTRT4,CURTRT3,CURTRT2,NCC,CC_01,CC_02,CC_04,CC_05,CC_06,CC_11,CC_21,SPGASCORE,BSA,ITCHSCORE,SKINSCORE,MNAPSI_SCORE,PSSDSIGNSC,PSSDSYMPSC,WPAI_ACTI,HADSTOT,HADSANX,HADSDEPR,MARSSCORE,BQ_1,BQ_2,BQ_5,BQ_6,AUDITSCORE,CC_OTH,cohort1,cohort2,cohort3,cohort4,cohort5,cohort6,cohort7,cohort8,cohort9,cohort10,cohort11,cohort12,cohort13,cohort14,cohort15,cohort16,gcohort,domain,STUDYID,SITEID,COUNTRCD,REGIONCD,TRTCOMP1,TRTCOMP2,TRTCOMP3,TRTCOMP4,TRTCOMP5,TRTCOMP6,PSACOMP,BL_MNAPSI_CAT,SPECBODREG,ADATBL,ADATVIS,ATFL,SENS1FL,SENS2FL,SENS3FL,SENS4FL,itflpasi,PASISCORE_C,PASI100,PASI90,PASI75,PASI_LE1,PASI_LE2,PASI_LE3,PASI_LE5,pasi_prim,itfldlqi,DLQISCORE_C,DLQI0_1,itflspga,SPGA0_1,pasi_prim_i,spga0,spga0_i,pasi75_i,pasi90_i,pasi100_i,pasi_le1_i,pasi_le2_i,pasi_le3_i,pasi_le5_i,dlqi0_1_i,spga0_1_i,pasi_prim_itfl,itfl,pasi_prim_itfl_i
1,103-001,Biologic Naïve,19,Male,24.538964902,6.7515400411,No,13.8,10,Never,Yes,No,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,18,4,0,0,28.333333333,10,10,7,5,2,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,103,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,0,0,1,0,1,1,1,1,Y,-10,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,103-002,Biologic Non-naïve,53,Male,29.031141869,48.501026694,Yes,8.4,6,Never,Yes,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,12,3,15,1,31.666666667,18,20,3,3,0,21,No,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,103,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.7,0,0,0,0,0,1,1,0,Y,0,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,103-003,Biologic Non-naïve,36,Male,27.412149448,12.596851472,No,7.2,8,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,5,52,2,55,54,30,15,8,7,20,No,No,No,No,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,103,Canada,North America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,0,0,1,0,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,103-004,Biologic Naïve,39,Female,32.587755102,3.65229295,No,6.7,7,Never,No,No,Yes,Yes,Yes,No,No,Yes,1,No,No,No,No,Yes,No,No,3,4.3,7,51,12,48.333333333,32,30,19,9,10,24,Yes,No,Yes,No,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,103,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.9,0,0,0,0,1,1,1,1,Y,-1,0,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,106-001,Biologic Naïve,60,Male,29.031510377,21.349760438,Yes,19.2,10,Never,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,5,15,8,30,48.562,76.666666667,56,30,5,3,2,18,Yes,No,No,No,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,106,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-17,0,0,1,0,0,1,1,0,Y,-10,1,Y,0,0,0,0,1,0,0,0,0,1,1,1,0,No,Y,No
1,106-002,Biologic Naïve,43,Male,27.102040816,22.455852156,No,9.8,1,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,10,2,0,4,11.666666667,6,0,9,7,2,21,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,106,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,106-003,Biologic Naïve,68,Female,34.484157572,3.7234770705,No,11.9,17,Never,Yes,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,2,5,8,0,4.571,83.333333333,86,40,22,13,9,25,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,106,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-11,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,106-004,Biologic Naïve,38,Female,29.017447199,17.130732375,No,10,4,Former,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,8,1,1,0,8.3333333333,2,0,3,3,0,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,106,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-4,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,106-005,Biologic Naïve,38,Female,25.556539279,7.2388774812,No,14.8,16,Never,No,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,8,7,0,0,71.666666667,54,60,26,15,11,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,106,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.4,0,0,1,0,0,1,1,0,Y,-9,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,106-006,Biologic Naïve,56,Female,23.828125,5.993155373,No,2.4,2,Never,No,Yes,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,10,1,14.393,13.742,10,4,10,7.263,3.307,3.956,23.603,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,106,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,,Y,Y,Y,N,N,N,,,,,,,,,,Y,,,N,,0,,0,0,0,0,0,0,0,0,0,0,,N,No
1,106-007,Biologic Naïve,48,Male,28.089010955,13.013004791,No,9.4,10,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,6,2,0,0,33.333333333,22,70,12,7,5,25,No,No,Yes,No,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,106,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,106-008,Biologic Naïve,55,Female,26.397259343,1.954825462,No,6.8,0,Never,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,5,0,0,18.491,3.3333333333,0,0,4,3,1,25,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,106,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,106-009,Biologic Naïve,37,Male,19.955469739,1.9712525667,No,10.4,2,Never,No,No,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,4,15,5,50,8,55,54,30,3,2,1,25,No,No,No,No,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,106,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,106-010,Biologic Naïve,37,Male,28.710479325,3.7152635181,Yes,25.1,8,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,4,20,4,45,0,55,40,20,20,11,9,24,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,106,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-6,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,106-011,Biologic Naïve,24,Male,45.622740704,4.5092402464,No,10,16,Never,Yes,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,12,2,0,59,68.333333333,22,0,14,8,6,21,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,106,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-8.5,0,0,1,0,1,1,1,0,Y,-16,1,Y,0,0,0,0,1,0,0,0,1,1,1,1,0,No,Y,No
1,106-012,Biologic Non-naïve,30,Female,19.753457476,0.5776865161,No,13.4,20,Former,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,12,10,80,0,91.666666667,88,90,29,16,13,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,106,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.5,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,106-013,Biologic Naïve,43,Female,34.649906012,4.9336071184,Yes,10.5,9,Never,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,15,5,37,8,60,52,20,24,12,12,22,No,No,No,Yes,0,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,106,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.5,0,0,1,0,1,1,1,0,Y,-2,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,106-014,Biologic Naïve,35,Male,24.221453287,1.0184804928,Yes,18,22,Former,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,20,5,34,10,80,60,80,26,14,12,22,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,106,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.7,0,1,1,1,1,1,1,1,Y,-22,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,106-015,Biologic Naïve,70,Male,24.307777234,8.9089664613,No,4.7,17,Never,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,5,3,40,49,45,42,50,12,7,5,23,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,106,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.9,0,0,1,1,1,1,1,0,Y,-7,0,Y,0,0,0,0,1,0,0,1,1,1,1,0,0,No,Y,No
1,107-001,Biologic Non-naïve,50,Female,23.387198586,46.978781656,No,3.6,3,Never,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,10,2,7,18.429,28.333333333,16,10,8,7,1,23,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,107,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-2.4,0,0,0,0,1,1,1,1,Y,-2,1,Y,1,1,0,0,0,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,107-002,Biologic Naïve,66,Female,27.439512899,0.9664613279,Yes,0.6,7,Never,Yes,Yes,No,No,Yes,No,No,Yes,2,No,No,No,No,No,Yes,Yes,2,1,7,0,18,35,54,70,24,16,8,22,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,107,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,107-003,Biologic Non-naïve,49,Male,26.579591837,23.65229295,Yes,14.2,27,Never,Yes,Yes,Yes,Yes,No,No,No,No,4,No,No,Yes,No,No,No,No,3,15,10,79,30.13,78.333333333,72,80,31,14,17,24,Yes,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,107,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.8,0,0,1,0,0,1,1,1,Y,-17,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,107-004,Biologic Non-naïve,36,Male,19.160158142,20.566735113,Yes,7.5,24,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,6,73,13.079,63.333333333,48,60,19,11,8,23,Yes,No,No,No,2,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,107,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.3,0,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,107-005,Biologic Non-naïve,30,Male,16.816608997,9.582477755,Yes,13.9,26,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,8,83,49.367,70,76,70,15,6,9,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,107,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.3,0,0,0,0,0,0,1,0,Y,-11,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,109-001,Biologic Naïve,58,Female,25.680524734,11.504449008,No,9.6,12.074,Missing,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,6,0.945,22.349,4,31.592,25.733,5.936,20.334,14.376,5.959,24.624,No,No,No,No,1.291,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,109,Canada,North America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,N,-3,0,0,0,0,0,0,0,0,Y,,,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,109-002,Biologic Non-naïve,69,Female,29.031510377,12.692676249,No,9.6,12.307,Missing,No,No,No,Yes,No,No,No,No,3,No,No,No,No,Yes,No,No,3,6,6.389,58.717,0,39.877,48.959,98.751,20.289,10.837,9.452,21.055,No,No,No,No,0.705,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,109,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-2.4,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,109-003,Biologic Non-naïve,66,Male,27.755102041,10.491444216,No,6.4,9.071,Missing,No,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,6,6.203,24.202,12,75.025,59.024,16.618,10.352,3.452,6.9,22.261,No,No,Yes,No,0.144,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,109,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,Y,N,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,109-004,Biologic Non-naïve,26,Male,29.031510377,10.940451745,No,9.4,17,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,5.353,90,32.636,95,94,60,14,8,6,24,No,No,No,No,1,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,109,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,N,Y,N,Y,N,,,,,,,,,,Y,,,N,,0,,0,0,0,0,0,0,0,0,0,0,,N,No
1,111-001,Biologic Naïve,45,Female,40.178571429,13.859000684,Yes,10.4,28,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,9.5,10,84,25.351,81.666666667,88,90,13,6,7,24,Yes,Yes,Yes,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,111,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.4,1,1,1,1,1,1,1,1,Y,-26,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,111-002,Biologic Non-naïve,50,Male,19.810453336,16.925393566,Yes,4.4,18.799,Missing,No,Yes,Yes,No,No,No,No,No,1,No,No,Yes,No,No,No,No,3,1.8,7.494,30.771,13.406,70.354,63.169,23.059,15.119,9.579,5.54,20.283,No,No,No,Yes,1.135,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,111,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,111-003,Biologic Non-naïve,57,Male,27.067901235,34.001368925,No,6.6,3,Former,No,No,Yes,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,4.9,3,1,19.501,83.333333333,44,0,7,2,5,23,No,No,No,Yes,2,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,111,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-2,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,111-004,Biologic Naïve,37,Female,37.556689342,31.030800821,No,16,17,Never,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,24,8,74,8.661,78.333333333,48,70,18,11,7,25,Yes,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,111,Canada,North America,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,,,,,,,,,,Y,-12,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,111-005,Biologic Non-naïve,29,Female,30.486657383,17.034907598,No,0,3,Current,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,0,0,1,13,7.85,20,16,20,38,20,18,17,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,111,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-1,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,111-006,Biologic Naïve,25,Female,43.283525914,3.0362765229,No,13.5,15,Never,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,9.6,7,49,1.928,53.333333333,18,40,20,14,6,24,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,111,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-13,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,111-007,Biologic Naïve,54,Female,29.017447199,54.242299795,No,11.4,12,Never,Yes,No,Yes,No,No,No,No,No,1,No,Yes,No,No,No,No,No,4,13,8,24,0,56.666666667,34,30,20,13,7,23,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,111,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,1,1,1,1,1,1,1,1,Y,-9,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,111-008,Biologic Naïve,55,Male,43.958288537,10.091718001,No,22.2,24,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,5,23,1,34,16,23.333333333,24,40,10,4,6,25,No,No,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,111,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-24,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,111-009,Biologic Naïve,48,Female,42.598077001,34.108145106,Yes,14.4,18,Current,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,10,8,90,30,95,92,50,18,10,8,24,No,Yes,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,111,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-15,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,111-010,Biologic Non-naïve,54,Female,43.438500229,27.12936345,Yes,11.6,16.713,Missing,Yes,Yes,No,Yes,No,No,No,No,3,Yes,No,No,No,No,Yes,No,4,9,2.41,17.53,0,11.089,6.529,51.808,21.251,11.433,9.817,24.572,No,No,Yes,No,0.842,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,111,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,111-011,Biologic Non-naïve,45,Male,32.548000836,26.149212868,Yes,4.7,4,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,5,2,2,0,33.333333333,14,10,9,5,4,24,No,No,No,No,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,111,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.7,1,1,1,1,1,1,1,1,Y,1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,111-012,Biologic Naïve,39,Male,28.026586665,7.3319644079,Yes,5.9,5,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,5,4,11,0,30,26,20,8,6,2,24,No,Yes,No,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,111,Canada,North America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,112-001,Biologic Non-naïve,54,Female,26.669612423,37.801505818,Yes,10.8,13,Former,Yes,No,No,Yes,No,No,No,No,4,Yes,No,No,No,Yes,Yes,No,3,10,7,23,9,43.333333333,28,30,13,9,4,23,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,112,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.4,0,0,0,0,0,0,1,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,112-002,Biologic Naïve,33,Male,27.395918367,9.5550992471,No,12,15,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,0,63,1,51.666666667,36,80,6,5,1,25,Yes,Yes,No,No,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,112,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,112-003,Biologic Naïve,40,Female,28.984375,10.715947981,No,6,1,Former,No,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,6,1,4,0,11.666666667,6,0,19,16,3,20,Yes,Yes,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,112,Canada,North America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,112-004,Biologic Naïve,50,Female,25.648917616,13.87816564,No,13.8,25,Former,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,16,9,94,9,95,100,80,24,12,12,24,Yes,Yes,No,Yes,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,112,Canada,North America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-18,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,115-001,Biologic Naïve,42,Male,34.881299459,21.790554415,No,18.3,10,Current,No,Yes,No,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,35,5.094,24,6,50,32,30,9,5,4,22,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,115,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.4,0,1,1,1,1,1,1,1,Y,-6,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,115-002,Biologic Non-naïve,65,Female,22.1484375,1.2320328542,Yes,26.1,25,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,21.321860465,9,79,27,80,80,90,19,9,10,25,No,No,Yes,No,0,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,115,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.5,0,1,1,0,0,1,1,1,Y,-9,0,Y,0,1,0,0,1,1,0,0,0,1,1,0,0,Yes,Y,Yes
1,115-003,Biologic Naïve,47,Male,26.14706701,14.116358658,No,23.4,6,Never,No,Yes,Yes,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,21.321860465,1,0,0,8.3333333333,4,0,10,6,4,21,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,115,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.7,0,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,115-004,Biologic Naïve,19,Male,25.079387325,1.1225188227,No,27,2,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,21.321860465,4,25,0,15,30,0,9,8,1,23,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,115,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.6,0,0,1,0,0,0,0,0,Y,2,0,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,115-005,Biologic Naïve,52,Female,21.875,4.7008898015,No,31.2,2,Former,Yes,Yes,No,Yes,Yes,No,No,Yes,2,No,No,No,No,No,No,Yes,3,21.321860465,6,18,40.285,51.666666667,46,20,21,16,5,23,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,115,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.8,0,0,1,0,0,0,0,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,115-006,Biologic Naïve,20,Female,18.366863905,13.801505818,No,18.6,15,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,33,7,69,0,68.333333333,58,70,23,15,8,23,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,115,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.4,0,1,1,1,1,1,1,1,Y,-12,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,115-007,Biologic Non-naïve,57,Male,31.581035509,9.4428473648,Yes,30.6,4,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,58,3,20,0,40,16,0,0,0,0,25,Yes,No,Yes,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,115,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.6,0,1,1,0,0,1,1,1,Y,-4,1,Y,0,1,0,0,1,1,0,0,0,1,1,1,0,Yes,Y,Yes
1,115-008,Biologic Non-naïve,23,Male,31.366649808,18.466803559,No,25.2,13,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,44,3,24,0,53.333333333,16,20,9,7,2,22,Yes,No,No,Yes,3,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,115,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,115-009,Biologic Naïve,21,Male,23.308564183,1.5770020534,No,29.4,4,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,40,3,5,0,36.666666667,14,20,0,0,0,25,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,115,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-29.4,1,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,115-010,Biologic Naïve,55,Male,43.529253725,20.503764545,No,27.3,12,Former,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,3,30,7,57,0,71.666666667,66,60,20,10,10,24,Yes,No,Yes,No,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,115,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.5,0,0,1,0,0,0,1,0,Y,-7,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,116-001,Biologic Naïve,56,Male,36.28288607,30.056125941,No,15.6,2,Former,Yes,Yes,No,Yes,Yes,No,No,Yes,4,No,No,No,No,Yes,Yes,Yes,4,15,1.915,50,12,26.666666667,36,20,13,9,4,24,Yes,No,No,Yes,2,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,116,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.9,0,0,1,0,0,1,1,1,Y,-1,1,Y,1,1,0,0,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,116-002,Biologic Non-naïve,52,Male,28.015537744,24.232717317,Yes,9.7,6,Never,No,No,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,3,16,4.395,23,0,46.666666667,26,30,14,7,7,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,116,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.5,0,0,1,0,1,1,1,1,Y,-3,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,116-003,Biologic Non-naïve,61,Male,31.248979592,14.269678303,No,19.5,10,Former,Yes,No,No,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,5,12,4.595,24,30,58.333333333,52,0,15,9,6,21,Yes,Yes,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,116,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.6,0,0,1,0,0,1,1,0,Y,-6,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,116-004,Biologic Naïve,26,Male,25.494276795,6.4503764545,No,1.8,2,Never,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,1,6.274,3,0,25,14,10,0,0,0,24,Yes,Yes,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,116,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,116-005,Biologic Non-naïve,56,Female,38.125,40.369609856,Yes,10.8,14,Never,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,12,5,35,0,43.333333333,36,50,11,7,4,24,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,116,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.1,0,0,1,0,0,1,1,0,Y,-13,1,Y,0,0,0,0,1,0,0,0,0,1,1,1,0,No,Y,No
1,116-006,Biologic Naïve,72,Female,45.875180913,52.399726215,No,14.5,14,Never,Yes,Yes,Yes,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,4,10,10,99,0,93.333333333,84,50,6,3,3,25,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,116,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.4,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,116-007,Biologic Naïve,35,Male,33.357854233,7.7125256674,Yes,17.3,8,Former,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,13,7,67,45,83.333333333,60,0,5,2,3,25,Yes,Yes,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,116,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.3,1,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,116-008,Biologic Non-naïve,74,Male,29.651527367,44.750171116,Yes,4.8,4,Never,No,No,No,Yes,No,No,No,No,7,Yes,No,No,No,Yes,Yes,No,3,21.321860465,2,5,0,16.666666667,6,10,9,6,3,25,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,116,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,116-009,Biologic Naïve,67,Male,25.859237362,31.846680356,Yes,17.8,14,Current,No,No,No,Yes,Yes,No,No,Yes,4,Yes,No,No,No,Yes,Yes,No,4,21.321860465,9,75,20,83.333333333,84,0,4,4,0,25,Yes,No,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,116,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.7,0,0,0,0,0,0,0,0,Y,-12,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,116-010,Biologic Non-naïve,39,Female,29.949702789,3.1567419576,Yes,8.4,29,Former,No,No,No,Yes,Yes,No,No,Yes,1,No,No,Yes,No,No,No,No,3,10,7,95,2,63.333333333,78,60,23,15,8,20,Yes,Yes,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,116,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,2.8,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,116-011,Biologic Naïve,61,Male,30.457013003,35.093771389,No,15.3,11,Current,Yes,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,5,16,7,38,31,41.666666667,32,30,19,6,13,25,Yes,No,Yes,No,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,116,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.1,0,1,1,0,1,1,1,1,Y,-10,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,116-012,Biologic Naïve,52,Male,29.249528233,25.535934292,Yes,7.6,19,Former,No,Yes,No,Yes,No,No,No,No,3,No,No,No,No,Yes,No,Yes,3,10,9,94,5,91.666666667,78,60,13,5,8,24,Yes,Yes,Yes,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,116,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.6,1,1,1,1,1,1,1,1,Y,-19,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,116-013,Biologic Naïve,61,Male,25.714112786,12.405201916,No,11.4,26,Current,No,No,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,15,8,85,2,80,70,30,2,1,1,25,No,Yes,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,116,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,1,1,1,1,1,1,1,1,Y,-25,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,116-014,Biologic Non-naïve,53,Female,28.391331141,39.104722793,No,0.9,0,Never,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,2,0.5,1,15,0,18.333333333,12,10,13,8,5,20,No,No,No,No,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,116,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,2.2,0,0,0,0,0,0,1,1,Y,0,,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,116-015,Biologic Naïve,50,Male,40.00594884,18.239561944,No,14.8,11,Never,Yes,Yes,No,Yes,Yes,No,No,Yes,6,Yes,No,No,Yes,Yes,Yes,No,3,19,7,70,0,51.666666667,54,70,13,6,7,25,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,116,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,1,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,116-016,Biologic Naïve,68,Male,35.087417549,17.379876797,No,11.4,6,Never,No,Yes,No,Yes,Yes,No,No,Yes,6,Yes,No,No,Yes,Yes,Yes,No,3,11,5,87,23,73.333333333,74,30,18,11,7,21,No,Yes,Yes,No,3,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,116,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,116-017,Biologic Naïve,58,Female,22.744353467,28.41889117,No,18,14,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,11,8,98,12,76.666666667,78,20,12,10,2,23,Yes,Yes,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,116,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,-11,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,117-001,Biologic Non-naïve,68,Male,27.33477188,16.344969199,Yes,4,0,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,3,0,2,16,5,2,0,6,4,2,24,No,No,Yes,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,117,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,1,1,1,1,1,1,1,1,Y,2,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,117-002,Biologic Non-naïve,48,Female,27.752877479,9.9520876112,No,7.6,9,Never,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,6.8,0,0,12.596,11.666666667,12,20,10,4,6,25,No,Yes,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,117,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.9,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,118-001,Biologic Non-naïve,54,Male,27.367313275,34.283367556,Yes,17.1,6,Former,No,No,Yes,Yes,No,No,No,No,2,No,Yes,No,No,No,No,No,4,14,7,32,27,81.666666667,58,0,16,11,5,24,Yes,Yes,Yes,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.3,0,0,1,0,1,1,1,0,Y,-5,1,Y,0,0,0,0,1,0,0,0,1,1,1,1,0,No,Y,No
1,118-002,Biologic Naïve,64,Male,37.715476915,4.9034907598,No,17.4,13,Current,Yes,Yes,Yes,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,26,10,80,54,100,100,70,4,2,2,25,No,No,Yes,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-9.6,0,0,0,0,0,0,0,0,Y,-4,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,118-003,Biologic Non-naïve,36,Female,34.615929705,28.906228611,Yes,12.8,8,Never,No,Yes,No,No,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,3,35,7,42,12,56.666666667,50,50,20,14,6,23,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.8,1,1,1,1,1,1,1,1,Y,-3,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-004,Biologic Non-naïve,42,Male,45.577024036,28.585900068,Yes,49.8,8,Current,No,Yes,Yes,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,No,No,5,72,7,21,50,50,50,60,17,9,8,21,No,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.6,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,118-005,Biologic Non-naïve,31,Male,46.335486745,11.674195756,No,34,22,Never,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,5,77,8,88,20,76.666666667,50,70,3,2,1,24,Yes,No,Yes,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-30.6,0,1,1,0,0,0,1,1,Y,,,Y,0,1,0,0,1,1,0,0,0,0,1,0,0,Yes,Y,Yes
1,118-006,Biologic Naïve,77,Male,27.777777778,10.704996578,Yes,12.8,5,Former,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,No,Yes,3,11,8,37,0,73.333333333,44,40,19,9,10,24,Yes,No,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.6,0,0,0,0,0,0,0,0,Y,1,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,118-007,Biologic Non-naïve,41,Female,35.463059313,18.726899384,No,14.4,7,Never,Yes,No,Yes,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,4,24,7,75,0,58.333333333,58,50,11,4,7,24,Yes,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,118-008,Biologic Naïve,78,Male,28.514145689,36.618754278,No,19.2,7,Former,No,Yes,Yes,Yes,No,No,No,No,7,No,No,No,No,No,Yes,No,3,19,4,0,0,35,12,10,9,7,2,20,Yes,No,No,Yes,4,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,118-009,Biologic Naïve,50,Male,25.687358277,16.73100616,No,27,6,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,26,8,85,0,58.333333333,60,0,2,2,0,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.2,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,118-010,Biologic Non-naïve,50,Female,27.625361988,34.740588638,No,11,14,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,14,7,65,0,73.333333333,56,20,16,10,6,24,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11,1,1,1,1,1,1,1,1,Y,-12,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-011,Biologic Non-naïve,67,Female,33.24099723,6.7515400411,Yes,1.2,5,Former,Yes,No,No,Yes,No,No,No,No,6,No,No,No,Yes,Yes,Yes,No,3,1.5,7,50,33,38.333333333,60,0,5,4,1,25,No,No,Yes,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,0,0,0,1,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,118-012,Biologic Non-naïve,32,Female,28.13365651,20.76386037,Yes,21.6,21,Never,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,19,9,61,0,95,90,70,18,9,9,17,Yes,Yes,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,N,,,,,,,,,,Y,-21,1,N,,0,,0,0,0,0,0,0,0,0,1,0,,N,No
1,118-013,Biologic Non-naïve,63,Female,22.432302516,11.778234086,Yes,15.2,16,Current,No,Yes,Yes,Yes,Yes,No,No,Yes,1,No,No,No,No,No,Yes,No,3,17,8,55,19,75,76,90,17,7,10,24,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.8,0,0,1,0,0,0,1,0,N,7,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,118-014,Biologic Non-naïve,52,Male,32.716049383,16.824093087,Yes,4.8,17,Former,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,8,8,25,0,55,62,80,19,9,10,23,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-015,Biologic Non-naïve,51,Female,37.922900057,50.828199863,Yes,9.4,4,Never,No,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,3,10,7,70,0,58.333333333,42,20,8,6,2,24,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.8,0,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,118-016,Biologic Non-naïve,35,Male,26.511804065,1.015742642,No,3.6,5,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,1.5,5,6,0,28.333333333,26,0,2,1,1,25,No,No,No,No,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-017,Biologic Naïve,68,Male,28.055705787,9.9192334018,Yes,11.4,6,Never,No,No,Yes,Yes,No,No,No,No,3,No,No,No,No,No,Yes,No,3,13,2.65,12,0,70,40,30,2,2,0,17,Yes,Yes,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,1,1,1,1,1,1,1,1,Y,-4,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-018,Biologic Naïve,45,Female,24.835646457,2.932238193,No,9.9,23,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,4.816,30,0,45,48,70,18,9,9,24,No,Yes,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-11,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,118-019,Biologic Non-naïve,47,Male,32.467268935,14.940451745,No,2.8,7,Former,Yes,No,No,No,No,No,No,No,2,No,Yes,No,No,Yes,No,No,3,2,3.034,53,0,71.666666667,66,10,8,7,1,24,No,No,No,No,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.6,0,0,0,0,1,1,1,0,Y,2,0,Y,0,0,0,0,0,0,0,0,1,1,1,0,0,No,Y,No
1,118-020,Biologic Non-naïve,40,Male,22.945335185,15.950718686,No,10,29,Former,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,17,8.517,98,0,100,100,80,27,17,10,25,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10,1,1,1,1,1,1,1,1,Y,-22,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-021,Biologic Naïve,46,Male,29.100346021,14.951403149,No,18.5,12,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,27,9.179,76,9,81.666666667,64,20,13,11,2,17,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.5,0,0,0,0,0,0,0,0,Y,-6,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,118-022,Biologic Non-naïve,70,Female,30.673677793,34.028747433,Yes,8.4,10,Current,No,Yes,No,Yes,Yes,No,No,Yes,3,No,No,No,No,No,Yes,No,3,10,4.919,37,0,58.333333333,42,40,16,11,5,25,No,No,Yes,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.9,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,118-023,Biologic Naïve,34,Male,42.103377228,1.7467488022,No,12.6,15,Never,Yes,No,No,Yes,No,No,No,No,5,No,No,No,Yes,Yes,Yes,No,3,14,9.586,75,0,71.666666667,76,40,9,6,3,24,Yes,No,No,Yes,2,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,0,0,1,0,0,1,1,0,Y,-4,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,118-024,Biologic Non-naïve,26,Male,33.902662994,9.1088295688,No,19.2,10,Never,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,37,3.658,35,40,41.666666667,14,50,7,4,3,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.2,1,1,1,1,1,1,1,1,Y,-10,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,118-025,Biologic Non-naïve,62,Female,30.043262298,10.280629706,Yes,17.5,13,Never,No,Yes,No,Yes,No,No,No,No,3,No,No,No,No,Yes,No,Yes,4,12,8.787,62,6,71.666666667,60,70,24,16,8,24,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.5,1,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,118-026,Biologic Non-naïve,53,Female,40.057683064,13.051334702,No,5.2,8,Never,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,6,5.935,20,0,38.333333333,26,40,10,6,4,25,Yes,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2,0,0,0,0,0,0,1,0,Y,-5,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,118-027,Biologic Non-naïve,55,Male,47.617594091,20.303901437,No,25.2,9,Current,No,No,Yes,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,Yes,No,5,22,2.09,1,0,56.666666667,28,20,18,8,10,22,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.4,0,0,1,0,0,0,1,0,Y,-8,1,Y,0,0,0,0,1,0,0,0,0,0,1,1,0,No,Y,No
1,118-028,Biologic Non-naïve,33,Female,40.2695595,19.23613963,Yes,1.2,1,Never,Yes,No,Yes,Yes,No,No,No,No,2,No,Yes,No,No,Yes,No,No,2,2,0.18,5,0,8.3333333333,10,0,5,2,3,24,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.2,1,1,1,1,1,1,1,1,Y,2,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-029,Biologic Non-naïve,31,Male,33.836451247,11.162217659,No,16.2,7,Current,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,20,6.047,67,0,65,54,60,23,13,10,23,Yes,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.2,1,1,1,1,1,1,1,1,Y,-1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-030,Biologic Naïve,46,Female,45.754598136,11.167693361,No,16.9,8,Never,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,25,7.775,3,0,81.666666667,60,0,8,6,2,24,Yes,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,0,1,1,1,1,1,1,1,Y,,,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,118-031,Biologic Non-naïve,33,Male,30.863035869,6.3518138261,No,17.4,9,Former,No,No,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,4,23,6,51,0,76.666666667,48,20,10,7,3,21,No,No,No,Yes,3,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-032,Biologic Non-naïve,59,Female,28.033591626,8.1889117043,No,17.4,24,Current,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,4,11,6.04,61,0,56.666666667,68,70,28,13,15,19,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-15,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,118-033,Biologic Non-naïve,43,Male,33.910034602,18.455852156,Yes,9,1,Never,Yes,Yes,No,Yes,Yes,Yes,No,No,6,Yes,No,No,No,Yes,Yes,No,3,7,5.694,19,0,30,20,0,0,0,0,24,Yes,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,1,1,1,1,1,1,1,1,Y,-1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-034,Biologic Non-naïve,60,Male,27.345679012,15.47980835,No,12.9,13,Never,No,No,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,19,4.551,67,0,65,38,30,25,13,12,20,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-9,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,118-035,Biologic Naïve,44,Male,29.065743945,20.350444901,No,13.8,19,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,25,8,89,0,65,48,60,18,11,7,21,Yes,No,Yes,Yes,3,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.8,1,1,1,1,1,1,1,1,Y,-18,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,118-036,Biologic Naïve,61,Male,24.485652005,15.386721424,Yes,11.1,11,Current,No,Yes,No,Yes,Yes,No,No,Yes,3,No,No,No,No,Yes,Yes,No,4,6,2,24,23,55,30,20,10,6,4,22,Yes,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.1,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-037,Biologic Naïve,58,Female,63.69165023,16.399726215,No,11.2,6,Never,Yes,Yes,No,Yes,No,No,No,No,9,No,No,No,Yes,Yes,Yes,No,3,16,6,60,0,75,68,30,2,0,2,24,Yes,No,No,Yes,0,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.2,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,118-038,Biologic Non-naïve,68,Female,34.285714286,14.406570842,Yes,27.9,18,Never,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,18,4,80.052,0,98.333333333,92,90,15,9,6,22.303,Yes,No,Yes,Yes,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25.5,0,1,1,0,0,1,1,1,Y,,,Y,0,1,0,0,1,1,0,0,0,1,1,0,0,Yes,Y,Yes
1,118-040,Biologic Naïve,35,Female,29.752066116,11.425051335,No,21.8,26,Never,No,No,Yes,No,Yes,No,Yes,No,1,No,No,No,No,Yes,No,No,4,32,7,89,22,90,94,100,23,12,11,22,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.8,1,1,1,1,1,1,1,1,Y,-24,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-041,Biologic Non-naïve,57,Male,27.143037495,44.459958932,No,7.2,1,Never,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,4,3,9,0,20,4,0,12,8,4,23,No,No,No,No,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-4.8,0,0,0,0,0,1,1,1,Y,,,Y,1,1,1,1,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,118-042,Biologic Non-naïve,48,Female,30.818540434,24.476386037,No,3.6,6,Never,Yes,Yes,No,No,Yes,No,No,Yes,3,Yes,No,No,Yes,Yes,No,No,3,2,2,15,0,43.333333333,24,0,25,12,13,25,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,0,0,0,0,1,1,1,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,1,1,1,0,0,No,Y,No
1,118-043,Biologic Naïve,32,Male,30.795847751,8.4845995893,Yes,25.9,25,Never,No,No,No,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,Yes,No,4,20,9,70,0,76.666666667,46,80,26,16,10,24,Yes,Yes,Yes,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.7,0,1,1,0,1,1,1,1,Y,-18,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,118-044,Biologic Non-naïve,51,Female,27.548209366,33.483915127,No,5.1,12,Current,Yes,Yes,Yes,No,No,No,No,No,4,No,No,No,No,Yes,Yes,Yes,3,5.5,4,13,0,28.333333333,22,10,27,12,15,21,No,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-2,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,118-045,Biologic Non-naïve,56,Male,38.159642555,23.488021903,No,9.2,5,Former,No,Yes,No,Yes,Yes,No,No,Yes,5,No,No,No,Yes,Yes,Yes,No,3,11,4,13,0,36.666666667,14,0,12,8,4,25,No,No,No,No,3,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5,0,0,0,0,0,0,1,1,Y,0,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,118-046,Biologic Non-naïve,38,Female,24.909732646,28.574948665,Yes,9.4,1,Never,Yes,No,No,No,No,No,No,No,1,No,No,No,No,No,No,No,2,6,2,6,0,23.333333333,12,0,17,9,8,21,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,118-047,Biologic Naïve,47,Male,43.854685378,29.612594114,Yes,19.2,11.809,Former,Yes,Yes,Yes,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,Yes,No,3,34,7,35.791,0,46.666666667,40,20,10.017,6.357,3.66,21.957,Yes,Yes,No,Yes,0.961,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,118-048,Biologic Naïve,46,Male,26.511804065,3.6194387406,No,6.1,8,Never,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,No,No,3,9,7,14,0,70,36,0,16,11,5,23,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,8.9,0,0,0,0,0,0,0,0,Y,3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,118-049,Biologic Naïve,34,Male,25.099501596,16.668035592,No,30,12,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,48,6,15,40,51.666666667,24,20,21,11,10,23,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-30,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-050,Biologic Naïve,61,Male,30.718336484,41.697467488,No,5.2,5,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,5,1,100,0,68.333333333,72,30,12,6,6,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.4,0,0,0,0,0,0,1,0,Y,0,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,118-051,Biologic Non-naïve,37,Male,24.914285714,25.823408624,No,14.4,2,Never,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,13,4,12,0,55,44,0,7,5,2,22,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.1,0,0,1,0,0,0,1,0,Y,2,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,118-052,Biologic Naïve,28,Male,35.012779665,1.8288843258,No,28.2,9,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,5,23,7,63,0,73.333333333,56,0,7,4,3,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.2,1,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-053,Biologic Non-naïve,49,Male,55.886195384,29.859000684,No,32.4,13,Current,No,Yes,Yes,Yes,No,No,No,No,7,No,No,No,Yes,Yes,No,No,5,31,7,79,0,86.666666667,48,70,3,0,3,24,No,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,118-054,Biologic Non-naïve,30,Male,50.814291125,20.87063655,No,11.4,2,Never,Yes,No,No,Yes,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,3,14,4,8,0,45,22,0,4,4,0,21,No,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,0,0,0,0,0,0,0,0,Y,3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,118-055,Biologic Naïve,34,Female,30.4833793,6.8692676249,No,12.6,4,Never,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,14,10,15,0,56.666666667,42,0,18,8,10,23,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-056,Biologic Naïve,64,Female,28.577960677,3.8795345654,No,15.2,14,Never,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,11,8,38,0,93.333333333,88,50,14,10,4,22,No,Yes,No,Yes,2,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.2,1,1,1,1,1,1,1,1,Y,-12,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-057,Biologic Naïve,48,Male,32.132963989,1.8863791923,No,8.4,10,Former,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,5,7,37,0,61.666666667,58,0,1,1,0,25,No,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.8,0,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,118-058,Biologic Naïve,38,Male,29.411764706,18.918548939,No,6.9,12,Former,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,2,5,8,86,0,68.333333333,68,30,8,4,4,20,No,No,No,Yes,2,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-11,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,118-059,Biologic Non-naïve,44,Male,42.292639818,3.9397672827,No,12,20,Current,No,No,No,Yes,Yes,No,No,Yes,4,Yes,No,No,Yes,Yes,No,No,3,9,7,75,0,80,72,80,17,12,5,24,Yes,No,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-060,Biologic Naïve,63,Male,27.331350864,2.7843942505,Yes,2.4,0,Never,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,3,2.3,0,2,0,11.666666667,4,0,5,4,1,25,Yes,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.4,1,1,1,1,1,1,1,1,Y,8,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-061,Biologic Non-naïve,41,Female,23.564013841,5.015742642,No,10.8,1,Never,Yes,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,Yes,No,3,7,0,16,0,18.333333333,12,30,1,1,0,24,No,No,Yes,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,0,0,0,0,0,0,1,0,Y,0,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,118-062,Biologic Naïve,43,Male,27.578282103,10.020533881,No,17.6,11,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,19,8,0,0,66.666666667,32,0,3,3,0,25,No,No,Yes,Yes,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-063,Biologic Non-naïve,38,Male,38.15512347,20.041067762,No,18,12,Never,No,No,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,17,7,0,0,66.666666667,70,30,11,6,5,24,No,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-064,Biologic Naïve,46,Male,24.79338843,20.117727584,No,14.7,9,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,11,7,79,0,83.333333333,72,0,4,3,1,17,No,No,No,Yes,2,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-8,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,118-065,Biologic Naïve,38,Male,33.510445598,6.2997946612,No,17.2,6,Former,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,10,9,45,0,70,44,20,11,6,5,20,Yes,No,No,Yes,4,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-17.2,1,1,1,1,1,1,1,1,Y,6,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-066,Biologic Naïve,32,Male,28.30449827,12.224503765,No,15.9,15,Former,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,29,9,35,0,71.666666667,30,30,16,12,4,24,Yes,No,No,No,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-067,Biologic Naïve,33,Male,23.836734694,8.4791238877,Yes,18,20,Never,Yes,No,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,32,4,33,0,43.333333333,24,40,8,3,5,24,Yes,No,No,Yes,4,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,-9,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-068,Biologic Non-naïve,60,Male,31.5234375,12.501026694,No,11.4,3,Former,No,No,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,No,No,3,14,2,11,0,53.333333333,12,20,15,7,8,24,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.9,0,0,1,0,1,1,1,1,Y,0,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,118-069,Biologic Naïve,38,Male,31.25,12.569472964,No,18.6,13,Former,No,Yes,Yes,No,No,No,No,No,3,No,No,No,Yes,No,Yes,No,4,19,3,40,0,46.666666667,42,50,12,8,4,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.6,1,1,1,1,1,1,1,1,Y,-10,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-070,Biologic Naïve,32,Female,34.894398531,5.5715263518,Yes,14.9,23,Former,Yes,No,Yes,Yes,Yes,No,No,Yes,3,Yes,No,No,Yes,Yes,No,No,3,27,3,2,0,63.333333333,34,50,24,10,14,25,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.9,1,1,1,1,1,1,1,1,Y,-22,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,118-071,Biologic Naïve,54,Male,32.007315958,1.4291581109,No,33.6,13,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,5,32,8,85,0,76.666666667,56,10,8,4,4,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-33.6,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-072,Biologic Naïve,28,Male,27.099251007,20.594113621,Yes,64.8,26,Current,Yes,No,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,5,87,8,44,0,78.333333333,72,80,28,13,15,23,Yes,No,No,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-64.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-073,Biologic Naïve,47,Male,30.299204646,15.663244353,No,17.8,9,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,2,12,0,33.333333333,16,0,4,4,0,21,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16,0,0,1,0,1,1,1,0,Y,-8,1,Y,0,0,0,0,1,0,0,0,1,1,1,1,0,No,Y,No
1,118-074,Biologic Naïve,21,Female,28.577960677,13.672826831,No,14.4,14,Never,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,16,4,10,0,33.333333333,14,10,7,6,1,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.8,0,1,1,1,1,1,1,1,Y,-9,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,118-075,Biologic Naïve,32,Male,29.377582645,0.4271047228,No,26,6,Never,Yes,No,No,No,Yes,Yes,No,No,0,No,No,No,No,No,No,No,4,53,2,7,0,15,8,20,16,8,8,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26,1,1,1,1,1,1,1,1,Y,2,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-076,Biologic Non-naïve,30,Male,25.794380033,14.71321013,No,15,21,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,16,5,63,0,55,64,40,21,12,9,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-077,Biologic Naïve,53,Male,25.963047941,30.729637235,Yes,18.6,9,Never,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,15,3,5,0,40,12,30,15,7,8,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.6,1,1,1,1,1,1,1,1,Y,-9,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,118-078,Biologic Naïve,29,Female,20.202020202,21.04312115,No,18.6,20.408,Never,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,27,8,52.503,0,86.666666667,82,90,7.159,4.522,2.636,23.809,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-079,Biologic Naïve,49,Female,19.467401286,25.859000684,No,12,5,Never,No,Yes,Yes,Yes,Yes,Yes,No,No,1,Yes,No,No,No,No,No,No,3,10,3,0,0,16.666666667,10,0,9,6,3,21,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-080,Biologic Naïve,53,Female,27.548209366,19.885010267,No,2.7,5,Former,No,Yes,No,Yes,Yes,No,No,Yes,4,Yes,No,No,Yes,Yes,No,No,3,3.5,2,16,0,23.333333333,6,0,12,10,2,21,Yes,No,No,No,1,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.7,1,1,1,1,1,1,1,1,Y,2,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-081,Biologic Naïve,33,Male,39.183673469,13.894592745,No,24.4,12,Former,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,29,6,48,0,60,66,20,9,6,3,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.2,0,1,1,0,1,1,1,1,Y,,,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,118-082,Biologic Naïve,33,Male,30.045913682,30.981519507,No,23,27,Never,Yes,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,36,8,86,0,71.666666667,64,100,31,16,15,11,Yes,No,No,Yes,4,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.8,0,1,1,0,1,1,1,1,Y,-24,0,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,118-083,Biologic Naïve,53,Female,27.750865052,22.335386721,No,12,7,Never,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,12,5,14,0,60,40,10,14,10,4,24,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-084,Biologic Naïve,66,Female,36.089965398,12.999315537,No,19.8,9,Never,Yes,No,No,Yes,Yes,No,No,Yes,2,No,No,No,No,Yes,No,No,4,18,0,0,0,56.666666667,54,60,9,5,4,23,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.4,0,0,1,0,0,1,1,0,Y,1,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,118-085,Biologic Naïve,48,Female,34.285714286,2.7077344285,No,15,24,Former,Yes,Yes,No,Yes,No,No,No,No,3,No,Yes,No,Yes,Yes,No,No,3,12,7,62,0,61.666666667,56,60,3,2,1,23,Yes,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.8,0,1,1,0,1,1,1,1,Y,-13,0,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,118-086,Biologic Naïve,50,Male,39.85025963,34.710472279,No,12.6,11,Never,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,13,8,0,0,60,50,50,13,11,2,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-087,Biologic Naïve,35,Male,29.041820221,4.0492813142,No,18,16,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,16,10,75,0,86.666666667,68,40,12,7,5,23,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,-11,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-088,Biologic Non-naïve,34,Male,23.148148148,21.108829569,No,18.6,15,Never,Yes,No,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,13,7,49,100,85,52,50,13,7,6,24,Yes,No,No,Yes,1,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-18.6,1,1,1,1,1,1,1,1,Y,-12,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-089,Biologic Naïve,40,Male,27.099251007,5.9055441478,No,21.6,10,Never,No,No,No,Yes,Yes,No,No,Yes,6,Yes,No,No,No,No,Yes,No,4,21,8,79,0,78.333333333,72,10,9,7,2,21,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-090,Biologic Naïve,21,Male,25.864512472,15.148528405,No,18.3,6,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,1,18,0,60,10,0,11,7,4,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.3,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,118-091,Biologic Naïve,51,Male,28.626436056,8.1505817933,No,30,16.439,Missing,No,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,5,30,8.818,29.913,0,92.684,75.359,76.112,12.415,5.005,7.41,24.351,No,No,No,Yes,2.144,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-30,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-092,Biologic Naïve,32,Female,41.015625,8.1916495551,No,20.7,23,Current,Yes,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,31,8,69,0,70,72,70,23,15,8,11,Yes,Yes,Yes,Yes,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.7,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-093,Biologic Naïve,32,Male,22.204081633,7.2032854209,No,24,9,Never,Yes,No,Yes,No,Yes,No,Yes,Yes,0,No,No,No,No,No,No,No,4,21,0,35,0,81.666666667,62,10,27,18,9,19,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24,1,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-094,Biologic Naïve,27,Male,29.263340201,3.2498288843,No,18.5,19,Current,No,No,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,4,25,8,75,0,93.333333333,84,70,29,19,10,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-095,Biologic Naïve,28,Female,21.410944985,11.279945243,No,41.9,24,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,59,8,81,0,86.666666667,82,80,32,17,15,21,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-39.5,0,1,1,0,0,1,1,1,Y,-5,0,Y,0,1,0,0,1,1,0,0,0,1,1,0,0,Yes,Y,Yes
1,118-096,Biologic Naïve,34,Male,29.983587931,7.2854209446,No,22.9,14,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,30,6,51,0,56.666666667,24,10,9,6,3,25,Yes,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-8,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,118-097,Biologic Naïve,64,Male,25.754323949,26.305270363,No,29.3,20,Former,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,34,8,53,0,78.333333333,34,30,27,15,12,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-29.3,1,1,1,1,1,1,1,1,Y,-20,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,118-098,Biologic Naïve,57,Male,25.259515571,10.305270363,No,31.2,30,Current,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,45,10,98,0,98.333333333,100,100,16,9,7,25,Yes,No,Yes,Yes,0,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-31.2,1,1,1,1,1,1,1,1,Y,-13,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-099,Biologic Naïve,70,Female,29.384756657,13.308692676,No,23.4,12.082,Missing,No,No,Yes,Yes,No,No,No,No,3,Yes,Yes,No,No,No,No,No,4,29,7.672,68.309,0,62.653,73.09,73.833,5.476,2.358,3.118,23.441,No,No,No,Yes,1.414,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-100,Biologic Naïve,52,Male,30.141396288,13.327857632,No,38.4,22,Current,No,No,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,5,42,10,100,0,95,100,70,17,8,9,24,Yes,Yes,No,Yes,2,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-38.4,1,1,1,1,1,1,1,1,Y,-13,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-101,Biologic Naïve,49,Female,17.469387755,33.341546886,No,13.4,6,Former,No,Yes,Yes,Yes,Yes,Yes,Yes,Yes,0,No,No,No,No,No,No,No,3,15,2,18,0,60,20,0,2,2,0,24,Yes,No,No,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.4,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,118-102,Biologic Naïve,37,Male,35.238845988,5.363449692,Yes,12,4,Never,Yes,Yes,No,Yes,Yes,Yes,No,No,3,Yes,No,No,Yes,Yes,No,No,3,15,2,18,0,61.666666667,48,0,8,4,4,21,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-103,Biologic Naïve,62,Male,27.609451755,10.36550308,No,17.4,7.137,Missing,No,Yes,No,Yes,No,No,No,No,3,Yes,No,No,No,Yes,No,No,4,20,5.187,12.134,0,68.768,60.8,33.673,11.153,6.825,4.327,21.09,Yes,No,No,Yes,1.94,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.6,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,118-104,Biologic Non-naïve,26,Male,27.398175682,12.375085558,No,27.9,13,Never,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,28,9,95,0,85,82,60,22,12,10,23,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27,0,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,118-105,Biologic Naïve,43,Male,26.511804065,4.3778234086,No,14.4,16,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,16,10,80,0,93.333333333,76,80,20,11,9,25,Yes,No,No,Yes,3,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.4,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,118-106,Biologic Naïve,43,Female,29.757785467,7.3921971253,No,22.8,17,Current,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,4,36,4,14,0,25,26,60,19,11,8,25,Yes,No,No,Yes,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.8,1,1,1,1,1,1,1,1,Y,-3,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-107,Biologic Naïve,27,Female,21.671258035,15.411362081,No,18.6,23,Never,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,12,6,81,0,78.333333333,72,70,16,14,2,20,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.7,0,1,1,1,1,1,1,1,Y,-10,0,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,118-108,Biologic Non-naïve,77,Male,24.280263614,4.4134154689,No,5.6,14,Current,No,Yes,Yes,Yes,Yes,No,No,Yes,1,Yes,No,No,No,No,No,No,4,6,7,75,0,40,58,70,5,3,2,22,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.4,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,118-109,Biologic Naïve,59,Female,32.8125,23.419575633,No,12.6,12.551,Missing,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,16,4.062,48.867,0,48.364,37.64,37.647,17.86,8.593,9.266,23.366,Yes,No,No,Yes,0.24,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,0,1,1,0,1,1,1,1,Y,,,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,118-110,Biologic Non-naïve,35,Male,21.551020408,27.422313484,No,15.6,4,Never,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,13,5,5,0,20,22,0,4,3,1,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.4,0,1,1,0,1,1,1,1,Y,2,0,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,118-111,Biologic Naïve,31,Male,23.200543232,3.4305270363,No,22.5,4.194,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,30,3.204,54.761,0,62.988,40.825,26.309,6.885,3.553,3.331,18.459,Yes,No,No,Yes,0.425,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,118-112,Biologic Non-naïve,59,Male,27.398175682,27.433264887,Yes,15,0,Current,No,Yes,No,Yes,No,No,No,No,3,No,No,No,No,No,Yes,No,4,19,0,18,0,0,0,0,4,0,4,25,Yes,No,No,Yes,3,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,118-113,Biologic Naïve,40,Male,41.808390023,0.076659822,No,35.1,26,Never,No,No,No,Yes,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,5,32,5,78,0,83.333333333,80,90,19,15,4,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,118,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-35.1,1,1,1,1,1,1,1,1,Y,-24,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,119-001,Biologic Non-naïve,42,Female,44.412661372,4.5859000684,No,3.9,16.944,Missing,No,Yes,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,3,5,4.804,71.725,0,66.012,44.136,57.772,16.782,13.569,3.213,23.93,No,No,No,Yes,2.092,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,119,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,119-002,Biologic Naïve,37,Female,27.548209366,27.293634497,No,42.4,17,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,91,6,37,0,45,44,70,19,10,9,20,Yes,Yes,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,119,Canada,North America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-39.6,0,1,1,0,0,1,1,1,Y,-10,0,Y,1,1,0,0,1,1,0,0,0,1,1,0,1,Yes,Y,Yes
1,119-003,Biologic Non-naïve,66,Male,29.714285714,42.685831622,Yes,9,12.27,Missing,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,6,4.466,63.535,0,83.762,71.545,47.06,15.524,6.044,9.48,22.834,Yes,Yes,No,Yes,0.277,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,119,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,119-004,Biologic Naïve,27,Female,28.981143438,3.7837097878,No,9.2,16.157,Missing,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,10,4.42,51.872,0,25.345,32.604,67.536,13.695,9.613,4.081,20.277,Yes,Yes,No,Yes,0.643,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,119,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,119-005,Biologic Naïve,46,Female,37.886485702,21.330595483,No,9.8,26,Never,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,10,10,95,1.128,93.333333333,94,90,27,13,14,24,Yes,Yes,No,Yes,2,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,119,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,119-006,Biologic Naïve,53,Female,40.837065753,15.370294319,No,13.2,20,Never,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,12,10,97,4,80,94,60,16,5,11,24,Yes,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,119,Canada,North America,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.2,1,1,1,1,1,1,1,1,Y,-20,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,119-007,Biologic Naïve,46,Male,35.643009699,14.759753593,No,17,13,Current,No,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,3,10,6,23,0,80,52,20,14,10,4,25,No,No,Yes,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,119,Canada,North America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17,1,1,1,1,1,1,1,1,Y,-10,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,119-008,Biologic Naïve,49,Male,32.979591837,20.621492129,No,4.3,17.764,Missing,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,2.6,5.902,63.894,0,65.763,35.21,23.368,18.511,12.124,6.387,23.136,Yes,Yes,Yes,No,1.333,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,119,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.3,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,119-009,Biologic Naïve,45,Male,31.541743326,11.611225188,No,14.4,13,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,12,8,74,9.091,66.666666667,68,50,8,7,1,24,No,Yes,Yes,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,119,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.4,0,1,1,1,1,1,1,1,Y,-12,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,119-010,Biologic Naïve,56,Male,23.608163265,31.794661191,No,18,13,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,12,8,74,2.356,63.333333333,72,50,16,9,7,23,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,119,Canada,North America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,,,Y,Y,Y,N,N,Y,-16.8,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,124-001,Biologic Naïve,64,Female,29.031510377,53.440109514,No,5.1,20.652,Missing,Yes,Yes,No,Yes,No,No,No,No,4,No,No,No,No,Yes,Yes,No,3,6,6.6,81.627,9.651,55.367,70.299,55.712,18.318,10.067,8.251,22.89,No,Yes,No,No,1.644,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,124,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,N,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,124-002,Biologic Naïve,39,Male,36.179138729,0.4271047228,No,7.5,27,Never,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,4,5,7.97,68,0,76.666666667,70,80,11,7,4,23,Yes,No,Yes,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,124,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.9,0,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,125-001,Biologic Non-naïve,56,Male,24.270925388,10.650239562,No,17.4,5,Never,Yes,Yes,No,Yes,Yes,No,No,Yes,4,No,No,No,No,No,Yes,No,4,23,8,0,9.088,51.666666667,20,10,2,2,0,24,No,No,No,Yes,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,125,Canada,North America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.9,0,1,1,0,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,125-002,Biologic Non-naïve,57,Male,48.198155064,22.655715264,No,27.6,27,Never,Yes,Yes,No,Yes,Yes,Yes,No,No,2,No,No,No,Yes,Yes,No,No,4,39,7,76,56.269,73.333333333,76,80,27,15,12,23,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,125,Canada,North America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.3,0,0,1,0,0,0,1,1,Y,-15,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,201-001,Biologic Naïve,56,Male,32.77051278,33.021218344,Yes,31.2,16,Never,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,10,4,50,25.048,58.333333333,46,50,21,14,7,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,201,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-29.8,0,1,1,0,1,1,1,1,Y,-6,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,201-002,Biologic Naïve,59,Female,36.484843025,47.345653662,No,19.5,5,Never,Yes,No,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,No,4,36,2,24,8,26.666666667,16,20,9,5,4,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,201,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.7,0,0,1,0,0,0,1,0,Y,0,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,201-003,Biologic Naïve,38,Female,22.308149911,22.368240931,No,24,25,Current,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,47,10,83,9.214,78.333333333,74,90,24,13,11,25,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,201,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24,1,1,1,1,1,1,1,1,Y,-21,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,201-004,Biologic Naïve,61,Male,27.774270925,39.89596167,No,26.5,6.573,Missing,No,No,No,Yes,No,No,No,No,8,No,No,No,No,Yes,Yes,No,4,43,5.787,30.037,13.381,58.901,43.634,32.866,13.167,9.744,3.423,21.665,No,No,No,Yes,0.21,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,201,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,201-005,Biologic Non-naïve,36,Male,24.968009738,18.800821355,No,10.6,17,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,No,No,Yes,No,3,8,8,89,29.515,93.333333333,88,90,7,3,4,25,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,201,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.4,0,0,1,0,1,1,1,1,Y,-14,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,201-006,Biologic Non-naïve,57,Female,27.51338489,9.1745379877,Yes,25.9,21,Current,Yes,No,No,Yes,No,No,No,No,4,Yes,No,No,No,Yes,Yes,No,4,44,8,70,9,78.333333333,76,100,27,16,11,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,201,Argentina,Latin America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.3,0,0,1,0,0,0,1,0,Y,-20,1,Y,0,0,0,0,1,0,0,0,0,0,1,1,0,No,Y,No
1,206-001,Biologic Naïve,72,Male,32.277494331,17.056810404,No,24.8,0,Never,No,Yes,No,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,Yes,No,3,55,0,0,19.67,1.6666666667,2,0,10,3,7,19,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-22.4,0,1,1,0,0,1,1,1,Y,4,,Y,1,1,0,0,1,1,0,0,0,1,1,0,1,Yes,Y,Yes
1,206-002,Biologic Naïve,70,Female,27.475629493,0.2792607803,No,21.1,12,Never,No,No,No,Yes,No,No,No,No,4,Yes,No,No,No,Yes,Yes,No,3,16,6,20,6.671,80,80,80,18,10,8,22,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Other Biologics,Anti TNFs,Infliximab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,N,-21.1,1,1,1,1,1,1,1,1,N,-12,1,N,1,1,1,1,1,1,1,1,1,1,1,1,1,,N,No
1,206-003,Biologic Non-naïve,42,Male,33.078285275,17.130732375,No,7.8,9,Former,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,21.321860465,4,0,6.743,68.333333333,46,70,6,4,2,25,No,No,No,No,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,0,0,0,0,0,0,0,0,0,Y,13,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,206-004,Biologic Naïve,57,Male,26.423569824,10.532511978,No,13.3,8,Former,No,No,Yes,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,21.321860465,3,47,2.688,45,34,30,14,9,5,22,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Other Biologics,Anti TNFs,Infliximab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-12.9,0,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,206-005,Biologic Naïve,32,Male,34.717838657,4.2272416153,No,27.6,7,Former,No,No,Yes,No,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,5,21.321860465,7,0,5.073,20,20,20,10,5,5,24,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-27.6,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,206-006,Biologic Naïve,40,Female,22.038567493,0.900752909,No,34.3,27,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,65,9,90,10.835,98.333333333,98,90,20,12,8,23,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-34.3,1,1,1,1,1,1,1,1,Y,-27,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,206-007,Biologic Naïve,41,Male,30.189590629,4.3613963039,No,6.7,5,Former,No,Yes,No,No,No,No,No,No,4,No,No,No,Yes,Yes,No,No,3,12,2,21,14.958,40,20,10,9,6,3,25,No,No,No,No,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.9,0,0,0,0,0,0,1,1,Y,-4,1,Y,1,1,0,0,0,0,0,0,0,0,1,1,1,Yes,Y,Yes
1,206-008,Biologic Non-naïve,44,Male,33.306122449,3.4633812457,No,11.9,0,Former,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,10,0,2,35.769,0,0,0,8,5,3,22,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.9,1,1,1,1,1,1,1,1,Y,1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,206-009,Biologic Naïve,34,Female,28.125,2.1683778234,No,10.2,3,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,No,Yes,No,No,3,12,7,69,25,51.666666667,42,30,10,6,4,23,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3,0,0,0,0,0,0,0,0,Y,-2,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,206-010,Biologic Naïve,58,Female,51.689521124,3.3867214237,No,7.6,10,Former,No,No,No,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,Yes,No,3,15,3,44.725,32.297,25,20,20,8.429,5.331,3.098,24.938,No,No,Yes,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.2,0,0,0,0,0,1,1,0,Y,3,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,206-011,Biologic Naïve,30,Male,33.910034602,4.6789869952,No,10.5,7,Never,Yes,No,Yes,No,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,3,15,4,9,28.82,26.666666667,22,0,10,8,2,25,No,No,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,1,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,206-012,Biologic Naïve,77,Male,24.337479719,3.0308008214,No,15.5,25.389,Missing,Yes,No,No,Yes,No,No,No,No,5,No,No,No,No,No,Yes,No,4,21,6.62,47.568,20.773,81.214,91.558,90.258,16.8,5.7,11.1,21.485,No,No,No,Yes,0.782,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,206-013,Biologic Non-naïve,53,Female,28.763971072,26.110882957,No,14.7,13,Current,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,4,43,7,80,33.062,63.333333333,80,80,6,3,3,24,No,No,No,Yes,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,206,Argentina,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,0,0,0,0,0,0,Y,-12,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,207-001,Biologic Naïve,62,Female,31.147842057,48.657084189,Yes,24.1,9,Former,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,No,No,No,No,4,21.321860465,1,1,15.066,20,18,40,9,5,4,25,Yes,Yes,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,207,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.1,1,1,1,1,1,1,1,1,Y,-9,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,208-001,Biologic Naïve,73,Female,36.982248521,3.8850102669,No,8,18,Never,No,Yes,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,No,Yes,3,11,6,30,0,41.666666667,40,90,27,14,13,25,Yes,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,208,Argentina,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-3.8,0,0,0,0,0,0,1,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,208-002,Biologic Naïve,34,Female,29.760862715,8.4900752909,No,10,12,Former,No,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,14,7,43,0,60,62,50,31,18,13,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,208,Argentina,Latin America,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-8.8,0,0,1,0,1,1,1,1,Y,-10,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,208-003,Biologic Naïve,46,Female,27.774270925,12.980150582,No,11.2,16,Former,Yes,No,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,16,2,0,0,31.666666667,20,80,16,6,10,24,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,208,Argentina,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.6,0,0,0,0,0,0,1,0,Y,-5,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,210-001,Biologic Naïve,51,Male,41.952024096,22.524298426,No,12,7,Never,No,Yes,No,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,21.321860465,5,0,0,40,32,30,11,6,5,24,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,210,Argentina,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.7,0,0,0,0,0,0,1,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,210-002,Biologic Naïve,31,Male,23.4375,3.523613963,Yes,23.6,9,Current,Yes,No,No,No,No,No,No,No,1,No,No,No,No,No,No,No,4,21.321860465,7,78,0,83.333333333,94,80,7,6,1,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,210,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.8,0,1,1,0,1,1,1,1,Y,-9,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,210-003,Biologic Naïve,41,Female,31.992171327,20.993839836,No,10.8,13,Former,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,11,5,37,0,45,38,20,19,7,12,24,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,210,Argentina,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,1,1,1,1,1,1,1,1,Y,-12,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,213-001,Biologic Non-naïve,67,Female,38.135421315,6.0533880903,No,5.6,0,Former,No,Yes,Yes,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,No,No,2,6,0,1,0,3.3333333333,0,70,13,5,8,25,No,No,No,No,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,213,Argentina,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.9,0,0,1,1,1,1,1,1,Y,0,,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,213-002,Biologic Naïve,46,Male,27.51338489,9.0485968515,No,22.2,16.2,Missing,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,45,3.998,46.49,3,56.941,71.544,32.781,5.454,3.687,1.767,24.746,No,No,No,Yes,1.588,Yes,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,213,Argentina,Latin America,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.8,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,228-001,Biologic Non-naïve,57,Male,27.548209366,24.566735113,No,0,1,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,0,0,0.653,2,0,0,6,40,9,3,6,19,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,228,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,0,,,,1,1,1,1,1,Y,2,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,228-002,Biologic Non-naïve,45,Female,17.998163453,30.080766598,No,1.3,3,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,1,2,2.357,5,0,28.333333333,18,0,6,6,0,24,No,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,228,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-0.5,0,0,0,1,1,1,1,1,Y,-1,0,Y,1,1,0,0,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,228-003,Biologic Non-naïve,67,Male,31.221303949,17.481177276,Yes,2.9,2,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,7.5,1,6,12,23.333333333,12,0,6,5,1,24,No,No,Yes,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,228,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,1.7,0,0,0,0,0,0,1,0,Y,-1,1,Y,0,0,0,0,0,0,0,0,0,0,1,1,0,No,Y,No
1,229-001,Biologic Non-naïve,43,Male,45.484080572,23.047227926,No,7.8,5,Never,No,No,Yes,No,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,No,4,18,3.409,31,4.28,68.333333333,36,10,18,10,8,17,No,No,No,No,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,229,Australia,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-1,0,0,0,0,0,0,0,0,Y,,,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,229-002,Biologic Non-naïve,33,Male,29.965397924,28.689938398,No,2.4,1,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,1,2,6.408,4,13.94,8.3333333333,6,0,5,3,2,25,Yes,Yes,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,229,Australia,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-2.3,0,1,1,1,1,1,1,1,Y,-1,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,229-003,Biologic Non-naïve,74,Male,29.031510377,26.020533881,Yes,2.4,2,Former,No,Yes,No,Yes,No,No,No,No,3,No,No,No,No,No,No,No,2,2,0,0,5,3.3333333333,0,0,2,1,1,25,No,No,No,No,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,229,Australia,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,5.8,0,0,0,0,0,0,0,0,Y,8,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,229-004,Biologic Naïve,41,Male,30.639380275,21.984941821,No,21.4,12,Never,Yes,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,47,8,49,0,50,46,30,8,4,4,18,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,229,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.7,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,229-005,Biologic Naïve,47,Male,30.32334259,10.272416153,Yes,27.6,9,Former,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,36,5,29.217,0.074,71.666666667,46,30,5.678,1.633,4.044,22.383,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,229,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-4.8,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,229-006,Biologic Non-naïve,61,Male,30.928431032,16.372347707,Yes,3,15,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,1,21.321860465,7,40,6.852,58.333333333,48,50,16,9,7,25,No,No,No,No,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,229,Australia,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-1.2,0,0,0,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,229-007,Biologic Non-naïve,32,Male,28.768661646,13.360711841,No,3.5,11.929,Missing,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,5,4.197,26.734,12,48.395,52.591,8.871,8.515,5.999,2.517,19.92,No,No,No,No,0.08,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,229,Australia,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.1,0,0,0,0,0,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,229-008,Biologic Non-naïve,30,Male,24.567474048,4.6379192334,Yes,1.2,8,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,21.321860465,6,10,0,13.333333333,16,10,13,11,2,25,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,229,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-1.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,229-009,Biologic Non-naïve,33,Female,33.21799308,6.6557152635,No,4.5,15,Current,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,21.321860465,8,76,8.881,75,84,50,20,13,7,21,No,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,229,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-3.3,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,229-010,Biologic Naïve,23,Female,21.267217631,2.3545516769,No,18.2,12,Former,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,48,7,63,26.524,50,38,20,12,8,4,24,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,229,Australia,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,,,,,,,,,1,Y,-12,1,Y,1,1,0,0,0,0,0,0,0,0,0,1,1,Yes,Y,Yes
1,230-001,Biologic Naïve,53,Male,27.471707128,28.793976728,No,12.3,12,Former,No,No,No,No,Yes,No,No,Yes,2,No,No,No,No,Yes,No,No,3,10,6,11,40,30,14,30,17,11,6,24,No,Yes,No,Yes,3,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,0,0,1,0,1,1,1,0,Y,0,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,230-002,Biologic Naïve,70,Male,32.52244898,36.824093087,Yes,20.4,11,Former,No,Yes,Yes,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,29,10,68,2,90,66,80,0,0,0,25,No,No,Yes,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17,0,0,1,0,0,0,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,230-003,Biologic Non-naïve,43,Male,31.673469388,18.828199863,Yes,6.5,3,Former,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,Yes,No,3,4,3.022,9,31,8.3333333333,4,10,6,6,0,24,No,Yes,No,Yes,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.7,0,0,1,1,1,1,1,0,Y,0,0,Y,0,0,0,0,1,0,0,1,1,1,1,0,0,No,Y,No
1,230-004,Biologic Non-naïve,77,Female,22.666666667,59.72073922,No,15.8,1,Never,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,14,1,1,36,13.333333333,4,0,5,5,0,25,Yes,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,230-005,Biologic Naïve,39,Female,48.699271592,9.0184804928,No,8.5,16,Former,Yes,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,3,9,9,86,13,96.666666667,88,80,22,15,7,23,Yes,Yes,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.1,0,0,0,0,0,0,1,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,230-006,Biologic Non-naïve,66,Male,31.561671506,29.237508556,Yes,16.2,15,Current,No,Yes,Yes,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,Yes,No,3,20,8.455,71,76,46.666666667,48,40,22,9,13,24,Yes,Yes,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.2,0,0,1,0,0,1,1,0,Y,-11,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,230-007,Biologic Naïve,43,Male,30.24691358,7.3264887064,No,16.5,9,Former,Yes,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,15,7,34,120,68.333333333,24,10,5,4,1,25,Yes,Yes,Yes,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,230-008,Biologic Naïve,57,Male,24.93372049,19.419575633,Yes,15.4,3,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,3,23,60,33.333333333,18,0,7,5,2,25,Yes,Yes,Yes,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.4,1,1,1,1,1,1,1,1,Y,2,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,230-009,Biologic Naïve,69,Male,32.690541781,30.384668036,No,15.8,9,Former,No,Yes,No,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,10,8,42,50,36.666666667,32,20,4,3,1,24,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.8,1,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,230-010,Biologic Non-naïve,47,Female,28.305995065,30.425735797,Yes,5,13,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,2,10,0,26.666666667,12,0,4,4,0,25,No,Yes,No,No,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,1.4,0,0,0,0,0,0,0,0,Y,-1,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,230-011,Biologic Naïve,44,Male,29.802775749,20.446269678,No,39.7,21,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,5,35,8,86,72,86.666666667,70,80,15,9,6,24,No,Yes,Yes,Yes,2,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28,0,0,0,0,0,0,0,0,Y,-12,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,230-012,Biologic Naïve,71,Male,24.485652005,20.495550992,Yes,18.7,2,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,3,23,0,12,113,43.333333333,10,10,19,10,9,21,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.5,0,1,1,0,1,1,1,1,Y,3,0,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,230-013,Biologic Naïve,41,Female,30.078125,29.514031485,Yes,15.3,12,Former,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,33,5,18,79,45,30,30,2,2,0,25,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.3,1,1,1,1,1,1,1,1,Y,-12,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,230-014,Biologic Naïve,71,Male,31.439821739,8.7474332649,Yes,17.5,14.623,Missing,No,Yes,No,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,Yes,4,12,6.981,56.352,72,74.2,59.544,76.459,17.15,10.35,6.8,23.923,Yes,Yes,Yes,Yes,0.74,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.7,0,1,1,1,1,1,1,1,Y,,,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,230-015,Biologic Naïve,25,Male,20.366452723,14.746064339,No,15.3,19,Never,Yes,Yes,No,No,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,19,6,66,20,73.333333333,60,80,22,16,6,25,Yes,No,Yes,Yes,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.3,1,1,1,1,1,1,1,1,Y,-18,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,230-016,Biologic Naïve,30,Female,56.198347107,16.747433265,Yes,4,12,Current,Yes,Yes,Yes,Yes,No,No,No,No,3,No,Yes,No,Yes,Yes,No,No,3,8,5,17,17,45,58,60,23,12,11,25,No,Yes,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,1,1,1,1,1,1,1,1,Y,-6,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,230-017,Biologic Non-naïve,76,Female,25.103878116,10.74880219,No,6.7,15,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,7,73,21.676,56.666666667,54,50,19,15,4,24,No,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.7,1,1,1,1,1,1,1,1,Y,-14,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,230-018,Biologic Non-naïve,63,Male,26.137436015,9.7631759069,No,15.3,21,Former,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,10,6,57,118,78.333333333,34,80,18,11,7,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,0,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,230-019,Biologic Naïve,59,Female,25.458065904,9.7631759069,No,15.2,6,Never,No,Yes,Yes,No,Yes,Yes,No,Yes,1,No,No,No,No,No,Yes,No,3,16,0,0,12,41.666666667,6,10,6,6,0,25,No,No,Yes,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.4,0,0,1,0,1,1,1,1,Y,-3,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,230-020,Biologic Non-naïve,28,Male,31.625326136,8.772073922,No,2.6,8,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,10,5,62,9,58.333333333,46,20,7,6,1,24,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.4,0,0,0,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,230-021,Biologic Non-naïve,52,Male,31.740582379,19.772758385,No,57.6,21,Former,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,5,85,5,28,54,46.666666667,28,60,17,8,9,14,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-55.2,0,1,1,0,0,1,1,1,Y,-16,0,Y,1,1,0,0,1,1,0,0,0,1,1,0,1,Yes,Y,Yes
1,230-022,Biologic Naïve,46,Female,23.340148914,28.785763176,No,17.4,10,Former,Yes,Yes,Yes,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,24,6,0,36,60,36,40,17,10,7,22,Yes,Yes,Yes,Yes,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17,0,1,1,1,1,1,1,1,Y,-10,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,230-023,Biologic Naïve,64,Male,40.036730946,51.802874743,No,19.3,2,Never,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,34,2,5,27,30,16,0,6,5,1,24,No,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.9,0,1,1,0,1,1,1,1,Y,-2,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,230-024,Biologic Naïve,55,Male,33.078285275,34.803559206,No,19.8,5,Never,No,No,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,Yes,No,3,31,3,46,17,31.666666667,22,0,9,6,3,24,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.8,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,230-025,Biologic Non-naïve,58,Male,31.122679946,24.859685147,No,6.6,6,Former,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,6.3,6,52,50,45,44,20,4,3,1,21,No,No,Yes,No,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,1,1,1,1,1,1,1,1,Y,-4,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,230-026,Biologic Non-naïve,43,Male,25.092849786,11.017111567,No,2,0,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,1,3,1,0,4,11.666666667,2,0,1,1,0,23,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,230-027,Biologic Naïve,52,Female,24.837018141,35.173169062,No,19.5,11,Former,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,26,7,0,18.689,16.666666667,14,0,8,4,4,23,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.5,1,1,1,1,1,1,1,1,Y,-11,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,230-028,Biologic Naïve,47,Male,31.377989166,11.145790554,No,18,8,Current,Yes,No,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,10,2,37,30,48.333333333,40,0,6,4,2,24,No,Yes,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,230-029,Biologic Naïve,53,Female,40.484429066,33.188227242,No,32.7,5,Current,Yes,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,4,55,1,90,77,18.333333333,12,90,11,8,3,25,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,230,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-31.1,0,1,1,0,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,231-001,Biologic Naïve,33,Male,29.923737218,15.06091718,No,13.9,23,Former,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,20,7.981,75,1,56.666666667,70,30,14,6,8,23,Yes,Yes,No,Yes,2,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,231,Australia,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.5,0,0,1,0,1,1,1,1,Y,-17,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,231-002,Biologic Non-naïve,48,Male,32.398097609,24.314852841,No,5.2,7.225,Missing,Yes,Yes,Yes,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,Yes,No,0,14,4.382,19.842,0,39.308,46.859,32.334,16.24,8.671,7.569,24.269,No,No,No,No,1.009,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,231,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,231-003,Biologic Naïve,33,Male,28.588371149,17.574264203,Yes,18.9,0,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,68,0,0,16,15,2,0,10,5,5,25,No,No,No,No,3,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,231,Australia,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-14.1,0,0,0,0,0,0,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,233-001,Biologic Naïve,30,Male,25.829072316,22.29431896,Yes,17.8,6,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,50,7.474,66,60,63.333333333,58,10,5,3,2,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,233,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.8,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,233-002,Biologic Non-naïve,51,Female,38.67768595,26.379192334,Yes,16.2,0,Current,No,No,No,Yes,No,No,No,No,6,No,Yes,Yes,Yes,Yes,No,No,3,28,0,0,0,8.3333333333,0,0,10,8,2,25,No,No,No,Yes,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,233,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-10.2,0,0,0,0,0,0,0,0,Y,2,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,233-003,Biologic Non-naïve,36,Female,27.160493827,15.433264887,Yes,18,2,Former,No,No,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,35,4,17,0,33.333333333,30,0,25,12,13,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,233,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,,Y,N,Y,N,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,233-004,Biologic Naïve,49,Female,33.49862259,46.502395619,Yes,18,6,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,23,1,0,0,45,20,10,1,1,0,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,233,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,0,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,233-005,Biologic Naïve,41,Female,21.551033488,6.4832306639,No,17.4,10.365,Missing,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,22,5.546,55.519,0,66.278,56.211,26.451,9.398,7.301,2.097,22.478,No,No,No,No,0.031,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,233,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-17.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,233-006,Biologic Naïve,41,Male,33.557933677,10.579055441,No,17.4,5.12,Missing,No,No,No,Yes,No,No,No,No,2,Yes,No,No,No,Yes,No,No,3,30,3.759,16.995,0,21.137,11.275,23.719,13.187,8.197,4.99,24.377,Yes,No,No,Yes,0.108,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,233,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-12,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,236-001,Biologic Naïve,38,Male,28.326974217,28.873374401,No,18.7,11,Former,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,35,6,66,0,63.333333333,58,50,10,4,6,22,Yes,No,No,Yes,3,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,236,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.7,0,0,1,0,0,0,1,0,Y,-10,1,Y,0,0,0,0,1,0,0,0,0,0,1,1,0,No,Y,No
1,236-003,Biologic Naïve,36,Female,44.953173777,21.423682409,No,7,22,Former,Yes,Yes,Yes,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,3,10,5,73,0,56.666666667,52,30,17,8,9,23,Yes,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,236,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.6,0,0,1,0,1,1,1,1,Y,-10,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,236-004,Biologic Naïve,51,Male,43.75,1.6509240246,No,27.1,19.882,Missing,Yes,No,Yes,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,90,8.353,79.553,28,91.478,95.844,55.627,12.28,3.714,8.566,23.769,Yes,Yes,No,Yes,0.498,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,236,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26.2,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,236-007,Biologic Non-naïve,38,Male,28.713211198,10.392881588,No,2.1,10,Former,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,5,6,12.593,0,50,22,20,8,6,2,20.893,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,236,Australia,Asia/Pacific,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.5,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,236-008,Biologic Naïve,62,Female,27.6816609,0,Yes,22,15,Never,No,Yes,No,Yes,Yes,No,No,Yes,4,Yes,No,No,No,Yes,Yes,No,4,40,3,5,0,26.666666667,6,80,29,17,12,19,Yes,No,No,Yes,3,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,236,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.3,0,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,236-009,Biologic Non-naïve,54,Female,19.37716263,1.6098562628,No,5.7,21,Current,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,5,5,76,30,66.666666667,76,90,27,15,12,24,No,No,Yes,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,236,Australia,Asia/Pacific,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.9,0,0,0,0,0,0,1,0,Y,-5,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,236-010,Biologic Non-naïve,52,Male,35.49382716,26.847364819,No,26.7,13.403,Missing,Yes,No,No,Yes,No,No,No,No,5,No,Yes,No,Yes,Yes,No,No,5,30,5.021,15.946,85,41.505,32.9,48.398,8.941,3.019,5.922,22.355,Yes,Yes,Yes,Yes,1.016,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,236,Australia,Asia/Pacific,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,20.4,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,236-011,Biologic Naïve,47,Female,22.857142857,25.935660507,No,20.3,14.507,Missing,Yes,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,20,7.649,61.602,3.262,54.515,48.777,77.475,11.774,7.24,4.533,23.71,Yes,No,No,Yes,3.927,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,236,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,237-001,Biologic Non-naïve,37,Male,53.140610054,3.0965092402,No,9.1,10,Current,No,Yes,Yes,Yes,Yes,No,No,Yes,3,No,Yes,No,Yes,Yes,No,No,4,10,4.947,51,0,76.666666667,54,0,14,6,8,23,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.2,0,0,0,0,0,0,1,0,Y,-1,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,237-002,Biologic Naïve,31,Male,26.941507695,11.134839151,No,17.7,3,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,30,3.406,3,7,33.333333333,4,10,10,4,6,25,Yes,No,No,No,2,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-15.7,0,0,1,0,1,1,1,1,Y,-2,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,237-003,Biologic Naïve,69,Female,27.466666667,2.0588637919,No,17.6,6,Former,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,No,No,Yes,No,3,30,4.349,21,35.915,63.333333333,24,20,8,4,4,25,No,No,No,Yes,3,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-16.7,0,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,237-004,Biologic Naïve,55,Male,30.756367763,34.513347023,No,18.7,3.55,Missing,Yes,Yes,No,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,Yes,No,3,40,4.841,15.418,53,49.435,46.926,25.006,24.729,12.2,12.529,21.723,No,No,No,No,0.23,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.8,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,237-005,Biologic Non-naïve,18,Female,38.408304498,11.518138261,No,24.4,18.219,Never,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,40,8.318,48.299,21.769,69.514,63.783,61.302,25.58,12.017,13.563,24.35,Yes,No,No,Yes,1.324,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.5,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,237-006,Biologic Naïve,48,Male,19.623233909,3.7618069815,No,18.2,5,Current,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,30,2,11,5,41.666666667,12,0,15,9,6,25,No,No,No,No,2,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.7,0,0,0,0,0,0,0,1,Y,-3,0,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,237-007,Biologic Naïve,48,Male,39.579941907,23.058179329,No,22.2,14,Former,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,45,6,1,22,45,20,0,36,20,16,24,No,No,No,No,4,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.1,0,0,1,0,0,0,0,1,Y,-13,1,Y,1,1,0,0,1,0,0,0,0,0,0,1,1,Yes,Y,Yes
1,237-008,Biologic Naïve,49,Male,32.111952407,28.999315537,No,20.2,5,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,45,5,51,20.684,56.666666667,24,0,15,11,4,25,No,No,No,Yes,3,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.2,0,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,237-009,Biologic Naïve,55,Male,35.958832178,14.997946612,No,19.9,4.625,Missing,No,Yes,Yes,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,3,20,1.847,21.989,26,35.304,14.222,40.212,10.553,7.358,3.195,23.617,No,No,No,No,0.908,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,237-010,Biologic Naïve,59,Female,28.90625,5.9986310746,No,20.2,22,Never,Yes,Yes,Yes,Yes,Yes,No,No,Yes,1,No,No,No,No,No,Yes,No,2,9,1,89,65.833,83.333333333,48,90,28,13,15,25,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-15.8,0,0,1,0,0,0,1,0,N,-11,0,N,0,0,0,0,1,0,0,0,0,0,1,0,0,,N,No
1,237-011,Biologic Non-naïve,55,Female,31.791603935,39.917864476,Yes,0,12.573,Missing,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,0,0,5.174,37.012,14,67.081,48.817,39.367,18.481,10.896,7.586,22.782,No,No,No,No,0.444,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,1,Y,,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,237-012,Biologic Non-naïve,32,Female,37.813802038,18.934976044,No,11.3,14,Current,Yes,No,No,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,2,15,4,48,3.257,50,46,30,15,8,7,24,No,No,Yes,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,237,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.9,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,238-001,Biologic Naïve,47,Female,30.487804878,33.026694045,No,8.5,13,Former,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,15,5.701,50,0,61.666666667,44,50,22,13,9,22,No,No,No,Yes,2,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,238,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.3,0,0,1,0,1,1,1,1,Y,-10,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,238-002,Biologic Naïve,68,Male,23.456790123,26.822724162,No,3.1,4,Current,Yes,Yes,No,Yes,Yes,Yes,No,No,3,No,No,No,No,Yes,Yes,No,3,7,3.076,10,0,16.666666667,10,0,9,7,2,24,Yes,Yes,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,238,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.3,0,0,0,0,1,1,1,1,Y,-2,0,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,239-001,Biologic Naïve,65,Male,29.352354501,33.700205339,No,27.9,22,Never,No,Yes,No,Yes,No,No,No,No,6,Yes,Yes,No,No,Yes,No,No,3,35,2,21,14,31.666666667,36,50,36,19,17,23,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26.5,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,239-002,Biologic Non-naïve,37,Male,26.566839754,20.700889802,No,16.5,21.534,Missing,Yes,Yes,No,No,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,12,5.086,54.57,96,66.706,57.843,58.342,14.511,6.364,8.147,24.144,No,Yes,Yes,Yes,0.432,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.9,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,239-003,Biologic Naïve,55,Female,34.626820731,4.7008898015,No,7.3,18,Never,Yes,Yes,Yes,Yes,Yes,No,No,Yes,6,No,Yes,No,Yes,Yes,Yes,No,3,8,10,75,93,81.666666667,90,80,28,17,11,22,Yes,Yes,Yes,Yes,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.7,0,0,0,0,0,0,0,0,Y,-8,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,239-004,Biologic Naïve,50,Male,43.357613597,28.700889802,Yes,28.7,18.514,Missing,No,Yes,Yes,Yes,Yes,No,Yes,Yes,5,No,No,No,Yes,Yes,Yes,Yes,4,34,6.351,29.281,40,63.352,48.113,47.907,24.311,12.759,11.552,21.08,Yes,Yes,Yes,Yes,0.801,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,239-005,Biologic Naïve,42,Male,31.564859473,4.0301163587,No,16,16.251,Missing,Yes,Yes,Yes,No,Yes,No,No,Yes,2,No,No,No,No,Yes,Yes,No,4,17,7.328,37.011,65,70.511,59.068,47.886,12.119,5.816,6.303,24.109,No,No,No,No,0.823,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-006,Biologic Naïve,27,Male,36.111111111,0.8405201916,No,17,11.372,Missing,Yes,Yes,No,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,4,19,6.523,37.185,23,80.405,40.583,39.76,11.534,8.183,3.351,20.348,Yes,Yes,Yes,Yes,0.079,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-007,Biologic Non-naïve,26,Male,26.775510204,5.8234086242,No,7.4,15.094,Missing,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,10,9.312,78.086,42,65.174,41.28,66.598,7.495,6.923,0.572,21.221,Yes,No,No,Yes,1.518,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.2,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,239-008,Biologic Non-naïve,42,Male,28.721121071,13.752224504,No,4.4,9.666,Missing,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,2,5,4.818,24.957,0,29.473,18.249,20.024,35.376,20.419,14.957,18.037,Yes,Yes,Yes,Yes,1.221,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.9,0,0,0,0,0,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,239-009,Biologic Naïve,35,Male,35.273368607,20.700889802,Yes,18.5,14.667,Missing,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,19,5.764,42.257,78,63.206,32.767,59.105,14.389,4.969,9.42,24.5,Yes,Yes,No,Yes,3.748,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-010,Biologic Non-naïve,55,Female,31.975014872,36.772073922,Yes,13,30,Former,Yes,No,No,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,Yes,No,3,19,10,73,0,91.666666667,100,100,28,12,16,25,No,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13,1,1,1,1,1,1,1,1,Y,-27,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-011,Biologic Naïve,69,Male,27.45865421,32.772073922,No,18,5,Never,Yes,Yes,Yes,Yes,No,No,No,No,5,Yes,No,No,No,Yes,Yes,No,3,37,2,0,37,51.666666667,50,30,12,7,5,24,No,No,No,No,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,239-012,Biologic Naïve,40,Female,21.551020408,10.877481177,No,16.3,16.608,Missing,Yes,Yes,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,17,6.09,4.558,31,70.95,65.304,85.932,20.707,12.049,8.658,24.903,Yes,Yes,Yes,Yes,1.431,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.1,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,239-013,Biologic Naïve,57,Female,31.163434903,5.9603011636,Yes,17.7,23,Former,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,29,6,79,0,60,70,80,25,14,11,20,Yes,Yes,Yes,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.7,1,1,1,1,1,1,1,1,Y,-16,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-014,Biologic Naïve,53,Female,24.382372979,1.7248459959,No,26.9,23,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,4,42,1,35,23,76.666666667,66,80,22,14,8,23,Yes,Yes,Yes,Yes,2,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26.1,0,1,1,1,1,1,1,1,Y,-23,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,239-015,Biologic Naïve,67,Male,28.405504356,11.813826146,Yes,16.2,17.527,Missing,Yes,Yes,Yes,No,No,No,No,No,2,No,No,No,No,Yes,No,No,3,25,2.049,15.979,41,60.765,22.588,54.643,13.488,9.981,3.507,24.138,Yes,Yes,Yes,Yes,1.444,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-016,Biologic Naïve,70,Female,29.73390041,1.1471594798,No,6.9,1.892,Former,Yes,Yes,Yes,Yes,Yes,No,No,Yes,5,No,No,No,No,Yes,Yes,Yes,3,5,4.52,23.211,7,50.099,37.021,22.871,12.909,3.966,8.943,24.236,No,Yes,Yes,No,1.562,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,239-017,Biologic Naïve,64,Female,30.078125,13.831622177,No,11.6,7.536,Missing,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,Yes,No,3,19,5.908,37.334,48,66.066,56.189,84.348,12.344,5.672,6.672,24.367,Yes,Yes,Yes,Yes,1.765,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.2,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,239-018,Biologic Non-naïve,35,Female,30.119375574,20.832306639,Yes,14.1,20.327,Missing,Yes,No,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,Yes,No,3,16,7.998,66.033,10.732,68.545,61.972,79.218,19.473,13.821,5.652,24.809,Yes,Yes,Yes,Yes,0.672,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,239-019,Biologic Naïve,42,Male,27.170631566,24.851471595,No,8,8.641,Missing,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,5,0.778,56.018,35,40.332,42.995,12.938,19.197,11.8,7.397,22.303,No,Yes,Yes,Yes,2.738,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-6.3,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,239-020,Biologic Naïve,52,Male,30.290147731,28.887063655,No,24.6,12,Former,No,No,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,55,7,62,34,56.666666667,38,0,6,3,3,22,Yes,Yes,Yes,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-23.4,0,1,1,0,1,1,1,1,Y,-10,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,239-021,Biologic Naïve,54,Female,50.598751897,12.73100616,No,15.6,19.473,Missing,Yes,No,No,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,Yes,No,4,16,7.43,71.919,70,74.567,75.576,57.756,20.061,8.741,11.32,20.56,Yes,Yes,Yes,Yes,0.317,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-022,Biologic Non-naïve,60,Male,33.950617284,22.893908282,Yes,3.9,11.016,Missing,Yes,Yes,Yes,Yes,No,No,No,No,9,Yes,No,No,Yes,Yes,Yes,No,2,15,4.163,33.399,39,52.468,50.849,79.784,21.28,13.144,8.136,24.376,Yes,No,Yes,Yes,0.179,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,2.3,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,239-023,Biologic Naïve,62,Male,33.333333333,21.661875428,Yes,30.6,12.194,Missing,No,Yes,Yes,Yes,No,No,No,No,6,No,No,No,Yes,Yes,Yes,No,4,45,7.082,24.775,34,54.707,48.638,33.478,5.044,2.052,2.992,20.696,Yes,Yes,Yes,Yes,0.346,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-30.4,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,239-024,Biologic Non-naïve,41,Male,26.296566837,18.926762491,Yes,6.3,20.222,Missing,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,7,6.469,58.802,21,64.108,64.908,57.981,16.929,10.418,6.511,22.204,No,Yes,Yes,Yes,0.433,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-2.8,0,0,0,0,0,0,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,239-025,Biologic Naïve,31,Female,25.209201358,4.9691991786,Yes,17.8,25,Former,Yes,No,Yes,No,No,No,No,No,2,No,No,No,No,Yes,No,No,3,28,5.95,67,15,63.333333333,64,90,23,13,10,20,Yes,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-17.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-026,Biologic Non-naïve,69,Female,36.26243886,63.080082136,Yes,2.4,16,Former,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,3,8.655,89,18.555,68.333333333,80,80,13,6,7,24,Yes,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-0.6,0,0,0,0,1,1,1,1,Y,-13,0,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,239-027,Biologic Naïve,21,Female,23.918830292,16.082135524,No,1.5,1,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,1,1,0.829,0,10,5,0,0,11,10,1,25,Yes,Yes,Yes,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-0.9,0,0,0,1,1,1,1,1,Y,2,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,239-028,Biologic Naïve,18,Female,17.632653061,1.9986310746,No,16.2,11.767,Current,No,No,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,30,5.847,49.558,60,40,40,60,12.969,6.839,6.131,22.031,Yes,Yes,Yes,Yes,2.528,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-15.2,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,239-029,Biologic Naïve,47,Male,27.77031264,17.097878166,No,20.4,14.087,Missing,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,23,6.959,62.396,7,56.07,42.736,26.383,7.089,4.32,2.769,20.511,Yes,Yes,Yes,Yes,1.157,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-20.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-030,Biologic Naïve,64,Male,27.450604871,52.123203285,No,15.2,10.063,Missing,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,29,5.943,56.376,104,40.173,37.79,10.175,18.254,9.167,9.087,18.039,Yes,Yes,Yes,Yes,0.248,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-12.8,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,239-031,Biologic Naïve,24,Female,18.359375,8.1423682409,No,16.8,6,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,29,6.737,7,37,31.666666667,32,20,18,11,7,24,No,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.8,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,239-032,Biologic Naïve,34,Male,24.30248706,1.0759753593,No,15.9,9.052,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,16,6.658,16.471,18,67.705,65.195,17.471,18.461,13.724,4.737,21.834,Yes,Yes,Yes,Yes,2.161,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-033,Biologic Naïve,67,Female,38.86602652,44.161533196,Yes,16.6,17,Never,No,Yes,Yes,Yes,Yes,No,No,Yes,3,No,Yes,No,Yes,Yes,No,No,4,15,8.002,95,67,38.333333333,42,40,19,10,9,25,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-12.5,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,239-034,Biologic Naïve,46,Male,28.405504356,28.427104723,Yes,26,7.331,Missing,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,32,6.54,95.885,117,73.074,85.84,16.569,13.381,6.24,7.142,24.084,Yes,Yes,Yes,Yes,3.218,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-035,Biologic Naïve,72,Male,30.102118579,34.444900753,Yes,13.8,8,Former,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,11,4,64,56,28.333333333,48,70,10,6,4,15,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,0,1,1,0,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,239-036,Biologic Naïve,52,Female,42.154390455,32.465434634,Yes,25,19,Never,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,36,10,87,23,56.666666667,82,90,33,16,17,25,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,239-037,Biologic Non-naïve,44,Female,36.198750191,11.890485969,Yes,4.8,6.335,Former,Yes,No,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,8,4.393,58.973,0,58.951,65.939,19.669,4.971,3.402,1.569,24.585,No,Yes,Yes,Yes,1.312,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,239,Australia,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,277-001,Biologic Naïve,36,Female,37.105751391,22.039698836,No,10.3,5,Never,No,Yes,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,3,35,6,23,0,58.333333333,56,50,5,3,2,24,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,277,Brazil,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-8.9,0,0,1,0,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,277-002,Biologic Naïve,74,Male,28.675466545,31.041752225,No,17.4,4,Former,No,Yes,No,Yes,Yes,Yes,No,No,7,No,No,No,Yes,Yes,Yes,No,3,15,7,0,34.825,40,50,30,18,10,8,21,No,No,No,Yes,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,277,Brazil,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.1,0,0,1,0,0,0,1,1,Y,-1,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,277-003,Biologic Naïve,38,Male,23.388686558,0.9281314168,No,25.6,5,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,45,3,0,20.232,48.333333333,28,10,22,13,9,24,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,277,Brazil,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.8,0,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,278-001,Biologic Naïve,60,Male,29.031510377,24.476386037,Yes,4.5,7.534,Missing,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,5,1.911,50.844,1,28.512,39.632,15.614,4.014,0.685,3.329,22.68,No,No,No,No,1.071,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,278,Brazil,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,279-001,Biologic Naïve,58,Male,33.568006968,26.778918549,No,12.7,18.951,Never,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,20,6.17,68.052,11,62.196,59.367,44.544,11.978,6.553,5.425,21.904,No,Yes,No,Yes,0.038,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,279,Brazil,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.1,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,279-002,Biologic Non-naïve,52,Male,30.98389248,9.9137577002,No,19.2,6,Never,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,25,8,0,1.001,75,28,0,8,5,3,24,Yes,Yes,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,279,Brazil,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.2,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,280-001,Biologic Non-naïve,31,Female,22.376318396,25.782340862,No,34.2,5,Never,No,Yes,No,Yes,Yes,Yes,No,No,1,Yes,No,No,No,No,No,No,5,84,9,50,20,55,60,0,10,6,4,21,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,280,Brazil,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-33,0,1,1,0,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,280-002,Biologic Non-naïve,46,Male,17.573696145,10.277891855,No,10.7,1,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,10,0,0,40,0,0,20,11,10,1,25,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,280,Brazil,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,0,1,1,1,1,1,1,1,Y,2,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,280-003,Biologic Non-naïve,54,Female,35.106670267,3.1923340178,No,21,24,Never,No,Yes,No,Yes,Yes,No,No,Yes,5,No,No,No,Yes,Yes,Yes,No,4,80,9,98,2,80,66,80,20,13,7,21,Yes,Yes,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,280,Brazil,Latin America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.1,0,1,1,1,1,1,1,1,Y,-17,0,Y,,1,,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,280-005,Biologic Non-naïve,63,Female,26.462560816,39.392197125,Yes,3.6,10,Former,No,Yes,No,Yes,Yes,No,No,Yes,4,No,No,No,No,No,Yes,Yes,3,2,6,0,0,61.666666667,42,0,15,8,7,23,No,No,No,No,1,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,280,Brazil,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.7,0,0,0,0,1,1,1,1,Y,-9,1,Y,1,1,0,0,0,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,280-006,Biologic Non-naïve,59,Male,23.720999405,34.308008214,No,9.6,8,Never,No,Yes,Yes,Yes,Yes,No,No,Yes,2,No,No,No,No,No,Yes,No,3,50,10,0,4,61.666666667,36,20,2,0,2,25,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,280,Brazil,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-9,0,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,280-007,Biologic Non-naïve,48,Female,26.989619377,20.314852841,Yes,5.4,18,Current,No,Yes,No,Yes,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,3,3,8,85,25,83.333333333,72,90,27,14,13,21,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,280,Brazil,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5,0,1,1,1,1,1,1,1,Y,-6,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,283-001,Biologic Non-naïve,25,Female,31.69704142,10.083504449,No,13.8,6,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,6,6,13,51.666666667,52,0,13,12,1,25,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,283,Brazil,Latin America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,1,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,286-001,Biologic Naïve,58,Female,31.239414355,22.184804928,No,22.1,7,Never,No,Yes,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,4,26,10,98,37.683,96.666666667,52,0,3,3,0,12,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,286,Brazil,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-22.1,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,286-002,Biologic Non-naïve,69,Male,33.126014062,22.223134839,No,27.6,2,Current,Yes,No,No,Yes,No,No,No,No,8,Yes,No,No,Yes,Yes,Yes,No,5,42,5,48,0,41.666666667,40,0,6,2,4,24,Yes,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,286,Brazil,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-27.6,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,286-003,Biologic Non-naïve,58,Male,33.910034602,32.996577687,Yes,2.4,12,Never,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,8,10,72,2,78.776,98.867,80,7,5,2,25,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,286,Brazil,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-2.4,1,1,1,1,1,1,1,1,Y,-12,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,288-001,Biologic Naïve,42,Female,33.095485675,8.4435318275,Yes,21.3,15.899,Former,No,Yes,No,Yes,Yes,Yes,No,No,2,No,No,No,Yes,Yes,No,No,3,14,7.745,55.505,38,70.084,55.354,67.441,15.688,8.041,7.647,24.065,No,No,Yes,Yes,0.535,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,288-002,Biologic Naïve,30,Male,40.123346122,6.8720054757,No,18,24,Never,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,3,13,1,1,25.144,43.333333333,8,90,14,11,3,25,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,-24,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,288-003,Biologic Naïve,24,Male,37.684635778,1.6536618754,No,22.8,14,Current,No,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,13,1,0,16,8.3333333333,10,50,23,13,10,25,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-17.2,0,0,1,0,0,0,0,0,Y,6,0,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,288-004,Biologic Naïve,44,Female,23.828125,19.334702259,No,20,17,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,14,5,55,5,50,48,0,20,10,10,23,Yes,No,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.4,0,1,1,1,1,1,1,1,Y,-12,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,288-005,Biologic Naïve,50,Male,28.863581957,20.618754278,Yes,9.8,18,Never,Yes,Yes,No,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,8,3,55,13,41.666666667,36,50,22,13,9,23,No,No,No,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-8.6,0,0,1,0,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,288-006,Biologic Non-naïve,49,Male,25.036332409,4.8624229979,No,8.4,18,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,7,51,5,78.333333333,64,80,10,8,2,25,No,No,No,No,2,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6.6,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,288-007,Biologic Non-naïve,57,Female,25.914634146,28.733744011,No,16.2,4,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,13,0,20,3,18.333333333,4,30,8,7,1,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-4,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,288-008,Biologic Naïve,39,Female,22.896468144,16.785763176,No,17.4,15,Current,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,17,3,2,0,38.333333333,28,60,22,14,8,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-15,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,288-009,Biologic Naïve,54,Female,33.945568114,3.2388774812,Yes,11.4,12,Never,Yes,Yes,No,Yes,Yes,Yes,No,No,4,No,No,No,Yes,Yes,Yes,Yes,3,11,7,82,5,76.666666667,68,60,17,9,8,18,No,No,Yes,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,0,0,1,0,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,288-010,Biologic Naïve,39,Male,28.91856331,10.746064339,No,25.8,21,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,30,9,0,18,36.666666667,30,20,28,18,10,24,No,No,Yes,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-20,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,288-011,Biologic Naïve,60,Female,40.64887651,24.90349076,No,17.9,19,Current,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,11,10,70,0,95,100,70,23,14,9,22,No,Yes,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.8,0,0,0,0,0,0,0,0,Y,-10,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,288-012,Biologic Non-naïve,53,Male,20.629818046,0.6132785763,No,21.6,6,Never,No,No,No,Yes,No,No,No,No,1,No,Yes,No,No,No,No,No,3,17,10,0,0,66.666666667,62,0,15,10,5,24,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,,,,,,,,,,Y,-6,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,288-013,Biologic Non-naïve,46,Female,21.893860562,2.546201232,Yes,21,16,Never,No,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,Yes,No,3,20,9,46,0,53.333333333,64,70,12,6,6,20,No,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,288,Brazil,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.7,0,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,305-002,Biologic Naïve,66,Male,32.690541781,20.635181383,Yes,12.4,3,Former,No,No,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,0,12,0,30,3,50,24,40,9,3,6,25,No,No,No,No,2,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,305,Colombia,Latin America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.5,0,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,305-003,Biologic Naïve,60,Female,25.315454294,10.806297057,No,11.5,20,Never,No,No,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,8,7,35,3.951,65,66,30,14,9,5,24,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,305,Colombia,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.1,0,0,0,0,0,0,0,1,Y,-7,0,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,305-004,Biologic Naïve,23,Female,21.230572024,0.9418206708,No,27.2,23,Never,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,44,8,16,27.004,48.333333333,40,50,9,6,3,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,305,Colombia,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.2,1,1,1,1,1,1,1,1,Y,-15,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,307-001,Biologic Non-naïve,40,Male,36.068818028,14.959616701,No,24,19,Never,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,20,7,87,0,83.333333333,82,20,15,10,5,18,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,307,Colombia,Latin America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-20.1,0,0,1,0,0,0,1,0,Y,-13,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,307-002,Biologic Non-naïve,41,Male,26.43982438,8.9883641342,No,5.4,22,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,21.321860465,8,80,0,88.333333333,80,80,8,6,2,21,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,307,Colombia,Latin America,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-2.6,0,0,0,0,0,1,1,0,Y,-18,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,307-003,Biologic Non-naïve,59,Male,31.7417889,12.041067762,Yes,38.4,15,Never,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,5,50,10,61,0,95,92,60,15,8,7,25,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,307,Colombia,Latin America,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-9,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,307-004,Biologic Non-naïve,58,Female,22.265625,1.2128678987,Yes,28.2,16,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,5,35,9,79,0,96.666666667,86,40,13,8,5,25,No,No,No,No,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,307,Colombia,Latin America,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-14,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,307-005,Biologic Non-naïve,32,Male,20.338326446,14.05338809,No,41.4,17,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,70,10,99,6,100,100,70,22,13,9,25,No,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,307,Colombia,Latin America,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-17,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,353-003,Biologic Non-naïve,30,Female,25.951557093,23.030800821,No,14.2,8,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,25,6,73,0,51.666666667,50,30,9,7,2,24,No,No,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,0,0,1,0,0,1,1,0,Y,-5,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,353-004,Biologic Naïve,62,Female,22.506925208,1.2457221081,No,27.5,23,Former,No,No,Yes,Yes,No,No,No,No,2,No,No,No,No,No,No,No,4,26,10,0,0,91.666666667,84,90,19,13,6,25,Yes,Yes,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,353,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,N,Y,N,Y,Y,,,,,,,,,,Y,-23,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,353-005,Biologic Naïve,30,Female,19.04507334,8.0821355236,No,14.2,19,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,10,9,80,0,85,78,30,16,8,8,22,No,Yes,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-17,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-006,Biologic Naïve,26,Female,20.700816741,7.0663928816,No,16.2,10,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,35,3,0,0,33.333333333,0,20,10,8,2,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.4,0,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,353-007,Biologic Naïve,20,Male,21.453287197,9.0841889117,No,21,14,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,35,7,79,0,73.333333333,74,60,13,2,11,24,Yes,No,No,No,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-12,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-008,Biologic Non-naïve,64,Male,28.685144681,25.141683778,No,1.4,2,Former,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,2,5,51,0,41.666666667,46,0,2,1,1,25,No,No,No,Yes,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-0.9,0,0,0,1,1,1,1,1,Y,6,0,Y,1,1,0,0,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,353-010,Biologic Non-naïve,46,Male,35.083029837,14.223134839,Yes,9.3,6,Never,No,Yes,No,Yes,No,No,No,No,2,No,Yes,No,No,No,No,No,3,15,3,0,0,56.666666667,6,20,17,5,12,20,No,Yes,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-2,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-011,Biologic Naïve,52,Male,28.735632184,26.223134839,No,10.1,5,Former,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,11,7,81,0,61.666666667,68,0,19,14,5,24,Yes,Yes,No,No,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,353,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-013,Biologic Naïve,42,Female,25.990903184,27.296372348,No,7.8,13,Never,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,6,53,0,45,42,30,17,11,6,24,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-014,Biologic Non-naïve,41,Female,20.202020202,27.299110198,Yes,0.3,9,Never,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,1,1,7,0,3,36.666666667,80,80,25,15,10,20,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,,Y,Y,Y,N,N,N,,,,,,,,,,N,-3,0,N,,0,,0,0,0,0,0,0,0,0,0,0,,N,No
1,353-015,Biologic Non-naïve,34,Male,19.789970953,17.327857632,No,5,1,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,4,6,60,3,36.666666667,32,0,8,5,3,25,No,No,No,Yes,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-1,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-016,Biologic Naïve,72,Male,27.440599174,0.0109514031,No,19.3,3,Former,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,4,25,5,9,0,58.333333333,30,0,4,3,1,25,No,No,No,No,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,1,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-017,Biologic Non-naïve,35,Female,29.031510377,31.334702259,Yes,13.2,7,Never,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,17,8,75,0,81.666666667,80,20,28,13,15,24,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,4,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-018,Biologic Naïve,23,Female,20.811654527,2.3436002738,No,5,4,Current,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,4,6,60,0,50,20,0,16,11,5,21,Yes,No,No,Yes,2,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-2,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-019,Biologic Naïve,37,Male,21.604938272,0.6324435318,Yes,44.7,9.39,Missing,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,85,5.498,57.863,0,69.484,69.253,73.166,11,4.065,6.935,24.761,No,No,Yes,Yes,1.387,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,353,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-44.3,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,353-021,Biologic Naïve,48,Male,29.760862715,25.429158111,No,5.2,20,Never,No,No,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,No,No,3,6,8,71,0,68.333333333,74,50,23,12,11,24,Yes,Yes,No,Yes,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,N,Y,N,Y,Y,,,,,,,,,,Y,1,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-022,Biologic Naïve,64,Female,20.703125,37.489390828,No,21.4,8,Former,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,25,1,0,0,33.333333333,22,10,12,11,1,24,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,353,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-20.6,0,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,353-023,Biologic Naïve,52,Female,36.628511967,32.509240246,No,10.6,4,Current,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,5,5,75,0,58.333333333,54,0,9,7,2,23,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-3,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,353-024,Biologic Naïve,54,Male,25.059307027,12.574948665,No,5.9,11,Current,No,No,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,3,4,4,50,0,61.666666667,50,10,12,3,9,25,No,Yes,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,353,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-4.3,0,0,0,0,1,1,1,1,Y,-3,0,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,353-025,Biologic Naïve,41,Male,24.489795918,3.485284052,Yes,15,19,Never,Yes,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,12,8,86,0,83.333333333,86,60,14,9,5,19,No,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,353,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,353-026,Biologic Naïve,66,Male,25.503615702,38.53798768,Yes,10.2,0,Never,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,30,3,14,0,38.333333333,16,10,4,4,0,23,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,0,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-027,Biologic Naïve,68,Male,23.597004206,18.488706366,No,7.8,2,Never,No,Yes,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,7,3,8,0,15,16,0,10,6,4,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,353,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-028,Biologic Non-naïve,39,Male,28.088991031,10.587268994,Yes,7.4,4,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,6,6,61,36,48.333333333,56,60,36,19,17,25,No,No,Yes,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,353,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-029,Biologic Naïve,18,Male,45.714285714,3.537303217,No,14.2,1,Former,No,No,No,No,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,No,3,30,4,26.185,0,36.666666667,20,0,8,5,3,24.692,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,353,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,N,Y,N,Y,Y,,,,,,,,,,Y,-1,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,353-030,Biologic Naïve,33,Male,31.561671506,12.41615332,No,26.3,5,Current,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,70,5,48,0,80,60,0,17,10,7,14,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,353,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-5,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,357-001,Biologic Naïve,66,Male,29.054752066,20.747433265,No,12.9,2,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,30,2,28,0,35,12,0,2,1,1,19,Yes,No,No,Yes,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,357,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-12.9,1,1,1,1,1,1,1,1,Y,1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,357-002,Biologic Non-naïve,29,Female,25.315454294,20.752908966,No,32,1,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,60,6,0,0,28.333333333,26,0,2,2,0,25,No,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,357,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-32,1,1,1,1,1,1,1,1,Y,-1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,357-003,Biologic Naïve,36,Female,23.795359905,32.876112252,No,11.9,13,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,50,3,40,9.533,90,66,50,14,6,8,20,Yes,No,No,No,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,357,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.9,1,1,1,1,1,1,1,1,Y,-10,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,357-004,Biologic Naïve,39,Male,18.991964938,2.0561259411,No,21.6,3,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,30,5,70,5.809,81.666666667,72,0,13,8,5,21,No,No,Yes,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,357,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,357-005,Biologic Naïve,28,Male,23.939480992,15.069130732,No,15.2,4,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,30,2,69,58.236,55,26,0,2,2,0,24,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,357,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-15.2,1,1,1,1,1,1,1,1,Y,0,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,359-001,Biologic Naïve,25,Male,24.391058839,19.457905544,No,14.521901872,3,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,21.321860465,5,30,0,25,16,0,5,4,1,23,No,No,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,359,France,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,,,,,1,1,1,1,1,Y,-2,1,Y,1,1,0,0,0,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,359-002,Biologic Naïve,33,Female,20.324438255,12.5229295,No,8,5.627,Missing,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,30,8.121,37.345,0,71.721,70.969,40.233,16.296,8.951,7.345,20.925,Yes,No,No,No,2.145,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,359,France,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,360-001,Biologic Naïve,46,Male,24.835646457,29.798767967,No,38.9,21,Current,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,5,78,10,51,45,66.666666667,88,100,31,19,12,21,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,360,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,1.6,0,0,0,0,0,0,0,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,360-002,Biologic Naïve,59,Male,29.031510377,2.0123203285,No,33.6,13,Former,No,Yes,No,Yes,No,No,No,No,1.5063613232,No,No,No,No,Yes,Yes,No,3.2017453799,60,4,26,5.488,68.333333333,46,40,20,7,13,25,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,360,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.8,0,0,1,0,0,0,1,,Y,,,Y,,0,,0,1,0,0,0,0,0,1,0,0,,Y,No
1,362-001,Biologic Naïve,43,Male,32.038578412,13.180013689,No,21.6,0,Current,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,No,No,Yes,No,5,24,1,50,25.747,63.333333333,32,0,5,1,4,24,No,No,Yes,No,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,362,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,362-002,Biologic Naïve,40,Male,25.925925926,16.17522245,No,9,20,Never,No,Yes,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,13,7,84,17.959,83.333333333,88,70,10,7,3,25,Yes,No,No,No,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,362,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,362-003,Biologic Naïve,61,Female,40.354297049,4.4654346338,No,6,12,Former,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,7,5,50,6.886,60,56,70,18,11,7,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,362,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,0,0,0,0,1,1,1,,Y,,,Y,,0,,0,0,0,0,0,1,1,1,0,0,,Y,No
1,362-004,Biologic Naïve,48,Female,47.59071981,6.559890486,No,9.5,18,Former,No,Yes,Yes,Yes,Yes,No,No,Yes,5,No,No,No,Yes,Yes,No,Yes,4,21,3,25,19.042,66.666666667,20,20,9,7,2,24,No,No,Yes,No,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,362,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,362-005,Biologic Naïve,42,Female,25.510204082,20.314852841,No,5.1,6,Former,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3.2017453799,5,6,25,15.599,56.666666667,56,0,10,8,2,24,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,362,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-5,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,363-001,Biologic Naïve,51,Female,29.031510377,42.417522245,No,1.2,6,Former,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,1,30,0,0,0,8.3333333333,0,0,3,3,0,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,363,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,8.8,0,0,0,0,0,0,0,1,Y,-6,1,Y,1,1,0,0,0,0,0,0,0,0,0,1,1,Yes,Y,Yes
1,363-002,Biologic Naïve,51,Male,38.154699965,25.423682409,No,5.6,17,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,20,7,67,15,61.666666667,66,40,21,10,11,24,Yes,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,363,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.1,0,0,0,0,1,1,1,1,Y,-17,1,Y,1,1,0,0,0,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,363-003,Biologic Naïve,26,Female,24.859073562,10.499657769,No,6.8,15,Current,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,10,4,0,0,56.666666667,44,10,9,7,2,25,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,363,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.6,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,363-004,Biologic Naïve,32,Female,37.105751391,19.143052704,No,9.8,11,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,40,2,1,0,35,24,30,6,5,1,18,Yes,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,363,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,1,1,1,1,1,1,1,1,Y,-10,1,Y,1,1,0,0,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,367-001,Biologic Non-naïve,33,Male,19.707963809,20.057494867,No,7.2,0,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,25,0,0,40.195,5,0,0,5,2,3,25,No,No,No,No,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,367,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,367-002,Biologic Non-naïve,45,Female,27.51338489,26.140999316,No,12.5,13,Current,Yes,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,2,20,7,63,28.464,66.666666667,72,50,10,3,7,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,367,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.9,0,1,1,1,1,1,1,1,Y,-6,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,368-001,Biologic Naïve,36,Male,25.142857143,18.0862423,Yes,22.5,20,Never,No,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,30,5,56,40,66.666666667,56,90,8,5,3,24,No,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,368,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-22.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,368-002,Biologic Naïve,57,Female,29.394687182,51.274469541,Yes,11.5,5,Former,Yes,Yes,Yes,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,35,2,0,2,76.666666667,64,0,13,10,3,21,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,368,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.3,0,0,1,0,1,1,1,1,Y,-4,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,368-003,Biologic Naïve,67,Female,42.214532872,10.056125941,No,13.2,8,Former,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,35,4,10,0,55,16,20,18,13,5,25,No,No,No,No,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,368,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-13.2,1,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,368-004,Biologic Naïve,61,Female,41.099773243,0.5886379192,No,36.3,28,Current,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,70,2,29,6,10,24,100,28,13,15,25,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,368,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-34.2,0,1,1,0,0,1,1,1,Y,-18,0,Y,0,1,0,0,1,1,0,0,0,1,1,0,0,Yes,Y,Yes
1,368-005,Biologic Naïve,51,Male,31.377989166,8.3832991102,No,28.8,13,Current,No,Yes,No,No,Yes,No,No,Yes,1,No,No,No,No,No,No,No,4,50,4,36,14,56.666666667,50,10,10,7,3,25,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,368,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25.8,0,0,1,0,0,1,1,1,Y,-9,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,369-001,Biologic Non-naïve,52,Male,36.429872495,27.099247091,Yes,25,6,Current,No,No,No,Yes,No,No,No,No,5,No,No,No,Yes,Yes,Yes,No,4,50,8,50,44,56.666666667,48,0,8,6,2,25,Yes,Yes,No,No,3,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.7,0,0,0,0,0,0,0,0,Y,-5,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,369-002,Biologic Naïve,46,Male,36.332408508,31.099247091,Yes,17.8,0,Former,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,4,30,2,0,7,76.666666667,36,20,7,3,4,24,Yes,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,-15.3,0,0,1,0,0,1,1,1,Y,0,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,369-003,Biologic Naïve,46,Male,21.887076365,26.510609172,No,18.8,19,Former,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,50,3,60,24,35,24,60,23,12,11,15,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,1,Y,-16,0,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,369-004,Biologic Naïve,67,Male,24.021275987,20.613278576,No,19.8,2,Former,No,No,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,10,5,52,0,36.666666667,42,0,6,6,0,25,Yes,No,No,No,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-19.8,1,1,1,1,1,1,1,1,Y,-1,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,369-005,Biologic Non-naïve,65,Male,31.097890752,22.384668036,No,16,13,Never,No,Yes,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,4,30,8,57,25,73.333333333,60,50,15,6,9,24,Yes,No,No,No,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.4,0,1,1,0,1,1,1,1,Y,-13,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,369-006,Biologic Naïve,57,Female,19.777698667,47.797399042,No,18.8,7,Never,No,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,60,3,14,21,43.333333333,34,0,12,9,3,25,Yes,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.4,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,369-007,Biologic Naïve,32,Female,48.068814303,29.253935661,No,13.4,19,Former,No,Yes,No,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,3,40,10,92,9,63.333333333,90,10,21,13,8,24,Yes,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-3.8,0,0,0,0,0,0,0,0,Y,-5,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,369-008,Biologic Non-naïve,38,Male,25.209201358,21.029431896,No,10.2,7,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,21.321860465,6,31,13,55,42,0,12,7,5,19,No,No,No,No,2,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.2,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,369-009,Biologic Naïve,69,Female,22.265625,30.92128679,No,3.6,1,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,2,4,0,3,0,31.666666667,8,0,9,5,4,25,Yes,No,No,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.2,0,0,0,0,1,1,1,1,Y,0,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,369-010,Biologic Naïve,42,Male,26.528510346,5.8151950719,No,0.3,2,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,1,1,0,6,6,15,2,0,17,9,8,24,Yes,Yes,No,No,3,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,0,0,0,1,1,1,1,1,Y,,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,369-011,Biologic Naïve,57,Female,30.46875,5.8535249829,No,7.4,9,Never,No,Yes,Yes,No,Yes,No,No,Yes,3,No,No,No,Yes,Yes,Yes,No,3,10,4,21,0,41.666666667,36,10,14,6,8,20,Yes,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.5,0,0,1,1,1,1,1,1,Y,-1,0,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,369-012,Biologic Non-naïve,50,Female,27.548209366,41.300479124,Yes,6,5,Former,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,2,6,5,56,0,51.666666667,68,0,14,9,5,25,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,369,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,371-001,Biologic Naïve,36,Female,24.609733701,4.372347707,No,25.3,19,Current,No,No,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,4,30,8,81,41,93.333333333,68,80,21,15,6,25,No,Yes,No,No,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,371,France,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-22.9,0,1,1,0,0,1,1,1,Y,-15,0,Y,1,1,0,0,1,1,0,0,0,1,1,0,1,Yes,Y,Yes
1,371-002,Biologic Naïve,30,Male,27.738854414,7.4606433949,No,4.7,12,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,10,5,61,0,41.666666667,38,30,17,12,5,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,371,France,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-0.7,0,0,0,0,0,0,1,1,Y,3,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,372-001,Biologic Naïve,56,Female,22.308149911,24.654346338,No,8.4,6,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,12,2,0,60.044,20,10,0,22,18,4,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,372,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.4,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,372-002,Biologic Naïve,47,Female,25.059307027,22.696783025,Yes,5.4,2,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,6,0,20.195,41.666666667,30,0,12,9,3,25,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,372,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-5.2,0,1,1,1,1,1,1,1,Y,-1,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,372-003,Biologic Naïve,23,Male,21.007667799,7.6714579055,No,12,13,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,16,6,9,7.904,53.333333333,54,0,10,7,3,22,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,372,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,-9,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,372-004,Biologic Naïve,28,Female,30.078125,5.864476386,No,12.4,2,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,6,5,0,2.727,50,8,0,1,1,0,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,372,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-11.4,0,1,1,1,1,1,1,1,N,-2,1,N,1,1,0,0,1,1,0,1,1,1,1,1,1,,N,No
1,372-005,Biologic Naïve,27,Female,20.446742024,10.702258727,No,7,5,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,3.5,2,0,20,55,24,0,8,6,2,17,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,372,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,372-006,Biologic Non-naïve,37,Female,24.508945765,5.7303216975,No,8.4,7,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,7,59,6.026,46.666666667,36,70,3,3,0,24,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,372,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-1.7,0,0,0,0,0,0,0,0,N,4,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,372-007,Biologic Naïve,25,Male,21.971335857,10.088980151,No,24,9,Current,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,45,7,0,10,60,24,100,8,5,3,23,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,372,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.1,0,0,1,0,0,1,1,1,Y,-8,1,Y,1,1,1,1,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,372-008,Biologic Non-naïve,46,Male,32.525951557,15.805612594,No,3.2,6,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,4,7,40,9.957,41.666666667,44,0,8,5,3,25,No,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,372,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,372-009,Biologic Non-naïve,59,Male,27.160493827,40.848733744,No,1.2,0,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,1,4,0,10,10,10,4,2,2,25,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,372,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,372-010,Biologic Non-naïve,26,Female,22.308149911,8.8596851472,No,0.5,3,Never,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,3,0,0,0,15,4,0,7,6,1,23,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,372,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-3,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,372-011,Biologic Non-naïve,30,Male,28.926223521,8.8788501027,Yes,4.8,10,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,3,14,8,21.666666667,42,70,24,12,12,25,No,No,No,No,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,372,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,372-012,Biologic Non-naïve,23,Female,22.862368541,9.0759753593,No,8,14,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,6,40,0,68.333333333,68,60,16,14,2,23,No,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,372,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.6,0,0,0,0,0,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,372-014,Biologic Naïve,37,Male,20.338326446,20.046543463,No,18,14,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,30,3,70,4,56.666666667,48,60,29,17,12,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,372,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-18,1,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,372-015,Biologic Non-naïve,24,Female,25.636917161,8.0082135524,No,3.2,10,Current,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,4,8,76,25.402,70,70,50,12,6,6,23,Yes,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,372,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.8,0,0,0,0,0,1,1,1,Y,-3,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,372-017,Biologic Naïve,64,Female,25.059307027,10.031485284,No,9.8,6,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,5,28,0,28.333333333,30,30,18,11,7,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,372,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,372-018,Biologic Non-naïve,47,Male,30.218857788,19.857631759,No,2,0,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,3,0,0,14.991,58.333333333,8,0,6,1,5,22,No,Yes,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,372,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,0,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,374-001,Biologic Non-naïve,29,Male,30.793382442,4.4982888433,No,0,0,Current,Yes,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,0,0,0,76,2.747,3.3333333333,14,10,14,8,6,23,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,374,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,N,0,,,,1,1,1,1,,N,0,,N,,0,,0,0,0,0,1,1,1,1,0,0,,N,No
1,374-002,Biologic Non-naïve,71,Female,29.031510377,50.006844627,No,27.9,12,Never,No,Yes,No,Yes,No,No,No,No,1.5063613232,No,No,No,No,Yes,No,No,3,70,10,100,9,98.333333333,100,70,16,10,6,25,No,No,Yes,No,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,374,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-23.7,0,0,1,0,0,0,1,0,Y,-4,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,374-003,Biologic Non-naïve,18,Female,19.834710744,12.473648186,No,3,7,Never,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,5,6,0,10,75,60,10,19,10,9,22,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,374,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,2,0,0,0,0,0,0,1,0,Y,1,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,374-004,Biologic Naïve,43,Male,23.959094229,22.910335387,No,4.8,3,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,7,2,0,4,18.333333333,6,10,14,9,5,21,No,No,No,Yes,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,374,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-3,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,376-001,Biologic Non-naïve,72,Male,34.955213633,43.003422313,No,12.9,11,Former,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,30,8,0,10.53,48.333333333,54,0,8,5,3,19,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,376,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-3,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,376-002,Biologic Non-naïve,56,Male,33.196080309,3.6221765914,No,30.1,18,Current,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,40,8,90,35.382,81.666666667,84,90,14,9,5,21,Yes,No,Yes,Yes,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,376,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-28.7,0,1,1,0,1,1,1,1,N,-7,0,N,1,1,0,0,1,1,0,0,1,1,1,0,1,,N,No
1,376-003,Biologic Naïve,43,Male,25.335001984,9.6865160849,No,8.6,5,Former,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,4,7,42,11.683,66.666666667,62,20,14,9,5,24,Yes,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,376,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-7.8,0,1,1,1,1,1,1,1,Y,-4,1,Y,0,1,0,0,1,1,0,1,1,1,1,1,0,Yes,Y,Yes
1,376-004,Biologic Non-naïve,37,Male,23.888440981,12.804928131,No,11,12.219,Missing,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,3,34.133,19.874,56.68,31.353,20.813,5.162,4.475,0.687,22.686,Yes,No,No,No,2.226,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,376,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,376-005,Biologic Non-naïve,58,Female,19.777698667,6.3271731691,No,8.4,13.735,Former,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,10,4.958,66.099,16.811,75.504,71.896,41.014,21.746,11.803,9.943,22.189,No,No,Yes,No,0.035,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,376,France,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-3,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,376-006,Biologic Non-naïve,60,Female,23.836734694,42.688569473,Yes,14.521901872,1,Former,Yes,No,No,Yes,No,No,No,No,2,No,No,No,No,No,No,Yes,1,21.321860465,1,0,22.039,5,6,30,23,12,11,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,376,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,1,Y,-1,,Y,1,1,1,1,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,376-007,Biologic Non-naïve,44,Female,35.436671239,30.321697467,No,1.2,11,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,4,5,25,2.496,33.333333333,50,40,21,11,10,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,376,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.2,1,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,376-010,Biologic Naïve,54,Female,22.491349481,11.104722793,No,14.521901872,25,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,21.321860465,6,76,19.752,60,62,70,20,12,8,25,No,No,Yes,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,376,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-19,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,376-011,Biologic Naïve,55,Female,33.177732341,3.3538672142,Yes,11.6,12.657,Missing,No,Yes,No,No,No,No,No,No,2,No,No,No,No,Yes,No,Yes,5,5,5.862,59.148,28.123,51.644,32.479,38.928,14.068,6.266,7.802,17.948,No,No,Yes,No,1.627,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,376,France,Europe,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,4,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,377-002,Biologic Naïve,49,Female,23.054562464,43.934291581,Yes,24,19,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,50,4,12,12.575,81.666666667,30,60,14,10,4,25,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,377,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24,1,1,1,1,1,1,1,1,Y,-18,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,377-003,Biologic Naïve,24,Female,19.233560749,6.0232717317,No,12.2,23.777,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,9.461,86.425,6,88.006,94.654,79.469,17.368,12.202,5.166,21.898,Yes,No,No,Yes,0.789,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,377,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,377-004,Biologic Naïve,74,Female,30.859375,29.040383299,Yes,3.5,5,Never,Yes,Yes,Yes,Yes,No,No,No,No,5,Yes,Yes,No,Yes,Yes,No,No,2,1,5,13,0,21.666666667,24,10,13,8,5,25,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,377,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.5,1,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,377-005,Biologic Naïve,38,Male,27.423822715,26.039698836,No,13.9,20,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,20,5,50,18,36.666666667,34,60,8,6,2,24,No,No,Yes,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,377,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,1,Y,-20,1,Y,1,1,1,1,0,0,0,0,0,0,0,1,1,Yes,Y,Yes
1,377-007,Biologic Naïve,71,Female,29.031510377,12.082135524,No,14.2,11,Former,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,No,Yes,3,25,6,4,0,48.333333333,38,0,26,15,11,23,No,No,Yes,Yes,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,377,France,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-10.6,0,0,0,0,0,0,1,1,Y,-5,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,377-008,Biologic Naïve,32,Female,24.221453287,13.013004791,No,7,9.974,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,0,24.202,0,33.333333333,26,31.442,16.121,8.961,7.16,19.567,No,Yes,Yes,Yes,2.179,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,377,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,0,0,1,1,1,1,1,,Y,,,Y,,0,,0,1,0,0,1,1,1,1,0,0,,Y,No
1,377-009,Biologic Naïve,41,Female,26.838647653,8.1779603012,No,3.7,4,Current,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,1,30,5,22,0,30,24,0,10,7,3,25,No,No,No,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,377,France,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.7,1,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,377-010,Biologic Non-naïve,48,Female,34.577632362,7.65229295,No,6.8,17,Never,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,10,1,37,40,25,26,80,17,10,7,24,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,377,France,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.8,0,0,0,0,0,0,1,,Y,,,Y,,0,,0,0,0,0,0,0,0,1,0,0,,Y,No
1,402-001,Biologic Naïve,49,Male,55.773391022,6.8364134155,No,45.6,12.929,Missing,Yes,Yes,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,5,80,6.277,26.764,21,68.126,44.777,62.717,18.261,8.801,9.46,20.662,Yes,No,Yes,Yes,0.668,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,402,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.1,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,402-002,Biologic Non-naïve,29,Male,23.545706371,15.156741958,No,27,20.316,Missing,Yes,No,No,No,No,No,No,No,2,No,No,No,No,No,No,No,4,80,7.027,79.777,104,57.687,33.266,70.669,20.007,12.253,7.753,18.103,Yes,No,Yes,Yes,1.834,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,402,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,412-001,Biologic Naïve,37,Female,42.436634389,16.599589322,No,10.1,23.6,Never,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,17,7.091,66.402,14.711,79.01,51.38,53.558,17.085,11.071,6.014,21.398,No,No,No,Yes,1.609,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,412,Germany,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,412-002,Biologic Non-naïve,53,Female,31.553659149,8.205338809,No,18.8,10,Current,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,Yes,4,8,4,24,35.106,41.666666667,32,30,2,2,0,24,No,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,412,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.8,0,0,1,0,1,1,1,0,Y,-9,1,Y,0,0,0,0,1,0,0,0,1,1,1,1,0,No,Y,No
1,413-001,Biologic Naïve,53,Male,36.250709188,9.2621492129,No,17.8,7,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,14,6,29,32,30,14,0,5,1,4,25,No,Yes,Yes,No,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,413,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,1.4,0,0,0,0,0,0,0,0,N,1,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,414-001,Biologic Non-naïve,40,Female,21.789965986,30.313483915,Yes,4.5,14,Current,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,2,8,6,76,8.826,48.333333333,34,50,17,11,6,22,No,Yes,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,414,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,1,1,1,1,1,1,1,1,Y,3,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,414-002,Biologic Naïve,40,Female,49.063724779,2.9349760438,No,10.3,2,Former,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,13,6,10,14.876,41.666666667,26,0,1,1,0,24,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,414,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,1,0,1,1,1,1,Y,0,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,414-003,Biologic Naïve,43,Male,28.244897959,15.375770021,No,6.2,7,Former,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,2,8,4,40,13.043,45,46,0,0,0,0,23,No,Yes,No,Yes,3,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,414,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,0,0,0,0,0,1,1,1,Y,0,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,418-001,Biologic Naïve,57,Male,31.435911303,4.3613963039,No,33.6,22,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,60,7,81,0,81.666666667,76,70,16,7,9,25,No,No,Yes,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,418,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.6,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,418-002,Biologic Naïve,57,Male,32.212293201,3.4305270363,No,13.5,29,Current,Yes,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,4,15,6,88,66,81.666666667,78,100,17,9,8,25,No,No,Yes,No,2,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,418,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.7,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,418-003,Biologic Naïve,73,Male,28.06642387,24.158795346,No,33.2,16,Former,No,No,Yes,Yes,No,No,No,No,8,No,No,No,No,No,No,No,4,21.321860465,10,84,52.64,100,100,100,4,1,3,25,No,No,Yes,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,418,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.3,0,0,1,0,0,0,0,0,Y,-5,0,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,418-005,Biologic Naïve,72,Male,24.382716049,20.988364134,No,10.5,9.344,Missing,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,35,2.371,17.024,0,28.204,0.195,38.546,15.08,10.153,4.927,24.102,No,No,No,No,0.222,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,418,Germany,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,418-006,Biologic Naïve,59,Female,26.037493991,6.1437371663,No,11.5,9,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,30,8,71,20,81.666666667,80,10,21,12,9,25,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,418,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.1,0,1,1,1,1,1,1,1,Y,-4,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,418-007,Biologic Naïve,65,Female,48.210372535,0.59137577,No,10.8,10.702,Missing,No,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,2,4,5.259,23.726,48,38.593,50.288,40.195,11.613,8.039,3.574,19.145,No,No,Yes,No,0.97,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,418,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,419-002,Biologic Naïve,42,Male,53.748992206,20.851471595,No,32.6,24,Current,Yes,Yes,No,Yes,Yes,No,No,Yes,4,No,No,No,Yes,Yes,Yes,No,4,48,6,72,55,58.333333333,52,90,20,11,9,25,No,Yes,Yes,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,419,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-29.9,0,1,1,0,0,1,1,1,Y,-21,0,Y,0,1,0,0,1,1,0,0,0,1,1,0,0,Yes,Y,Yes
1,419-003,Biologic Naïve,45,Female,25.455577437,20.947296372,No,22.2,8,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,30,8,82,1.101,53.333333333,78,80,12,4,8,25,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,419,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.4,0,0,0,0,0,0,0,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,419-004,Biologic Naïve,39,Female,26.026174896,14.116358658,No,16.3,14,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,8,76,14.039,60,60,20,22,10,12,18,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,419,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.3,1,1,1,1,1,1,1,1,Y,-14,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,419-005,Biologic Naïve,39,Female,24.092970522,1.9685147159,No,22.2,15,Current,No,No,No,Yes,Yes,No,No,Yes,9,Yes,No,No,No,No,Yes,No,3,30,9,30,10.227,83.333333333,76,80,19,11,8,25,No,No,Yes,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,419,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-15,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,420-001,Biologic Naïve,19,Female,29.036737786,6.0725530459,No,7.3,14,Never,No,Yes,Yes,No,No,No,No,No,2,No,No,No,No,Yes,No,No,3,8,8,80,0,48.333333333,64,70,13,10,3,25,Yes,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.3,1,1,1,1,1,1,1,1,Y,-14,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,420-002,Biologic Non-naïve,46,Male,32.808641975,13.021218344,No,7.6,18,Current,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,18,4,51,23,26.666666667,30,30,6,5,1,25,Yes,Yes,No,Yes,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.2,0,0,1,0,1,1,1,0,Y,-11,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,420-003,Biologic Naïve,46,Male,24.4140625,28.030116359,No,8.8,11,Former,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,19,4,40,33,53.333333333,50,50,19,12,7,25,No,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.8,1,1,1,1,1,1,1,1,Y,-9,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,420-004,Biologic Naïve,53,Female,22.189349112,36.164271047,No,7,6,Never,Yes,Yes,Yes,No,Yes,No,No,Yes,1,No,No,No,No,No,No,Yes,3,18,4,10,12.18,33.333333333,18,0,17,10,7,23,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.2,0,0,1,1,1,1,1,1,Y,-6,1,Y,1,1,0,0,1,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,420-005,Biologic Naïve,40,Female,37.55205235,40.498288843,No,5.1,18,Former,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,18,7,0,8,46.666666667,28,60,18,9,9,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.1,1,1,1,1,1,1,1,1,Y,-18,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,420-006,Biologic Naïve,55,Male,30.159156738,35.181382615,No,10.5,3.941,Missing,No,Yes,No,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,22,1.704,54.962,29,51.844,17.3,40.398,8.105,6.042,2.063,23.746,No,No,No,No,1.716,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.1,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,420-007,Biologic Naïve,34,Male,18.590124926,10.444900753,No,14.6,24,Former,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,No,No,No,4,40,7,69,23,66.666666667,70,70,13,6,7,24,Yes,No,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.6,1,1,1,1,1,1,1,1,Y,-24,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,420-008,Biologic Naïve,28,Female,45.061728395,6.5763175907,No,22.7,22,Current,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,66,7,70,6.817,81.666666667,70,70,27,13,14,25,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.5,0,1,1,0,1,1,1,1,Y,-17,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,420-009,Biologic Naïve,60,Male,28.734672057,40.295687885,No,22.5,12,Never,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,No,Yes,No,4,59,8,31,23,50,26,20,4,3,1,20,No,No,No,No,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.7,0,0,1,0,0,0,1,0,Y,-11,1,Y,0,0,0,0,1,0,0,0,0,0,1,1,0,No,Y,No
1,420-010,Biologic Naïve,28,Female,34.256055363,14.406570842,No,11.6,20,Never,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,27,6,0,19.087,36.666666667,24,70,31,19,12,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,0,1,1,1,1,1,1,1,Y,-19,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,420-011,Biologic Non-naïve,44,Male,34.602076125,31.685147159,No,22.8,12,Never,Yes,Yes,No,No,No,No,No,No,7,No,No,No,Yes,Yes,Yes,No,4,33,1,17,2,48.333333333,20,50,6,2,4,24,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.6,0,1,1,0,1,1,1,1,Y,-10,0,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,420-012,Biologic Naïve,53,Male,35.185185185,20.750171116,Yes,4.1,16,Current,Yes,No,Yes,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,11,3,28,36,16.666666667,28,30,9,5,4,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.5,0,0,1,1,1,1,1,0,Y,-3,0,Y,0,0,0,0,1,0,0,1,1,1,1,0,0,No,Y,No
1,420-013,Biologic Naïve,44,Female,42.517006803,35.778234086,No,5.6,17.181,Missing,Yes,Yes,Yes,Yes,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,3,14,6.322,42.027,30,46.801,34.804,11.069,28.132,14.433,13.699,18.554,No,No,Yes,Yes,1.612,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.3,0,1,1,1,1,1,1,1,Y,,,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,420-014,Biologic Naïve,36,Male,25.029760996,20.780287474,No,11.1,19,Never,Yes,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,19,6,67,39,53.333333333,42,60,8,6,2,20,Yes,No,Yes,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.3,0,1,1,1,1,1,1,1,Y,,,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,420-015,Biologic Naïve,55,Female,32.888888889,18.009582478,No,8.7,16,Never,Yes,Yes,No,Yes,Yes,No,No,Yes,6,No,No,No,Yes,Yes,Yes,No,3,10,8,4,22,66.666666667,72,40,16,9,7,23,No,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.5,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,420-016,Biologic Naïve,57,Male,35.802469136,31.039014374,No,8.1,13,Never,Yes,Yes,No,Yes,Yes,No,No,Yes,5,Yes,No,No,Yes,Yes,Yes,No,3,14,6,35,21,68.333333333,44,30,9,5,4,25,Yes,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-8.1,1,1,1,1,1,1,1,1,Y,,,N,1,1,1,1,1,1,1,1,1,1,1,0,1,,N,No
1,420-017,Biologic Naïve,23,Male,30.930438076,9.4072553046,Yes,24,21,Never,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,80,1,25,1,60,42,90,13,9,4,23,Yes,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.4,0,0,1,0,0,0,1,0,Y,-4,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,420-018,Biologic Naïve,20,Male,26.82742078,14.075290897,No,14.7,8,Never,Yes,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,15,3,60,15,61.666666667,20,10,5,3,2,24,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.5,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,420-019,Biologic Naïve,42,Male,21.146319909,21.097878166,No,5,20,Never,Yes,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,14,3,15,8,45,24,40,14,6,8,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5,1,1,1,1,1,1,1,1,Y,-19,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,420-020,Biologic Non-naïve,48,Male,28.086260331,31.110198494,No,18.8,5,Current,Yes,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,26,3,38.649,45,26.666666667,10,20,6,1,5,22.464,No,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17,0,1,1,0,1,1,1,1,Y,-4,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,420-021,Biologic Naïve,61,Female,45.703125,47.96440794,No,4.6,0,Current,Yes,No,No,Yes,Yes,No,No,Yes,6,Yes,No,No,Yes,Yes,Yes,No,3,10,0,0,4.576,6.6666666667,4,10,7,4,3,23,No,Yes,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,1.7,0,0,0,0,0,0,0,0,Y,1,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,420-022,Biologic Naïve,19,Male,26.643598616,5.144421629,Yes,14.7,17.877,Current,No,No,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,19,4.49,76.464,30,76.549,64.061,63.493,16.873,9.353,7.52,24.516,Yes,Yes,No,Yes,0.175,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.9,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,420-023,Biologic Non-naïve,32,Male,26.729927495,15.154004107,Yes,13.8,25,Current,Yes,Yes,No,No,Yes,No,No,Yes,1,No,No,No,No,Yes,No,No,4,12,7,76,20,66.666666667,60,70,14,6,8,25,Yes,No,No,No,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.8,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,420-024,Biologic Naïve,48,Male,37.756022587,8.1615331964,No,4.4,6,Never,No,Yes,No,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,No,3,5,6,37,35,40,26,0,31,18,13,21,Yes,No,No,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.4,0,0,0,0,0,1,1,1,Y,-1,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,420-025,Biologic Naïve,25,Male,25.880570635,11.173169062,No,18,12,Current,No,Yes,No,No,Yes,No,No,Yes,2,Yes,No,No,No,Yes,No,No,4,27,7,0,10,58.333333333,52,20,16,6,10,24,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,420-026,Biologic Naïve,26,Male,34.936844934,0.0958247775,No,12.6,22,Current,No,No,Yes,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,3,18,8,73,11,51.666666667,60,50,9,6,3,22,Yes,No,No,No,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.7,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,420-027,Biologic Naïve,31,Male,24.543462381,15.189596167,No,17.8,13,Current,Yes,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,22,5,0,2,46.666666667,42,40,19,11,8,20,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.7,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,420-028,Biologic Naïve,52,Male,25.147415886,6.2669404517,No,5.7,4,Never,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,10,1,0,32.728,10,10,0,11,8,3,25,Yes,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.9,0,0,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,420-029,Biologic Naïve,33,Male,30.778701139,4.0301163587,No,14.3,5,Current,No,Yes,No,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,No,4,14,7,5,10,53.333333333,38,10,24,15,9,21,Yes,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.5,0,0,1,0,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,420-030,Biologic Naïve,30,Male,24.30248706,11.947980835,No,9.9,3,Current,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,12,3,2,44,13.333333333,16,20,5,4,1,24,Yes,Yes,No,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.5,0,1,1,1,1,1,1,1,Y,-1,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,420-031,Biologic Naïve,20,Male,24.994202376,0.4188911704,No,20.7,18,Current,No,No,No,No,Yes,No,No,Yes,1,No,No,No,No,No,No,No,4,22,9,92,26.524,90,66,80,15,9,6,13,Yes,No,No,No,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.3,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,420-032,Biologic Naïve,30,Female,46.308815576,8.1752224504,No,8.4,21,Current,No,Yes,Yes,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,2,12,6,26,10.09,60,30,50,19,7,12,22,Yes,No,No,No,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.4,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,420-033,Biologic Naïve,33,Male,24.857954545,3.3757700205,No,12.9,18,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,18,6,37,1,73.333333333,58,80,20,10,10,25,Yes,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,420-034,Biologic Naïve,36,Male,24.021275987,0.5366187543,No,12.9,20,Never,No,No,No,No,Yes,No,No,Yes,2,No,No,No,No,No,No,No,3,34,1,10,4,26.666666667,18,60,27,15,12,25,Yes,Yes,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,420,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.6,0,0,0,0,0,0,0,0,Y,-7,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,422-001,Biologic Naïve,44,Male,24.933560274,14.631074606,No,11.2,19,Current,Yes,No,No,No,No,No,No,No,1,No,No,No,No,No,No,No,3,13,8,0,30,68.333333333,42,50,12,6,6,23,No,No,Yes,Yes,3,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.2,1,1,1,1,1,1,1,1,Y,-19,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,422-002,Biologic Naïve,27,Female,20.047445621,14.787132101,No,8.4,4,Never,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,7,1,2,31.193,31.666666667,4,0,6,5,1,25,No,Yes,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,422-003,Biologic Naïve,43,Male,30.34607438,20.449007529,No,7.2,14,Former,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,4.5,4,25,6.063,26.666666667,20,30,18,10,8,24,No,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-7.2,1,1,1,1,1,1,1,1,Y,6,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,422-004,Biologic Naïve,25,Male,23.722810652,2.6009582478,No,29.6,18,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,13,7,52,15.608,38.333333333,26,70,18,11,7,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-29.6,1,1,1,1,1,1,1,1,Y,-16,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,422-005,Biologic Naïve,25,Male,26.12244898,12.605065024,No,12,1,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,17,3,60,6.93,20,16,0,2,2,0,24,No,No,No,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,422-006,Biologic Non-naïve,55,Female,35.996326905,22.866529774,No,4.8,8.817,Missing,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,4,4.782,73.885,14.646,69.891,76.076,59.471,17.772,10.72,7.052,20.203,No,No,Yes,No,0.277,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,9,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,422-007,Biologic Non-naïve,56,Female,27.34375,24.8678987,No,9,22,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,13,8,0,33.404,88.333333333,48,100,35,17,18,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,1,1,1,1,1,1,1,1,Y,-22,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,422-008,Biologic Naïve,51,Male,31.699070161,35.715263518,Yes,5.2,7,Former,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,7,3,21,17,76.666666667,50,30,8,3,5,23,No,No,Yes,Yes,2,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,0,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,422-009,Biologic Non-naïve,30,Male,21.329437546,13.719370294,No,6.4,11,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,4,5,33,15,65,42,30,4,2,2,25,No,Yes,No,No,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.3,0,0,0,0,0,0,1,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,422-010,Biologic Non-naïve,50,Male,38.276113952,22.754277892,Yes,11.1,9,Never,No,Yes,No,Yes,No,No,No,No,5,No,No,No,Yes,Yes,No,Yes,3,13,3,90,50.006,68.333333333,40,20,9,4,5,23,No,No,No,No,2,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.3,0,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,422-011,Biologic Naïve,60,Male,37.736988286,5.7713894593,No,11.7,13,Current,Yes,Yes,No,Yes,No,No,No,No,7,No,No,No,Yes,Yes,Yes,No,3,10,8,70,13.559,78.333333333,68,70,16,9,7,24,No,Yes,No,Yes,3,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.3,0,0,0,0,0,0,0,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,422-012,Biologic Non-naïve,21,Male,23.374726077,3.6906228611,No,4.2,3,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,9,5,6.649,6.803,30,16,10,12.862,5.774,7.087,24.379,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.3,0,0,0,0,0,0,1,0,Y,3,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,422-013,Biologic Non-naïve,29,Female,36.328125,7.8795345654,Yes,13.4,26,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,19,8,74,18.418,76.666666667,78,70,27,14,13,25,No,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.7,0,0,0,0,0,0,0,0,Y,0,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,422-014,Biologic Naïve,50,Male,19.655451497,15.800136893,No,12.2,14.325,Missing,No,Yes,No,Yes,No,No,No,No,3,No,No,No,No,No,No,No,3,17,8.442,32.164,29.731,70.975,62.171,56.402,9.959,6.493,3.466,20.464,Yes,No,No,No,0.609,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,422-015,Biologic Naïve,41,Female,31.861629495,33.872689938,No,3.6,5,Never,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,6,4,65,17.054,45,34,30,15,7,8,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.6,0,0,0,0,1,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,1,1,1,0,0,No,Y,No
1,422-016,Biologic Naïve,64,Female,21.303948577,20.810403833,Yes,2.1,10.447,Missing,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,1,4,3.462,12.836,26.406,20.401,17.521,52.343,14.218,8.718,5.5,21.961,Yes,No,No,Yes,0.732,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.2,0,0,0,1,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,422-017,Biologic Naïve,18,Male,20.047445621,2.8117727584,No,12.6,1,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,24,2,0,6.039,18.333333333,12,0,11,3,8,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.6,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,422-018,Biologic Naïve,42,Male,23.306680053,11.82477755,Yes,3.1,12,Never,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,2,6,3,4,6.803,30,22,40,24,13,11,25,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.5,0,0,1,1,1,1,1,1,Y,-4,0,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,422-019,Biologic Naïve,50,Male,24.355421181,10.841889117,No,21.3,17,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,7,75,11.279,71.666666667,72,90,22,13,9,25,Yes,Yes,Yes,Yes,4,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,422-020,Biologic Naïve,36,Female,22.275309917,22.844626968,No,12.8,14,Former,Yes,No,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,17,2,34,22.538,51.666666667,22,20,7,6,1,23,No,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.7,0,0,0,0,0,0,1,0,Y,-11,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,422-021,Biologic Naïve,27,Female,22.204081633,8.8432580424,No,4.4,17,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,4,2,77,4.128,50,40,20,12,7,5,25,No,No,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,0,0,0,0,0,1,1,1,Y,-15,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,422-022,Biologic Naïve,37,Male,30.585811928,3.8439425051,No,4.2,18,Former,No,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,2,6,8,70,2.85,88.333333333,76,70,36,18,18,21,No,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.6,0,0,1,1,1,1,1,1,Y,-12,0,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,422-023,Biologic Naïve,54,Female,31.209174046,34.85284052,Yes,10.4,5,Never,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,11,7,0,36.644,66.666666667,22,0,9,5,4,21,Yes,Yes,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.9,0,0,1,0,0,1,1,0,Y,-5,1,Y,0,0,0,0,1,0,0,0,0,1,1,1,0,No,Y,No
1,422-024,Biologic Naïve,20,Female,21.192742415,8.9637234771,No,5.3,2.84,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,12,3.006,32.769,39.665,33.493,41.161,10.58,6.601,2.423,4.178,24.486,Yes,No,No,Yes,0.854,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.5,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,422-025,Biologic Naïve,28,Male,21.604938272,4.0191649555,No,30.6,25,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,42,0,55,27.377,61.666666667,50,30,13,6,7,25,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,422,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-29.7,0,1,1,1,1,1,1,1,Y,-21,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,424-001,Biologic Naïve,18,Female,22.699724518,6.8281998631,No,13.5,8,Never,No,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,19,8,70,0,78.333333333,92,30,15,9,6,25,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.7,0,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,424-002,Biologic Naïve,28,Male,29.031510377,7.0581793292,No,20.2,24,Former,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,39,9,87,13,83.333333333,86,80,22,11,11,24,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.5,0,0,0,0,0,0,0,0,Y,-17,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,424-003,Biologic Naïve,29,Male,23.725346969,17.360711841,No,12.9,5,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,25,5,23,10,36.666666667,24,20,8,6,2,23,No,No,No,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.3,0,0,0,0,0,0,1,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,424-004,Biologic Naïve,26,Female,51.388285609,9.4976043806,No,11,11,Never,Yes,No,No,No,Yes,No,No,Yes,3,No,No,No,Yes,Yes,Yes,No,3,14,5,41,0,48.333333333,48,30,15,7,8,22,Yes,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.1,0,0,1,0,1,1,1,0,Y,-5,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,424-005,Biologic Naïve,30,Male,24.810964083,9.6454483231,No,12.3,7,Never,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,12,3,25,0,33.333333333,24,60,12,7,5,25,Yes,Yes,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,424-006,Biologic Naïve,43,Male,26.481481481,31.633127995,No,10.2,12,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,2,5,0,43.333333333,36,30,14,8,6,25,Yes,Yes,No,Yes,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,0,1,1,1,1,1,1,1,Y,-5,0,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,424-007,Biologic Naïve,36,Male,26.594984129,23.786447639,No,10.2,1,Former,No,Yes,Yes,No,Yes,No,Yes,Yes,0,No,No,No,No,No,No,No,3,26,0,0,24,23.333333333,2,20,3,1,2,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.5,0,0,1,0,1,1,1,0,Y,-1,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,424-008,Biologic Naïve,54,Female,23.40979965,47.86036961,No,10.2,27,Former,Yes,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,13,10,56,0,89.525,69.463,100,17,6,11,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,0,1,1,1,1,1,1,1,Y,-26,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,424-009,Biologic Naïve,65,Male,27.441962829,40.616016427,No,11.6,11,Former,Yes,No,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,17,8,48,32,66.666666667,56,20,3,1,2,24,No,Yes,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.3,0,0,1,0,0,1,1,0,Y,-10,1,Y,0,0,0,0,1,0,0,0,0,1,1,1,0,No,Y,No
1,424-010,Biologic Non-naïve,63,Male,31.047694544,16.654346338,Yes,10.4,6,Never,No,Yes,Yes,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,8.1,5,15,2,58.333333333,40,0,3,3,0,24,No,No,No,No,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.3,0,0,0,0,0,0,0,0,Y,-5,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,424-011,Biologic Naïve,47,Female,33.177732341,19.79192334,Yes,10.2,5,Never,No,No,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,17,3,23,0,18.333333333,16,10,23,11,12,24,Yes,No,No,Yes,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8,0,0,1,0,0,1,1,0,Y,3,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,424-012,Biologic Naïve,63,Male,34.363338613,15.811088296,No,14.6,6,Never,Yes,No,Yes,Yes,Yes,No,Yes,Yes,2,No,No,No,No,No,Yes,No,3,15,2,24,4,33.333333333,6,0,3,0,3,22,Yes,No,No,Yes,1,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.7,0,0,0,0,0,0,0,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,424-013,Biologic Naïve,46,Female,52.617712372,1.0266940452,No,21.6,20,Never,No,No,Yes,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,4,34,8,71,0,78.333333333,74,70,14,7,7,24,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.6,0,1,1,0,1,1,1,1,Y,-20,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,424-014,Biologic Naïve,39,Male,37.544641494,14.023271732,No,14.4,6,Current,No,No,No,Yes,Yes,No,No,Yes,2,No,No,No,No,No,Yes,No,3,20,7,29,5,40,42,0,11,3,8,25,Yes,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,424,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,0,0,0,0,0,0,1,0,Y,-5,1,Y,0,0,0,0,0,0,0,0,0,0,1,1,0,No,Y,No
1,430-001,Biologic Naïve,43,Female,29.62962963,30.516084873,No,15.8,6,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,4,30,0,26.42,5,51.666666667,32,0,4,3,1,25,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,430,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.8,0,0,0,0,0,0,0,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,430-002,Biologic Naïve,54,Male,23.682124455,42.554414784,Yes,14.7,17,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,23,5,71,4,51.666666667,34,40,31,13,18,24,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,430,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-1.2,0,0,0,0,0,0,0,0,N,-1,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,430-003,Biologic Naïve,21,Male,37.839506173,14.554414784,No,4.8,24.214,Missing,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,8,8.085,73.879,0,86.929,67.42,73.809,33.025,19.264,13.761,22.212,No,No,No,No,2.601,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,430,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,430-004,Biologic Non-naïve,49,Male,41.712158114,32.635181383,Yes,10.2,7,Current,Yes,No,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,Yes,3,10,2,37,100,65,32,30,6,0,6,18,No,No,Yes,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,430,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,0,0,0,0,0,0,0,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,430-005,Biologic Naïve,22,Male,30.974519986,7.5811088296,No,16.2,8,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,5,18,8,79,4,98.333333333,84,30,8,2,6,25,Yes,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,430,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.2,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,434-001,Biologic Naïve,26,Female,27.688778134,5.6536618754,No,16.5,15.296,Missing,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,13,5.52,22.314,0,62.664,46.672,44.816,18.313,9.662,8.651,24.651,No,Yes,No,Yes,2.317,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,434,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-15.9,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,434-002,Biologic Naïve,34,Male,24.161722462,0.4134154689,No,16.4,3,Never,Yes,No,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,35,0,4,14.456,8.3333333333,0,10,11,8,3,25,No,Yes,No,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,434,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.4,1,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,434-003,Biologic Naïve,46,Female,31.975014872,2.71321013,No,11.5,18.933,Missing,No,No,Yes,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,3,20,5.442,56.797,0,47.729,35.968,31.956,18.697,8.189,10.508,21.225,No,No,No,Yes,0.953,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,434,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,434-004,Biologic Non-naïve,56,Female,24.538964902,37.275838467,Yes,13.6,23,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,8,79,11,61.666666667,76,60,29,14,15,24,Yes,Yes,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,434,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,0,0,1,0,0,1,1,0,Y,-11,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,434-005,Biologic Naïve,51,Female,49.603174603,31.077344285,No,17.2,18,Former,Yes,No,Yes,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,4,25,8,88,2,68.333333333,68,40,25,13,12,23,Yes,Yes,No,Yes,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,434,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.6,0,1,1,1,1,1,1,1,Y,-13,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,434-006,Biologic Non-naïve,39,Female,41.401633483,28.596851472,No,5.1,4,Never,No,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,7,7,76,5,56.666666667,56,10,18,10,8,24,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,434,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.2,0,0,0,0,0,0,1,0,Y,2,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,434-007,Biologic Naïve,55,Male,33.412409369,20.684462697,No,21.2,0.326,Missing,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,15,1.624,3.717,9.178,19.073,4.099,12.327,16.148,8.246,7.902,21.6,Yes,No,No,No,2.327,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,434,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.9,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,434-008,Biologic Naïve,52,Female,31.239414355,3.9014373717,Yes,4,14,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,8,6,35,46.541,38.333333333,44,50,27,15,12,23,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,434,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.8,0,0,0,0,1,1,1,0,Y,1,0,Y,0,0,0,0,0,0,0,0,1,1,1,0,0,No,Y,No
1,434-009,Biologic Naïve,28,Female,21.208448753,6.6064339493,No,28.4,30,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,22,10,100,31.109,95,96,100,34,19,15,25,Yes,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,434,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.5,0,1,1,1,1,1,1,1,Y,-30,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,435-001,Biologic Naïve,38,Female,25.344352617,5.4428473648,No,3.7,14,Never,Yes,Yes,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,2,7,62,13.866,60,46,0,15,10,5,23,No,Yes,No,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,435,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.7,1,1,1,1,1,1,1,1,Y,-3,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,435-002,Biologic Non-naïve,38,Female,25.864512472,18.302532512,Yes,6,10,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,10,6,29,27.958,40,50,30,3,2,1,25,No,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,435,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.9,0,0,1,0,1,1,1,1,Y,1,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,436-001,Biologic Naïve,35,Male,26.874496103,10.866529774,No,7.7,13,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,3,49,30.001,56.666666667,26,30,8,6,2,24,Yes,Yes,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.7,1,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,436-002,Biologic Naïve,66,Female,27.440599174,7.9863107461,No,13.4,7,Former,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,11,5,0,10,68.333333333,38,70,7,5,2,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.4,1,1,1,1,1,1,1,1,Y,-3,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,436-003,Biologic Naïve,39,Male,21.913805698,6.7570157426,No,22.4,20,Never,No,No,No,No,No,No,No,No,1,No,No,No,No,No,No,No,3,40,8,0,0,68.333333333,50,50,21,10,11,18,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.4,1,1,1,1,1,1,1,1,Y,-19,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,436-004,Biologic Non-naïve,18,Female,32.270787766,3.6550308008,No,6.1,8,Never,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,6,2,0,1,20,10,0,22,12,10,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.1,1,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,436-005,Biologic Non-naïve,59,Female,31.992171327,47.279945243,Yes,0.5,3,Current,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,2,1,5,6,0,20,26,10,38,20,18,24,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.3,0,0,0,1,1,1,1,1,Y,3,0,Y,1,1,0,0,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,436-006,Biologic Non-naïve,61,Male,28.734693878,12.845995893,No,9.6,1,Former,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,11,2,8,0,23.333333333,8,0,2,2,0,25,Yes,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,1,1,1,1,1,1,1,1,Y,2,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,436-007,Biologic Non-naïve,48,Female,25.689561925,33.757700205,Yes,4.3,11,Current,No,No,No,No,No,No,No,No,1,No,No,No,No,No,No,Yes,2,4,5,40,0,41.666666667,52,70,29,15,14,24,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,436-008,Biologic Naïve,31,Male,30.040816327,7.2142368241,No,36,11.031,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,40,7.428,58.641,2,60.646,42.992,11.784,13.045,5.886,7.159,24.496,Yes,Yes,No,Yes,0.429,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-35,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,436-009,Biologic Naïve,58,Male,30.793382442,29.152635181,No,11.1,4.939,Missing,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,14,3.312,57.524,0,50.851,41.081,7.45,20.732,13.841,6.892,19.109,Yes,Yes,No,Yes,1.611,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-11.1,1,1,1,1,1,1,1,1,Y,,,N,1,1,1,1,1,1,1,1,1,1,1,0,1,,N,No
1,436-010,Biologic Naïve,55,Female,30.32334259,42.234086242,Yes,33.1,14,Never,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,5,29,10,57,0,91.666666667,72,60,25,15,10,24,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-32.6,0,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,436-011,Biologic Non-naïve,65,Female,29.515938607,46.19301848,Yes,1.8,1,Former,No,No,No,Yes,No,No,No,No,3,No,No,No,No,No,No,Yes,2,1,2,43,0,25,28,40,15,8,7,25,No,No,No,No,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,1,1,1,1,1,1,1,1,Y,1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,436-012,Biologic Naïve,49,Female,21.224489796,45.645448323,Yes,7.5,19.044,Missing,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,2,5,8.567,51.493,0,49.433,47.741,48.691,14.019,10.654,3.365,24.595,Yes,No,No,Yes,1.357,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,436-013,Biologic Naïve,48,Male,25.75,14.822724162,No,6.6,18.063,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,4.668,65.711,0,47.319,43.473,46.083,8.555,3.213,5.342,23.602,Yes,No,No,Yes,2.488,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,436-014,Biologic Naïve,41,Female,38.946813258,10.948665298,Yes,19.5,2,Current,Yes,Yes,No,No,No,No,No,No,3,No,No,No,Yes,Yes,No,Yes,4,21,1,1,37,11.666666667,14,0,6,3,3,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.9,0,1,1,1,1,1,1,1,Y,-1,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,436-015,Biologic Naïve,70,Female,32.242063492,40.919917864,Yes,6.8,12.7,Missing,Yes,Yes,No,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,Yes,Yes,3,9,7.459,51.509,0,55.54,64.009,5.759,14.678,11.429,3.249,23.196,No,No,No,No,1.805,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,436-016,Biologic Non-naïve,75,Female,26.573129252,13.127994524,Yes,6.1,17,Former,No,No,No,Yes,No,No,No,No,3,No,No,No,No,No,No,Yes,2,9,8,80,0,56.666666667,76,80,22,11,11,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.3,0,0,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,436-017,Biologic Naïve,60,Male,25.680074054,20.988364134,No,6.3,13.705,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,5.578,68.66,0,72.202,63.439,53.868,7.451,5.983,1.467,21.354,No,No,No,Yes,0.985,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,436-018,Biologic Naïve,28,Male,29.320987654,23.318275154,No,30,15.692,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,46,9.285,74.612,45,75.112,69.795,70.488,15.203,8.823,6.379,21.916,Yes,Yes,Yes,Yes,0.424,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,436,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-30,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,438-001,Biologic Naïve,29,Female,29.054752066,14.631074606,No,3.5,13,Current,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,5,7,28,4,48.333333333,44,20,17,9,8,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.5,1,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,438-002,Biologic Naïve,30,Male,37.576598451,0.6132785763,No,26.1,1,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,20,1,10,47,3.3333333333,10,0,1,1,0,25,No,No,No,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25.1,0,1,1,1,1,1,1,1,Y,0,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,438-003,Biologic Non-naïve,44,Male,21.913805698,7.279945243,No,3,22.418,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,1,5,3.927,19.408,16,46.358,43.826,49.885,14.758,7.399,7.359,24.541,No,No,No,No,0.992,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.7,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,438-004,Biologic Non-naïve,46,Male,26.851851852,1.2183436003,No,13.7,3,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,10,6,15,33,40,28,10,3,3,0,23,No,No,No,No,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,0,0,0,0,0,0,0,0,Y,-2,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,438-005,Biologic Naïve,36,Male,23.765432099,0.9965776865,No,5.8,7,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,15,3,26,28,25,24,50,10,6,4,25,No,No,No,No,2,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.8,1,1,1,1,1,1,1,1,Y,-4,0,Y,1,1,0,0,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,438-006,Biologic Naïve,54,Female,21.799307958,4.5119780972,No,8.1,12,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,4,38,70,41.666666667,14,0,19,11,8,25,No,No,No,No,3,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.1,1,1,1,1,1,1,1,1,Y,0,0,Y,0,1,0,0,1,1,1,1,1,1,1,0,0,Yes,Y,Yes
1,438-007,Biologic Naïve,46,Male,22.491349481,2.5297741273,Yes,11.4,6,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,13,4,39,0,53.333333333,26,20,18,10,8,21,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,1,Y,-6,1,Y,1,1,0,0,0,0,0,0,0,0,0,1,1,Yes,Y,Yes
1,438-008,Biologic Naïve,61,Male,25.39343112,5.4565366188,Yes,15.7,8,Former,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,Yes,3,10,7,65,19,66.666666667,66,40,7,4,3,24,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.5,0,0,0,0,0,0,1,1,Y,-5,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,438-009,Biologic Naïve,47,Male,36.753650306,0,No,33.4,23.699,Missing,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,26,8.156,97.617,0,95.085,82.204,72.429,18.109,8.561,9.548,22.788,No,No,No,No,1.285,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-31.9,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,438-010,Biologic Non-naïve,31,Male,39.415927618,7.9753593429,No,3.2,2,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,3,5,30,2.068,40,32,0,17,8,9,25,Yes,No,No,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,0,0,0,0,0,1,1,0,Y,0,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,438-011,Biologic Naïve,54,Female,43.145956607,0.0574948665,Yes,23.8,16,Former,Yes,No,No,Yes,No,No,No,No,3,No,No,Yes,No,Yes,No,Yes,3,4,7,56,30,68.333333333,56,50,12,2,10,24,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,438,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,1,Y,-2,0,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,440-001,Biologic Naïve,34,Female,23.120623596,30.127310062,No,7.4,5,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,10,8,50,16.182,70,54,0,2,2,0,24,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,440,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.4,0,0,0,0,1,1,1,1,Y,-4,1,Y,1,1,0,0,0,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,440-002,Biologic Non-naïve,27,Male,27.757487217,17.924709103,No,22.2,16,Current,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,23,9,59,21.101,90,86,90,19,8,11,18,No,Yes,No,Yes,2,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,440,Germany,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.2,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,440-003,Biologic Naïve,51,Male,26.775510204,0.6160164271,No,15.4,5,Current,No,No,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,20,8,4,18.809,65,54,50,26,11,15,23,No,No,No,Yes,3,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,440,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.3,0,0,1,0,0,1,1,1,Y,-4,1,Y,1,1,0,0,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,440-004,Biologic Naïve,21,Female,23.58832922,2.5160848734,No,22.2,4,Former,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,27,0,35.423,42.409,43.333333333,18,10,11,7,4,22.013,No,Yes,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,440,Germany,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22,0,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,440-005,Biologic Non-naïve,55,Male,24.382716049,2.5270362765,No,17.8,14,Current,No,No,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,4,16,10,100,6.304,91.666666667,100,50,33,18,15,24,No,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,440,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16,0,0,1,0,1,1,1,0,Y,-9,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,441-001,Biologic Naïve,37,Female,25.711008267,17.240246407,No,24.5,24,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,40,6,67,0,73.333333333,76,80,13,3,10,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,441,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.5,1,1,1,1,1,1,1,1,Y,-24,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,441-002,Biologic Naïve,42,Male,26.989619377,14.272416153,No,38.6,9,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,5,60,2,50,30.593,20,14,0,11,7,4,25,No,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,441,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-38,0,1,1,1,1,1,1,1,Y,1,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,441-003,Biologic Naïve,30,Male,36.611538947,10.250513347,No,5.4,16,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,5,8,75,1.998,75,60,40,10,6,4,24,No,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,441,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,0,0,0,0,0,0,0,0,Y,-15,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,441-004,Biologic Naïve,49,Female,25.593737062,29.201916496,No,22.6,3,Never,No,No,No,Yes,No,No,No,No,6,No,No,Yes,No,No,No,Yes,4,15,6,0,5.85,13.333333333,14,20,18,10,8,25,Yes,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,441,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.6,1,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,441-005,Biologic Naïve,41,Male,31.884501581,10.907597536,No,20.4,2.819,Missing,No,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,No,5,25,6.889,14.327,27.827,31.928,25.106,21.854,4.327,3.492,0.835,24.802,No,No,No,Yes,0.65,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,441,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,441-006,Biologic Naïve,32,Male,28.086419753,6.9869952088,Yes,12.6,12,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,6,19,7.916,45,60,40,32,14,18,25,Yes,Yes,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,441,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,441-007,Biologic Naïve,70,Male,37.983929876,13.002053388,Yes,38.4,19.235,Missing,No,Yes,No,Yes,No,No,No,No,5,Yes,No,No,No,No,Yes,No,5,40,5,35.859,47.092,73.14,46.679,58.493,22.371,7.956,14.415,24.558,No,Yes,No,Yes,0.184,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,441,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-38.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,445-001,Biologic Naïve,34,Male,25.241789776,13.820670773,No,36,18,Never,Yes,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,38,7,50,36,46.666666667,24,40,12,7,5,23,Yes,Yes,Yes,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-33.5,0,1,1,0,0,1,1,1,Y,-17,1,Y,0,1,0,0,1,1,0,0,0,1,1,1,0,Yes,Y,Yes
1,445-002,Biologic Non-naïve,41,Male,39.183673469,9.9739904175,No,30,5,Never,No,Yes,No,Yes,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,5,26,7,71,33,63.333333333,64,20,4,2,2,25,Yes,Yes,No,Yes,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.3,0,0,1,0,0,0,0,0,Y,-3,0,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,445-004,Biologic Naïve,34,Male,23.666910153,17.040383299,No,9.9,17,Never,Yes,Yes,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,9,6,64,0,61.666666667,62,50,4,2,2,23,No,No,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,445-005,Biologic Naïve,44,Male,28.457139789,7.4633812457,Yes,12.6,3.899,Former,No,Yes,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,10,2,35.614,81,27.783,30.191,2.138,9.586,6.748,2.838,22.542,Yes,Yes,Yes,Yes,0.922,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,445-006,Biologic Naïve,35,Female,29.031510377,15.742642026,No,18.3,8,Former,No,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,12,7,60,0,60,48,30,1,1,0,24,Yes,No,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.3,0,0,1,0,0,1,1,1,Y,-8,1,Y,1,1,0,0,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,445-007,Biologic Naïve,65,Female,23.051754908,60.788501027,No,12,6.09,Missing,No,Yes,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,Yes,4,8,3.435,31.959,1.637,50.553,30.453,4.035,9.736,7.411,2.325,23.156,Yes,Yes,Yes,Yes,1.158,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.1,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,445-008,Biologic Naïve,34,Female,26.511804065,6.81724846,No,7.2,3,Current,No,Yes,No,No,Yes,No,No,Yes,1,No,No,No,No,Yes,No,No,3,4,6,13,12.916,50,28,10,20,11,9,23,No,No,No,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.8,0,0,1,0,1,1,1,1,Y,-1,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,445-009,Biologic Naïve,45,Male,26.880934989,4.1587953457,Yes,8.7,23,Current,No,Yes,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,Yes,3,6,7,67,16,55,56,70,18,7,11,25,Yes,No,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.1,0,0,0,0,0,0,0,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,445-010,Biologic Naïve,32,Male,29.031510377,5.9055441478,No,17.2,11,Former,No,Yes,Yes,Yes,Yes,No,No,Yes,3,No,No,No,No,Yes,Yes,No,4,15,3,15,34.571,28.333333333,32,20,28,16,12,25,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.1,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,445-011,Biologic Naïve,18,Male,23.057725694,0.9144421629,No,12,2,Current,Yes,Yes,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,10,3,6,35,15,12,0,7,5,2,24,Yes,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,445-012,Biologic Naïve,52,Male,29.384756657,3.7399041752,Yes,7.1,3,Never,No,Yes,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,4,6,35,20.648,41.666666667,32,10,14,7,7,24,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,445,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.6,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,446-001,Biologic Naïve,21,Female,17.224803717,12.131416838,Yes,3.5,14,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,9,9,21,29.95,28.333333333,42,50,15,4,11,24,No,Yes,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,446,Germany,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.9,0,0,1,1,1,1,1,1,Y,-11,0,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,446-002,Biologic Naïve,48,Female,24.973985432,7.3839835729,Yes,14.5,19,Current,No,Yes,Yes,Yes,Yes,No,No,Yes,3,No,No,No,No,No,No,No,3,32,4,43,15.668,40,40,10,25,14,11,25,No,No,No,Yes,2,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,446,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.5,1,1,1,1,1,1,1,1,Y,-13,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,446-003,Biologic Non-naïve,61,Female,33.121306786,27.394934976,Yes,4.5,9,Former,No,Yes,No,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,No,No,3,10,3,31,9.528,33.333333333,28,50,6,2,4,23,No,No,No,No,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,446,Germany,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.9,0,0,0,0,0,0,1,0,Y,-6,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,447-001,Biologic Naïve,52,Male,30.470914127,11.074606434,No,2.4,2,Never,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,3,3,0,27,20,4,0,11,8,3,23,No,No,No,No,4,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,447,Germany,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,0,0,1,1,1,1,1,1,Y,-2,1,Y,1,1,0,0,1,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,447-003,Biologic Naïve,36,Male,36.131344664,1.3196440794,No,9.3,1,Current,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,10,4,10,0,33.333333333,22,10,6,2,4,24,No,No,Yes,No,3,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,447,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.1,0,0,0,0,0,0,1,1,Y,0,,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,447-004,Biologic Naïve,38,Female,30.846276673,1.1115674196,No,8.8,8,Never,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,7,8,26,0,40,44,0,27,10,17,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,447,Germany,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,0,0,0,0,0,1,1,0,Y,-7,1,Y,0,0,0,0,0,0,0,0,0,1,1,1,0,No,Y,No
1,447-005,Biologic Naïve,36,Male,27.700831025,5.8726899384,No,5.9,13,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,7,6,50,0,50,66,40,4,1,3,25,No,Yes,No,No,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,447,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.7,0,0,1,0,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,448-001,Biologic Naïve,54,Male,28.703703704,10.195756331,No,18.9,16,Current,Yes,Yes,No,No,Yes,No,No,Yes,2,No,No,No,No,Yes,Yes,No,4,25,5,63,30.284,58.333333333,48,30,11,4,7,25,No,Yes,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,448,Germany,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,452-001,Biologic Naïve,44,Female,42.240587695,25.667351129,Yes,15.2,18,Former,No,No,Yes,No,Yes,Yes,No,Yes,3,No,No,No,Yes,Yes,No,No,2,25,6,0,0,50,22,0,8,6,2,25,No,No,No,Yes,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.4,0,0,1,0,1,1,1,1,Y,-11,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,452-002,Biologic Non-naïve,54,Male,34.316108553,40.752908966,No,13.6,8,Former,No,Yes,No,Yes,Yes,No,No,Yes,4,No,No,No,Yes,Yes,Yes,No,3,12,4,36,22.404,41.666666667,28,40,10,7,3,24,No,No,No,Yes,1,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.4,0,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,452-003,Biologic Naïve,70,Male,28.982007004,16.876112252,No,16.8,1,Former,No,Yes,Yes,Yes,Yes,No,No,Yes,1.5063613232,No,No,No,No,Yes,No,No,3,30,5,53,0,43.333333333,44,0,4,3,1,24,Yes,No,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.8,1,1,1,1,1,1,1,1,Y,-1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,452-004,Biologic Non-naïve,52,Male,35.354273192,29.87816564,No,2.4,17,Never,No,No,No,Yes,Yes,No,No,Yes,8,Yes,No,No,Yes,Yes,Yes,No,1,1,8,37,0,73.333333333,46,40,15,7,8,20,No,No,No,Yes,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,0,0,0,0,0,1,1,1,Y,-9,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,452-005,Biologic Non-naïve,56,Male,29.054752066,34.88569473,No,12,5,Former,No,Yes,Yes,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,2,12,5,20,0,33.333333333,24,20,12,8,4,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,452-006,Biologic Naïve,24,Male,32.60588843,11.904175222,No,24.6,9,Never,Yes,Yes,Yes,Yes,Yes,No,No,Yes,1.5063613232,No,No,No,No,Yes,No,No,4,55,6,56,0,43.333333333,44,20,7,2,5,25,No,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,,,Y,Y,Y,N,N,Y,-15.4,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,452-007,Biologic Naïve,54,Female,27.407657278,16.917180014,No,23.4,16,Former,Yes,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,25,7,0,0,46.666666667,54,30,25,13,12,25,No,No,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.4,1,1,1,1,1,1,1,1,Y,-15,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,452-008,Biologic Naïve,43,Female,28.373702422,10.924024641,No,15.6,6,Never,No,Yes,Yes,Yes,Yes,No,No,Yes,1.5063613232,No,No,No,No,Yes,No,No,3,15,6,22,0,50,26,30,2,2,0,24,No,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,,,Y,Y,Y,N,N,Y,0,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,452-009,Biologic Naïve,58,Female,32.490548204,5.0787132101,No,16.2,9,Former,No,Yes,Yes,Yes,Yes,No,No,Yes,2,Yes,No,No,No,No,No,No,3,15,7,52,0,35,30,40,16,7,9,24,No,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,-15.9,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,452-010,Biologic Naïve,19,Male,30.159156738,12.087611225,No,15.7,8,Current,Yes,Yes,No,Yes,No,No,No,No,1.5063613232,No,No,No,No,Yes,No,No,3,15,0,0,0,36.666666667,6,0,12,6,6,23,No,No,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,,,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.7,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,452-012,Biologic Naïve,62,Female,24.835763499,35.154004107,No,15,4,Current,No,Yes,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,18,2,0,0,23.333333333,10,10,15,8,7,23,No,No,No,No,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,-15,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,452-013,Biologic Non-naïve,48,Male,31.456432841,47.203285421,No,13.8,1,Former,Yes,Yes,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,16,2,0,0,20,10,0,4,4,0,22,No,No,No,Yes,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,452,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,-13.8,1,1,1,1,1,1,1,1,Y,-1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-001,Biologic Naïve,49,Male,27.440599174,22.7816564,No,15.5,9,Current,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,No,No,Yes,No,3,15,7,69,18,66.666666667,62,50,9,5,4,18,No,No,No,Yes,1,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.2,0,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,453-002,Biologic Naïve,60,Female,30.043262298,11.79192334,No,28,16,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,26,9,54,0,36.666666667,58,80,16,11,5,22,Yes,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25,0,0,1,0,0,1,1,1,Y,-13,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,453-003,Biologic Non-naïve,67,Female,27.041644132,12.810403833,No,19.3,10,Never,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,4,16,7,73,18,61.666666667,38,60,12,8,4,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.3,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-004,Biologic Non-naïve,46,Male,34.686090878,18.825462012,No,13.2,21,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,17,8,90,0,90,86,70,18,10,8,23,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,0,0,0,0,0,0,0,0,Y,-8,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,453-005,Biologic Non-naïve,53,Male,38.944571912,40.884325804,Yes,10.4,9,Current,Yes,Yes,Yes,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,Yes,Yes,3,20,6,46,0,56.666666667,58,40,5,3,2,24,No,No,Yes,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.4,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-006,Biologic Non-naïve,58,Male,29.983587931,29.883641342,No,0,13,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,10,5,64,0,56.666666667,48,50,13,9,4,25,Yes,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,1,Y,-13,1,Y,1,1,1,1,0,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,453-007,Biologic Non-naïve,71,Female,28.685144681,9.8863791923,No,16.1,1.14,Missing,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,12,3.658,20.977,0,38.756,38.398,0.063,15.598,10.553,5.044,22.696,No,No,No,Yes,0.045,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,453-008,Biologic Naïve,51,Male,30.350329518,3.9890485969,No,12.5,10,Current,No,Yes,No,Yes,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,3,20,7,50,0,60,52,20,11,9,2,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-11.9,0,1,1,1,1,1,1,1,Y,-5,0,N,1,1,0,0,1,1,0,1,1,1,1,0,1,,N,No
1,453-009,Biologic Naïve,29,Female,25.217358576,11.674195756,No,12.3,13,Current,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,20,5,19,0,16.666666667,24,40,18,9,9,25,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-010,Biologic Non-naïve,47,Female,26.026174896,15.926078029,No,15.6,21,Never,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,19,10,24,0,58.333333333,80,50,18,13,5,24,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.6,1,1,1,1,1,1,1,1,Y,-21,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,453-011,Biologic Naïve,64,Male,26.989619377,32.97467488,No,18,0,Former,No,Yes,Yes,Yes,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,3,15,0,35.697,36.586,16.666666667,6,0,0,0,0,21.903,No,No,No,Yes,3,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.9,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,453-012,Biologic Non-naïve,47,Male,36.227508755,31.017111567,No,0,0,Former,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,No,0,0,0,0,0,3.3333333333,4,10,12,6,6,23,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,1,Y,0,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,453-013,Biologic Non-naïve,53,Male,39.426643055,11.019849418,No,17.8,19,Never,No,No,No,Yes,No,No,No,No,5,No,No,No,Yes,Yes,Yes,No,3,13,8,99,3.283,73.333333333,76,70,16,10,6,24,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.3,0,0,1,0,0,0,1,,Y,-2,0,Y,,0,,0,1,0,0,0,0,0,1,0,0,,Y,No
1,453-014,Biologic Non-naïve,25,Female,24.690405463,18.020533881,No,19.2,21,Never,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,41,8,100,22.152,88.333333333,88,80,19,10,9,21,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.2,1,1,1,1,1,1,1,1,Y,-20,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,453-015,Biologic Non-naïve,61,Male,27.45865421,35.049965777,No,28.2,24.255,Former,No,Yes,No,Yes,No,No,No,No,7,Yes,No,No,No,Yes,Yes,No,4,45,6.111,35.468,20,60.605,42.873,81.189,16.729,8.649,8.08,22.69,Yes,No,No,Yes,0.451,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25.1,0,0,1,0,0,0,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,453-016,Biologic Naïve,36,Male,32.846606348,8.076659822,No,16.5,2,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,25,4,15,0,48.333333333,30,10,4,3,1,25,Yes,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,453-017,Biologic Non-naïve,75,Male,28.604764952,54.088980151,No,20.3,25.194,Missing,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,4,21,7.844,71.774,33.266,55.263,69.524,37.706,21.271,9.052,12.219,24.956,No,No,No,Yes,1.305,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.3,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-018,Biologic Non-naïve,43,Male,24.983563445,23.09650924,No,17.5,17,Never,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,15,4,59,0,66.666666667,44,40,8,7,1,21,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,0,1,1,1,1,1,1,1,Y,-15,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,453-019,Biologic Naïve,43,Male,33.139755081,30.357289528,Yes,17,22,Never,Yes,Yes,No,No,No,No,No,No,4,No,No,No,Yes,Yes,No,No,3,15,7,76,10.002,75,76,40,19,10,9,25,No,No,No,Yes,1,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.4,0,1,1,0,1,1,1,1,Y,-9,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,453-020,Biologic Naïve,59,Male,35.083029837,7.4031485284,No,20.8,10,Current,Yes,Yes,No,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,No,No,4,38,1,41,17,46.666666667,42,0,8,5,3,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.8,1,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-021,Biologic Non-naïve,57,Male,48.907136819,40.435318275,No,12,6,Former,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,Yes,3,8,1,5,2,18.333333333,4,10,8,5,3,22,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,453-022,Biologic Naïve,56,Female,36.102022606,45.442847365,No,17.4,16,Former,Yes,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,27,4,30,25.536,23.333333333,52,20,10,6,4,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.4,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,453-023,Biologic Naïve,67,Female,33.792470156,43.490759754,No,15.3,20,Current,Yes,Yes,No,Yes,No,No,No,No,7,No,No,No,Yes,Yes,Yes,No,3,15,9,47,28.976,46.666666667,38,60,9,3,6,25,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,0,0,0,0,0,0,1,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,453-024,Biologic Non-naïve,38,Male,30.040816327,24.517453799,No,11,10,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,5,10,2,12,0,55,16,10,13,11,2,24,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.4,0,1,1,1,1,1,1,1,Y,-9,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,453-025,Biologic Non-naïve,43,Male,49.123310266,13.535934292,No,15,10,Current,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,15,10,54,0,73.333333333,18,40,3,1,2,25,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.2,0,1,1,1,1,1,1,1,Y,-7,0,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,453-026,Biologic Non-naïve,58,Male,37.983881622,31.567419576,No,13.5,7,Never,Yes,Yes,Yes,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,3,7,3,0,18.01,30,26,20,6,4,2,25,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,0,0,0,0,1,0,Y,2,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,453-027,Biologic Naïve,42,Male,21.84700852,22.568104038,Yes,15.4,7,Current,Yes,Yes,No,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,15,5,19,19.362,40,10,0,9,7,2,25,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.4,1,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-028,Biologic Non-naïve,33,Male,22.093170054,27.649555099,Yes,10,15,Never,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,10,6,24,4,76.666666667,38,60,7,5,2,25,Yes,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,0,0,0,0,0,1,1,1,Y,-8,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,453-029,Biologic Non-naïve,40,Male,36.227508755,13.653661875,Yes,15.9,14,Never,Yes,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,14,7,78,0,80,74,80,17,11,6,25,No,No,Yes,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.9,1,1,1,1,1,1,1,1,Y,-10,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-030,Biologic Naïve,50,Male,34.188034188,15.668720055,No,11.8,11,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,10,3,1,0,60,14,70,3,3,0,21,No,No,No,No,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.2,0,1,1,1,1,1,1,1,Y,1,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,453-031,Biologic Naïve,65,Male,27.763429752,43.682409309,Yes,16,15,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,18,7,63,10,53.333333333,58,70,9,5,4,23,No,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.5,0,0,0,0,0,0,1,0,Y,-12,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,453-032,Biologic Naïve,73,Female,29.411764706,17.749486653,No,10.6,8,Never,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,3,15,3,0,0,33.333333333,32,0,1,1,0,25,No,No,No,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10,0,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,453-033,Biologic Naïve,19,Female,25.282569899,12.769336071,No,14.9,13,Never,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,15,3,24,0,43.333333333,20,40,10,5,5,16,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.3,0,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,453-034,Biologic Naïve,46,Male,28.859212313,20.785763176,No,15.1,19,Current,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,15,5,52,30,66.666666667,58,50,8,5,3,25,No,No,No,Yes,2,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.9,0,1,1,0,1,1,1,1,Y,-7,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,453-035,Biologic Naïve,43,Female,27.379664684,3.7973990418,No,20.1,23,Current,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,25,8,74,8,76.666666667,80,70,18,10,8,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.1,1,1,1,1,1,1,1,1,Y,-23,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,453-036,Biologic Naïve,20,Female,18.591130341,8.93908282,No,22.8,27,Never,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,40,8,85,0,71.666666667,52,70,15,13,2,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.8,1,1,1,1,1,1,1,1,Y,-25,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-037,Biologic Naïve,42,Female,34.516765286,4.9965776865,No,17,24,Current,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,5,20,10,97,8,100,98,80,18,9,9,25,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,3.6,0,0,0,0,0,0,0,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,453-038,Biologic Non-naïve,61,Male,32.950680272,31.047227926,Yes,9.2,0,Never,No,Yes,Yes,Yes,Yes,Yes,No,No,4,No,No,No,Yes,Yes,No,Yes,2,10,1,9,0.876,8.3333333333,16,20,10,4,6,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-039,Biologic Naïve,50,Female,27.414453693,14.05338809,No,18.6,25,Never,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,30,10,98,0,96.666666667,74,50,5,5,0,13,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-8.4,0,0,0,0,0,0,0,0,Y,-3,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,453-040,Biologic Naïve,46,Male,29.411764706,6.0533880903,No,15.9,10,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,20,3,30,0,21.666666667,28,0,4,4,0,24,No,No,No,Yes,1,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.1,0,0,0,0,0,0,0,0,Y,7,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,453-041,Biologic Naïve,33,Male,26.296566837,20.07118412,No,15.4,8,Never,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,20,7,39,0,33.333333333,36,0,4,4,0,25,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.6,0,0,0,0,0,0,0,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,453-042,Biologic Naïve,57,Male,27.77031264,33.092402464,Yes,1.2,1,Current,No,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,1,1,2,0,0,3.3333333333,2,0,2,1,1,25,No,No,No,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,1.2,0,0,0,0,0,1,1,1,Y,1,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,453-043,Biologic Non-naïve,52,Male,32.407407407,26.105407255,Yes,8.7,6,Never,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,5,3,17,8.699,23.333333333,20,20,30,16,14,20,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.7,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,453-044,Biologic Non-naïve,58,Female,33.462224866,50.130047912,No,10.8,9,Current,Yes,Yes,No,Yes,Yes,No,No,Yes,2,No,No,No,No,No,No,No,4,10,6,34,0,80,46,0,10,7,3,25,No,No,No,No,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,1,0,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,453-045,Biologic Non-naïve,39,Male,32.7449283,12.128678987,No,12,21,Never,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,No,4,8,8,76,0,68.333333333,62,70,8,5,3,25,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-3.6,0,0,0,0,0,0,0,0,Y,-8,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,453-046,Biologic Non-naïve,65,Male,30.407626561,42.149212868,Yes,13.5,8,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,7,60,0,66.666666667,56,0,10,8,2,25,No,No,No,No,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,0,1,1,0,1,1,1,1,Y,1,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,453-047,Biologic Naïve,40,Male,29.218407597,11.151266256,No,22,20,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,60,8,61,31,86.666666667,70,30,5,3,2,24,Yes,No,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.8,0,0,1,0,0,0,1,1,Y,-15,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,453-048,Biologic Non-naïve,59,Male,29.772228003,18.206707734,No,10.7,12,Former,No,Yes,No,Yes,No,No,No,No,3,No,No,No,No,Yes,No,No,4,10,5,40,10,58.333333333,38,20,7,4,3,22,Yes,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.5,0,0,1,0,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,453-049,Biologic Non-naïve,69,Female,27.885187388,9.2265571526,Yes,11,19,Current,No,Yes,Yes,Yes,No,No,No,No,3,Yes,No,No,No,No,No,Yes,2,10,8,72,0,66.666666667,70,60,13,6,7,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.4,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,453-050,Biologic Non-naïve,42,Male,26.12244898,21.28678987,No,6,10,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,3,26,0,23.333333333,14,20,1,1,0,25,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,1,1,1,1,1,1,1,1,Y,-10,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,453-051,Biologic Non-naïve,43,Male,26.729927495,19.296372348,Yes,14.1,12,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,21,6,78,6.085,30,26,10,13,6,7,25,No,No,No,Yes,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.6,0,0,1,0,0,1,1,0,Y,-2,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,453-052,Biologic Non-naïve,47,Female,20.761245675,29.305954825,Yes,0,0,Current,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,No,No,No,Yes,0,0,0,2,0,0,0,0,3,3,0,25,No,No,No,No,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,1,Y,0,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,453-053,Biologic Non-naïve,67,Female,36.982248521,35.315537303,Yes,10,8.428,Missing,Yes,Yes,No,Yes,Yes,No,No,Yes,6,Yes,No,No,Yes,Yes,No,No,3,10,8.942,68.799,6.995,70.511,89.439,49.538,20.116,12.785,7.331,23.548,No,No,No,Yes,0.112,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-054,Biologic Non-naïve,35,Male,31.481481481,18.321697467,No,10.5,8,Never,No,Yes,Yes,Yes,No,No,No,No,3,Yes,No,No,No,No,Yes,No,2,10,4,33,0,36.666666667,24,0,3,3,0,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.9,0,1,1,1,1,1,1,1,Y,-4,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,453-055,Biologic Naïve,39,Female,23.051754908,35.326488706,No,15,9,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,3,35,0,53.333333333,22,30,9,8,1,19,No,No,No,Yes,2,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,0,0,0,0,0,0,0,0,Y,-5,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,453-056,Biologic Naïve,54,Male,29.411764706,6.340862423,No,15.6,22,Current,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,No,No,No,Yes,5,8,8,90,10,88.333333333,82,80,29,15,14,22,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-0.4,0,0,0,0,0,0,0,0,N,-5,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,453-057,Biologic Non-naïve,36,Female,31.637396694,13.344284736,No,9.1,22,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,14,2,41,0,61.666666667,46,50,3,2,1,25,No,No,No,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.1,1,1,1,1,1,1,1,1,Y,-22,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,453-058,Biologic Naïve,71,Male,33.950617284,4.3586584531,No,15.1,11,Former,Yes,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,3,10,6,22,10,58.333333333,32,30,10,4,6,25,No,No,No,Yes,1,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,0,0,0,0,0,0,1,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,453-059,Biologic Naïve,55,Male,29.411764706,25.363449692,No,12.6,18,Never,Yes,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,3,30,7,50,0,61.666666667,50,50,4,3,1,25,No,No,No,Yes,3,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.9,0,0,1,0,0,1,1,1,Y,-18,1,Y,1,1,0,0,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,453-060,Biologic Non-naïve,28,Female,23.306680053,21.374401095,No,15.5,14,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,5,20,10,53.333333333,46,20,10,6,4,24,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.7,0,0,1,0,1,1,1,0,Y,-12,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,453-061,Biologic Naïve,42,Male,49.116241772,17.382614648,No,11.4,8,Current,Yes,Yes,No,Yes,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,3,40,0,36,0,33.333333333,16,0,7,3,4,25,No,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,1,1,1,1,1,1,1,1,Y,1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-062,Biologic Naïve,78,Female,34.449607435,31.411362081,No,16.2,15,Never,No,Yes,Yes,Yes,No,No,No,No,7,No,No,No,Yes,Yes,No,No,3,16,0,23,19.337,63.333333333,42,0,7,5,2,25,No,No,No,No,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.7,0,0,1,0,0,0,1,0,Y,-12,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,453-063,Biologic Naïve,47,Male,25.661152035,18.412046543,Yes,22.6,12,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,29,10,87,22,88.333333333,94,30,20,11,9,22,No,No,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.6,0,1,1,0,1,1,1,1,Y,-9,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,453-064,Biologic Naïve,45,Female,25.605536332,1.5879534565,No,7.8,19,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,8,79,0,65,60,70,6,4,2,23,No,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,1.7,0,0,0,0,0,0,0,0,Y,-5,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,453-065,Biologic Non-naïve,35,Female,39.256529402,10.450376454,Yes,9.2,24,Never,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,5,10,97,68.515,98.333333333,80,100,4,3,1,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,453-066,Biologic Non-naïve,42,Female,34.516765286,19.449691992,No,20.4,21,Current,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,19,10,19,23.889,83.333333333,54,0,8,6,2,25,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.8,0,1,1,0,1,1,1,1,Y,-9,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,453-067,Biologic Naïve,59,Male,28.405504356,23.449691992,No,20.4,18,Never,No,Yes,No,Yes,No,No,No,No,6,Yes,No,No,No,Yes,Yes,No,4,22,5,52,15,56.666666667,50,30,14,9,5,23,Yes,No,No,No,1,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,453,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.4,1,1,1,1,1,1,1,1,Y,-18,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,454-001,Biologic Non-naïve,44,Female,30.407626561,13.409993155,No,42.9,30,Never,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,75,9,88,0,95,96,100,8,5,3,25,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-36.6,0,0,1,0,0,0,0,1,Y,-19,0,Y,1,1,0,0,1,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,454-002,Biologic Non-naïve,52,Female,20.829995193,45.155373032,No,21.2,19,Former,Yes,Yes,Yes,No,No,No,No,No,2,No,No,No,No,No,No,No,3,60,10,56,2,85,78,30,11,8,3,21,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.2,1,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,454-003,Biologic Non-naïve,33,Female,24.740937287,5.7440109514,Yes,3,13.746,Current,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,2,4,6.297,33.571,9.231,42.636,50.462,53.947,9.971,5.563,4.408,22.922,No,No,No,No,0.791,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,454-004,Biologic Naïve,58,Male,29.065743945,5.2046543463,No,24.3,28.469,Missing,No,Yes,Yes,No,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,25,7.889,51.193,12.024,73.373,63.955,86.486,19.171,10.619,8.553,19.862,No,No,No,Yes,1.255,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.5,0,0,0,0,0,0,0,1,Y,,,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,454-005,Biologic Naïve,69,Female,24.877719683,11.422313484,No,21.6,8,Current,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,30,0,11,48.806,53.333333333,18,20,4,3,1,25,No,No,Yes,No,3,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,454-006,Biologic Non-naïve,32,Male,30.273711807,16.435318275,No,17.4,1,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,40,1,0,10,6.6666666667,0,0,1,1,0,25,No,No,No,No,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-16.2,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,454-007,Biologic Non-naïve,48,Male,38.103947569,35.51266256,Yes,14.8,21,Never,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,No,No,4,70,7,60,0,85,96,100,25,10,15,23,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-11.2,0,0,1,0,0,0,1,0,Y,-16,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,454-008,Biologic Non-naïve,63,Female,26.093275201,44.610540726,No,22.8,15.172,Missing,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,20,8.99,42.51,0,78.229,69.415,30.191,8.894,5.143,3.751,20.508,No,No,No,Yes,1.412,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,454-009,Biologic Non-naïve,60,Female,27.476239809,10.669404517,Yes,27,12.252,Missing,No,Yes,Yes,Yes,No,No,No,No,6,No,No,No,No,No,No,Yes,4,50,4.269,10.306,0,47.74,37.075,25.193,18.338,12.545,5.793,20.918,Yes,Yes,No,Yes,0.845,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,454-010,Biologic Non-naïve,45,Male,26.583175803,5.6700889802,Yes,3,17.357,Missing,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,10,7.465,55.729,100,94.904,82.579,55.539,18.59,9.432,9.158,23.885,Yes,No,No,No,0.381,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,8.1,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,454-011,Biologic Non-naïve,50,Female,37.182260681,22.743326489,Yes,20.1,9.91,Missing,No,No,No,Yes,No,No,No,No,2,No,No,Yes,No,No,No,No,2,25,4.473,49.261,10,41.72,20.099,55.897,17.387,8.899,8.488,23.406,No,No,No,Yes,1.504,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,454-012,Biologic Naïve,45,Male,27.6816609,2.8199863107,Yes,28.8,25,Never,No,Yes,No,No,No,No,No,No,1,No,No,Yes,No,No,No,No,3,30,5,85,17.821,61.666666667,62,90,34,18,16,24,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-28.8,1,1,1,1,1,1,1,1,Y,-15,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,454-013,Biologic Naïve,26,Male,34.93877551,3.8767967146,No,18,17,Former,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,25,8,82,64,45,66,50,11,8,3,20,No,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,0,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,454-014,Biologic Naïve,48,Female,31.61177325,20.898015058,Yes,17.1,18.978,Missing,Yes,Yes,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3.2017453799,53,5.669,40.866,50.05,71.008,70.774,79.924,14.069,8.058,6.011,20.068,Yes,Yes,No,No,2.135,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.7,0,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,454-015,Biologic Naïve,25,Male,26.287807183,5.325119781,No,21.6,12,Never,No,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,30,7,72,0,66.666666667,58,0,8,3,5,25,Yes,Yes,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16,0,0,0,0,0,0,0,1,Y,,,Y,1,1,1,1,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,454-016,Biologic Naïve,34,Male,29.065743945,3.3812457221,No,28.8,20.261,Missing,No,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,5,30,2.852,34.783,14.833,69.814,63.356,69.177,20.241,9.994,10.247,24.555,No,No,No,Yes,0.097,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.8,1,1,1,1,1,1,1,1,Y,,,Y,0,1,0,0,1,1,1,1,1,1,1,0,0,Yes,Y,Yes
1,454-017,Biologic Non-naïve,63,Female,29.000594884,45.382614648,No,8.1,7.194,Missing,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,4.376,36.719,0,53.208,49.281,20.943,17.66,8.886,8.774,24.237,No,No,No,Yes,1.419,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.9,0,0,0,0,0,0,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,454-018,Biologic Naïve,35,Male,28.378215191,16.429842574,No,33,24.074,Missing,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,30,5.716,45.234,27.538,68.143,41.259,54.945,17.128,10.126,7.002,16.324,Yes,No,No,Yes,0.888,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17,0,0,0,0,0,0,0,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,454-019,Biologic Naïve,50,Male,29.797227343,15.430527036,No,24.3,25.613,Missing,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,25,7.256,98.899,48.166,85.113,84.379,79.194,18.687,11.997,6.69,22.237,No,No,No,No,0.167,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.9,0,0,0,0,0,0,0,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,454-020,Biologic Non-naïve,40,Male,29.263340201,6.4503764545,No,13.8,11.961,Missing,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,20,8.715,71.319,23.951,60.835,77.269,60.583,17.462,10.354,7.107,24.061,Yes,Yes,No,No,1.588,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,454,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,1.3,0,0,0,0,0,0,0,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,455-001,Biologic Naïve,59,Male,36.927155662,4.8514715948,No,29.7,25,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,38,8,78,7,75,74,80,25,14,11,25,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,455,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.1,0,1,1,0,1,1,1,1,Y,-16,0,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,455-002,Biologic Naïve,56,Female,41.259413556,12.306639288,No,16,11,Former,Yes,No,No,Yes,Yes,No,No,Yes,3,Yes,No,No,Yes,Yes,No,No,3,28,7,0,0,46.666666667,34,20,18,11,7,22,No,No,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,455,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-12.7,0,0,1,0,0,0,1,0,Y,-8,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,459-001,Biologic Non-naïve,63,Male,25.087235996,26.562628337,No,9.6,6,Former,No,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,12,4,0,2,25,8,0,2,1,1,24,No,No,No,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-9.6,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,459-002,Biologic Naïve,31,Male,24.685714286,17.352498289,No,36.2,29,Never,Yes,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,5,14,9,67,6,70,52,100,23,13,10,25,Yes,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-35.6,0,1,1,1,1,1,1,1,Y,-23,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,459-003,Biologic Naïve,47,Female,26.927437642,35.356605065,No,14.1,21,Never,Yes,Yes,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,10,8,73,12,76.666666667,82,50,17,9,8,25,Yes,Yes,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-14,0,1,1,1,1,1,1,1,Y,-21,1,Y,1,1,1,1,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,459-004,Biologic Non-naïve,42,Male,23.986870345,19.425051335,No,15.6,1,Former,Yes,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,12,0,0,2,26.666666667,8,0,5,2,3,25,No,Yes,No,No,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.9,0,0,0,0,0,0,0,0,Y,5,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,459-005,Biologic Non-naïve,35,Female,26.078971534,17.514031485,No,32.6,16,Never,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,13,8,48,0,75,48,80,2,2,0,25,Yes,Yes,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-32.6,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,459-006,Biologic Non-naïve,62,Male,28.060018904,20.709103354,Yes,16.6,8.11,Missing,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,10,5.128,50.206,2,57.432,45.791,32.9,16.074,11.872,4.202,20.482,No,No,No,Yes,0.519,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.7,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,459-007,Biologic Naïve,49,Male,31.314566116,22.034223135,No,38.6,18,Current,No,No,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,Yes,4,18,10,0,58,80,82,40,20,9,11,25,No,No,Yes,No,4,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,1.9,0,0,0,0,0,0,0,0,Y,-13,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,459-008,Biologic Non-naïve,52,Male,39.29938792,20.046543463,Yes,15.5,16,Current,No,Yes,No,No,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,11,8,77,40,53.333333333,58,20,2,2,0,25,No,No,Yes,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,0,0,0,0,0,0,0,0,0,Y,11,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,459-009,Biologic Non-naïve,32,Male,28.055555556,18.067077344,Yes,17.4,16,Current,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,11,7,71,10,86.666666667,82,40,6,3,3,24,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,0,0,0,0,0,0,0,1,Y,-16,1,Y,1,1,0,0,0,0,0,0,0,0,0,1,1,Yes,Y,Yes
1,459-010,Biologic Naïve,25,Female,19.267171444,4.0657084189,No,17.7,25,Current,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,6,53,0,75,44,50,21,11,10,24,No,Yes,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.3,0,0,0,0,0,0,0,0,Y,-17,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,459-011,Biologic Naïve,29,Female,24.859073562,12.906228611,No,19.2,20,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,11,6,63,34,75,68,50,14,9,5,23,Yes,Yes,No,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,459,Hungary,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.2,0,0,0,0,0,0,0,1,Y,-13,0,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,476-001,Biologic Naïve,42,Female,21.484375,0.167008898,No,20.7,7.431,Missing,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,50,5.56,69.238,20.771,29.009,36.435,39.74,13.439,7.222,6.217,23.84,Yes,Yes,Yes,Yes,0.349,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,476-002,Biologic Naïve,30,Female,20.202020202,5.1471594798,No,27.4,12.967,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,75,0.586,72.865,26.391,56.225,44.067,26.38,10.184,8.452,1.732,21.495,Yes,Yes,No,Yes,0.068,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,476-003,Biologic Non-naïve,29,Female,38.514057631,27.23613963,Yes,21.3,8,Former,No,No,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,Yes,3,35,7,41,24,90,60,50,10,8,2,22,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,,,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-14.5,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,476-004,Biologic Non-naïve,41,Male,26.775510204,3.4277891855,No,13.6,16,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,40,5,83,0.098,36.666666667,38,60,18,12,6,25,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.8,0,0,0,0,0,0,1,0,Y,-14,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,476-005,Biologic Naïve,82,Male,30.083829097,4.8952772074,No,20.7,8,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,50,0,20,10,58.333333333,32,50,14,3,11,25,No,Yes,Yes,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,5.8,0,0,0,0,0,0,0,0,Y,8,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,476-006,Biologic Non-naïve,50,Male,21.049817902,33.848049281,No,8.2,1,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,25,6,0,3.313,8.3333333333,22,0,4,4,0,25,No,No,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.3,0,0,0,0,0,0,0,0,Y,-1,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,476-007,Biologic Naïve,50,Male,24.801587302,15.030800821,No,8.1,8,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,25,0,0,18.613,61.666666667,4,0,8,7,1,21,No,Yes,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-2,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,476-008,Biologic Naïve,54,Female,25.78125,26.943189596,No,7.8,20,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,25,7,84,17.487,86.666666667,86,90,16,12,4,25,No,No,Yes,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-3.7,0,0,0,0,0,0,1,0,Y,-10,0,N,0,0,0,0,0,0,0,0,0,0,1,0,0,,N,No
1,476-009,Biologic Naïve,55,Female,19.834710744,30.92128679,No,10.5,3,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,25,9,83,9.498,75,48,0,14,13,1,25,No,No,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.7,0,0,0,0,0,1,1,1,Y,-2,1,Y,1,1,0,0,0,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,476-010,Biologic Non-naïve,58,Male,26.874496103,38.009582478,No,12.7,7,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,20,2,11,24.124,31.666666667,8,0,7,1,6,25,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,Y,N,Y,Y,,,,,,,,,,Y,-5,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,476-011,Biologic Non-naïve,34,Male,32.140248356,19.017111567,No,15.8,16,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,30,8,71,10.426,58.333333333,72,40,15,8,7,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,476-012,Biologic Naïve,68,Male,31.955922865,45.032169747,No,16.2,3,Former,No,Yes,No,Yes,No,No,No,No,5,No,No,No,No,No,Yes,No,3,35,6,41,29.773,61.666666667,46,0,2,2,0,24,Yes,No,Yes,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.4,0,0,0,0,0,0,0,0,Y,-3,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,476-014,Biologic Non-naïve,72,Male,27.414453693,10.154688569,No,8.3,3,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,2,20,2,0,40.257,21.666666667,8,0,9,6,3,23,No,No,No,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,,Y,N,Y,N,Y,Y,,,,,,,,,,Y,-3,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,476-015,Biologic Non-naïve,62,Male,29.410734918,43.301848049,No,17.3,21,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,50,7,0,24.105,85,76,70,22,12,10,19,No,No,No,No,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-11.5,0,0,0,0,0,0,0,0,Y,-18,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,476-016,Biologic Naïve,45,Male,24.725182933,12.194387406,No,16.9,9,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,35,6,71,19.328,60,70,70,20,13,7,25,No,No,No,No,4,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,476,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,N,,,,,,,,,,Y,,,N,,0,,0,0,0,0,0,0,0,0,0,0,,N,No
1,477-001,Biologic Non-naïve,71,Male,26.325113379,13.253935661,No,15.2,1,Former,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,30,8,12,17.913,23.333333333,8,0,9,6,3,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.2,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,477-002,Biologic Non-naïve,48,Male,22.382271468,28.840520192,No,12,22,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,30,9,48,17.284,85,86,70,7,5,2,22,No,Yes,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-12,1,1,1,1,1,1,1,1,Y,-22,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,477-003,Biologic Non-naïve,32,Female,25.796372504,9.8672142368,No,6.3,7,Never,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,3,5,0,31.807,35,30,20,15,12,3,19,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6.3,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,477-004,Biologic Naïve,53,Female,36.207063547,4.900752909,No,3.9,20,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,9,10,28,0.317,28.333333333,26,50,18,11,7,23,No,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-1.8,0,0,0,0,0,1,1,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,477-005,Biologic Non-naïve,26,Male,20.802469136,8.887063655,No,3,21,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,5,5,65,14.921,58.333333333,60,50,22,14,8,25,No,Yes,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-3,1,1,1,1,1,1,1,1,Y,-12,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,477-006,Biologic Non-naïve,38,Female,25.924925736,18.934976044,Yes,8.7,17,Never,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,7,67,12.7,73.333333333,68,30,17,13,4,22,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-8.7,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,477-007,Biologic Non-naïve,61,Female,31.7401298,26.970568104,Yes,12.6,9,Former,Yes,Yes,Yes,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,No,No,3,20,7,70,36.424,48.333333333,62,50,16,10,6,23,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-12.6,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,477-008,Biologic Non-naïve,59,Female,24.445235552,47.983572895,Yes,2.6,15,Current,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,5,8,75,17.015,70,60,100,12,3,9,23,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-0.2,0,0,0,0,0,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,477-009,Biologic Naïve,33,Female,25.78125,5.9876796715,No,5.1,19,Current,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,No,3,8,8,0,9.351,80,78,70,13,10,3,20,No,Yes,Yes,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-3.1,0,0,0,0,1,1,1,0,Y,-5,0,Y,0,0,0,0,0,0,0,0,1,1,1,0,0,No,Y,No
1,477-010,Biologic Non-naïve,45,Male,31.797373975,33.363449692,Yes,6,5,Former,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,3,9,8,15,3.541,51.666666667,38,20,6,3,3,18,Yes,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6,1,1,1,1,1,1,1,1,Y,-1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,477-011,Biologic Non-naïve,74,Female,34.602076125,27.446954141,Yes,6.8,10.992,Never,No,Yes,Yes,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,3,30,0,42.096,9.193,58.238,47.763,54.928,8.589,4.446,4.143,22.01,No,No,No,No,0.512,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-5.9,0,0,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,477-012,Biologic Naïve,55,Male,28.08988764,8.4271047228,No,8,25,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,9,61,11.094,76.666666667,86,60,16,8,8,23,No,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.6,0,0,0,0,0,1,1,0,Y,-15,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,477-013,Biologic Non-naïve,66,Female,38.103947569,26.46954141,Yes,3.6,11,Never,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,3,8,0,63,21.143,61.666666667,58,0,13,5,8,24,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,477-014,Biologic Naïve,59,Male,29.9136168,13.46201232,No,6.6,15,Former,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,10,0,0,42.891,20,4,0,6,3,3,25,No,No,No,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-5.4,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,477-015,Biologic Naïve,40,Female,34.422173617,19.452429843,Yes,9.6,5,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,2,3,2.185,40,26,0,2,1,1,21,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-9.6,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,477-016,Biologic Non-naïve,49,Male,36.848072562,32.495550992,Yes,6,17,Never,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,9,6,72,20.046,81.666666667,64,30,17,12,5,24,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,477,Israel,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-16,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,480-001,Biologic Non-naïve,52,Male,24.508945765,18.995208761,Yes,8.4,12,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,2,6,8,19,4.745,66.666666667,62,20,15,8,7,24,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,480,Israel,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-8.4,1,1,1,1,1,1,1,1,Y,-11,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,480-005,Biologic Naïve,38,Male,43.209876543,3.3100616016,No,26.6,15,Never,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,60,7,69,0,66.666666667,64,50,19,11,8,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,480,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-21.9,0,0,1,0,0,0,1,1,Y,-14,1,Y,1,1,0,0,1,0,0,0,0,0,1,1,1,Yes,Y,Yes
1,480-006,Biologic Naïve,24,Female,34.746994319,8.758384668,No,8.4,14,Current,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,10,1,57,44,45,32,30,14,10,4,20,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,480,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,480-007,Biologic Naïve,61,Male,29.270994027,19.808350445,No,20.8,11,Former,Yes,No,No,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,Yes,No,4,20,5,1,0,75,56,20,15,9,6,22,Yes,Yes,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,480,Israel,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-4.9,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,483-002,Biologic Naïve,46,Male,38.964546121,22.527036277,No,9.4,29,Never,No,Yes,No,Yes,No,No,No,No,6,No,No,No,Yes,Yes,Yes,No,3,12,8,91,0,88.333333333,84,80,22,14,8,24,Yes,Yes,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,483,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.2,0,0,1,0,1,1,1,1,Y,-21,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,483-003,Biologic Naïve,46,Male,29.320987654,1.0924024641,No,8.2,30,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,6,69,0,68.333333333,72,80,14,7,7,25,No,Yes,No,No,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,483,Israel,Middle East,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,0,0,0,0,0,0,1,0,Y,-8,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,483-004,Biologic Non-naïve,64,Female,42.718612499,14.592744695,No,14.3,21,Never,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,35,4,0,0,63.333333333,24,80,27,19,8,25,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,483,Israel,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-5.1,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,501-001,Biologic Naïve,66,Female,29.515938607,32.783025325,No,14.6,5.731,Missing,Yes,Yes,No,Yes,No,No,No,No,5,Yes,No,No,No,Yes,Yes,No,3,10,7.073,11.252,0,49.61,45.597,4.499,12.181,6.025,6.156,24.96,No,No,No,Yes,0.241,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,501,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,501-002,Biologic Naïve,38,Male,29.352354501,16.772073922,No,4.6,3,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,No,Yes,Yes,No,2,8,1,6,0,18.333333333,12,0,2,2,0,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,501,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.4,0,0,0,0,1,1,1,1,Y,-2,1,Y,1,1,0,0,0,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,501-003,Biologic Naïve,54,Male,28.905075731,15.780971937,No,24.3,8,Former,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,40,8,0,38,83.333333333,50,0,9,5,4,25,No,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,501,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.3,1,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,501-004,Biologic Naïve,53,Female,22.892819979,43.805612594,Yes,8.7,12,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,Yes,3,15,8,0,4,51.666666667,34,70,20,9,11,25,Yes,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,501,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.5,0,1,1,1,1,1,1,1,Y,-10,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,501-005,Biologic Non-naïve,34,Female,22.060353798,12.542094456,Yes,0,0,Never,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,0,0,1,0,0,18.333333333,18,80,30,19,11,22,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,501,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,1,Y,,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,502-001,Biologic Naïve,50,Female,22.491349481,23.92881588,Yes,10.8,21,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,5,8.744,77,24,80,80,80,26,14,12,24,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.8,0,0,0,0,0,1,1,1,Y,-21,1,Y,1,1,0,0,0,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,502-002,Biologic Non-naïve,65,Male,32,4.9308692676,No,19.2,8,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,5,70,70,71.666666667,66,30,13,6,7,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.5,0,0,0,0,0,0,0,1,Y,-5,0,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,502-003,Biologic Naïve,61,Female,45.546372819,33.987679671,Yes,30.6,19,Never,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,45,7.619,60,4.761,80,80,70,20,12,8,20,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.6,0,1,1,0,0,1,1,1,Y,-19,1,Y,1,1,0,0,1,1,0,0,0,1,1,1,1,Yes,Y,Yes
1,502-004,Biologic Naïve,38,Male,23.374726077,2.9897330595,No,18,21.969,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,25,5.392,76.994,2.18,51.685,41.582,32.538,18.597,14.228,4.37,24.341,No,No,No,No,0.963,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.3,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,502-005,Biologic Non-naïve,65,Male,19.834710744,22.045174538,No,35.1,30,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,65,9.934,96,100,90,90,90,31,15,16,11,No,No,Yes,No,4,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-32,0,1,1,0,0,0,1,1,Y,-27,0,Y,1,1,0,0,1,1,0,0,0,0,1,0,1,Yes,Y,Yes
1,502-006,Biologic Naïve,77,Female,19.486961451,34.102669405,No,6.2,9,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,5,4.766,43,25.117,50,48,50,17,9,8,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.8,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,502-007,Biologic Naïve,20,Female,26.446280992,4.1149897331,No,18,8,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,45,6.715,70,7.624,65,64,0,12,5,7,24,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.3,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,502-008,Biologic Naïve,28,Female,34.285714286,3.1156741958,No,21,1,Former,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,45,4.996,12,20.368,43.333333333,28,0,7,5,2,22,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.8,0,0,1,0,0,1,1,1,Y,-1,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,502-009,Biologic Naïve,35,Male,24.835646457,2.12183436,No,20.4,22.333,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,45,5.316,57.251,12.63,61.423,56.496,91.938,14.095,10.183,3.912,24.959,No,No,No,Yes,0.381,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.2,0,1,1,0,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,502-010,Biologic Naïve,71,Male,27.131411791,31.383983573,No,11,20,Never,No,No,No,No,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,3,8,7,59,14.881,70,58,40,17,8,9,24,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11,1,1,1,1,1,1,1,1,Y,-18,0,Y,1,1,0,0,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,502-011,Biologic Naïve,64,Male,25.351541374,4.3832991102,No,23.1,10.086,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,6.798,55.172,6.061,78.678,77.015,11.751,22.506,12.488,10.018,18.682,No,No,No,No,0.388,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.5,0,1,1,0,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,502-012,Biologic Naïve,67,Male,34.285714286,8.3832991102,No,26,7.619,Missing,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,20,5.515,67.141,56.163,22.351,27.631,71.071,22.421,12.523,9.897,20.629,No,No,No,No,1.065,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.8,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,502-013,Biologic Naïve,62,Male,26.86873566,7.3839835729,No,22.8,4,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,18,2,10,31.731,11.666666667,16,10,9,5,4,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.1,0,1,1,0,1,1,1,1,Y,-3,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,502-014,Biologic Naïve,53,Male,27.968016064,3.3839835729,No,31,20.882,Missing,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,25,8.347,62.263,100,90.351,85.826,43.961,14.27,11.384,2.885,22.811,No,No,No,No,0.853,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-31,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,502-015,Biologic Naïve,60,Male,24.835646457,39.920602327,No,3,5,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,2,0,9.767,100,31.666666667,14,10,13.66,10.352,3.309,24.393,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.1,0,0,0,1,1,1,1,1,Y,,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,502-016,Biologic Naïve,26,Female,19.53125,1.4236824093,No,16.5,27,Current,No,No,No,No,No,No,No,No,1,No,Yes,No,No,No,No,No,3,10,7,75,29.047,76.666666667,68,80,14,10,4,25,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,1,1,1,1,1,1,1,1,Y,-25,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,502-017,Biologic Naïve,31,Male,32.653061224,0.59137577,No,7.5,18.041,Missing,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,12,0.997,31.384,13.562,48.513,21.701,40.992,6.779,3.711,3.068,24.989,No,No,No,No,0.655,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,0,0,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,502-018,Biologic Naïve,18,Female,24.973985432,0.6735112936,No,7.5,8.258,Missing,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,15,6.577,33.858,13.043,40.486,42.098,25.774,18.074,10.554,7.52,24.642,No,No,No,No,0.483,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,502-019,Biologic Naïve,59,Male,33.897210744,0.7501711157,No,8.4,4,Former,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,3,15,7,55,18.64,46.666666667,50,20,5,2,3,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.9,0,1,1,1,1,1,1,1,Y,2,0,Y,,1,,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,502-020,Biologic Naïve,34,Male,27.440599174,14.809034908,Yes,10.5,15.505,Missing,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,13,5.212,32.965,12.519,59.076,42.342,29.995,30.695,15.364,15.331,21.809,No,No,No,Yes,2.023,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.2,0,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,502-021,Biologic Naïve,40,Female,24.973985432,4.4106776181,No,6,16.996,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,6.954,7.002,14.393,64.015,42.702,7.213,9.498,7.699,1.799,22.924,No,No,No,No,1.278,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,0,0,1,0,1,1,1,1,Y,,,Y,1,1,1,1,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,502-022,Biologic Naïve,33,Female,20.281233099,4.848733744,No,6.3,3,Never,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,1,2,26.043,18.333333333,6,0,7,6,1,20,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.1,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,502-023,Biologic Naïve,64,Male,27.126736111,9.3470225873,Yes,7.5,23.971,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,4.089,46.608,40,39.702,40.055,52.449,23.766,9.166,14.6,24.929,No,No,No,No,1.679,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.3,0,0,1,0,1,1,1,1,Y,,,Y,1,1,1,1,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,502-024,Biologic Naïve,44,Male,26.594984129,9.3607118412,No,9.3,5.037,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,7.74,80.917,6.432,76.701,67.802,33.388,17.263,9.926,7.337,23.426,No,No,No,No,0.991,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,502-025,Biologic Naïve,72,Female,27.34375,7.5290896646,Yes,5.4,2,Never,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,8,5,31,58.206,31.666666667,38,20,20,9,11,25,No,No,No,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,0,0,1,1,1,1,1,1,Y,0,0,Y,1,1,1,1,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,502-026,Biologic Naïve,40,Male,28.086260331,10.234086242,No,10.8,11.603,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,4.604,42.528,3.689,47.917,42.246,24.202,18.165,9.326,8.839,24.186,No,No,No,No,0.137,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,502-027,Biologic Naïve,25,Male,22.819404548,2.417522245,No,4.8,1,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,2,8,26.104,16.666666667,16,0,4,4,0,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,502-028,Biologic Naïve,62,Female,30.439952438,5.2758384668,No,13.2,22.401,Missing,No,No,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,Yes,3,25,7.706,34.964,24.506,74.21,76.556,67.196,19.051,10.668,8.383,23.928,No,No,Yes,No,0.299,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,502-029,Biologic Naïve,41,Female,24.221453287,5.3716632444,No,8,13.597,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,4.64,77.451,0.779,76.733,55.369,86.435,28.448,17.625,10.823,20.659,No,No,No,No,1.108,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,502-030,Biologic Naïve,51,Male,23.808797045,4.4955509925,No,6.8,26.249,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,7,4.47,45.454,18.017,60.981,59.087,87.912,11.605,3.602,8.003,22.982,No,No,No,No,2.345,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,502-031,Biologic Non-naïve,57,Male,23.888440981,6.2477754962,Yes,5.8,10.21,Missing,No,No,No,Yes,No,No,No,No,2,No,Yes,No,No,No,Yes,No,3,8,3.279,96.06,26.447,43.192,31.799,68.259,15.254,4.882,10.372,24.456,No,No,Yes,Yes,0.971,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.8,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,502-032,Biologic Naïve,29,Male,22.30547056,3.4168377823,No,10.8,13.454,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,7,6.832,47,7.718,68.354,50.841,50.004,11.122,7.394,3.729,24.642,No,No,No,No,0.018,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,502-034,Biologic Naïve,57,Female,20.438165585,4.681724846,No,6.2,0.431,Missing,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,7,4.622,9.208,28.096,32.386,40.107,17.77,17.95,7.645,10.305,23.014,No,No,No,No,0.949,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.2,0,0,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,502-035,Biologic Naïve,45,Male,22.093170054,5.2073921971,No,15.2,13.322,Missing,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,15,8.776,58.426,12.551,76.607,72.423,35.573,14.92,6.658,8.262,19.841,No,No,No,Yes,1.825,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,0,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,502-036,Biologic Naïve,48,Female,24.84098009,5.3908281999,No,7.8,11.974,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,8,4.3,60.341,25.258,62.419,51.904,23.525,20.076,8.286,11.79,22.7,No,No,Yes,No,2.485,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,502,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,0,1,1,1,1,1,1,1,Y,,,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,503-001,Biologic Naïve,59,Female,25.605536332,30.746064339,No,7.2,18.11,Missing,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,2,3,7.256,63.19,0,76.896,54.068,48.193,25.66,15.541,10.119,22.472,No,No,Yes,No,1.225,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,503,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2,0,0,0,0,0,0,0,1,Y,,,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,503-002,Biologic Naïve,74,Female,31.992171327,45.752224504,Yes,14.8,3,Current,No,Yes,No,Yes,No,No,No,No,9,No,No,No,Yes,Yes,Yes,No,3,30,7,34,0,50,20,20,10,3,7,25,No,Yes,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,503,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,1,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,503-003,Biologic Naïve,48,Male,27.160493827,20.865160849,No,10.2,1,Former,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,0,41.178,0,23.333333333,8,0,8.884,3.016,5.869,19.055,No,No,Yes,No,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,503,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.7,0,1,1,1,1,1,1,1,Y,-1,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,503-004,Biologic Non-naïve,79,Female,27.639801314,3.1156741958,Yes,13.4,15.321,Missing,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,2,20,4.977,78.253,0,75.997,76.975,78.81,6.034,4.705,1.329,19.339,No,No,No,Yes,0.299,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,503,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,0,0,1,0,0,0,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,504-001,Biologic Naïve,43,Female,21.612811791,20.878850103,No,11,7,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,4,2,8,28.333333333,24,10,13,8,5,23,No,No,No,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,504,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-1.2,0,0,0,0,0,0,0,0,N,3,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,506-001,Biologic Non-naïve,18,Female,19.486961451,4.7474332649,No,9.2,11,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,10,9,81,12.46,91.666666667,82,60,22,13,9,15,No,Yes,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.7,0,0,1,0,1,1,1,1,Y,-10,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,506-002,Biologic Non-naïve,35,Female,28.398718001,19.16495551,Yes,3.3,8,Current,No,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,2,18,0,0,2.329,43.333333333,74,70,24,15,9,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.3,0,0,0,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,506-003,Biologic Non-naïve,47,Female,22.758306782,38.828199863,Yes,5,24,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,10,6,82,32.933,90,68,100,34,19,15,22,No,No,Yes,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,506-004,Biologic Non-naïve,51,Male,25.381468542,19.822039699,Yes,9,12.706,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,25,4.274,52.389,10.83,30.66,43.105,40.172,9.564,4.415,5.149,23.833,No,No,No,No,0.534,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,506-005,Biologic Naïve,60,Female,25,19.863107461,No,10,5,Former,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,35,0,0,4.416,48.333333333,14,10,17,10,7,25,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,0,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,506-006,Biologic Naïve,44,Female,24.435186669,1.6783025325,No,8.5,6,Never,Yes,No,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,35,3,17,26.062,29.245,22.005,0,15,8,7,24,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.7,0,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,506-007,Biologic Naïve,65,Male,28.068918152,35.775496235,No,15.8,4,Current,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,3,60,1,0,19.976,28.333333333,16,10,6,3,3,24,No,No,Yes,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-3,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,506-008,Biologic Non-naïve,18,Male,20.017729989,2.8856947296,No,9.4,5,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,63,3,15,17.851,25,10,50,23,11,12,24,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.5,0,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,506-009,Biologic Naïve,62,Male,29.411764706,15.657768652,Yes,21,16,Never,No,Yes,No,Yes,No,No,No,No,3,Yes,No,No,No,Yes,No,No,4,55,10,97,31.237,100,100,60,14,9,5,19,No,No,No,Yes,4,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.3,0,1,1,0,1,1,1,1,Y,-15,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,506-010,Biologic Non-naïve,57,Male,24.355421181,37.013004791,No,7.9,8,Current,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,15,6,42,8.973,53.333333333,48,10,4,4,0,24,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-6,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,506-011,Biologic Non-naïve,41,Male,32.871972318,18.934976044,No,17.6,10,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,63,6,43,14.814,66.666666667,60,60,16,8,8,23,No,No,Yes,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-4,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,506-012,Biologic Non-naïve,42,Female,22.647376961,36.016427105,No,11.4,9.263,Never,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,38,7.85,75.158,23.53,78.575,58.706,36.203,10.193,8.814,1.378,23.441,No,No,No,Yes,2.594,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,506,Italy,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,506-013,Biologic Non-naïve,25,Female,21.077195228,0.7638603696,Yes,7.6,24.597,Current,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,3.2017453799,5,2,19.904,25.923,50.391,23.263,66.889,32.202,20.453,11.749,21.862,Yes,No,Yes,Yes,0.193,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,506,Italy,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6.4,0,0,1,0,1,1,1,,Y,,,Y,,0,,0,1,0,0,0,1,1,1,0,0,,Y,No
1,506-014,Biologic Naïve,19,Female,19.53125,4.4982888433,No,31.8,25.657,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,60,4.765,61.305,0,62.243,49.993,91.163,18.853,7.444,11.409,24.104,Yes,No,No,Yes,1.23,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-31.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,506-015,Biologic Naïve,50,Male,43.209876543,10.094455852,Yes,5.4,6.614,Missing,No,No,No,Yes,No,No,No,No,6,No,No,No,Yes,Yes,Yes,No,3.2017453799,4,5.061,76.188,0,33.358,43.22,44.577,21.87,12.363,9.507,24.284,No,No,No,Yes,0.663,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,0,0,0,0,0,0,0,0,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,506-016,Biologic Naïve,18,Female,20.703125,0.7857631759,No,13.2,14.541,Missing,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,38,8.65,39.803,23.29,64.316,68.154,63.716,28.161,15.389,12.772,24.123,Yes,No,No,Yes,2.791,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,506,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.4,0,1,1,1,1,1,1,1,Y,,,Y,,1,,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,509-002,Biologic Naïve,55,Female,25.099501596,4.8240930869,No,14.4,9,Never,No,Yes,No,Yes,No,No,No,No,3,Yes,No,No,No,Yes,No,No,3,35,5,58,21,68.333333333,52,70,12,4,8,24,No,No,Yes,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,509,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.6,0,0,0,0,0,0,1,0,Y,3,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,509-003,Biologic Naïve,41,Male,22.647376961,24.722792608,No,16.8,23,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,38,2,10,31,63.333333333,24,100,22,10,12,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,509,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.8,1,1,1,1,1,1,1,1,Y,-21,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,509-004,Biologic Non-naïve,61,Male,27.727478497,10.92128679,No,16.2,10,Former,Yes,No,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,4,12,0,91,31,98.333333333,44,90,13,4,9,25,No,No,Yes,No,4,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,509,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,0,1,1,0,1,1,1,1,Y,-8,0,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,509-005,Biologic Non-naïve,26,Female,19.713321528,5.0130047912,Yes,16.7,16.389,Missing,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,40,5.038,37.065,0,68.764,48.007,43.1,6.568,4.032,2.536,21.487,Yes,Yes,No,Yes,0.235,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,509,Italy,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.8,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,509-006,Biologic Non-naïve,71,Female,25.593737062,7.1649555099,No,16.2,16.138,Missing,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,35,5.563,83.405,18,87.662,68.862,70.475,18.431,9.63,8.801,24.326,No,No,No,Yes,1.033,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,509,Italy,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,509-007,Biologic Non-naïve,76,Male,29.726516052,31.279945243,Yes,13.5,9.477,Missing,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,35,6.353,55.552,45,71.333,68.202,50.028,18.241,9.985,8.256,22.105,Yes,No,No,Yes,1.303,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,509,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.9,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,509-009,Biologic Naïve,44,Male,35.111238788,16.303901437,No,22.2,1,Current,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,35,3,0,16,5,14,0,13,5,8,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,509,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.2,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,509-010,Biologic Naïve,59,Male,31.533446712,20.303901437,No,20.4,13.049,Missing,Yes,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,Yes,No,4,52,2.752,21.304,30,37.483,30.838,21.391,10.305,8.432,1.873,22.516,No,No,No,Yes,1.949,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,509,Italy,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.2,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,509-011,Biologic Naïve,43,Male,29.938271605,34.310746064,No,34.2,15.834,Missing,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,65,8.735,60.051,10,85.397,75.125,50.506,13.79,7.128,6.662,23.631,No,No,No,Yes,2.332,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,509,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-34.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,511-001,Biologic Naïve,46,Female,32,1.7604380561,No,3.6,12,Never,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,6,7,59,0,71.666666667,70,70,18,7,11,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,511,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,511-002,Biologic Non-naïve,35,Female,22.679952409,29.98220397,No,12.1,2,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,4,31,0,48.333333333,40,0,25,17,8,23,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,511,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.1,0,0,0,0,0,0,1,1,Y,-1,1,Y,1,1,0,0,0,0,0,0,0,0,1,1,1,Yes,Y,Yes
1,512-001,Biologic Non-naïve,49,Female,20.761245675,10.510609172,No,8.3,16,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,8,81,16.431,88.333333333,90,0,12,6,6,25,No,Yes,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,512,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,N,-7.7,0,1,1,1,1,1,1,1,Y,-14,0,N,0,1,0,0,1,1,0,1,1,1,1,0,0,,N,No
1,513-001,Biologic Naïve,43,Male,23.566632231,20.602327173,No,16.8,21,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,16,7,52,36,81.666666667,72,60,21,9,12,20,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-20,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,513-002,Biologic Naïve,46,Male,25.013520822,25.464750171,No,18.9,11,Never,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,20,3,77,33.406,68.333333333,66,20,22,14,8,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.9,1,1,1,1,1,1,1,1,Y,-9,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,513-003,Biologic Naïve,32,Female,24.464601603,15.47980835,No,24.4,21,Never,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,54,7,87,0,66.666666667,86,80,12,8,4,22,No,Yes,No,No,2,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.3,0,1,1,1,1,1,1,1,Y,-20,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,513-004,Biologic Naïve,43,Female,34.626038781,28.501026694,No,3.9,16,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,6,7,70,0,73.333333333,78,70,18,8,10,24,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.9,0,0,0,0,0,1,1,0,Y,-5,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,513-005,Biologic Naïve,34,Male,24.092970522,11.635865845,No,7.8,12,Current,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,2,6,5,33,16,65,40,30,11,7,4,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.8,1,1,1,1,1,1,1,1,Y,-12,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,513-006,Biologic Non-naïve,55,Female,24.77209671,5.6755646817,No,12.2,12,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,6,80,0,66.666666667,74,0,3,3,0,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11,0,1,1,0,1,1,1,1,Y,-8,0,Y,1,1,1,1,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,513-007,Biologic Naïve,30,Female,21.453287197,1.6262833676,No,6.9,11,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,6,6,67,0,58.333333333,24,20,12,8,4,23,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,,,,,,,,,,Y,-6,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,513-008,Biologic Naïve,56,Male,20.761245675,14.524298426,No,10.4,16,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,12,5,38,0,45,38,20,11,6,5,22,Yes,No,Yes,No,4,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,0,1,1,1,1,1,1,1,Y,-15,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,513-009,Biologic Naïve,54,Male,25.484764543,36.569472964,No,18.6,15,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,40,6,32,0,71.666666667,68,70,3,2,1,25,Yes,No,Yes,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.6,0,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,513-010,Biologic Naïve,42,Male,26.82742078,12.637919233,No,8.3,1,Former,No,Yes,No,No,Yes,Yes,No,No,1,No,No,No,No,Yes,No,No,2,10,2,0,22,35,22,0,4,4,0,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,0,0,1,0,1,1,1,1,Y,0,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,513-011,Biologic Naïve,20,Male,26.026174896,1.8097193703,No,11.7,3,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,4,1,0,41.666666667,20,20,1,1,0,24,Yes,No,No,Yes,3,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.5,0,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,513-012,Biologic Naïve,30,Male,32.007315958,15.808350445,No,0.6,1,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,1,1,10,0,5,2,0,2,1,1,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,1,1,1,1,1,1,1,1,Y,-1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,513-013,Biologic Non-naïve,49,Male,30.026594984,28.273785079,No,6.1,2,Former,No,No,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,2,6,2,10,34.408,40,26,10,6,3,3,25,No,No,No,No,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.9,0,0,0,0,0,0,1,1,Y,-1,1,Y,1,1,0,0,0,0,0,0,0,0,1,1,1,Yes,Y,Yes
1,513-014,Biologic Naïve,56,Male,27.471707128,25.722108145,No,8.2,7,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,10,2,0,6,11.666666667,16,10,4,3,1,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.2,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,513-015,Biologic Naïve,40,Female,26.14268848,30.724161533,No,10,4,Current,No,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,No,3,18,2,44,11,51.666666667,22,0,14,9,5,23,Yes,No,No,Yes,2,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10,1,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,513-016,Biologic Naïve,21,Male,22.16066482,3.4250513347,No,6,0,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,6,0,4,0,26.666666667,4,0,2,2,0,25,Yes,No,No,Yes,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,513-017,Biologic Naïve,46,Male,38.781163435,32.59137577,No,15,10,Former,Yes,Yes,No,No,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,3,25,8,61,24.776,73.333333333,66,30,7,3,4,25,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,0,0,0,0,0,1,Y,-9,1,Y,1,1,0,0,0,0,0,0,0,0,0,1,1,Yes,Y,Yes
1,513-018,Biologic Naïve,37,Female,24.973985432,12.186173854,No,7.7,6,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,7,3,15,5,55,14,10,19,12,7,23,Yes,Yes,No,Yes,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.7,1,1,1,1,1,1,1,1,Y,-3,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,513-019,Biologic Naïve,37,Male,22.598140496,22.370978782,No,10.6,7,Never,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,12,4,8,0,76.666666667,24,10,15,11,4,24,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.6,0,0,0,0,0,0,0,0,Y,2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,513-020,Biologic Naïve,57,Male,30.071168432,38.206707734,No,6.8,0,Never,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,2,9,0,0,2,25,2,0,14,7,7,22,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.6,0,0,1,0,1,1,1,1,Y,1,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,513-021,Biologic Naïve,44,Female,23.323418064,26.759753593,No,1.2,1,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,1,2,3,0,0,6.6666666667,10,0,6,6,0,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1,0,0,1,1,1,1,1,1,Y,-1,,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,513-022,Biologic Naïve,47,Male,19.623233909,25.804243669,No,5.6,6,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,4,7,40,8,70,66,10,16,8,8,22,No,No,No,No,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.4,0,0,1,0,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,513-023,Biologic Naïve,23,Female,18.730489074,4.2245037645,No,15.8,7,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,4,68,2,68.333333333,52,0,17,10,7,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.8,1,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,513-024,Biologic Naïve,33,Male,24.111507465,3.446954141,No,21.6,11,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,35,2,0,7,36.666666667,12,50,4,2,2,25,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.6,1,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,513-025,Biologic Naïve,23,Female,33.412409369,16.755646817,No,22.6,12,Current,Yes,Yes,No,No,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,3,55,9,65,0,85,96,60,26,13,13,22,Yes,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,513,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,,,,,,,,,,N,-12,1,N,,0,,0,0,0,0,0,0,0,0,1,0,,N,No
1,514-001,Biologic Naïve,20,Male,21.303948577,10.214921287,No,21.2,5,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,40,2.585,1,40,80,20,0,7,7,0,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,514,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,514-002,Biologic Naïve,64,Female,21.926125822,57.388090349,No,17.6,8,Former,No,No,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,3,40,6,29,20,40,32,0,9,5,4,25,No,No,No,No,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,514,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.6,0,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,514-003,Biologic Naïve,39,Female,21.71806609,4.4435318275,No,26.7,11,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,40,7,42,70,38.333333333,56,20,18,7,11,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,514,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.8,0,0,0,0,0,0,0,0,Y,3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,514-004,Biologic Naïve,35,Male,33.792470156,14.464065708,Yes,41.4,4,Never,No,No,No,Yes,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,4,70,4,36,40,15,14,40,0,0,0,24,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,514,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-39.4,0,1,1,0,1,1,1,1,Y,-3,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,514-005,Biologic Non-naïve,52,Female,30.078125,1.6153319644,Yes,15.6,23,Former,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,18,6,81,36,81.666666667,58,100,18,10,8,25,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,514,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,0,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,514-006,Biologic Naïve,34,Male,21.604938272,11.898699521,No,15.6,1,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,13,3,9,21,46.666666667,40,0,13,8,5,24,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,514,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,0,0,0,0,0,0,0,1,Y,0,,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,514-007,Biologic Non-naïve,46,Female,22.024322513,5.8206707734,No,21.1,21,Current,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,5,40,10,89,4,93.333333333,86,80,21,12,9,23,Yes,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,514,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-16.9,0,0,1,0,0,0,1,0,Y,,,N,0,0,0,0,1,0,0,0,0,0,1,0,0,,N,No
1,514-008,Biologic Naïve,40,Female,21.719250114,23.600273785,No,19.5,25,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,35,4,0,28,91.666666667,62,20,25,14,11,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,514,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.5,1,1,1,1,1,1,1,1,Y,-25,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,516-001,Biologic Naïve,58,Male,21.604938272,5.7713894593,No,27.1,9,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,40,1,3,17,76.666666667,64,10,13,8,5,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,516,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.1,1,1,1,1,1,1,1,1,Y,-9,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,516-002,Biologic Naïve,34,Female,20.766651425,9.607118412,No,12.7,12,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,1,3,0,68.333333333,2,50,16,6,10,23,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,516,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.9,0,0,1,0,1,1,1,1,Y,-12,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,516-003,Biologic Naïve,62,Male,22.229061934,19.731690623,No,12.4,6,Former,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,3,21.321860465,4,1,26.308,51.666666667,40,10,17,9,8,24,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,516,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,0,1,1,1,1,1,1,1,Y,-4,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,516-005,Biologic Naïve,51,Female,29.031510377,2.5325119781,No,7.8,7,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,10,8,7,0,91.666666667,68,10,23,14,9,24,Yes,Yes,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,516,Italy,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.5,0,0,0,0,0,1,1,1,Y,-4,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,517-001,Biologic Naïve,43,Male,30.299204646,18.828199863,No,15.3,7,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,15,7,80,26.413,78.333333333,54,20,5,2,3,25,No,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,517,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.3,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,517-002,Biologic Naïve,54,Male,23.67125363,12.618754278,No,12,6,Never,No,No,Yes,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,3,18,4,31,20.671,41.666666667,40,10,17,11,6,19,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,517,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.7,0,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,517-003,Biologic Naïve,45,Male,33.950617284,23.668720055,No,20.1,8,Current,No,Yes,Yes,No,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,3,30,1,45,24.826,36.666666667,36,30,15,10,5,21,No,No,No,Yes,1,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,517,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.9,0,0,0,0,0,0,0,1,Y,-5,0,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,517-004,Biologic Naïve,56,Male,22.724403484,25.199178645,No,12.8,4.943,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,14,0,26.682,5.728,29.34,7.693,15.974,7.636,4.108,3.528,22.823,Yes,No,No,No,1.381,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,517,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,518-001,Biologic Naïve,31,Female,29.031510377,1.659137577,No,15.6,3,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,16,6,0,0,56.666666667,34,0,3,3,0,21,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,518,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.6,1,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,518-002,Biologic Naïve,44,Female,29.031510377,1.9685147159,No,18,11,Never,No,No,No,No,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,4,16,3,49,100,45,38,40,1,1,0,25,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,518,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.2,0,0,1,0,1,1,1,1,Y,-11,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,518-003,Biologic Naïve,45,Female,29.031510377,1.1307323751,No,23.4,5,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,21,6,0,81,63.333333333,40,0,7,4,3,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,518,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.4,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,518-004,Biologic Naïve,46,Male,29.031510377,4.0054757016,No,17.6,13,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,16,1,0,0,50,24,70,15,7,8,23,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,518,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.7,0,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,518-005,Biologic Naïve,25,Male,24.280263614,2.173853525,No,17.1,1.397,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,6,28.11,0,43.333333333,24,0,10.84,7.573,3.267,23.219,No,No,No,No,0.499,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,518,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.1,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,518-006,Biologic Naïve,46,Female,29.031510377,4.3449691992,Yes,12.3,4,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,8,3,0,70,62,0,8,7,1,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,518,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,1,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,518-007,Biologic Naïve,19,Male,29.031510377,11.041752225,No,19.8,15.055,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,18,6.732,79.95,0,53.759,57.539,60.742,6.753,4.393,2.36,18.453,Yes,No,Yes,Yes,0.448,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,518,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,519-001,Biologic Naïve,19,Female,20.449137418,11.40862423,No,16.7,9,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,19,4,16,16.478,38.333333333,40,30,19,10,9,24,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,519,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-10.1,0,0,0,0,0,0,0,0,Y,-6,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,519-002,Biologic Non-naïve,43,Male,23.959094229,21.752224504,No,16.2,9,Current,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,20,7,53,10,21.666666667,20,30,14,6,8,24,No,Yes,No,No,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,519,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.2,0,0,0,0,0,0,1,1,Y,-2,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,519-003,Biologic Naïve,59,Male,24.441802087,20.66255989,No,19.2,17,Current,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,26,8,80,5,98.333333333,94,70,25,16,9,23,Yes,No,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,519,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.7,0,0,1,0,0,0,1,0,Y,-9,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,519-004,Biologic Naïve,53,Female,23.875432526,3.6303901437,No,15.8,15,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,35,10,50,7,86.666666667,86,100,15,8,7,25,No,No,Yes,No,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,519,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,519-005,Biologic Naïve,26,Male,27.041644132,10.625598905,No,28.4,17,Never,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,32,0,58,0,55,34,50,15,9,6,23,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,519,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.6,0,0,0,0,0,0,0,0,Y,-1,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,519-006,Biologic Naïve,52,Female,22.031725685,0.8514715948,No,8.4,18.346,Missing,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,4,8,3.507,11.288,0,45.733,60.885,64.999,26.427,14.846,11.581,22.788,No,No,Yes,No,0.704,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,519,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,521-001,Biologic Non-naïve,54,Male,33.910034602,10.01779603,No,17,8.549,Missing,Yes,No,No,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,30,6.076,28.998,39.336,38.17,49.009,37.761,18.638,11.324,7.314,23.778,Yes,No,No,Yes,0.236,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,521,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,521-002,Biologic Non-naïve,72,Male,32.876887229,63.055441478,No,0,3,Former,No,No,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,0,0,0,1,0,10,2,0,11,6,5,24,No,No,No,No,1,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,521,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,1,Y,,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,521-004,Biologic Non-naïve,47,Male,27.757487217,20.498288843,No,18,21,Current,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,3,20,8,87,45.934,70,82,90,23,12,11,22,Yes,No,Yes,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,521,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-10.3,0,0,0,0,0,0,0,0,Y,-14,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,521-005,Biologic Naïve,47,Male,31.047694544,9.6837782341,No,10.6,7,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,1,9,4.817,51.666666667,12,50,16,8,8,17,Yes,No,No,No,4,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,521,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.6,1,1,1,1,1,1,1,1,Y,-1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,521-006,Biologic Non-naïve,54,Male,28.373702422,20.933607118,No,13,8,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,12,7,48,18.249,78.333333333,78,60,12,6,6,25,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,521,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11,0,0,1,0,1,1,1,1,Y,-6,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,521-007,Biologic Naïve,33,Male,35.49382716,0.5722108145,No,50.8,16,Current,Yes,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,4,70,8,87.898,20.939,61.666666667,66,90,10,3,7,22.49,No,No,Yes,Yes,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,521,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-45.5,0,0,1,0,0,0,0,1,Y,,,Y,1,1,1,1,1,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,521-008,Biologic Non-naïve,54,Male,39.246467818,4.887063655,No,19.1,8.515,Missing,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,2,12,5.199,41.215,36.308,24.276,40.849,42.761,13.391,3.933,9.458,22.7,No,No,No,No,0.442,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,521,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,0,0,0,0,0,0,0,1,Y,,,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,521-009,Biologic Naïve,46,Female,21.227887617,26.171115674,No,10.9,20,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,25,7,40,0,51.558,69.491,70,24,12,12,24,No,No,No,No,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,521,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-10.3,0,1,1,1,1,1,1,1,Y,-20,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,521-010,Biologic Non-naïve,51,Female,36.328125,34.083504449,Yes,12.4,3,Never,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,2,15,3,56,24.61,35,14,60,4,1,3,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,521,Italy,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,0,0,0,0,0,0,1,1,Y,-2,1,Y,1,1,0,0,0,0,0,0,0,0,1,1,1,Yes,Y,Yes
1,524-001,Biologic Naïve,42,Female,31.487889273,35.835728953,No,19.6,18,Never,Yes,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,Yes,4,10,9,90,43,83.333333333,82,60,10,7,3,22,No,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,524,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.4,0,1,1,1,1,1,1,1,Y,-17,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,524-002,Biologic Non-naïve,51,Male,33.05785124,8.0164271047,Yes,6.5,17,Current,Yes,No,No,Yes,No,No,No,No,5,No,No,No,Yes,Yes,Yes,No,4,3,9,70,20,75,68,60,19,9,10,25,No,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,524,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.3,0,0,1,0,1,1,1,1,Y,-13,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,524-003,Biologic Naïve,48,Male,25.680074054,9.5550992471,No,9.2,14,Never,Yes,No,No,No,No,No,No,No,2,No,No,No,No,Yes,Yes,No,3,12,4,12,11,45,46,40,15,8,7,25,No,No,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,524,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.2,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,524-004,Biologic Naïve,41,Male,27.757487217,3.3347022587,No,18.9,1,Current,No,No,No,No,No,No,No,No,2,No,No,No,No,Yes,Yes,No,4,9,3,37,0,28.333333333,24,20,11,5,6,23,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,524,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,524-005,Biologic Naïve,42,Female,37.649252393,3.3921971253,Yes,18,24,Never,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,18,8,89,4,88.333333333,84,70,19,11,8,25,Yes,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,524,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,-23,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,524-006,Biologic Naïve,37,Male,38.758394868,12.41615332,No,22,9,Former,Yes,No,No,No,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,5,12,6,57,5,60,52,20,17,10,7,22,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,524,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.1,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,525-001,Biologic Naïve,53,Female,32.557694149,14.631074606,No,50.4,10,Never,No,Yes,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,No,Yes,4,75,10,20,19.848,86.666666667,68,100,16,9,7,25,No,Yes,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,525,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-8,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,526-001,Biologic Naïve,18,Male,21.604938272,2.8364134155,No,12.7,6,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,5.093,51,0,63.333333333,52,0,5,4,1,18,Yes,Yes,No,Yes,4,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.1,0,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,526-002,Biologic Naïve,34,Male,20.775623269,9.6947296372,Yes,17.2,5,Current,Yes,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,35,5,52,15,50,50,0,6,3,3,25,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.6,0,1,1,1,1,1,1,1,Y,-3,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,526-003,Biologic Non-naïve,51,Female,39.442073936,10.554414784,Yes,30.4,20,Never,No,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,65,8.119,66,27.99,65,80,80,32,16,16,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-1.4,0,0,0,0,0,0,0,0,Y,-2,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,526-004,Biologic Naïve,49,Male,29.411764706,22.349075975,No,9,18,Former,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,Yes,No,2,18,6,83,31,78.333333333,58,50,15,7,8,23,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.8,0,0,1,0,1,1,1,1,Y,-18,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,526-005,Biologic Naïve,58,Male,26.775510204,11.37303217,No,7.6,8,Current,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,Yes,No,2,12,0,0,3.644,10,10,30,10,4,6,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7,0,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,526-006,Biologic Non-naïve,68,Male,22.675736961,1.0704996578,No,6.5,22,Current,No,Yes,No,Yes,No,No,No,No,7,Yes,No,No,No,No,Yes,No,4,8,4,84,63,78.333333333,42,70,27,13,14,18,No,Yes,Yes,Yes,4,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.1,0,0,0,0,0,0,0,0,Y,8,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,526-007,Biologic Naïve,47,Male,29.700413223,6.417522245,No,9,4,Former,Yes,Yes,No,Yes,Yes,Yes,No,No,6,Yes,No,No,No,Yes,Yes,No,3,15,4,2,32,48.333333333,34,10,4,3,1,23,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,1,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,526-008,Biologic Naïve,38,Male,26.264943847,31.419575633,No,10.5,2,Former,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,18,0,3.228,8,40,6,0,0,0,0,25,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,526-009,Biologic Naïve,52,Male,27.755102041,35.457905544,No,11.2,13,Former,Yes,Yes,No,No,Yes,No,No,Yes,1,No,No,No,No,Yes,No,No,3,18,3,17,4,36.666666667,32,20,13,7,6,24,No,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.2,1,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,526-010,Biologic Naïve,26,Female,25.711662075,19.457905544,No,11.7,5.635,Missing,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,21,5.188,46.319,16.156,55.176,39.284,31.698,14.109,6.262,7.847,23.407,No,No,Yes,Yes,0.874,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.3,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,526-011,Biologic Naïve,28,Male,36.295922232,11.600273785,No,10.6,12,Current,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,13,3,24,60,80,44,0,15,5,10,25,No,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.8,0,0,1,0,1,1,1,1,Y,-12,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,526-012,Biologic Non-naïve,33,Male,30.44982699,29.790554415,No,11.7,2,Former,Yes,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,24,7,0,33,56.666666667,34,10,6,1,5,25,No,No,No,No,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,0,0,1,0,1,1,1,1,Y,-1,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,526-013,Biologic Non-naïve,52,Male,26.234567901,24.840520192,Yes,10.8,2,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,6,48,2,65,58,0,12,6,6,25,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,0,0,0,0,0,0,0,0,Y,-1,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,526-014,Biologic Naïve,47,Female,23.4375,17.859000684,No,2.4,7,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,5,2,0,68,35,8,10,12,3,9,25,No,No,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,0,0,1,1,1,1,1,1,Y,-7,1,Y,1,1,0,0,1,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,526-015,Biologic Naïve,32,Male,24.30248706,2.8583162218,No,36,4,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,60,7,0,14.151,48.333333333,44,30,14,8,6,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-33.9,0,1,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,0,1,1,0,1,Yes,Y,Yes
1,526-016,Biologic Non-naïve,45,Male,29.726516052,16.917180014,Yes,7.2,3,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,10,8,0,49,76.666666667,62,0,4,1,3,25,No,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.6,0,0,0,0,0,0,1,1,Y,-3,1,Y,1,1,0,0,0,0,0,0,0,0,1,1,1,Yes,Y,Yes
1,526-017,Biologic Naïve,38,Female,32.653061224,20.919917864,No,36,13,Former,Yes,No,Yes,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,95,7,67,15,65,72,70,16,7,9,23,Yes,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11,0,0,0,0,0,0,0,0,Y,-12,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,526-018,Biologic Naïve,59,Female,26.729927495,2.0041067762,No,12.6,8,Former,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,12,9,0,8.864,80,78,60,16,7,9,24,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,0,0,0,0,0,0,0,0,Y,-6,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,526-019,Biologic Naïve,66,Male,31.172839506,6.984257358,No,10.2,5,Current,No,No,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,No,3,20,8,11,0,70,58,30,16,10,6,23,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,0,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,526-020,Biologic Naïve,31,Male,26.12244898,9.9849418207,No,14.4,18.455,Missing,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,25,4.947,51.6,2,36.417,20.988,40.906,16.886,9.736,7.15,15.571,No,No,No,No,2.941,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,526-021,Biologic Naïve,46,Female,25.510204082,34.984257358,No,9.9,18,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,9,73,33.991,83.333333333,80,70,11,10,1,23,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.3,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,526-022,Biologic Naïve,43,Female,21.077195228,8.0602327173,No,17.3,19,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,38,5,59,45,78.333333333,68,30,15,8,7,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.5,0,0,1,0,1,1,1,0,Y,-17,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,526-023,Biologic Naïve,44,Female,19.53125,11.09650924,No,10.8,4,Current,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,3,26,18.165,35,22,20,13,8,5,21,No,No,No,No,2,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,1,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,526-024,Biologic Naïve,34,Male,24.187046493,8.1177275838,No,11.4,15,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,5,16,17.54,71.666666667,50,50,8,5,3,25,Yes,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,1,1,1,1,1,1,1,1,Y,-15,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,526-025,Biologic Naïve,43,Male,28.164523329,14.130047912,No,10.8,9,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,1,14,6,78.333333333,62,0,19,11,8,25,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,0,0,1,0,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,526-026,Biologic Non-naïve,28,Male,22.724403484,7.7207392197,No,10.2,5,Current,Yes,No,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,8,8,50,30,65,42,30,8,4,4,23,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,526-027,Biologic Naïve,51,Male,27.131411791,20.041067762,No,16.5,16,Never,Yes,Yes,No,Yes,No,No,No,No,4,No,No,No,No,Yes,Yes,No,3,22,5,49,13,48.333333333,56,40,19,11,8,23,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,526-028,Biologic Naïve,44,Female,17.689788852,30.384668036,No,18.6,6,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,7,50,22.311,75,70,60,21,12,9,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.4,0,1,1,0,1,1,1,1,Y,0,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,526-029,Biologic Naïve,35,Male,24.074074074,3.4414784394,No,3.2,1,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,0,0,8.432,36.666666667,16,0,1,1,0,24,No,No,Yes,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,2.2,0,0,0,0,0,0,0,0,Y,2,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,526-031,Biologic Naïve,48,Female,21.35930625,20.563997262,No,7.2,11,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,10,9,80,13.236,85,86,30,19,13,6,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.4,0,0,0,0,0,1,1,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,526-032,Biologic Naïve,27,Male,26.296566837,5.6344969199,No,20.1,14,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,40,0,0,35.003,56.666666667,2,30,5,3,2,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.7,0,0,1,0,0,1,1,1,Y,-10,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,526-033,Biologic Naïve,21,Female,22.571047502,5.6427104723,No,6,3,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,9,7,0,10.901,50,24,0,3,2,1,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,526-034,Biologic Naïve,51,Female,36.160420776,1.6427104723,No,12,3,Current,Yes,No,Yes,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,Yes,No,4,20,0,0,41,95,66,0,4,2,2,24,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,526-035,Biologic Naïve,34,Female,40.404040404,1.4291581109,No,11.7,11,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,30,5,26,18.605,63.333333333,38,60,15,8,7,24,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.9,0,0,0,0,0,0,1,0,Y,-8,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,526-036,Biologic Naïve,55,Male,25.535446392,10.702258727,No,15.3,4,Former,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,30,1,0,16,6.6666666667,2,0,17,6,11,25,No,Yes,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,0,0,1,0,0,1,1,1,Y,-1,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,526-037,Biologic Naïve,42,Female,21.8299522,34.767967146,Yes,5.1,2,Never,Yes,No,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,2,9,0,0,13.241,21.666666667,0,0,17,11,6,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.9,0,0,1,0,1,1,1,1,Y,-2,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,526-038,Biologic Naïve,44,Female,30.043262298,27.315537303,No,16.2,8,Current,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,25,5,50,13.276,70,54,70,7,4,3,23,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.2,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,526-039,Biologic Non-naïve,43,Male,31.020408163,18.316221766,Yes,41.4,27,Current,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,5,70,10,75,60,91.666666667,94,90,27,13,14,25,No,Yes,Yes,No,2,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.4,0,0,0,0,0,0,0,0,Y,-8,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,526-040,Biologic Naïve,56,Male,26.583175803,31.334702259,No,10.5,23,Never,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,10,80,1,90,90,50,21,10,11,23,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,1,1,1,1,1,1,1,1,Y,-13,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,526-041,Biologic Naïve,34,Male,26.173832551,12.372347707,No,14.7,8,Former,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,7,8,23.542,65,48,40,6,5,1,23,No,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.7,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,526-042,Biologic Naïve,41,Male,27.700831025,21.453798768,No,12.6,19,Never,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,0,20,35.278,51.666666667,18,20,20,10,10,25,No,No,No,No,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,526,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,527-001,Biologic Non-naïve,73,Female,31.64556962,43.080082136,Yes,14.6,20,Never,Yes,Yes,No,Yes,No,No,No,No,7,No,No,No,Yes,Yes,Yes,No,3,60,7,24,28.829,73.333333333,52,50,29,14,15,25,No,No,No,No,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,527,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13,0,0,1,0,1,1,1,1,Y,-19,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,527-002,Biologic Non-naïve,55,Male,25.510204082,27.091033539,No,23.8,15,Never,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,4,50,8,44,1.962,83.333333333,72,40,17,8,9,25,No,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,527,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.6,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,527-003,Biologic Non-naïve,52,Female,27.217302947,41.363449692,Yes,0.4,1,Never,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,0,1,1,21,10.677,26.666666667,6,40,12,9,3,25,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,527,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.4,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,529-002,Biologic Naïve,70,Male,34.717838657,21.185489391,No,36.3,12,Former,No,Yes,No,Yes,No,No,No,No,4,No,No,No,No,No,No,Yes,4,10,9,85,0,71.666666667,46,50,11,5,6,25,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,529,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-34.5,0,1,1,0,1,1,1,1,Y,-11,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,529-003,Biologic Naïve,52,Female,20.415224913,2.2614647502,No,15.8,1,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,25,7,6,0,83.333333333,40,20,5,5,0,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,529,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,0,1,1,1,1,1,1,1,Y,-1,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,529-004,Biologic Non-naïve,34,Female,23.140495868,1.3661875428,No,28.2,19,Current,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,70,9,63,1,85,90,100,25,14,11,25,Yes,Yes,Yes,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,529,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.8,0,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,530-001,Biologic Non-naïve,40,Female,23.030045351,11.438740589,No,2.4,22,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,1,3,5,64,0,51.666666667,46,80,20,12,8,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,530,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-8,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,530-002,Biologic Non-naïve,49,Female,25.689561925,36.06844627,Yes,5.4,10.281,Missing,Yes,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,Yes,No,2,4,4.206,19.634,38.263,72.71,56.495,29.752,14.942,6.969,7.973,22.716,No,No,No,No,0.48,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,530,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,531-001,Biologic Non-naïve,50,Male,26.309016558,16.747433265,Yes,12,7,Former,No,No,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,15,2,22,0,23.333333333,28,10,12,5,7,25,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,531-002,Biologic Non-naïve,73,Female,23.046875,11.841204654,No,25,9.549,Missing,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3.2017453799,30,7.96,3.137,41.372,34.479,57.037,58.325,17.439,11.696,5.744,22.448,No,No,No,No,0.418,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.4,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,531-003,Biologic Non-naïve,33,Male,29.983587931,21.253935661,No,22,19.455,Missing,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,40,6.787,68.038,0,82.109,60.084,59.537,10.516,7.78,2.736,20.358,Yes,No,Yes,Yes,2.083,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.4,0,0,1,0,0,0,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,531-005,Biologic Naïve,64,Male,17.301038062,30.034223135,Yes,29,26.752,Missing,No,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,4,50,7.589,81.86,0,81.312,76.151,64.965,15.446,10.272,5.174,23.958,No,No,No,Yes,1.484,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.6,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,531-006,Biologic Naïve,63,Male,26.12244898,21.11430527,Yes,12.5,2,Former,Yes,No,No,No,No,No,No,No,1,No,No,No,No,No,No,No,3,35,1,27,0,58.333333333,18,0,3,2,1,25,No,No,No,No,1,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,531-007,Biologic Naïve,63,Male,26.851851852,1.0321697467,No,10,11.476,Missing,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,10,4.154,28.688,0,59.277,31.128,50.807,5.715,4.158,1.557,22.019,No,No,Yes,No,1.725,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,531-008,Biologic Naïve,58,Female,22.985397512,23.961670089,No,17.1,20,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,0,2,0,78.333333333,22,0,20,18,2,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,0,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,531-009,Biologic Naïve,46,Female,29.031510377,35.882272416,No,6,3,Current,No,Yes,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,2,6,4,14,0,25,24,10,1,1,0,25,No,No,No,No,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,1,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,531-010,Biologic Naïve,30,Male,31.855955679,11.186858316,Yes,5,12.442,Missing,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,6,4.427,14.687,0,69.165,40.407,30.329,24.171,16.145,8.025,19.539,No,No,No,No,0.714,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,531-011,Biologic Naïve,50,Female,26.70362358,2.0396988364,No,6,19,Former,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,6,9,86,0,70,68,40,22,12,10,25,No,No,No,Yes,3,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,1,1,1,1,1,1,1,1,Y,-15,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,531-012,Biologic Naïve,61,Male,26.729927495,8.3258042437,No,20.1,12.462,Missing,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,20,7.852,34.051,0,66.985,66.198,59.672,14.406,7.987,6.419,22.124,No,No,No,No,0.923,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.1,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,531-013,Biologic Non-naïve,66,Female,25.351541374,4.3531827515,Yes,5,11.902,Missing,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,2,5,6.022,36.263,0,83.595,57.386,48.912,13.37,8.372,4.998,24.462,No,No,No,No,0.028,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,531,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,0,0,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,536-001,Biologic Naïve,37,Male,27.099251007,1.9794661191,No,14.7,15.293,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,15,3.785,48.302,43,63.558,51.973,34.5,13.132,6.179,6.952,21.244,No,Yes,Yes,No,1.874,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,536,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.7,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,536-002,Biologic Naïve,51,Female,35.379812695,3.2224503765,No,2.8,2,Current,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,1,5,0,0,0,0,0,0,17,10,7,23,No,No,No,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,536,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,536-003,Biologic Naïve,54,Female,25.559329155,22.26146475,No,1.8,15,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,1,10,7,76,2,51.666666667,72,90,14,8,6,15,No,No,Yes,No,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,536,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,2.7,0,0,0,0,0,0,1,1,Y,,,N,1,1,0,0,0,0,0,0,0,0,1,0,1,,N,No
1,538-001,Biologic Naïve,69,Male,26.989619377,2.1327857632,No,9.1,5,Former,No,Yes,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,3,12,9,56,0,58.333333333,66,50,6,5,1,25,No,No,Yes,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,538,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,538-002,Biologic Non-naïve,65,Female,22.031725685,59.383983573,No,12.3,17,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,No,No,Yes,No,3,30,8,65,0,66.666666667,64,60,13,9,4,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,538,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,538-003,Biologic Non-naïve,51,Female,24.740937287,15.47980835,No,0,23,Former,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,20,8,68,90,55,76,70,22,14,8,25,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,538,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,1,Y,,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,538-004,Biologic Naïve,71,Female,26.218820862,21.916495551,Yes,4.8,17,Never,No,Yes,No,Yes,No,No,No,No,6,No,No,No,No,No,Yes,Yes,3,10,9,51,0,90,90,20,24,12,12,16,No,Yes,Yes,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,538,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,538-005,Biologic Non-naïve,55,Female,29.031510377,31.37303217,Yes,0,3,Former,No,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,4,5,3,0,3.005,56.876,27.035,80,22,15,7,25,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,538,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,,Y,0,0,N,,0,,0,0,0,0,1,1,1,1,0,0,,N,No
1,538-006,Biologic Naïve,59,Female,22.832879346,5.4373716632,No,9.8,17.748,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,15,5.998,35.23,23.074,61.284,60.581,82.362,19.044,10.355,8.689,20.548,No,No,No,No,2.22,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,538,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,539-001,Biologic Non-naïve,35,Male,28.405504356,7.1622176591,No,40.4,10,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,90,4,22,4,26.666666667,26,30,20,8,12,25,No,No,Yes,No,4,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-40.4,1,1,1,1,1,1,1,1,Y,-10,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,539-003,Biologic Non-naïve,47,Male,26.775510204,16.720054757,Yes,7.6,5,Former,Yes,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,4,8,1,31,6.389,56.666666667,4,40,15,9,6,25,No,No,No,No,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-7,0,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,539-004,Biologic Non-naïve,41,Male,30.421849648,14.872005476,No,36,3,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,5,11,36,55,46,20,4,1,3,25,No,No,No,No,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-36,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,539-005,Biologic Non-naïve,38,Female,19.265306122,24.262833676,Yes,20.2,20,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,53,8,68,29.159,83.333333333,78,80,23,14,9,25,No,Yes,No,Yes,4,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.2,1,1,1,1,1,1,1,1,Y,-19,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,539-006,Biologic Non-naïve,33,Female,32.454716898,4.8733744011,No,14.1,6,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,9,7,28,12.274,76.666666667,70,30,12,4,8,25,No,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.9,0,1,1,1,1,1,1,1,Y,-6,1,Y,,1,,0,1,1,0,1,1,1,1,1,0,Yes,Y,Yes
1,539-007,Biologic Non-naïve,27,Male,25.910684347,7.0499657769,No,22,3,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,31,1,11,5,43.333333333,8,0,16,9,7,25,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.2,0,1,1,1,1,1,1,1,Y,-3,1,Y,,1,,0,1,1,0,1,1,1,1,1,0,Yes,Y,Yes
1,539-008,Biologic Naïve,44,Male,40.391156463,30.119096509,No,28.9,15,Current,Yes,Yes,Yes,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,4,51,10,59,15,80,82,60,22,9,13,25,Yes,No,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-1,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,539-009,Biologic Naïve,51,Male,20.244897959,3.6550308008,No,12.4,4,Current,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,18,3,0,41,21.666666667,6,0,10,4,6,25,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-1.3,0,0,0,0,0,0,0,0,Y,0,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,539-010,Biologic Naïve,57,Male,28.344671202,4.4654346338,No,19.1,12,Current,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,4,11,4,0,12,58.333333333,54,40,13,7,6,24,No,Yes,Yes,No,0,Yes,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-6.7,0,0,0,0,0,0,0,0,N,-1,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,539-011,Biologic Naïve,46,Male,30.44982699,11.540041068,No,9.4,7,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,8,0,3,19,53.333333333,34,0,13,8,5,24,No,No,Yes,No,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.6,0,1,1,1,1,1,1,1,Y,-1,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,539-012,Biologic Naïve,36,Female,33.984375,8.6954140999,No,17,13,Current,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,18,8,72,0.459,73.333333333,78,70,13,4,9,23,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.9,0,0,0,0,0,0,0,0,Y,-7,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,539-013,Biologic Naïve,45,Male,29.454659842,23.731690623,Yes,24.2,7,Former,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,51,3,3,25,31.666666667,12,10,10,6,4,25,No,No,No,No,3,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.8,0,0,0,0,0,0,0,1,Y,-7,1,Y,1,1,0,0,0,0,0,0,0,0,0,1,1,Yes,Y,Yes
1,539-014,Biologic Non-naïve,25,Female,20.829995193,16.772073922,No,16.1,4,Current,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,21,3,8,6,28.333333333,22,0,16,8,8,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.1,1,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,539-015,Biologic Naïve,43,Male,28.808864266,2.8281998631,No,10.7,4,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,10,2,20,46,53.333333333,32,10,12,6,6,14,No,No,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2,0,0,0,0,0,0,0,0,Y,-4,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,539-016,Biologic Naïve,45,Male,24.489795918,15.780971937,No,38.8,16,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,72,10,100,21,93.333333333,98,70,21,11,10,18,Yes,Yes,No,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-34.6,0,0,1,0,0,0,1,1,Y,-13,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,539-017,Biologic Non-naïve,46,Female,36.51263743,10.904859685,Yes,17.8,3,Never,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,26,6,80,10.556,66.666666667,76,70,21,11,10,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.8,1,1,1,1,1,1,1,1,Y,1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,539-018,Biologic Non-naïve,63,Male,27.757487217,41.905544148,Yes,37.4,10,Current,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,45,1,11,28,60,28,30,3,2,1,21,No,No,No,Yes,0,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-37.4,1,1,1,1,1,1,1,1,Y,-10,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,539-019,Biologic Naïve,42,Female,24.337479719,31.019849418,No,19.3,7,Current,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,35,8,51,47.255,70,78,40,17,9,8,25,Yes,No,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.7,0,0,0,0,0,0,0,0,Y,-1,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,539-020,Biologic Naïve,35,Male,32.192904936,21.021218344,Yes,24.9,14,Current,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,41,8,49,43,73.333333333,68,70,16,7,9,25,No,Yes,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.9,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,539-021,Biologic Naïve,41,Male,26.794938017,11.09650924,No,17.4,1,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,56,5,4,8,33.333333333,26,0,4,4,0,25,Yes,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.4,1,1,1,1,1,1,1,1,Y,-1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,539-022,Biologic Non-naïve,39,Female,37.655817175,35.12936345,Yes,19,20.974,Missing,Yes,Yes,No,Yes,No,No,No,No,3,No,Yes,No,Yes,Yes,No,No,4,22,4.467,81.011,4,38.934,45.502,70.005,29.533,14.17,15.363,24.148,No,Yes,Yes,Yes,0.489,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,539-023,Biologic Naïve,20,Male,19.159827276,9.0513347023,No,15,11,Never,Yes,No,Yes,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,36,3,0,49.064,61.666666667,6,0,13,7,6,19,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,1,1,1,1,1,1,1,1,Y,-11,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,539-024,Biologic Naïve,51,Male,29.387755102,1.697467488,No,24.9,24,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,43,6,89,27.735,91.666666667,90,100,29,12,17,24,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-24.9,1,1,1,1,1,1,1,1,Y,-23,1,N,1,1,1,1,1,1,1,1,1,1,1,1,1,,N,No
1,539-025,Biologic Non-naïve,53,Male,26.297577855,22.19301848,No,22.8,12,Former,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,30,7,2,3,63.333333333,80,70,9,2,7,24,No,No,Yes,Yes,3,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.8,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,539-026,Biologic Naïve,50,Male,29.28390291,13.585215606,No,28,8,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,80,10,0,34.375,63.333333333,64,0,11,2,9,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25.6,0,1,1,0,0,1,1,1,Y,-7,1,Y,1,1,0,0,1,1,0,0,0,1,1,1,1,Yes,Y,Yes
1,539-027,Biologic Non-naïve,32,Male,20.902385858,9.5852156057,No,24.1,6,Former,No,Yes,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,54,8,13,2,66.666666667,26,50,24,13,11,21,No,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.1,1,1,1,1,1,1,1,1,Y,-1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,539-028,Biologic Naïve,44,Male,24.221453287,11.441478439,No,26.8,18,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,41,5,54,19,76.666666667,68,60,17,9,8,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,539,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26.2,0,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,540-001,Biologic Non-naïve,53,Female,30.811246105,23.745379877,No,2.7,1,Current,No,No,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,1,5,1,0,0,11.666666667,10,0,15,9,6,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,540,Italy,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,3,0,0,0,0,0,0,0,0,Y,3,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,540-002,Biologic Non-naïve,56,Male,20.56932966,7.7453798768,No,1.2,7,Former,No,No,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,2,3,1,42,0,45,40,40,8,3,5,21,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,540,Italy,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,2.7,0,0,0,0,0,0,1,0,Y,-7,1,Y,0,0,0,0,0,0,0,0,0,0,1,1,0,No,Y,No
1,554-001,Biologic Naïve,46,Female,28.393351801,14.915811088,No,21.9,16,Never,Yes,Yes,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,31,10,100,12,100,100,70,30,17,13,25,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,554,Mexico,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.1,0,0,1,0,0,0,1,0,Y,-15,1,Y,0,0,0,0,1,0,0,0,0,0,1,1,0,No,Y,No
1,554-002,Biologic Non-naïve,60,Male,35.316916703,20.919917864,Yes,6.6,21,Former,No,No,No,Yes,No,No,No,No,4,No,Yes,No,Yes,Yes,No,No,2,7,5,15,4,51.666666667,50,90,21,13,8,22,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,554,Mexico,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,6.1,0,0,0,0,0,0,0,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,554-003,Biologic Non-naïve,53,Female,27.688888889,17.995893224,No,7.6,13,Never,Yes,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,8.9,6,79,0,96.666666667,96,60,26,17,9,24,No,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,554,Mexico,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,554-004,Biologic Naïve,41,Female,23.718836565,18.004106776,No,9.7,5,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,15,2,30,8,23.333333333,14,50,15,8,7,23,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,554,Mexico,Latin America,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,554-005,Biologic Naïve,20,Male,26.026174896,19.052703628,No,11.4,6,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,5,0,0,50,26,30,12,8,4,25,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,554,Mexico,Latin America,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,554-006,Biologic Naïve,43,Male,28.393351801,17.125256674,No,15.9,19,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,9.2,3,36,0,71.666666667,44,20,1,1,0,25,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,554,Mexico,Latin America,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.7,0,1,1,0,1,1,1,1,Y,-4,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,579-001,Biologic Non-naïve,72,Female,32.508521651,43.405886379,Yes,7.4,6,Never,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,No,No,3,10,8,60,0,56.666666667,66,40,16,7,9,25,Yes,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,579,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,0,0,1,0,1,1,1,1,Y,4,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,579-002,Biologic Non-naïve,51,Male,34.114237411,16.41889117,No,3,1,Current,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,2,12,1,5,3,16.666666667,10,0,2,2,0,25,No,No,Yes,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,579,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.4,0,0,0,0,0,1,1,0,Y,0,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,580-001,Biologic Naïve,20,Female,22.857142857,5.8316221766,No,17.2,13,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,52,8,75,5,70,76,80,17,7,10,23,Yes,Yes,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17,0,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,580-002,Biologic Naïve,28,Female,22.589551436,13.522245038,No,6.3,15,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,20,5,12,10,56.666666667,18,50,17,10,7,22,Yes,Yes,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,0,0,0,0,0,0,0,0,Y,10,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,580-003,Biologic Naïve,51,Male,23.76641014,15.745379877,No,8.4,7,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,15,9,86,14,75,68,0,10,5,5,25,Yes,Yes,Yes,Yes,2,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,0,0,1,0,1,1,1,0,Y,-4,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,580-004,Biologic Naïve,47,Female,28.577960677,31.822039699,No,9.8,14,Never,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,Yes,3,15,7,69,0,68.333333333,54,40,10,10,0,20,Yes,Yes,Yes,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.8,0,0,1,0,1,1,1,0,Y,-6,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,580-005,Biologic Non-naïve,40,Female,34.936844934,10.773442847,No,6.6,3,Current,No,No,No,Yes,No,No,No,No,5,Yes,Yes,No,Yes,Yes,No,Yes,2,5,8,75,36,76.666666667,76,0,2,2,0,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.6,0,0,0,0,1,1,1,0,Y,0,0,Y,0,0,0,0,0,0,0,0,1,1,1,0,0,No,Y,No
1,580-006,Biologic Naïve,52,Female,23.951226593,40.101300479,No,30.6,4,Former,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,70,10,50,0,92.919,80.304,0,2,1,1,25,Yes,Yes,Yes,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-29.2,0,1,1,0,1,1,1,1,Y,-4,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,580-007,Biologic Non-naïve,66,Male,26.851851852,6.0999315537,No,4.8,6,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,9,7,4,4,45,30,70,1,0,1,25,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,0,0,1,1,1,1,1,1,Y,-6,1,Y,1,1,0,0,1,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,580-008,Biologic Naïve,30,Male,28.08988764,16.205338809,No,4.4,3,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,7,9,0,46.666666667,36,30,7,5,2,23,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.7,0,0,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,580-009,Biologic Naïve,46,Male,30.071168432,11.537303217,No,22.7,17,Former,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,38,7,0,6,70,60,100,11,6,5,19,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.3,0,0,0,0,0,0,0,0,Y,-10,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,580-010,Biologic Non-naïve,45,Male,29.320987654,32.703627652,No,10.4,12,Never,Yes,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,15,6,20,0,41.666666667,22,10,15,10,5,25,No,No,No,Yes,1,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.2,0,0,0,0,0,0,0,0,Y,-7,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,580-011,Biologic Naïve,38,Male,29.218407597,19.635865845,No,7.1,1,Former,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,7,3,14,30,48.333333333,10,0,11,4,7,23,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,0,0,0,0,0,1,1,0,Y,-1,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,580-012,Biologic Naïve,50,Male,31.353578787,4.4407939767,No,4.1,1,Former,No,Yes,No,Yes,No,No,No,No,8,No,No,No,Yes,Yes,Yes,No,2,5,3,20,0,55,30,20,10,5,5,20,Yes,Yes,No,No,3,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.3,0,0,1,1,1,1,1,1,Y,0,,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,580-013,Biologic Non-naïve,47,Male,26.583175803,19.312799452,No,6.9,1,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,0,7,4,11.666666667,0,70,10,9,1,23,No,No,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.3,0,1,1,1,1,1,1,1,Y,1,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,580-014,Biologic Naïve,62,Female,28.650137741,3.9534565366,No,2,3,Former,Yes,Yes,No,Yes,No,No,No,No,7,Yes,No,Yes,No,Yes,Yes,No,2,5,7,76,0,30,14,0,2,1,1,24,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.8,0,0,0,0,1,1,1,0,Y,0,0,Y,0,0,0,0,0,0,0,0,1,1,1,0,0,No,Y,No
1,580-015,Biologic Naïve,40,Male,24.835646457,25.086926762,Yes,8.4,7,Current,No,Yes,No,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,5,5,5,0,53.333333333,54,0,16,10,6,25,No,No,No,No,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.4,0,0,1,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,580-016,Biologic Naïve,26,Male,22.038401159,8.1040383299,No,8.3,3,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,7,0,0,70,28,0,6,6,0,24,Yes,No,Yes,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.3,1,1,1,1,1,1,1,1,Y,1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,580-017,Biologic Naïve,56,Male,26.19618735,9.106091718,No,1.8,6,Former,No,Yes,No,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,2,5,0,0,0,36.666666667,6,0,8,4,4,23,No,No,No,No,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,0,0,0,0,1,1,1,1,Y,-3,0,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,580-018,Biologic Naïve,22,Female,26.346494034,6.3162217659,No,7.2,13,Former,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,15,7,61,0,65,56,80,17,11,6,20,Yes,Yes,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.4,0,0,1,1,1,1,1,1,Y,-12,1,Y,1,1,0,0,1,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,580-019,Biologic Naïve,49,Male,32.179930796,8.3969883641,No,19.9,16,Current,Yes,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,35,10,50,0,80,48,80,21,7,14,25,No,Yes,No,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.6,0,0,0,0,0,0,0,0,Y,-13,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,580-020,Biologic Naïve,42,Female,29.384756657,16.459958932,Yes,2.6,12,Current,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,Yes,3,5,8,78,7,85,78,60,8,5,3,24,No,Yes,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,580,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,0,0,0,0,1,1,1,1,Y,-11,1,Y,1,1,0,0,0,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,582-001,Biologic Naïve,23,Male,21.545090797,5.7467488022,No,1.9,2,Former,Yes,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,2,11,2,9,9.3,41.666666667,20,0,3,1,2,22,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.9,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,582-002,Biologic Naïve,52,Male,28.405504356,8.4462696783,No,7.5,17,Current,Yes,Yes,Yes,Yes,Yes,No,No,Yes,3,No,No,No,No,Yes,Yes,No,2,5,7,25,4,48.333333333,68,80,14,10,4,21,Yes,Yes,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.5,1,1,1,1,1,1,1,1,Y,-15,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,582-003,Biologic Naïve,63,Male,28.395061728,42.650239562,No,6.2,5,Former,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,6,8,71,8,68.333333333,74,10,7,5,2,25,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.4,0,0,1,1,1,1,1,1,Y,-3,0,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,582-004,Biologic Naïve,21,Male,20.576131687,0.6242299795,No,5.4,7,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,5,7,83,0,61.666666667,46,10,3,3,0,25,Yes,Yes,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.4,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,582-005,Biologic Naïve,56,Female,20.449137418,8.7474332649,No,7,12,Current,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,3,6,4,0,0,55,56,70,15,10,5,24,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.2,0,0,0,0,1,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,1,1,1,0,0,No,Y,No
1,582-006,Biologic Naïve,55,Male,37.6917458,4.7474332649,No,3.7,28,Former,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,2,8,90,10,76.666666667,78,100,27,12,15,24,Yes,No,Yes,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.9,0,0,1,1,1,1,1,0,Y,-6,0,Y,0,0,0,0,1,0,0,1,1,1,1,0,0,No,Y,No
1,582-007,Biologic Naïve,56,Female,23.225431848,7.7672826831,No,3.3,7,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,9,81,7,80,72,0,12,8,4,24,No,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.3,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,582-008,Biologic Non-naïve,64,Male,24.915315921,9.954825462,No,2.7,1,Former,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,2,2,0,0,16,30,6,10,0,0,0,25,No,No,No,Yes,1,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-1.5,0,0,0,0,1,1,1,1,Y,-1,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,582-009,Biologic Naïve,48,Male,27.141582391,19.79192334,No,1.8,6.641,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,1,2,8.417,40.016,3,46.602,48.825,4.156,15.705,7.118,8.587,19.113,Yes,No,Yes,No,1.097,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,582-010,Biologic Naïve,29,Female,19.369834711,7.8631074606,No,4.2,12.943,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,4,3.115,47.422,0,48.027,46.858,38.29,26.4,15.62,10.78,23.484,Yes,No,No,Yes,1.705,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,582-011,Biologic Naïve,44,Male,32.050303715,2.3846680356,No,5.8,10.803,Missing,Yes,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,5,4.953,8.272,3,45.536,37.728,32.443,12.521,8.471,4.05,24.042,No,No,No,Yes,0.863,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,582-012,Biologic Naïve,57,Male,24.93372049,3.0527036277,No,6.3,1,Never,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,6,0,4,6,43.333333333,10,10,1,1,0,25,Yes,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.3,1,1,1,1,1,1,1,1,Y,-1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,582-013,Biologic Naïve,38,Female,24.391058839,10.88569473,No,6.6,15,Former,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,6,8,28,6,78.333333333,58,40,4,4,0,25,Yes,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,1,1,1,1,1,1,1,1,Y,-15,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,582-014,Biologic Naïve,34,Female,25.503615702,17.002053388,No,6.5,24,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,5,10,97,9,96.666666667,90,90,27,13,14,20,No,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,582-015,Biologic Naïve,45,Female,22.589551436,26.097193703,Yes,5.5,14,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,4,52,19,48.333333333,34,30,17,9,8,20,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.5,1,1,1,1,1,1,1,1,Y,-14,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,582-016,Biologic Naïve,52,Female,27.776706146,25.568788501,No,3.3,13,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,2,3,11,0,50,20,40,11,5,6,25,Yes,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.3,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,582-017,Biologic Naïve,41,Female,22.14532872,5.5879534565,No,7.5,8,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,8,80,0,73.333333333,68,40,5,4,1,21,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.5,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,582-018,Biologic Naïve,67,Female,36.289737262,28.607802875,No,3,8,Former,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,2,5,8,0,6,71.666666667,54,10,4,2,2,25,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3,1,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,582-019,Biologic Naïve,29,Female,25.816630213,2.045174538,No,11.6,8.556,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,10,0.476,15.58,0,54.217,23.589,19.979,12.151,8.41,3.741,24.618,No,No,No,Yes,1.623,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,582-020,Biologic Naïve,38,Female,27.34375,12.711841205,No,6.5,6,Missing,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,6,3.058,49.348,6,41.427,41.575,65.713,21.486,11.976,9.51,23.639,No,No,No,Yes,0.796,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-6.5,1,1,1,1,1,1,1,1,Y,,,N,1,1,1,1,1,1,1,1,1,1,1,0,1,,N,No
1,582-021,Biologic Naïve,55,Male,24.508945765,5.7248459959,No,4.7,8,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,3,5,4,78,5,80,56,50,1,1,0,24,Yes,Yes,Yes,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,582,Netherlands,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.7,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,583-001,Biologic Naïve,50,Male,35.444234405,14.726899384,No,23.1,11,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,5,21.321860465,7,50,14,53.333333333,46,30,15,8,7,18,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-10,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,583-002,Biologic Naïve,56,Female,24.221453287,24.060232717,Yes,8.1,10,Current,Yes,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,2,20,4,45,20.138,35,38,30,17,7,10,25,No,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.3,0,0,0,0,0,0,0,0,Y,-1,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,583-003,Biologic Naïve,56,Male,24.857954545,19.088295688,No,5.9,4.994,Missing,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,20,2.934,27.682,12.799,34.744,36.38,17.39,18.963,11.526,7.437,23.96,Yes,Yes,Yes,No,1.936,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.9,1,1,1,1,1,1,1,1,Y,,,Y,,1,,0,1,1,1,1,1,1,1,0,0,Yes,Y,Yes
1,583-004,Biologic Naïve,64,Female,28.934068902,4.7255304586,No,11.1,15.944,Current,Yes,No,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,30,7,36.727,1.463,74.59,79.98,40.558,15.667,11.478,4.19,19.237,No,Yes,Yes,Yes,2.351,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.7,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,583-005,Biologic Naïve,63,Female,43.436132179,13.80698152,Yes,8.4,5,Former,Yes,No,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,20,6,10,18.647,68.333333333,64,30,21,13,8,25,No,Yes,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.8,0,0,0,0,0,0,1,0,Y,0,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,583-006,Biologic Naïve,40,Male,20.371208692,10.472279261,No,7,3,Never,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,1,10,3,5,0,31.666666667,12,10,9,5,4,22,No,No,No,No,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,1,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,583-007,Biologic Naïve,27,Male,20.616319444,23.668720055,No,3.6,11,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,25,2,0,6.864,18.333333333,12,10,16,10,6,23,No,No,Yes,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-10,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,583-008,Biologic Naïve,21,Male,19.655451497,16.544832307,Yes,30.2,10.085,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,70,7.882,37.812,23.736,51.815,59.344,69.209,13.959,6.809,7.15,23.063,Yes,Yes,No,Yes,2.652,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.2,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,583-009,Biologic Naïve,35,Male,17.283950617,24.856947296,No,0.8,8,Former,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,10,6,12,0,61.666666667,64,70,30,20,10,23,Yes,Yes,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,4.2,0,0,0,0,0,0,1,0,N,-6,0,N,0,0,0,0,0,0,0,0,0,0,1,0,0,,N,No
1,583-010,Biologic Naïve,47,Male,33.529887848,21.212867899,No,17.2,13,Current,No,No,Yes,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,No,3,50,2,0,20,51.666666667,26,40,13,5,8,24,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-10,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,583-011,Biologic Naïve,21,Male,24.021275987,0.4325804244,No,12.8,10.461,Missing,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,1,40,6.022,64.093,16,46.684,64.29,77.009,17.526,9.698,7.828,22.459,Yes,Yes,No,Yes,0.637,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,583,Netherlands,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,604-001,Biologic Non-naïve,40,Male,32.195179584,18.518822724,No,19.8,13,Former,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,34,8,67,28,61.666666667,62,60,1,1,0,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,604,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-19.8,1,1,1,1,1,1,1,1,Y,-12,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,604-002,Biologic Non-naïve,67,Male,30.116213152,30.496919918,No,19.8,17,Former,No,Yes,Yes,No,No,No,No,No,5,No,No,No,Yes,Yes,Yes,Yes,4,38,9,50,21,68.333333333,50,40,7,3,4,25,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,604,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.5,0,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,604-003,Biologic Naïve,61,Male,31.637396694,8.5174537988,Yes,20.3,17,Never,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,23,7,18,0,53.333333333,52,80,5,0,5,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,604,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.3,1,1,1,1,1,1,1,1,Y,-9,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,604-004,Biologic Naïve,61,Male,27.6816609,41.645448323,No,54.7,29,Current,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,5,73,10,16,86,91.666666667,58,80,13,5,8,25,Yes,Yes,Yes,Yes,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,604,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-52,0,1,1,0,0,1,1,1,Y,-19,0,Y,0,1,0,0,1,1,0,0,0,1,1,0,0,Yes,Y,Yes
1,604-005,Biologic Non-naïve,53,Female,39.411064842,39.846680356,No,47.9,27,Current,No,Yes,Yes,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,Yes,Yes,5,79,9,89,0,88.333333333,86,80,16,8,8,25,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,604,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-45.9,0,1,1,0,1,1,1,1,Y,-18,0,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,607-001,Biologic Non-naïve,48,Male,30.023243802,21.026694045,No,16.5,26,Former,No,Yes,No,No,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,3,26,4,7,13.908,73.333333333,30,70,14,9,5,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,607,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,1,1,1,1,1,1,1,1,Y,-21,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,607-002,Biologic Non-naïve,46,Male,37.448347107,26.453114305,No,11,3.03,Missing,No,Yes,Yes,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,3,13,4.713,13.872,11.981,33.497,27.19,49.153,8.005,3.166,4.84,23.166,No,No,No,Yes,0.813,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,607,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.3,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,607-003,Biologic Non-naïve,39,Female,33.874063759,5.1772758385,Yes,15,6.562,Missing,No,Yes,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,Yes,No,3,20,6.904,9.911,5.787,59.332,41.174,22.172,11.783,8.067,3.716,20.419,No,No,Yes,Yes,3.173,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,607,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,614-001,Biologic Naïve,64,Female,28.515625,35.019849418,No,16.5,17,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,No,Yes,Yes,No,3,24,6,36,32,48.333333333,38,70,5,3,2,24,No,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.6,0,1,1,1,1,1,1,1,Y,-17,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,614-002,Biologic Naïve,45,Female,19.723183391,29.691991786,No,16.6,26,Current,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,36,8,69,14.121,83.333333333,74,70,22,13,9,25,No,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,Anti TNFs,Infliximab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.6,1,1,1,1,1,1,1,1,Y,-25,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,614-003,Biologic Naïve,64,Male,27.398175682,54.395619439,No,18.9,13,Never,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,60,8,36,20.809,66.666666667,50,10,8,5,3,23,No,No,Yes,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.2,0,0,1,0,0,1,1,1,Y,-6,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,614-004,Biologic Naïve,29,Male,37.832874197,13.77412731,No,27.4,17,Current,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,43,7,18,17,31.666666667,26,50,17,8,9,25,Yes,Yes,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.2,0,0,1,0,0,0,1,1,Y,-14,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,614-005,Biologic Naïve,54,Male,26.423569824,17.834360027,No,19,6,Former,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,24,6,20,3,31.666666667,44,20,11,9,2,25,No,Yes,Yes,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,0,0,1,0,0,0,1,1,Y,-6,1,Y,1,1,0,0,1,0,0,0,0,0,1,1,1,Yes,Y,Yes
1,614-006,Biologic Naïve,69,Female,26.53375883,9.9822039699,Yes,10.7,14,Never,Yes,Yes,No,Yes,No,No,No,No,4,No,No,No,No,Yes,Yes,No,2,11,7,0,4,55,26,80,14,8,6,24,No,No,Yes,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,Anti TNFs,Infliximab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.1,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,614-007,Biologic Naïve,63,Female,36.848072562,15.786447639,Yes,28.2,12.216,Missing,No,No,Yes,Yes,No,No,No,No,6,No,No,Yes,Yes,Yes,Yes,No,4,47,5.893,59.495,17,67.989,61.589,43.888,10.735,3.86,6.875,19.368,No,No,Yes,Yes,0.71,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26.4,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,614-008,Biologic Naïve,20,Female,24.056934746,2.71321013,No,20.3,11,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,54,7,12,0,38.333333333,30,30,17,9,8,24,No,Yes,Yes,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-20.3,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,614-009,Biologic Non-naïve,37,Male,24.569314372,33.957563313,No,18.8,22,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,21,5,22,40,41.666666667,42,30,19,11,8,22,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-18.8,1,1,1,1,1,1,1,1,Y,-22,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,614-010,Biologic Naïve,41,Male,28.086419753,19.68788501,No,25.5,12.367,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,29,6.346,24.839,0,50.575,37.917,26.124,4.917,3.947,0.97,23.506,Yes,No,Yes,Yes,1.129,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.7,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,614-011,Biologic Naïve,28,Male,28.373702422,22.548939083,Yes,32.5,30,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,71,10,93,29,86.666666667,88,100,18,7,11,25,No,Yes,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25.2,0,0,1,0,0,0,0,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,614-012,Biologic Non-naïve,20,Female,20.957171163,10.277891855,No,19.8,19,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,21,4,41,0,50,28,70,19,9,10,24,No,No,Yes,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.6,0,1,1,0,1,1,1,1,Y,-15,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,614-013,Biologic Naïve,50,Male,32.653061224,27.624914442,No,34.7,15,Never,Yes,No,Yes,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,58,9,70,10,83.333333333,90,50,15,7,8,21,No,No,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-32.3,0,1,1,0,0,1,1,1,Y,-12,0,Y,1,1,0,0,1,1,0,0,0,1,1,0,1,Yes,Y,Yes
1,614-014,Biologic Naïve,36,Male,36.139455782,14.12183436,No,35.6,9,Current,No,No,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,5,41,2,0,11,20,8,10,14,5,9,25,Yes,No,Yes,Yes,3,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-32.9,0,1,1,0,0,1,1,1,Y,-3,0,Y,1,1,0,0,1,1,0,0,0,1,1,0,1,Yes,Y,Yes
1,614-015,Biologic Naïve,58,Male,25.535446392,40.391512663,No,16.5,9,Former,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,28,2,0,0,40,26,20,27,14,13,21,Yes,No,No,Yes,2,Yes,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,Anti TNFs,Infliximab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-14.4,0,0,1,0,0,1,1,0,Y,,,N,0,0,0,0,1,0,0,0,0,1,1,0,0,,N,No
1,614-016,Biologic Naïve,43,Male,25.464010865,25.089664613,Yes,20.7,28,Current,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,3,68,8,80,10,60,46,70,11,8,3,25,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.7,0,0,1,0,0,1,1,0,Y,-23,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,614-017,Biologic Naïve,45,Female,23.711844631,35.364818617,No,18.1,22,Never,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,No,4,42,4,47,0,45,32,50,19,11,8,25,No,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.1,1,1,1,1,1,1,1,1,Y,-21,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,614-018,Biologic Naïve,62,Male,25.142857143,22.740588638,No,17.8,30,Former,No,Yes,No,Yes,No,No,No,No,6,No,No,No,No,Yes,Yes,No,4,17,10,93,10,100,92,100,27,18,9,23,No,Yes,Yes,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.7,0,1,1,0,1,1,1,1,Y,-21,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,614-019,Biologic Naïve,37,Male,28.964734689,14.069815195,No,23.6,15.941,Missing,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,25,6.198,58.715,33,80.099,65.022,74.726,15.282,6.646,8.637,18.464,No,No,Yes,Yes,0.018,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.4,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,614-020,Biologic Naïve,33,Female,40.057683064,13.59890486,No,19.2,15,Former,Yes,Yes,No,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,23,8,47,10,65,46,0,13,8,5,24,No,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.2,1,1,1,1,1,1,1,1,Y,-15,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,614-021,Biologic Non-naïve,30,Female,44.077134986,10.119096509,Yes,20.4,21.106,Missing,Yes,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,Yes,No,4,40,9.331,68.985,0,70.554,81.286,58.781,19.05,9,10.05,20.829,Yes,Yes,Yes,Yes,3.166,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,614-022,Biologic Non-naïve,44,Male,26.277285079,24.553045859,No,18.6,11.601,Missing,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,5,20,7.345,44.426,30,65.482,45.315,57.046,21.704,12.552,9.152,21.028,No,No,Yes,Yes,1.11,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.8,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,614-023,Biologic Naïve,52,Male,33.24099723,29.659137577,No,12.9,16.357,Missing,Yes,Yes,No,No,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,19,8.214,82.338,0,86.619,78.541,57.155,17.425,8.14,9.286,24.033,No,No,Yes,Yes,1.812,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,Anti TNFs,Infliximab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.5,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,614-024,Biologic Naïve,41,Male,38.200183655,6.12183436,No,10.6,21,Never,No,Yes,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,4,7,5,87,0,78.333333333,76,70,28,14,14,22,No,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.9,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,614-025,Biologic Naïve,41,Male,26.19618735,14.704996578,No,15.9,8,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,No,Yes,Yes,No,4,13,5,0,10,48.333333333,26,0,6,1,5,25,Yes,No,Yes,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,614,Poland,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.2,0,0,1,0,0,1,1,0,Y,-5,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,616-001,Biologic Naïve,24,Male,21.09375,20.481861739,No,19.8,15,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,15,7,0,6.683,10,0,70,16,10,6,20,Yes,Yes,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,616,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.8,1,1,1,1,1,1,1,1,Y,-11,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,616-002,Biologic Naïve,45,Male,27.440599174,20.613278576,No,18.1,20.13,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,8.115,87.817,69,82.174,70.267,77.154,7.002,5.647,1.355,24.936,No,Yes,No,Yes,0.942,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,616,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.4,0,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,616-003,Biologic Naïve,42,Male,33.641975309,20.700889802,Yes,11,15.875,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,3.95,29.992,54,49.425,22.922,25.753,10.004,7.82,2.184,24.692,No,Yes,No,Yes,2.852,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,616,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.4,0,0,0,0,0,0,0,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,616-004,Biologic Naïve,46,Male,23.095409007,18.395619439,No,19.2,10,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,3,10,17,6.6666666667,14,10,22,11,11,24,No,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,616,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,617-001,Biologic Non-naïve,35,Female,24.801587302,16.440793977,Yes,21.1,21,Never,Yes,Yes,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,57,9,74,4,56.666666667,68,70,23,12,11,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.8,0,1,1,1,1,1,1,1,Y,-21,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,617-002,Biologic Naïve,34,Male,21.913580247,12.459958932,No,10.2,19,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,13,8,29,24,63.333333333,60,40,27,18,9,23,Yes,Yes,Yes,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.8,0,0,1,0,1,1,1,1,Y,-19,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,617-003,Biologic Non-naïve,35,Male,25.951557093,19.471594798,No,8.4,9,Current,No,Yes,Yes,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,2,7.5,4,9,1,18.333333333,12,20,0,0,0,25,No,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.8,0,1,1,1,1,1,1,1,Y,-9,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,617-004,Biologic Naïve,41,Male,36.085402118,20.479123888,No,15.4,29,Never,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,32,6,74,0,68.333333333,74,0,3,2,1,24,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.6,0,1,1,1,1,1,1,1,Y,-27,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,617-005,Biologic Naïve,44,Male,26.794938017,29.514031485,Yes,3.8,14,Never,Yes,Yes,No,Yes,Yes,Yes,No,No,1,No,No,No,No,No,No,No,2,14,4,30,2,28.333333333,24,20,3,2,1,25,Yes,Yes,No,Yes,1,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.6,0,0,0,0,1,1,1,1,Y,-14,1,Y,1,1,0,0,0,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,617-006,Biologic Naïve,38,Male,26.575890591,8.5174537988,No,4,23,Former,No,Yes,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,4,4,54,10,46.666666667,34,70,21,12,9,24,No,Yes,Yes,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.3,0,0,0,0,0,1,1,0,Y,-11,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,617-007,Biologic Non-naïve,49,Female,50.78125,17.519507187,No,11.6,19,Current,No,Yes,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,3,11,9,89,12,55,68,60,20,10,10,22,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-6.9,0,0,0,0,0,0,1,0,Y,-8,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,617-008,Biologic Naïve,58,Male,27.744748315,37.522245038,Yes,12.1,23,Former,No,Yes,No,Yes,No,No,No,No,3,Yes,No,No,No,Yes,No,No,3,27,8,48,28,58.333333333,60,60,20,12,8,21,No,No,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10,0,0,1,0,0,1,1,1,Y,-19,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,617-009,Biologic Naïve,46,Male,30.056810675,11.537303217,No,18.3,26,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,27,5,63,2,53.333333333,52,90,22,12,10,25,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.7,0,1,1,1,1,1,1,1,Y,-26,1,Y,1,1,1,1,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,617-010,Biologic Naïve,27,Male,26.82742078,6.598220397,No,20,17,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,36,1,90,14,85,66,60,14,7,7,25,Yes,Yes,Yes,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.2,0,1,1,0,1,1,1,1,Y,-13,0,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,617-011,Biologic Non-naïve,36,Male,26.592669673,17.631759069,No,21.2,11,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,53,7,3,15,68.333333333,46,10,5,2,3,24,Yes,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.6,0,1,1,1,1,1,1,1,Y,-11,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,617-012,Biologic Naïve,19,Female,22.761467536,11.649555099,No,19.2,30,Never,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,5,34,8,94,0,81.666666667,70,80,27,19,8,24,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.2,1,1,1,1,1,1,1,1,Y,-30,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,617-013,Biologic Non-naïve,45,Female,35.75595619,28.651608487,No,9.4,12,Current,Yes,Yes,No,Yes,Yes,Yes,No,No,3,No,No,No,Yes,Yes,No,No,3,9.5,5,0,17,50,28,20,21,11,10,24,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.9,0,0,0,0,0,0,1,0,Y,-7,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,617-014,Biologic Naïve,24,Male,37.576598451,7.6687200548,No,19.2,15,Current,Yes,Yes,No,No,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,4,38,10,20,33,50,42,50,13,8,5,24,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.2,1,1,1,1,1,1,1,1,Y,-15,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,617-015,Biologic Naïve,46,Male,26.093275201,20.744695414,No,20.8,27,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,28,10,87,19,95,92,60,16,7,9,25,No,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.8,1,1,1,1,1,1,1,1,Y,-25,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,617-016,Biologic Non-naïve,30,Male,21.224489796,15.742642026,No,10.1,11,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,22,7,62,21,66.666666667,50,80,16,7,9,22,No,Yes,Yes,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.3,0,0,1,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,617-017,Biologic Naïve,30,Female,20.932120125,20.804928131,No,18.4,30,Former,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,27,3,57,1,76.666666667,62,70,21,13,8,24,No,Yes,Yes,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.4,1,1,1,1,1,1,1,1,Y,-30,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,617-018,Biologic Naïve,65,Male,32.699167658,35.898699521,Yes,16.8,12,Never,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,4,26,5,72,6,76.666666667,52,40,14,8,6,25,No,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,617-019,Biologic Naïve,42,Female,22.679952409,37.924709103,No,18.9,30,Current,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,26,9,97,0,81.666666667,66,100,31,17,14,15,Yes,Yes,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.9,1,1,1,1,1,1,1,1,Y,-29,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,617-020,Biologic Non-naïve,50,Male,37.654320988,26.924024641,No,11.7,17,Former,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,15,7,71,5,70,44,30,2,1,1,23,Yes,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,1,0,0,1,1,0,Y,-5,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,617-021,Biologic Naïve,41,Female,21.469150482,34.078028747,No,12,22,Former,No,Yes,No,No,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,27,10,100,0,65,74,20,21,14,7,24,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.5,0,0,0,0,0,0,0,0,Y,-9,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,617-022,Biologic Naïve,25,Male,24.072542533,10.078028747,No,18.3,23,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,28,8,91,1,70,70,80,17,9,8,22,No,Yes,Yes,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.2,0,0,1,0,0,0,1,0,Y,-12,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,617-023,Biologic Naïve,31,Male,23.88946281,17.097878166,No,7,9,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,7,57,0,51.666666667,54,100,20,12,8,23,Yes,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7,1,1,1,1,1,1,1,1,Y,-9,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,617-024,Biologic Naïve,50,Male,31.095278348,26.110882957,Yes,27,19,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,43,5,51,4,78.333333333,30,50,10,4,6,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25.8,0,1,1,0,1,1,1,1,Y,-19,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,617-025,Biologic Naïve,50,Male,31.919307989,10.110882957,No,16.6,22,Former,Yes,Yes,Yes,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,No,No,4,38,10,100,23,75,84,40,12,4,8,25,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,0,0,1,0,0,0,1,0,Y,-14,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,617-026,Biologic Naïve,33,Male,33.121744792,14.110882957,No,29.7,20,Current,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,5,56,8,78,27,73.333333333,66,30,7,5,2,25,Yes,Yes,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.9,0,1,1,0,1,1,1,1,Y,-20,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,617-027,Biologic Naïve,37,Male,27.776929886,1.0458590007,Yes,7.2,24,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,6.5,7,66,63,73.333333333,58,90,13,6,7,24,No,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,1,1,1,1,1,1,1,1,Y,-4,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,617-028,Biologic Non-naïve,44,Male,31.561671506,31.170431211,Yes,12.2,13,Never,Yes,Yes,No,Yes,No,No,No,No,5,No,No,No,Yes,Yes,Yes,No,4,16,7,77,23,46.666666667,60,10,9,4,5,22,Yes,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.5,0,0,1,0,0,1,1,0,Y,-12,1,Y,0,0,0,0,1,0,0,0,0,1,1,1,0,No,Y,No
1,617-029,Biologic Non-naïve,48,Male,41.661635068,32.169746749,No,10.2,17,Former,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,Yes,4,24,4,34,11,43.333333333,36,60,20,9,11,18,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.9,0,1,1,1,1,1,1,1,Y,-17,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,617-030,Biologic Non-naïve,25,Male,32.111952407,16.186173854,Yes,12.7,24,Never,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,16,7,77,2,63.333333333,58,50,20,10,10,24,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.4,0,0,0,0,0,0,1,0,Y,-14,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,617-031,Biologic Non-naïve,56,Female,34.293552812,18.187542779,Yes,10.2,11.457,Missing,Yes,Yes,Yes,Yes,No,No,No,No,10,Yes,No,No,Yes,Yes,Yes,Yes,3,13,5.298,41.677,0,80.093,59.392,55.625,14.966,7.116,7.851,21.352,No,No,No,Yes,0.213,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.8,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,617-032,Biologic Naïve,42,Male,24.535123967,3.3976728268,No,19.2,15,Never,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,34,8,38,0,48.333333333,56,50,11,4,7,24,No,No,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.6,0,1,1,1,1,1,1,1,Y,-14,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,617-033,Biologic Naïve,20,Male,22.857142857,11.230663929,No,19.5,26,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,30,3,0,0,75,62,40,19,10,9,23,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.3,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,617-034,Biologic Non-naïve,35,Male,30.930438076,11.230663929,Yes,9.3,10,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,8,75,0,66.666666667,66,60,13,7,6,24,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.3,1,1,1,1,1,1,1,1,Y,-6,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,617-035,Biologic Non-naïve,41,Female,31.553659149,33.289527721,No,12.8,30,Former,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,22,8,82,0,70,74,80,4,3,1,25,No,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.8,1,1,1,1,1,1,1,1,Y,-26,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,617-036,Biologic Naïve,36,Male,26.851851852,15.364818617,No,20.5,19,Current,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,4,32,8,80,0,70,62,60,16,9,7,24,No,No,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.9,0,1,1,1,1,1,1,1,Y,-19,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,617-037,Biologic Naïve,19,Male,24.91349481,11.378507871,No,20.6,24,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,28,7,74,0,76.666666667,70,70,18,15,3,25,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.6,1,1,1,1,1,1,1,1,Y,-24,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,617-038,Biologic Naïve,23,Male,21.913805698,2.2176591376,No,9.2,11,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,8,56,0,70,70,40,19,12,7,17,Yes,Yes,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.6,0,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,617-039,Biologic Naïve,34,Male,34.748905744,10.436687201,No,43.2,18,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,5,94,6,10,43,63.333333333,36,60,27,11,16,24,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-40.3,0,1,1,0,0,1,1,1,Y,-16,0,Y,0,1,0,0,1,1,0,0,0,1,1,0,0,Yes,Y,Yes
1,617-040,Biologic Naïve,49,Female,24.816326531,32.473648186,Yes,27.2,24,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,5,36,9,90,6,95,92,90,38,19,19,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.2,1,1,1,1,1,1,1,1,Y,-19,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,617-041,Biologic Naïve,31,Male,32.653061224,6.4941820671,No,18.2,26.281,Missing,No,Yes,No,No,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,4,21,7.615,78.404,0,83.068,81.895,76.766,23.191,10.779,12.412,22.717,Yes,Yes,No,Yes,0.325,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,617,Poland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.2,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,626-001,Biologic Non-naïve,59,Female,34.765625,49.653661875,Yes,15.6,20,Current,No,Yes,No,Yes,Yes,Yes,No,Yes,3,No,No,No,Yes,Yes,No,No,4,15,10,68,24,91.666666667,92,80,17,11,6,21,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,626,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-7.2,0,0,0,0,0,0,0,0,Y,-10,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,626-002,Biologic Naïve,37,Female,35.75595619,4.6488706366,No,9.9,15,Former,Yes,Yes,Yes,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,Yes,3,10,8,34,0,66.666666667,72,20,14,7,7,23,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,626,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.3,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,626-003,Biologic Non-naïve,38,Female,29.585798817,24.865160849,No,4.4,4,Never,No,Yes,No,Yes,Yes,Yes,No,Yes,1,No,No,No,No,No,Yes,No,2,5,0,5,11,15,4,0,14,7,7,24,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,626,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.9,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,627-001,Biologic Naïve,21,Female,23.388686558,5.2402464066,Yes,15,14,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,18,10,56,0,70,54,70,18,14,4,25,No,No,No,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.7,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,627-002,Biologic Naïve,63,Male,30.7598702,36.295687885,Yes,16.2,8.213,Missing,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,15,3.538,21.302,40,69.803,35.652,43.766,9.204,8.601,0.603,18.724,No,No,No,No,2.115,Yes,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,627-003,Biologic Naïve,23,Female,24.21875,20.334017796,No,11.2,25,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,3,12,6,81,0,71.666666667,82,70,22,17,5,24,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.2,1,1,1,1,1,1,1,1,Y,-26,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,627-004,Biologic Naïve,36,Female,21.09375,14.392881588,No,15.2,11.016,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,4.817,49.724,0,69.036,28.845,65.51,8.666,1.456,7.21,20.592,No,No,No,Yes,1.291,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,627-005,Biologic Non-naïve,48,Female,22.862368541,38.392881588,No,11,0.51,Missing,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,15,2.912,33.683,0,22.87,38.193,22.074,19.894,11.893,8,23.571,No,No,No,No,1.1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,627-006,Biologic Naïve,43,Female,21.907582458,5.4127310062,Yes,17,25,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,25,9,85,0,85,94,80,26,14,12,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,627-007,Biologic Naïve,20,Male,29.012345679,8.4106776181,No,19.7,2,Current,Yes,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,25,4,3,0,25,26,20,25,15,10,24,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.2,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,627-008,Biologic Naïve,40,Female,27.335640138,11.488021903,No,13.5,7,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,15,6,10,0,65,50,10,14,4,10,24,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.6,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,627-009,Biologic Non-naïve,37,Male,32.876887229,22.425735797,Yes,4.1,7.374,Never,Yes,Yes,Yes,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,Yes,No,2,5,0,43.745,0,0,2,4.39,18.206,10.404,7.802,22.377,No,No,No,No,1.524,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.8,0,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,627-010,Biologic Naïve,60,Male,35.15625,4.6023271732,Yes,15.4,5,Former,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,3,20,5,50,0,86.666666667,58,30,17,9,8,24,No,No,No,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.6,0,0,0,0,0,0,1,0,Y,3,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,627-011,Biologic Naïve,56,Male,28.08988764,16.640657084,No,32.3,20.962,Missing,No,Yes,Yes,Yes,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,4,50,7.076,41.341,0,83.983,69.976,76.689,19.481,9.785,9.696,22.107,No,No,No,Yes,0.745,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-31.4,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,627-012,Biologic Naïve,40,Male,30.873312035,2.6420260096,Yes,10.8,12,Former,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,15,8,60,0,75,70,0,14,11,3,25,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.3,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,627-013,Biologic Non-naïve,60,Male,25.180785124,8.6598220397,No,18.5,14,Former,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,4,45,8,35.546,0,53.333333333,58,60,17,6,11,24.029,No,No,No,No,4,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,627-014,Biologic Naïve,46,Male,35.785147392,10.661190965,Yes,12.1,16,Former,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,15,1,58,0,55,10,70,27,15,12,23,Yes,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.5,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,627-015,Biologic Non-naïve,41,Female,22.582709172,37.661875428,No,27.9,12,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,40,8,85,0,73.333333333,82,80,16,11,5,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.5,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,627-016,Biologic Naïve,26,Male,26.395803401,10.674880219,No,19.8,24.305,Missing,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,18,7.764,40.257,0,81.253,65.471,95.724,16.434,12.187,4.248,23.747,No,No,No,No,0.032,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.6,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,627-017,Biologic Naïve,48,Female,30.103806228,34.718685832,Yes,16.2,9,Never,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,3,15,3,3,0,40,24,20,15,7,8,25,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,627-018,Biologic Non-naïve,42,Female,31.640625,37.73853525,No,18.9,4,Never,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,15,8,65,0,60,68,0,7,4,3,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.9,0,0,0,0,0,0,0,0,Y,7,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,627-019,Biologic Non-naïve,25,Male,20.902385858,12.774811773,No,11.7,9.85,Missing,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,10,1.504,30.409,0,36.863,24.876,57.072,14.085,6.565,7.52,23.976,No,No,No,No,0.938,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.1,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,627-020,Biologic Naïve,27,Male,27.166919271,23.775496235,No,16.8,20,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,7,70,0,78.333333333,62,90,22,11,11,23,No,No,No,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,627-021,Biologic Non-naïve,41,Male,38.424270774,22.795345654,Yes,16.2,2,Former,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,15,3,10,0,28.333333333,28,10,13,7,6,25,No,No,No,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.4,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,627-022,Biologic Naïve,46,Male,27.777777778,11.830253251,No,27.6,16,Current,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,20,8,87,0,88.333333333,80,70,23,14,9,25,No,No,No,No,1,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,627-023,Biologic Naïve,35,Female,23.42209073,26.833675565,No,13.7,21,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,8,73,0,60,46,90,15,9,6,25,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.9,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,627-024,Biologic Non-naïve,55,Male,26.874496103,22.833675565,No,14.1,13.656,Former,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,15,6,82.878,0,46.666666667,62,40.053,16.661,9.01,7.651,24.266,No,No,No,No,0.76,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.1,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,627-025,Biologic Non-naïve,40,Female,27.309968138,24.832306639,Yes,6.9,13.261,Missing,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,10,2.554,83.051,0,60.831,67.658,44.071,20.63,12.958,7.673,22.791,No,No,No,No,0.205,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.1,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,627-026,Biologic Naïve,39,Male,29.760837606,10.891170431,No,11.6,12.641,Missing,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,Yes,No,3,15,5.067,7.083,0,50.994,31.658,42.374,19.401,9.965,9.435,23.655,No,No,No,No,0.295,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,627-027,Biologic Naïve,21,Male,25.727555214,3.9726214921,Yes,11.1,14,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,5,29,0,65,52,60,23,12,11,24,No,No,No,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6,0,0,0,0,0,0,0,0,Y,-5,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,627-028,Biologic Non-naïve,24,Female,21.484375,14.948665298,No,5.1,15.345,Missing,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,3.803,47.841,0,70.255,54.521,53.187,16.537,11.977,4.56,19.961,No,No,No,Yes,0.333,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.7,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,627-029,Biologic Non-naïve,57,Male,26.874496103,36.960985626,No,2.6,16.714,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,8,6.519,90.374,0,50.563,41.279,62.781,17.691,10.903,6.788,24.978,No,No,No,No,1.21,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.4,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,627-030,Biologic Non-naïve,41,Male,26.12244898,11.000684463,No,16.8,23,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,10,70,0,91.666666667,92,100,18,11,7,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,627,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,630-001,Biologic Naïve,72,Male,35.362907461,11.006160164,No,54.7,14,Former,No,Yes,Yes,No,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,5,80,9,78,47,86.666666667,84,70,18,9,9,21,Yes,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,630,Portugal,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-50.7,0,1,1,0,0,0,1,1,Y,-13,1,Y,1,1,0,0,1,1,0,0,0,0,1,1,1,Yes,Y,Yes
1,630-002,Biologic Naïve,49,Male,28.086260331,22.847364819,No,14.9,6,Current,No,No,Yes,Yes,Yes,No,No,Yes,3,Yes,No,No,No,Yes,Yes,No,3,22,7,65,53,75,68,0,11,8,3,18,Yes,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,630,Portugal,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14,0,1,1,1,1,1,1,1,Y,-3,0,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,630-003,Biologic Naïve,37,Male,34.815730562,20.010951403,No,26.1,10,Current,Yes,Yes,No,Yes,No,No,No,No,9,No,No,No,Yes,Yes,Yes,No,4,26,5,27,14,36.666666667,38,10,12,6,6,24,Yes,No,No,Yes,1,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,630,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.3,0,0,1,0,0,1,1,1,Y,-6,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,632-001,Biologic Naïve,39,Male,31.013705104,12.640657084,No,17.8,12,Never,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,1,15,2,0,13,31.666666667,10,0,7,4,3,17,Yes,Yes,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-002,Biologic Naïve,56,Female,23.795359905,0.3093771389,No,5.4,26,Current,No,No,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,0,2.4,1,0,3.226,76.666666667,46,90,30,16,14,21,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-5.4,1,1,1,1,1,1,1,1,Y,-25,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,632-003,Biologic Non-naïve,25,Female,24.167162403,6.9733059548,No,4.8,6.956,Never,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,0,6,5.056,36.624,0,33.179,40.395,56.7,28.974,16.821,12.153,22.59,No,No,No,Yes,0.199,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-004,Biologic Naïve,21,Female,22.582709172,17.661875428,No,10.4,11.789,Missing,Yes,No,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,2,15,5.584,11.594,25.716,29.321,28.676,50.943,16.992,6.128,10.864,20.018,Yes,Yes,Yes,Yes,1.086,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-005,Biologic Naïve,35,Male,24.489795918,0.8021902806,No,9.6,17,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,5,58,21.686,56.666666667,44,30,31,17,14,25,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,632-006,Biologic Naïve,28,Female,30.824829932,3.8685831622,No,17.9,14,Current,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,1,9.1,4,0,0,21.666666667,26,40,10,6,4,25,Yes,No,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.9,1,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-007,Biologic Naïve,33,Female,24.391058839,9.2128678987,No,9.2,10,Never,No,Yes,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,0,13,0,0,0,28.333333333,16,0,20,12,8,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-8.8,0,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,632-008,Biologic Naïve,49,Female,24.622960911,10.740588638,No,9.6,18,Current,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,0,12,5,82,8,38.333333333,58,80,16,4,12,25,No,No,Yes,No,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,0.1,0,0,0,0,0,0,0,0,Y,,,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,632-009,Biologic Non-naïve,68,Female,25.711008267,10.327173169,No,11.4,20.556,Missing,No,No,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,4,11,5.889,16.116,0,54.699,21.033,42.673,12.981,5.012,7.97,23.131,No,Yes,No,Yes,1.637,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.1,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,632-010,Biologic Naïve,46,Female,24.654832347,30.819986311,No,4.5,17,Former,No,No,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,0,4.7,6,58,0,63.333333333,58,40,27,18,9,11,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,1,1,1,1,1,1,1,1,Y,-10,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-011,Biologic Naïve,50,Female,22.321428571,0.1642710472,No,1.2,7,Never,Yes,No,No,No,No,No,No,No,2,No,No,No,No,No,Yes,No,0,1.7,8,71,0,70,70,50,11,8,3,24,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,0,0,0,1,1,1,1,1,Y,,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,632-012,Biologic Naïve,27,Female,23.951226593,0.5284052019,Yes,5.8,18.166,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,0,8.8,7.192,62.413,0,67.924,59.807,56.513,16.378,11.502,4.877,21.312,No,No,No,No,1.673,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-013,Biologic Naïve,26,Male,24.801587302,14.088980151,No,7,7.839,Missing,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,0,2.1,2.56,34.254,14,53.99,47.042,22.145,6.014,3.255,2.759,22.923,Yes,No,No,Yes,3.553,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-014,Biologic Naïve,21,Male,19.692665289,1.3442847365,No,2.4,13.889,Missing,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,0,0.2,3.064,10.115,0,16.068,16.805,40.373,8.987,6.552,2.435,23.257,Yes,No,No,No,2.134,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.6,0,0,0,1,1,1,1,1,Y,,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,632-015,Biologic Non-naïve,56,Female,23.120623596,10.108145106,No,4.5,16.793,Missing,No,No,No,Yes,No,No,No,No,3,No,No,No,No,No,Yes,Yes,0,7,3.461,59.587,0,44.839,43.183,68.644,25.842,14.95,10.892,21.482,No,No,No,Yes,0.343,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-016,Biologic Non-naïve,33,Female,21.218317195,13.67008898,No,1.2,1,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,0,1.3,3,25,0,26.666666667,26,30,11,7,4,18,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-017,Biologic Naïve,68,Female,27.181630086,4.8323066393,No,7.2,3,Former,No,No,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,2,8,3,2,10,6.6666666667,4,10,3,1,2,24,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,632-018,Biologic Non-naïve,36,Female,25,14.140999316,No,0.5,9,Current,No,No,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,1,0.5,8,70,30,38.333333333,44,30,20,12,8,23,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.5,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-019,Biologic Naïve,46,Male,36.506219578,21.67008898,No,26.5,20.18,Missing,Yes,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,8.9,3.804,74.422,12,54.988,34.883,78.648,8.362,3.742,4.619,23.841,No,Yes,No,Yes,0.729,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.9,0,1,1,0,0,1,1,1,Y,,,Y,1,1,1,1,1,1,0,0,0,1,1,0,1,Yes,Y,Yes
1,632-021,Biologic Naïve,40,Male,32.966026678,18.064339493,No,8.4,12,Current,Yes,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,11,7,78,0,55,38,50,27,16,11,21,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.3,0,0,0,0,0,0,1,1,Y,-12,1,Y,1,1,0,0,0,0,0,0,0,0,1,1,1,Yes,Y,Yes
1,632-022,Biologic Naïve,38,Female,27.43484225,24.062970568,No,9.7,22.302,Missing,Yes,No,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,2,3,9.129,19.209,0,59.908,72.514,45.526,26.987,18.193,8.794,24.751,Yes,No,Yes,Yes,1.293,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,632-023,Biologic Non-naïve,48,Female,23.21799308,7.1485284052,No,3.7,15.479,Missing,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,0,1.1,4.053,29.168,0,51.095,45.883,54.492,18.569,12.446,6.123,22.688,No,No,No,Yes,2.377,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.7,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-024,Biologic Non-naïve,44,Female,24.005486968,13.503080082,No,4.8,20,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,0,5.4,9,60,0,81.666666667,72,70,17,10,7,24,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,632-025,Biologic Naïve,63,Female,26.775934115,46.414784394,No,3,9.653,Missing,Yes,No,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,1,0.9,1.784,32.313,0,54.957,50.589,45.496,17.057,8.96,8.097,23.401,No,No,No,Yes,1.709,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,632,Portugal,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.6,0,0,0,0,0,0,1,1,Y,,,Y,1,1,1,1,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,651-001,Biologic Naïve,35,Male,25.106332703,5.0403832991,No,14,3,Never,No,No,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,16,0,0,0,15,4,0,10,6,4,16,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,651,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.6,0,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,651-002,Biologic Naïve,27,Male,28.055705787,1.4318959617,No,10.8,12,Never,No,Yes,No,Yes,No,No,No,No,3,Yes,No,No,No,Yes,No,No,3,2,7,51,0,60,62,70,11,8,3,25,No,No,No,No,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,651,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-7.8,0,0,0,0,0,1,1,1,Y,4,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,651-003,Biologic Naïve,34,Female,33.732501265,5.3388090349,No,11.3,16.605,Missing,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,3,7.86,75.267,0,65.546,71.115,75.399,30.132,19.206,10.926,20.285,No,No,Yes,No,1.169,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,651,Romania,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-2.9,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,651-004,Biologic Non-naïve,52,Female,36.436644854,13.856262834,No,4.8,14.063,Former,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,4,5.804,69.391,0,80.367,61.525,39.632,14.923,7.594,7.329,19.804,No,No,Yes,No,3.01,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,651,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.2,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,651-005,Biologic Non-naïve,50,Male,36.753650306,8.7748117728,No,11.1,10,Former,No,No,No,Yes,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,2,9.3,3,28,0,28.333333333,32,30,12,5,7,20,No,No,Yes,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,651,Romania,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.5,0,0,0,0,0,0,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,651-006,Biologic Naïve,39,Male,28.531855956,13.177275838,No,12,1.743,Former,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,23,0,59.735,40,28.184,15.989,3.76,10.455,7.235,3.22,22.342,No,No,No,Yes,0.535,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,651,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,655-001,Biologic Naïve,20,Female,30.119401915,3.6358658453,No,12.5,23,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,6,64,4.803,86.666666667,46,70,23,11,12,24,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,655,Romania,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-12.5,1,1,1,1,1,1,1,1,Y,-23,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,655-002,Biologic Naïve,30,Male,25.712198685,7.1403148528,No,12.5,6.729,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,27,5.74,39.491,58.571,52.414,37.102,13.638,16.292,8.08,8.212,24.668,No,No,No,No,2.429,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,655,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.5,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,655-003,Biologic Naïve,35,Male,29.069767442,7.227926078,No,11.5,14,Former,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,24,7,71,33.075,80,74,50,18,9,9,24,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,655,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.1,0,0,1,0,0,1,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,655-004,Biologic Naïve,32,Male,26.493025631,5.916495551,No,13,9,Former,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,27,2,13,6.438,48.333333333,26,30,20,12,8,20,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,655,Romania,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.6,0,0,0,0,0,0,0,0,Y,-7,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,655-005,Biologic Non-naïve,28,Male,18.01595699,12.468172485,No,13.2,15,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,28,8,76,16.772,56.666666667,38,60,16,13,3,24,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,655,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.2,1,1,1,1,1,1,1,1,Y,-13,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,655-006,Biologic Non-naïve,50,Male,29.454659842,7.8302532512,No,13.3,11,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,30,0,1,17.571,68.333333333,52,30,8,7,1,22,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,655,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.3,1,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,655-007,Biologic Naïve,26,Female,23.875114784,11.12936345,No,13.5,26,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,25,10,71,51.83,90,82,80,17,13,4,24,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,655,Romania,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.5,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,655-008,Biologic Non-naïve,60,Female,28.577960677,37.382614648,No,12.9,19,Former,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,22,6,0,5.995,63.333333333,62,60,20,13,7,23,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,655,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.1,0,0,0,0,0,0,1,1,Y,-7,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,655-009,Biologic Naïve,34,Male,29.839409722,2.636550308,No,11.8,19,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,9,91,12.319,80,78,80,29,17,12,20,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,655,Romania,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.8,1,1,1,1,1,1,1,1,Y,-16,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,655-010,Biologic Naïve,38,Male,23.939480992,2.6475017112,No,11.5,19.425,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,21,9,57.194,15.259,84.848,92.003,84.377,13.271,7.269,6.002,24.173,No,No,No,No,0.958,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,655,Romania,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.1,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,655-011,Biologic Non-naïve,22,Male,25.499131944,4.7282683094,No,11.6,2,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,22,3,20,20.272,23.333333333,34,0,8,5,3,25,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,655,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.6,1,1,1,1,1,1,1,1,Y,-1,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,655-012,Biologic Naïve,38,Female,22.321428571,16.470910335,No,10.1,16,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,7,64,30.575,81.666666667,66,80,23,16,7,21,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,655,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,655-013,Biologic Naïve,53,Male,34.220041322,7.227926078,No,12.5,18,Former,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,23,7,55,5.125,61.666666667,52,50,17,8,9,25,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,655,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.9,0,0,1,0,1,1,1,1,Y,-18,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,655-014,Biologic Naïve,52,Female,32.435425814,3.1567419576,No,11.6,19,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,25,8,0,29.359,86.666666667,90,90,12,9,3,24,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,655,Romania,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.6,1,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,655-015,Biologic Naïve,23,Female,20.719787397,4.2354551677,No,13.5,28,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,27,5,43,9.371,76.666666667,58,90,26,17,9,24,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,655,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.5,1,1,1,1,1,1,1,1,Y,-27,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,655-016,Biologic Naïve,64,Male,34.013605442,9.0513347023,No,12.5,16,Never,No,Yes,No,Yes,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,3,22,10,40,14.957,35,26,0,23,15,8,23,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,655,Romania,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.5,1,1,1,1,1,1,1,1,Y,-14,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,655-017,Biologic Naïve,33,Male,18.587892133,3.6249144422,No,14,26,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,28,6,30,6.084,86.666666667,52,80,11,7,4,24,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,655,Romania,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.8,0,1,1,0,1,1,1,1,Y,-9,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,655-018,Biologic Naïve,70,Male,27.143037495,20.131416838,No,13,18,Current,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,27,8,24,3.982,58.333333333,66,60,12,3,9,19,No,No,No,Yes,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,655,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13,1,1,1,1,1,1,1,1,Y,-18,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-001,Biologic Non-naïve,70,Male,27.6816609,13.267624914,No,27,16,Former,No,Yes,Yes,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,4,40,8,63,9.847,55,56,40,14,9,5,24,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-002,Biologic Naïve,62,Male,19.607156612,25.081451061,Yes,24.6,19,Current,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,30,5,57,54,56.666666667,38,60,7,5,2,24,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.6,1,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,656-003,Biologic Non-naïve,43,Male,22.758306782,11.466119097,No,23.8,15,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,32,6,45,15,53.333333333,48,50,17,10,7,24,No,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.9,0,1,1,0,1,1,1,1,Y,-14,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,656-004,Biologic Non-naïve,52,Female,28.698979592,12.123203285,Yes,24.3,24,Current,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,4,40,9,72,50,73.333333333,68,100,16,8,8,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-24.3,1,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,656-005,Biologic Non-naïve,48,Female,29.357521924,30.392881588,No,19,17,Current,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,25,7,24,11.475,60,82,60,10,6,4,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19,1,1,1,1,1,1,1,1,Y,-17,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-006,Biologic Naïve,57,Male,28.076319285,25.713894593,No,13.5,9,Former,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,No,No,No,No,4,11,7,0,30.566,71.666666667,46,40,7,5,2,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.7,0,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,656-007,Biologic Naïve,53,Male,26.061679308,23.750855578,No,20,13,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,25,5,0,41,35,30,40,11,6,5,21,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20,1,1,1,1,1,1,1,1,Y,-12,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-008,Biologic Non-naïve,65,Female,47.023374726,59.575633128,No,10.2,21,Former,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,21.321860465,5,0,0,61.666666667,54,40,14,8,6,24,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.2,1,1,1,1,1,1,1,1,Y,-21,1,Y,1,1,0,0,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-009,Biologic Naïve,59,Male,27.15271059,27.731690623,No,18.1,14,Former,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,40,4,39,23,60,54,80,6,5,1,25,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-18.1,1,1,1,1,1,1,1,1,Y,-14,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-010,Biologic Non-naïve,44,Male,35.349072087,11.808350445,No,20.8,25,Current,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,30,5,74,0,96.666666667,80,90,26,19,7,23,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-20.8,1,1,1,1,1,1,1,1,Y,-25,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-011,Biologic Non-naïve,52,Female,30.46875,22.830937714,No,9.7,23,Current,Yes,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,40,5,83,1,53.333333333,72,70,18,13,5,21,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-9.7,1,1,1,1,1,1,1,1,Y,-23,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-012,Biologic Naïve,40,Female,20.079601276,5.8097193703,No,15.1,10,Current,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,No,No,Yes,3,30,8,6,0,61.666666667,40,0,9,7,2,25,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-15.1,1,1,1,1,1,1,1,1,Y,-10,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-013,Biologic Naïve,63,Male,29.954368579,11.830253251,No,12.1,28,Former,No,Yes,Yes,Yes,No,No,No,No,3,Yes,No,No,No,Yes,No,No,3,25,7,24,16,80,62,30,13,11,2,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-7.4,0,0,0,0,0,0,1,1,Y,-22,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,656-014,Biologic Naïve,59,Female,36.982248521,2.6694045175,No,20.6,18,Never,No,Yes,Yes,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,Yes,4,45,9,11,19,73.333333333,42,30,17,10,7,24,No,Yes,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.6,1,1,1,1,1,1,1,1,Y,-17,1,Y,1,1,0,0,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-015,Biologic Naïve,26,Male,36.523009496,2.6776180698,No,20,17,Never,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,4,55,5,10,6,31.666666667,18,0,4,2,2,25,No,Yes,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.8,0,1,1,0,1,1,1,1,Y,-17,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,656-016,Biologic Non-naïve,50,Male,33.770988512,18.751540041,No,10.9,23,Former,No,Yes,Yes,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,3,20,6,18,51,81.666666667,46,50,5,5,0,25,No,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.3,0,1,1,1,1,1,1,1,Y,-22,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,656-017,Biologic Non-naïve,41,Female,18.685121107,27.906913073,No,10.2,21,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,25,5,0,0,68.333333333,34,70,14,9,5,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-10.2,1,1,1,1,1,1,1,1,Y,-21,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-018,Biologic Naïve,59,Female,30.46875,40.65982204,No,13.8,13,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,5,0,22.637,55,46,40,12,7,5,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.8,1,1,1,1,1,1,1,1,Y,-11,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,656-019,Biologic Naïve,22,Female,32.8125,8.9034907598,No,21.3,27,Current,No,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,45,9,60,0,85,82,70,13,7,6,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-21.3,1,1,1,1,1,1,1,1,Y,-27,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-020,Biologic Naïve,40,Female,21.09375,3.9890485969,No,11.1,19,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,10,40,0,66.666666667,72,80,10,9,1,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-9.9,0,0,1,0,1,1,1,1,Y,-19,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,656-021,Biologic Naïve,44,Male,25.640242972,2.9048596851,No,11.4,14,Never,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,33,3,42,13,46.666666667,52,30,4,2,2,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-8.6,0,0,1,0,0,1,1,1,Y,-14,1,Y,1,1,0,0,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,656-022,Biologic Non-naïve,63,Female,28.959000152,23.151266256,Yes,11,15,Never,No,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,Yes,No,No,3,24,6,30,0,56.666666667,58,70,5,5,0,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-11,1,1,1,1,1,1,1,1,Y,-15,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-023,Biologic Non-naïve,56,Male,29.036737786,20.90349076,Yes,16.7,21,Current,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,56,8,86,17,83.333333333,80,20,2,2,0,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-16.7,1,1,1,1,1,1,1,1,Y,-21,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-024,Biologic Non-naïve,66,Male,25.94548396,20.736481862,Yes,22.6,21,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,5,60,8,57,32,86.666666667,80,20,3,2,1,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-22.6,1,1,1,1,1,1,1,1,Y,-21,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-025,Biologic Naïve,43,Male,23.67125363,4.1341546886,No,13.8,26,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,48,2,23,50,80,30,70,17,13,4,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-13.8,1,1,1,1,1,1,1,1,Y,-26,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-026,Biologic Naïve,41,Male,28.596757128,21.136208077,No,11.9,22,Current,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,31,5,22,0,60,60,40,0,0,0,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-11.9,1,1,1,1,1,1,1,1,Y,-22,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-027,Biologic Naïve,61,Male,31.773931855,36.952772074,No,21.4,19,Current,Yes,Yes,Yes,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,53,10,67,50,90,54,80,1,1,0,25,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.4,1,1,1,1,1,1,1,1,Y,-19,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,656-028,Biologic Naïve,53,Female,26.81359045,6.4449007529,No,13.1,27,Current,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,36,7,89,0,75,64,80,8,7,1,25,No,No,Yes,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-10.5,0,0,1,0,0,1,1,1,Y,-25,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,656-029,Biologic Naïve,40,Male,24.075473811,19.800136893,Yes,17.1,27,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,62,8,61,0,76.666666667,92,80,5,5,0,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-16.2,0,1,1,1,1,1,1,1,Y,-27,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,656-030,Biologic Non-naïve,50,Female,26.82742078,23.65229295,No,16.2,20,Former,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,4,48,10,18,0,86.666666667,82,70,9,7,2,25,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-10.8,0,0,0,0,0,0,0,0,Y,-17,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,656-031,Biologic Non-naïve,59,Male,29.714285714,23.871321013,No,22.8,27,Former,Yes,Yes,Yes,Yes,No,No,No,No,2,Yes,No,No,No,Yes,No,No,4,50,6,71,36,76.666666667,62,70,7,7,0,24,No,Yes,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.5,0,1,1,1,1,1,1,1,Y,-16,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,656-032,Biologic Naïve,30,Male,35.294117647,14.409308693,Yes,25.2,22,Current,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,Yes,4,40,6,82,0,81.666666667,68,80,15,9,6,25,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,656,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-23.1,0,1,1,0,0,1,1,1,Y,-21,1,Y,1,1,0,0,1,1,0,0,0,1,1,1,1,Yes,Y,Yes
1,657-001,Biologic Non-naïve,65,Male,24.21875,4.5968514716,Yes,16,20,Former,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,60,10,42,10,75,70,50,16,6,10,24,Yes,No,Yes,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.7,0,1,1,0,1,1,1,1,Y,-20,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,657-002,Biologic Non-naïve,61,Male,24.158817969,27.649555099,Yes,12.8,6,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,7,3,11,20.387,33.333333333,34,20,15,5,10,25,Yes,No,No,Yes,4,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,0,0,1,0,0,1,1,1,Y,-6,1,Y,1,1,0,0,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,657-003,Biologic Naïve,49,Male,28.400547964,10.570841889,No,15.7,19,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,4,80,15,73.333333333,34,40,9,5,4,24,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,0,1,1,1,1,1,1,1,Y,-14,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,657-004,Biologic Non-naïve,34,Male,17.301038062,12.082135524,Yes,16.9,12,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,9,45,7.138,71.666666667,40,50,10,5,5,23,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,0,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,657-005,Biologic Non-naïve,73,Male,22.038567493,2.6639288159,Yes,12.6,4,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,10,3,22,0.271,11.666666667,16,50,12,8,4,25,No,No,No,Yes,2,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,1,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,657-006,Biologic Naïve,47,Female,24.609733701,25.004791239,No,13.8,1,Current,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,10,3,0,12,20,10,0,5,3,2,25,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.8,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,657-007,Biologic Non-naïve,33,Female,36.328125,10.056125941,No,12.6,8,Never,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,10,4,8,0,46.666666667,34,10,17,10,7,19,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,1,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,657-008,Biologic Naïve,39,Male,52.393185506,3.0554414784,No,19.5,19,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,12,8,66,4,66.666666667,66,60,17,9,8,25,No,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.1,0,0,1,0,0,0,1,1,Y,-4,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,657-009,Biologic Non-naïve,51,Female,41.401633483,30.726899384,No,2.4,4,Former,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,2,3,2,0,11.953,11.666666667,14,0,16,8,8,25,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.6,0,0,0,0,0,1,1,0,Y,7,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,657-010,Biologic Non-naïve,60,Male,35.74594641,3.7289527721,No,12,9,Current,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,2,8,2,59,27.457,65,30,20,6,2,4,22,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,0,0,1,0,0,1,1,1,Y,-2,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,657-011,Biologic Non-naïve,46,Female,20.069204152,2.7323750856,No,17.6,3,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,0,66,13.739,8.3333333333,0,0,1,1,0,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.7,0,0,1,0,1,1,1,0,Y,-2,1,Y,0,0,0,0,1,0,0,0,1,1,1,1,0,No,Y,No
1,657-012,Biologic Non-naïve,60,Male,28.905075731,7.7316906229,No,36,18,Never,Yes,No,No,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,Yes,No,4,70,10,100,38.933,100,92,0,20,10,10,20,Yes,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26.3,0,0,0,0,0,0,0,0,Y,-9,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,657-013,Biologic Non-naïve,53,Female,31.25,16.733744011,No,19.8,18,Current,No,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,4,60,10,95,4,100,100,20,28,19,9,17,No,No,Yes,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.4,0,1,1,1,1,1,1,1,Y,-8,0,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,657-014,Biologic Naïve,60,Female,42.214532872,5.7987679671,No,11.2,20,Former,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,8,9,91,46,86.666666667,82,60,18,12,6,25,No,No,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,0,0,0,0,0,0,1,0,Y,-8,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,657-015,Biologic Non-naïve,48,Male,24.816326531,22.080766598,No,23.2,22,Current,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,40,6,60,30,88.333333333,66,90,22,12,10,24,No,Yes,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.2,1,1,1,1,1,1,1,1,Y,-22,1,Y,1,1,0,0,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,657-016,Biologic Naïve,51,Female,21.604938272,22.023271732,No,21,30,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,13,9,99,4,96.666666667,90,90,35,19,16,21,No,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,0,0,0,0,0,0,0,0,Y,-9,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,657-017,Biologic Naïve,70,Male,30.387105298,16.114989733,No,31.2,3,Former,No,Yes,No,Yes,No,No,No,No,5,No,No,No,Yes,Yes,Yes,No,4,51,7,1,10,43.333333333,0,0,4,1,3,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.5,0,1,1,0,0,1,1,1,Y,-3,1,Y,0,1,0,0,1,1,0,0,0,1,1,1,0,Yes,Y,Yes
1,657-018,Biologic Non-naïve,65,Male,29.714285714,25.971252567,Yes,11.8,20,Never,No,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,11,3,60,2,41.666666667,46,50,19,12,7,23,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.6,0,0,1,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,657-019,Biologic Non-naïve,18,Male,22.893074082,7.9698836413,No,4.5,8,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,6,3,24,11.583,51.666666667,28,20,5,3,2,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.5,0,0,0,0,0,1,1,1,Y,-3,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,657-020,Biologic Non-naïve,68,Male,33.306122449,20.054757016,No,8.2,5,Current,No,No,No,Yes,No,No,No,No,4,No,No,No,No,No,Yes,No,3,4,0,14,11.021,18.333333333,22,60,25,14,11,16,Yes,No,No,No,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.6,0,1,1,1,1,1,1,1,Y,3,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,657-021,Biologic Naïve,49,Female,22.038567493,21.308692676,No,6.3,9,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,3,0,4,24,18.333333333,2,0,6,6,0,25,Yes,Yes,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.3,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,0,0,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,657-022,Biologic Non-naïve,71,Female,28.19428425,43.969883641,Yes,9.2,9,Current,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,2,6,8,59,0.298,58.333333333,58,30,16,5,11,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,1,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,657-023,Biologic Naïve,50,Male,27.777777778,6.0670773443,Yes,18.3,19,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,No,No,Yes,No,4,9,7,70,70,68.333333333,62,50,18,12,6,25,No,No,Yes,Yes,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,0,0,1,0,0,0,1,0,Y,-3,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,657-024,Biologic Non-naïve,34,Male,29.411764706,12.07118412,No,18.1,18,Never,No,No,No,Yes,No,No,No,No,3,Yes,No,No,No,Yes,Yes,No,3,7,9,70,6,96.666666667,62,70,14,13,1,24,No,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.9,0,1,1,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,657-025,Biologic Non-naïve,73,Female,22.52150804,16.084873374,Yes,8.1,2,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,6,4,11,10,23.333333333,22,0,6,5,1,22,No,No,Yes,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.6,0,0,0,0,0,0,1,1,Y,-1,1,Y,1,1,0,0,0,0,0,0,0,0,1,1,1,Yes,Y,Yes
1,657-026,Biologic Naïve,49,Male,28.680111098,14.255989049,No,11.8,22,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,8,90,10,68.333333333,78,100,14,9,5,21,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.6,0,0,1,0,1,1,1,1,Y,-20,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,657-027,Biologic Non-naïve,47,Female,23.148148148,21.097878166,Yes,16.4,19,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,5,38,3.892,48.333333333,36,50,15,9,6,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.1,0,0,0,0,0,0,0,0,Y,-13,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,657-028,Biologic Naïve,65,Male,34.416133317,0.9609856263,No,11.6,10,Never,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,3,10,5,20,90,65,30,50,6,4,2,25,No,No,Yes,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.6,0,0,0,0,0,1,1,0,Y,-6,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,657-029,Biologic Naïve,46,Male,22.839506173,5.1718001369,No,20.3,18,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,35,7,76,30,80,72,70,20,9,11,23,Yes,Yes,Yes,Yes,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.2,0,0,0,0,0,0,0,0,Y,-14,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,657-030,Biologic Naïve,59,Male,23.547880691,10.173853525,Yes,10.2,6,Former,No,Yes,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,4,6,5,49,20,56.666666667,30,0,2,2,0,25,No,Yes,No,No,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,0,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,657-031,Biologic Naïve,37,Female,19.948059769,17.18275154,No,0.3,0,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,1,1,0,0,17.882,3.3333333333,0,0,11,7,4,24,Yes,Yes,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.3,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,657-032,Biologic Non-naïve,72,Male,31.487889273,17.210130048,Yes,11.4,21,Never,No,No,No,Yes,No,No,No,No,4,No,No,No,No,No,Yes,No,3,12,8,80,21.592,68.333333333,74,70,33,19,14,24,No,No,No,No,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,0,0,1,0,1,1,1,1,Y,-7,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,657-033,Biologic Non-naïve,59,Female,46.060090703,9.2621492129,No,26.9,24,Former,No,No,No,No,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,30,5,0,20,46.666666667,46,20,29,18,11,16,No,Yes,Yes,Yes,3,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.8,0,0,1,0,0,0,1,0,Y,-4,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,657-034,Biologic Non-naïve,38,Male,25.102391333,16.298425736,Yes,29.8,28,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,60,6,42,62,55,36,100,24,13,11,25,Yes,Yes,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.4,0,0,1,0,0,0,0,0,Y,-13,0,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,657-035,Biologic Naïve,56,Female,27.041644132,29.325119781,Yes,16.8,22,Former,Yes,Yes,No,Yes,No,No,No,No,3,Yes,No,No,No,Yes,Yes,No,3,12,9,81,22,90,74,80,24,16,8,22,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,657,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14,0,0,1,0,0,1,1,1,Y,-22,1,Y,1,1,0,0,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,659-001,Biologic Naïve,37,Male,28.408163265,27.942505133,No,18,8,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,3,2,27,20.65,38.333333333,20,40,18,8,10,23,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,659-002,Biologic Naïve,72,Female,22.571047502,10.869267625,No,22.3,20,Never,No,No,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,50,6,69.948,0,61.666666667,62,60,20,10,10,22.628,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-21.9,0,1,1,1,1,1,1,1,Y,-20,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,659-003,Biologic Naïve,36,Male,25.059307027,18.516084873,No,12,2,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,15,3,0,0,25,16,0,11,8,3,18,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,659,Romania,Europe,Other Biologics,Anti TNFs,Infliximab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.2,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,659-004,Biologic Naïve,72,Male,32.596371882,10.806297057,No,12,8.908,Missing,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,25,3.609,25.114,0,52.385,29.962,0.978,12.478,8.719,3.759,24.887,No,No,No,Yes,0.526,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.1,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,659-005,Biologic Naïve,27,Male,27.939031714,11.65229295,No,28.8,1,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,0,0,0,3.3333333333,0,0,6,4,2,24,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,659-006,Biologic Naïve,26,Male,28.72678773,25.368925394,No,13.2,8,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,2,6,21,0,26.666666667,36,50,8,4,4,22,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,659-007,Biologic Naïve,58,Female,30.483158055,10.028747433,Yes,22.2,19.356,Missing,No,No,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,65,3.256,42.482,0,37.037,23.422,57.396,14.829,8.109,6.72,24.179,No,No,No,Yes,1.658,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,659-008,Biologic Naïve,22,Female,18.645344042,6.9596167009,No,15,4,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,30,3,10,0,16.666666667,10,10,14,9,5,22,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,1,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,659-009,Biologic Naïve,28,Female,26.171875,1.7138945927,No,8.4,7.054,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,2,5.063,40.1,0,63.191,69.77,35.67,17.538,8.32,9.218,24.597,No,No,No,Yes,1.257,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,659-010,Biologic Naïve,23,Male,33.893352812,4.8213552361,No,16.8,25,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,2,10,0,25,90,86,90,8,6,2,25,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-16.8,1,1,1,1,1,1,1,1,Y,-24,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,659-011,Biologic Naïve,70,Male,35.918367347,24.93908282,No,27.6,9,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,15,3,6,0,21.666666667,18,10,9,7,2,17,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.6,1,1,1,1,1,1,1,1,Y,-6,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,659-013,Biologic Non-naïve,68,Male,24.691358025,11.085557837,No,9.6,8.166,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,2,4.851,49.158,0,73.702,57.653,16.401,14.273,10.425,3.849,23.616,No,No,Yes,No,2.237,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,659,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,661-001,Biologic Non-naïve,50,Male,23.547880691,17.374401095,No,19.2,10,Former,No,No,No,No,No,No,No,No,1,No,No,No,No,No,No,Yes,4,20,3,57,0,41.666666667,36,20,10,8,2,24,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,661,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,0,0,1,0,0,1,1,0,Y,-4,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,661-002,Biologic Naïve,68,Female,28.125,38.778918549,No,15.8,18,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,No,Yes,No,Yes,4,16,5,83,0,61.666666667,50,80,21,14,7,25,No,No,No,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,661,Romania,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.3,0,0,0,0,0,0,1,0,Y,-18,1,Y,0,0,0,0,0,0,0,0,0,0,1,1,0,No,Y,No
1,661-003,Biologic Naïve,53,Female,33.126014062,33.431895962,No,16.4,30,Former,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,18,10,97,0,81.666666667,92,100,22,11,11,24,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,661,Romania,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13,0,0,1,0,0,0,1,0,Y,-23,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,661-004,Biologic Naïve,20,Female,23.4375,10.891170431,No,18.3,9,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,30,6,0,6.717,51.666666667,28,50,15,13,2,23,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,661,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.4,0,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,661-005,Biologic Naïve,36,Male,24.897060232,1.3607118412,Yes,16.4,25,Never,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,24,8,60,0,78.333333333,58,70,9,6,3,25,No,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,661,Romania,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.5,0,1,1,1,1,1,1,1,Y,-19,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,661-006,Biologic Non-naïve,44,Male,30.44982699,8.8569472964,Yes,11.3,11,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,12,7,20,0,75,72,50,15,7,8,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,661,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.3,0,0,0,0,0,0,1,1,Y,-2,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,661-007,Biologic Naïve,70,Female,24.242424242,13.80971937,Yes,14.8,12,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,19,1,40,0,18.333333333,22,30,21,15,6,18,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,661,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.6,0,1,1,0,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,661-008,Biologic Non-naïve,64,Male,27.769797951,43.085557837,No,14.4,15,Former,No,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,4,18,5,59,44,68.333333333,22,40,19,14,5,25,No,No,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,661,Romania,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.4,0,1,1,1,1,1,1,1,Y,-11,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,661-009,Biologic Non-naïve,32,Male,24.343809494,9.5852156057,No,27.9,22,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,32,10,76,20,86.666666667,80,60,13,7,6,24,Yes,No,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,661,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.1,0,1,1,1,1,1,1,1,Y,-14,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,661-010,Biologic Naïve,27,Male,31.919307989,1.2785763176,No,18.5,1.11,Missing,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,23,2.701,67.45,0,38.64,12.06,23.172,6.463,5.219,1.244,22.062,No,No,No,Yes,0.505,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,661,Romania,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.2,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,678-002,Biologic Naïve,37,Male,17.993079585,14.57357974,No,13.5,8,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,13,4,18,13,13.333333333,20,20,5,5,0,25,Yes,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.8,0,0,0,0,0,0,0,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,678-003,Biologic Non-naïve,28,Male,32.552083333,8.1779603012,No,9.4,17,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,7.5,7,41,0,76.666666667,46,70,8,7,1,22,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,1.3,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,678-005,Biologic Naïve,38,Male,44.186340109,12.722792608,No,15.8,1,Former,No,No,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,16,2,9,0,23.333333333,6,0,0,0,0,25,Yes,Yes,Yes,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.8,0,0,1,0,1,1,1,1,Y,9,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,678-006,Biologic Naïve,35,Male,26.528510346,10.81724846,No,13,25,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,8,69,0,91.666666667,64,80,4,0,4,19,Yes,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.5,0,0,1,0,1,1,1,0,Y,-22,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,678-007,Biologic Naïve,51,Male,23.529411765,0.4982888433,No,12.8,15,Former,No,No,Yes,No,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,12,0,2,0,53.333333333,0,70,6,5,1,23,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.8,1,1,1,1,1,1,1,1,Y,,,Y,0,1,0,0,1,1,1,1,1,1,1,0,0,Yes,Y,Yes
1,678-008,Biologic Naïve,40,Female,22.038567493,19.274469541,No,12.8,16,Current,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,5,69,0,75,58,70,6,4,2,23,No,No,Yes,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.1,0,0,0,0,0,0,0,0,Y,-14,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,678-009,Biologic Naïve,21,Female,20.224339805,0.5722108145,No,10.2,16,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,10,2,48,0,76.666666667,38,90,6,5,1,25,No,No,No,No,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,678-010,Biologic Naïve,48,Male,25.249337205,0.4599589322,No,12,8,Never,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,3,57,0,55,40,0,4,2,2,25,Yes,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-9.5,0,0,1,0,0,1,1,1,Y,-8,1,Y,1,1,0,0,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,678-011,Biologic Naïve,37,Female,17.070485387,19.381245722,No,13.2,17,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,7,59,0,51.666666667,26,60,18,16,2,24,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-11.2,0,0,1,0,1,1,1,1,Y,1,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,678-012,Biologic Naïve,37,Female,17.480144999,1.0321697467,No,12,19,Current,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,7,3,0,66.666666667,64,100,23,14,9,25,No,No,Yes,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2,0,0,0,0,0,0,0,0,Y,-19,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,678-013,Biologic Naïve,34,Female,23.918830292,1.0020533881,No,10.2,18,Never,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,1,3,0,60,14,50,1,1,0,23,No,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-13,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,678-014,Biologic Naïve,24,Female,21.849957807,11.351129363,No,13,26,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,7,2,0,68.333333333,46,100,13,8,5,25,Yes,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.2,0,0,0,0,0,0,0,0,Y,-26,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,678-015,Biologic Naïve,37,Male,21.366869143,13.045859001,No,15.4,16,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,6,0,0,53.333333333,44,50,17,11,6,18,No,Yes,No,No,4,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,0.4,0,0,0,0,0,0,0,0,Y,-15,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,678-016,Biologic Naïve,45,Male,37.224489796,1.8097193703,No,14.6,7,Current,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,13,3,10,0,40,26,40,5,3,2,24,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.2,0,0,0,0,0,0,0,0,Y,-7,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,678-017,Biologic Naïve,43,Male,23.717756588,5.0513347023,No,16.5,15,Former,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,5,61,0,66.666666667,68,70,23,13,10,17,No,Yes,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,678,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.7,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,679-001,Biologic Non-naïve,59,Male,25.180785124,28.435318275,No,6.8,10,Never,No,Yes,Yes,Yes,Yes,No,Yes,Yes,0,No,No,No,No,No,No,No,2,3,3,0,0,20,16,20,10,5,5,21,No,No,No,No,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.6,0,0,1,0,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,679-002,Biologic Non-naïve,68,Male,27.6816609,51.942505133,Yes,3.7,22,Former,Yes,No,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3.2017453799,5,1,30,19.673,16.666666667,8,80,11,5,6,25,Yes,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.8,0,0,1,1,1,1,1,1,Y,-22,1,Y,1,1,0,0,1,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,679-003,Biologic Non-naïve,56,Female,26.666666667,5.196440794,Yes,8.4,24,Never,No,Yes,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,2,8,10,61,9.539,71.666666667,80,100,32,19,13,25,No,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,0,0,0,0,0,1,1,0,Y,-6,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,679-004,Biologic Non-naïve,62,Male,22.308149911,16.97467488,No,9.7,1,Former,No,Yes,Yes,Yes,Yes,Yes,No,Yes,1,No,No,No,No,No,Yes,No,2,13,2,0,0,13.333333333,4,0,0,0,0,25,Yes,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,0,0,0,0,0,0,1,0,Y,5,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,679-005,Biologic Non-naïve,49,Male,28.685144681,12,No,13.2,2,Current,No,Yes,Yes,No,Yes,Yes,No,No,0,No,No,No,No,No,No,No,2,5,2,0,0,10,8,0,3,2,1,24,Yes,No,No,No,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.4,0,0,0,0,0,0,1,0,Y,1,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,679-008,Biologic Non-naïve,47,Male,29.065743945,25.273100616,No,3,2,Never,Yes,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,2,10,2,8,0,41.666666667,42,0,5,2,3,24,No,No,No,No,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.2,0,0,0,0,1,1,1,1,Y,-1,1,Y,1,1,0,0,0,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,679-009,Biologic Naïve,31,Female,28.398718001,25.388090349,No,37.6,10,Never,Yes,Yes,Yes,No,Yes,Yes,No,Yes,1,No,No,No,No,Yes,No,No,4,12,7,74,0,68.333333333,74,30,4,2,2,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-36.1,0,1,1,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,679-010,Biologic Non-naïve,63,Male,28.075042938,7.4250513347,No,4.4,12,Former,Yes,No,Yes,Yes,Yes,No,No,Yes,3,No,No,No,No,Yes,No,Yes,2,4,5,31,0,25,28,30,2,2,0,25,No,No,No,No,3,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.3,0,0,0,0,0,0,1,1,Y,-5,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,679-011,Biologic Non-naïve,46,Female,23.233456177,21.508555784,Yes,5.5,12,Never,No,No,No,Yes,Yes,Yes,Yes,Yes,2,Yes,No,No,No,Yes,No,No,3,4,2,38,13,23.333333333,22,20,2,2,0,25,No,No,Yes,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.3,0,0,1,0,1,1,1,1,Y,-3,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,679-012,Biologic Non-naïve,70,Female,23.533042707,18.546201232,Yes,8,14,Never,No,No,No,Yes,Yes,No,Yes,Yes,0,No,No,No,No,No,No,No,3,12,9,72,0,65,60,90,12,6,6,25,Yes,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,0,0,0,0,0,0,1,0,Y,-7,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,679-013,Biologic Naïve,58,Female,34.927679158,16.558521561,Yes,26.4,17,Never,No,Yes,No,Yes,Yes,Yes,Yes,Yes,3,No,No,No,Yes,Yes,No,No,4,35,10,89,0,60,90,90,7,3,4,25,No,No,No,No,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.6,0,0,1,0,0,0,0,0,Y,-10,0,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,679-014,Biologic Non-naïve,38,Male,25.795918367,6.5872689938,No,4.1,10,Never,No,No,No,No,Yes,Yes,Yes,Yes,2,No,No,No,Yes,Yes,No,No,3,3,3,16,0,35,22,40,2,2,0,25,Yes,Yes,Yes,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.8,0,0,0,0,0,0,1,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,679-015,Biologic Naïve,50,Male,23.781212842,7.7371663244,Yes,16.5,16,Never,No,No,No,Yes,Yes,Yes,Yes,Yes,1,No,No,No,No,Yes,No,No,4,20,7,56,0,60,60,70,7,6,1,25,Yes,No,No,No,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.2,0,0,0,0,0,0,0,0,Y,-11,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,679-016,Biologic Non-naïve,53,Male,24.691358025,23.770020534,Yes,0.6,8,Former,Yes,Yes,No,Yes,Yes,No,No,Yes,2,No,No,No,No,Yes,No,No,1,20,5,4,12,35,26,20,0,0,0,25,Yes,No,No,Yes,4,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,N,,,,,,,,,,Y,,,N,,0,,0,0,0,0,0,0,0,0,0,0,,N,No
1,679-017,Biologic Naïve,25,Male,23.120623596,15.813826146,Yes,17.8,20,Never,No,Yes,No,Yes,Yes,Yes,Yes,Yes,1,No,No,No,No,Yes,No,No,3,15,8,20,14,71.666666667,36,80,11,8,3,25,Yes,No,No,No,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.9,0,0,0,0,0,0,0,0,Y,-9,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,679-018,Biologic Naïve,37,Male,29.740627413,8.8514715948,No,20.6,9,Never,No,Yes,No,No,Yes,No,Yes,Yes,2,No,No,No,Yes,Yes,No,No,3,22,4,12,20,50,24,30,1,1,0,25,Yes,No,No,No,4,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.1,0,1,1,0,1,1,1,1,Y,-6,0,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,679-019,Biologic Naïve,24,Male,26.12244898,4.9582477755,No,19.1,18,Never,No,Yes,Yes,Yes,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,4,55,6,24,0,56.666666667,42,80,20,12,8,18,Yes,No,No,No,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,679,Korea,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.3,0,0,0,0,0,0,0,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,684-001,Biologic Naïve,44,Male,37.107377648,0.5174537988,Yes,18,16.724,Missing,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,5,18,9.777,78.79,0,64.079,73.289,62.281,19.548,10.024,9.524,20.298,No,Yes,Yes,No,1.263,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,684,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.4,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,684-002,Biologic Naïve,63,Male,26.989619377,1.5550992471,No,27.1,11,Never,No,No,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,5,20,8,83,40,71.666666667,70,0,15,6,9,23,Yes,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,684,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.9,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,684-003,Biologic Naïve,32,Male,26.093275201,0.6981519507,No,5.9,6,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,2,5,8,84,0,68.333333333,72,0,15,6,9,25,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,684,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,,,Y,Y,Y,N,N,Y,-3.9,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,684-004,Biologic Naïve,58,Female,23.875114784,0.5284052019,Yes,9,12,Never,No,No,No,No,No,No,No,No,1.5063613232,No,No,No,No,No,No,No,4,10,7,76,38,65,68,0,17,7,10,22,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,684,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.4,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,684-005,Biologic Naïve,58,Male,21.170217558,5.6427104723,Yes,10.5,9,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,5,10,7,76,20,70,76,0,22,11,11,25,Yes,No,Yes,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,684,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,-8.3,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,684-006,Biologic Naïve,72,Female,23.423557406,9.6399726215,No,5.1,15.034,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,4,9.998,79.141,0,78.754,82.632,83.155,15.959,7.013,8.946,24.205,Yes,No,No,No,1.766,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,684,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,684-007,Biologic Naïve,59,Male,30.119401915,0.501026694,No,22.4,14.772,Missing,No,No,No,No,No,No,No,No,1.5063613232,No,No,No,No,Yes,No,No,4,15,5.411,56.331,9,67.36,58.116,51.351,22.525,11.167,11.357,24.06,No,No,No,No,0.723,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,684,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,-19.2,0,0,1,0,0,0,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,684-008,Biologic Naïve,54,Male,25.180785124,0.2299794661,Yes,16.7,7.482,Missing,No,No,Yes,Yes,No,No,No,No,3,No,No,Yes,No,Yes,No,Yes,4,10,7.243,13.656,0,65.097,47.587,27.42,12.685,6.459,6.226,24.847,Yes,No,No,No,1.752,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,684,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.4,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,687-001,Biologic Naïve,22,Female,17.928215425,10.01779603,No,10.4,4,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,10,3,0,0,28.333333333,10,10,0,0,0,24,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.9,0,0,1,0,1,1,1,1,Y,-4,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,687-002,Biologic Naïve,46,Female,22.313278429,14.346338125,Yes,11.2,13,Current,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,3,11,7,0,0,58.333333333,46,0,17,3,14,21,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.4,0,0,1,0,1,1,1,0,Y,-4,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,687-005,Biologic Naïve,51,Male,33.05785124,10.034223135,No,11,7,Current,No,No,No,Yes,No,No,No,No,4,Yes,No,No,No,No,No,No,3,3,5,0,0,25,8,0,14,9,5,25,Yes,No,No,No,2,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,1,0,1,1,1,0,Y,0,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,687-006,Biologic Naïve,65,Male,25.56495392,19.96440794,No,10.4,2,Former,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,11,3,0,0,28.333333333,28,0,8,4,4,25,No,No,No,Yes,4,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,0,0,1,0,1,1,1,0,Y,0,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,687-007,Biologic Naïve,54,Male,30.756367763,20.021902806,No,12.1,5,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,4,0,0,65,48,20,9,6,3,23,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.6,0,0,0,0,0,0,1,0,Y,-4,1,Y,0,0,0,0,0,0,0,0,0,0,1,1,0,No,Y,No
1,687-008,Biologic Naïve,65,Male,23.711844631,30.036960986,No,17.7,26,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,7,9,39,0,96.666666667,96,70,23,13,10,25,No,No,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.9,0,0,0,0,0,0,1,0,Y,-7,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,687-009,Biologic Naïve,29,Male,21.690280707,1.9520876112,No,10.5,6,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,No,3,11,6,0,0,85,68,40,7,5,2,25,No,No,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.9,0,0,1,0,1,1,1,1,Y,-6,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,687-010,Biologic Naïve,46,Male,22.129739728,19.989048597,No,12.2,26,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,9,30,18,86.666666667,76,50,19,12,7,25,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.9,0,0,1,0,0,1,1,1,Y,-9,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,687-011,Biologic Non-naïve,38,Male,23.738662132,15.030800821,No,6.1,7,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,5,0,0,0,31.666666667,6,20,9,4,5,25,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,687-012,Biologic Naïve,26,Female,22.761467536,0.9582477755,No,10.2,8,Never,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,0,0,0,21.666666667,4,60,6,5,1,25,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.8,0,0,1,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,687-013,Biologic Naïve,38,Male,33.425160698,4.9664613279,No,11.3,9,Never,No,Yes,No,No,No,No,No,No,2,Yes,No,No,No,No,No,No,3,11,7,0,0,58.333333333,44,20,13,7,6,25,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.7,0,1,1,1,1,1,1,1,Y,-7,0,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,687-014,Biologic Naïve,48,Male,31.804657843,10.995208761,No,10.3,11,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,10,7,50,0,56.666666667,54,50,7,1,6,25,No,No,No,Yes,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,687-015,Biologic Naïve,32,Female,19.53125,20.908966461,No,15.2,18,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,7,0,0,55,30,70,18,10,8,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.1,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,687-016,Biologic Naïve,50,Female,23.384353741,5.9301848049,Yes,10.9,19,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,4,100,0,80,70,100,23,11,12,25,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,687-017,Biologic Naïve,45,Male,29.03178981,24.966461328,Yes,11.5,7,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,11,2,0,0,31.666666667,24,40,12,6,6,25,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.4,0,0,1,0,0,1,1,0,Y,-3,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,687-018,Biologic Naïve,37,Male,22.343515593,21.048596851,No,11.2,16,Never,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,11,2,0,0,88.333333333,28,70,17,9,8,25,No,No,No,No,2,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.2,0,1,1,1,1,1,1,1,Y,-15,1,Y,0,1,0,0,1,1,0,1,1,1,1,1,0,Yes,Y,Yes
1,687-019,Biologic Naïve,66,Male,23.88946281,22.997946612,No,10.1,4,Former,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,11,3,0,0,35,4,0,13,6,7,25,No,No,No,No,3,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.1,0,0,1,0,1,1,1,0,Y,-4,1,Y,0,0,0,0,1,0,0,0,1,1,1,1,0,No,Y,No
1,687-020,Biologic Naïve,46,Male,20.061728395,36.38329911,No,10.5,9,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,11,8,0,0,78.333333333,32,90,6,2,4,25,No,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,687,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.3,0,0,1,0,1,1,1,0,Y,-4,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,688-001,Biologic Non-naïve,29,Female,18.195482774,1.3771389459,No,0,4.166,Former,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,0,0,0,26.521,14.373,13.161,21.372,25.827,12.169,9.479,2.69,22.614,No,No,No,No,0.798,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,1,Y,,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,688-002,Biologic Naïve,24,Female,21.755468534,0.7665982204,No,12,5,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,0,0,20.236,20,2,20,9,4,5,24,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.3,0,0,1,0,0,1,1,0,Y,5,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,688-003,Biologic Naïve,49,Male,24.618103775,9.0704996578,No,20,15.102,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,16,6.055,62.804,80,79.636,48.894,46.522,4.426,2.214,2.212,23.531,Yes,No,No,No,0.705,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.2,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,688-004,Biologic Naïve,43,Female,20.829995193,2.0479123888,Yes,12,9,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,3,5,30.011,33.333333333,20,30,11,4,7,23,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,688-005,Biologic Non-naïve,45,Male,25.880570635,18.127310062,Yes,4,5,Current,No,No,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,5,0,40,15.823,10,14,20,9,5,4,23,No,No,No,No,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,1,1,1,1,1,1,1,1,Y,1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,688-006,Biologic Non-naïve,48,Male,28.719723183,9.3661875428,No,15,21,Never,No,No,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,15,4,0,20,70,52,50,25,14,11,21,Yes,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,0,0,1,0,0,1,1,0,Y,-15,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,688-007,Biologic Naïve,20,Male,25.762980579,10.179329227,No,13.2,10,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,15,6,70,24.4,61.666666667,58,20,10,5,5,25,Yes,No,No,No,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,0,1,1,0,1,1,1,1,Y,-7,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,688-008,Biologic Naïve,29,Female,17.689788852,0.9856262834,No,13.2,26,Former,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,15,5,81,28.054,46.666666667,46,70,29,13,16,24,Yes,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.2,1,1,1,1,1,1,1,1,Y,-26,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,688-009,Biologic Non-naïve,42,Male,28.735632184,6.9349760438,No,16.9,1,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,17,1,0,10.949,23.333333333,4,0,1,1,0,21,No,No,No,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.9,0,0,1,0,0,1,1,0,Y,0,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,688-010,Biologic Naïve,63,Male,22.837370242,0.8323066393,No,12.2,19,Former,No,No,Yes,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,4,13,7,83,26.714,70,64,70,27,13,14,24,No,No,No,No,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,688-011,Biologic Naïve,29,Female,17.781971259,12.328542094,No,12,26,Never,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,7,74,41.178,68.333333333,72,70,6,3,3,21,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,688-012,Biologic Naïve,23,Female,31.596260388,0.6570841889,No,16.1,4,Never,Yes,No,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,21,7,64,15.609,18.333333333,22,10,22,10,12,15,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.1,1,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,688-013,Biologic Naïve,63,Male,20.983987603,5.0568104038,No,12,15,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,15,6,39,10.393,51.666666667,74,30,0,0,0,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,-15,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,688-014,Biologic Non-naïve,35,Male,26.346494034,14.009582478,No,13.6,4,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,2,7,36.642,35,16,10,17,12,5,19,No,No,No,No,4,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.6,1,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,688-015,Biologic Non-naïve,30,Male,23.781212842,1.3798767967,No,0,0,Current,No,No,No,Yes,No,No,No,No,1,No,Yes,No,No,No,No,No,0,0,0,3,6.547,8.3333333333,10,0,18,10,8,25,No,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,1,Y,0,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,688-016,Biologic Naïve,36,Male,28.373702422,20.83504449,No,12,12,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,13,3,66,48.357,66.666666667,54,80,14,6,8,24,Yes,No,No,Yes,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.7,0,1,1,1,1,1,1,1,Y,-10,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,688-017,Biologic Naïve,57,Male,24.005486968,12.065708419,No,27,25,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,20,7,58,29.334,81.666666667,74,60,12,6,6,23,No,No,No,Yes,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26.7,0,1,1,1,1,1,1,1,Y,-21,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,688-018,Biologic Naïve,57,Male,25.306932047,2.3764544832,No,13.2,1,Current,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,15,5,67,38.548,40,42,40,11,6,5,18,No,No,No,Yes,3,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,0,0,1,0,0,1,1,0,Y,3,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,688-020,Biologic Non-naïve,34,Male,24.489795918,12.550308008,No,13.8,28,Current,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,13,3,25,21.543,26.666666667,32,80,14,7,7,22,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,0,0,1,0,0,1,1,0,Y,-18,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,688-021,Biologic Naïve,37,Female,21.484375,10.98973306,No,12,25,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,15,2,0,0.743,20,16,80,19,11,8,24,No,No,No,Yes,2,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,-27,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,688-022,Biologic Naïve,20,Male,20.747550193,5.5742642026,No,12,13,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,13,8,62,13.085,55,64,70,15,8,7,25,No,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,688-023,Biologic Non-naïve,28,Male,25.451113844,22.587268994,No,14,22.982,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,16,8.192,98.495,37.103,61.125,55.698,63.986,14.369,10.843,3.526,23.937,No,No,No,No,1.937,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,688-024,Biologic Naïve,52,Male,25.180785124,1.9767282683,No,12,14,Former,Yes,No,Yes,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,4,15,3,38,40.657,75,52,50,3,2,1,25,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,0,1,1,0,1,1,1,1,Y,-9,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,688-025,Biologic Non-naïve,33,Female,16.796875,14.652977413,No,4.8,27,Current,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,10,8,89,26.446,86.666666667,84,90,30,18,12,17,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,N,,,,,,,,,,N,,,N,,0,,0,0,0,0,0,0,0,0,0,0,,N,No
1,688-026,Biologic Non-naïve,54,Male,26.423569824,3.1156741958,Yes,4.5,9,Former,No,No,No,Yes,No,No,No,No,3,No,No,No,No,No,Yes,Yes,4,10,1,0,17.25,10,18,80,4,0,4,21,No,No,No,No,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,1,1,1,1,1,1,1,1,Y,-9,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,688-027,Biologic Non-naïve,51,Female,25.06574622,3.8357289528,No,14.4,2.955,Missing,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,15,4.011,17.22,6.197,26.435,7.501,43.563,19.155,6.17,12.985,22.148,Yes,No,No,Yes,1.398,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,688-028,Biologic Naïve,26,Male,28.710479325,3.4004106776,No,16.9,21.295,Never,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,12,6,67.999,15.97,73.002,65.13,76.414,14.578,8.198,6.38,19.079,Yes,No,No,Yes,1.433,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.5,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,688-029,Biologic Naïve,49,Male,26.472107438,0.6899383984,No,12,23,Former,No,Yes,No,Yes,No,No,No,No,3,No,Yes,No,No,No,No,No,4,15,0,78,8.142,75,58,90,30,17,13,23,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.7,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,688-030,Biologic Naïve,47,Female,22.939750693,2.0123203285,No,11.1,4,Never,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,4,18,0,1,25.728,26.666666667,4,0,5,3,2,24,No,No,No,Yes,2,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,0,0,0,0,0,0,0,0,Y,-1,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,688-031,Biologic Naïve,32,Male,27.348429511,4.6735112936,No,18.9,14,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,8,41,18.255,73.333333333,74,30,10,4,6,23,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.9,0,0,0,0,0,0,0,0,Y,-12,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,688-034,Biologic Naïve,31,Male,22.662706612,11.181382615,No,12,11.118,Missing,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,2.761,14.267,32.052,42.392,28.376,33.976,10.928,6.542,4.386,20.62,No,No,No,No,1.109,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,688-035,Biologic Naïve,31,Female,27.395192041,11.219712526,No,17.4,18,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,7,22,6.192,61.666666667,60,50,14,9,5,21,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.7,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,688-036,Biologic Naïve,61,Female,28.634825735,3.2635181383,No,12,16,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,15,5,78,23.953,83.333333333,44,100,4,3,1,23,No,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,-1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,688-037,Biologic Naïve,52,Male,24.76756592,3.3155373032,No,14.9,29,Current,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,10,100,40.99,68.333333333,96,90,41,21,20,25,No,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,0,0,0,0,0,0,0,0,Y,-26,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,688-038,Biologic Non-naïve,56,Female,23.388686558,21.420944559,No,5.7,6,Current,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,1,4,5,17,1.398,15,10,20,16,7,9,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,688,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.7,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,689-001,Biologic Non-naïve,30,Female,20.069204152,6.8062970568,No,3.3,19,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,4,40,0,58.333333333,44,70,15,11,4,16,Yes,No,No,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,689,Korea,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.3,1,1,1,1,1,1,1,1,Y,-18,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,707-001,Biologic Non-naïve,25,Male,31.141868512,1.9411362081,No,30.6,4,Never,Yes,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,30,7,68.671,11.43,25,36,0,20,11,9,20.877,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.2,0,1,1,0,0,1,1,1,Y,-1,0,Y,0,1,0,0,1,1,0,0,0,1,1,0,0,Yes,Y,Yes
1,707-002,Biologic Non-naïve,26,Female,30.043262298,6.0342231348,No,26.4,18.885,Former,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,15,4.31,60.716,39.848,55.456,38.12,66.447,17.356,5.479,11.876,23.458,Yes,No,No,No,2.293,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.6,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,707-004,Biologic Non-naïve,45,Female,37.460978148,7.947980835,Yes,24.9,9,Never,No,No,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,Yes,4,11,5,28,11.703,35,30,60,9,3,6,23,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.3,0,1,1,0,1,1,1,1,Y,,,Y,0,1,0,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,707-005,Biologic Naïve,50,Female,29.296875,9.8097193703,No,29.9,13,Never,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,15,6,44,15.281,56.666666667,40,70,20,8,12,22,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.7,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,707-006,Biologic Naïve,40,Female,29.242108636,4.1615331964,No,29.9,21.157,Missing,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,11,7.721,83.168,5.866,81.335,61.371,62.084,8.893,2.421,6.472,19.676,No,No,No,No,0.482,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-29.1,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,707-007,Biologic Non-naïve,25,Male,26.775510204,3.9917864476,No,23.6,1,Never,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,10,1,38.203,43.78,16.666666667,8,20,7,3,4,16.559,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.1,0,1,1,0,1,1,1,1,Y,0,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,707-008,Biologic Naïve,50,Female,22.265625,5.2183436003,No,12,14.857,Missing,Yes,No,No,No,No,No,No,No,1.5063613232,No,No,No,No,No,No,No,3,11,0.3,46.562,3.525,57.357,31.152,17.227,18.42,10.845,7.575,18.746,No,No,No,No,0.122,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.3,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,707-009,Biologic Non-naïve,55,Male,34.717838657,2.8884325804,No,17.4,5,Never,No,No,No,Yes,No,No,No,No,5,No,No,No,Yes,Yes,Yes,No,3,10,5,20,16.06,41.666666667,36,20,15,7,8,24,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.7,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,707-010,Biologic Naïve,46,Male,35.891513998,4.0684462697,No,20.1,10.099,Missing,No,No,No,Yes,No,No,No,No,1.5063613232,No,No,No,No,Yes,No,No,3,11,6.574,60.934,14.699,47.894,51.779,45.255,25.062,13.745,11.317,23.354,Yes,No,No,No,0.485,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.3,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,707-011,Biologic Naïve,36,Female,29.666548,10.926762491,No,18.6,15.986,Missing,No,No,No,Yes,No,No,No,No,2,Yes,No,No,No,Yes,No,No,3,11,0.809,40.006,19.73,71.089,45.916,51.028,26.347,16.247,10.101,22.192,No,No,No,No,0.518,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,707-012,Biologic Naïve,62,Male,25.951557093,5.3935660507,No,27,14.854,Missing,No,No,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,4,12,6.117,20.2,51.545,64.961,69.471,54.16,17.879,12.887,4.992,23.984,No,No,No,No,0.885,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.8,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,707-013,Biologic Naïve,50,Male,37.421898493,3.9123887748,No,15,11,Current,No,No,No,Yes,No,No,No,No,7,Yes,No,No,No,Yes,Yes,No,3,10,5,21,49.725,45,56,30,15,6,9,23,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.2,0,0,1,0,1,1,1,1,Y,-9,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,707-014,Biologic Non-naïve,54,Female,29.666548,6.2587268994,Yes,2.4,18.479,Missing,No,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,Yes,No,1,3,1.98,34.096,130,59.819,48.307,48.148,18.811,9.898,8.913,21.764,No,No,No,No,1.644,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,6.8,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,707-015,Biologic Naïve,45,Female,32.818073722,20.27652293,Yes,12,1.328,Never,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,10,5,9.083,54.528,23.333333333,46,3.039,9.561,4.534,5.027,23.258,No,No,No,No,1.743,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,707-016,Biologic Naïve,52,Male,22.634676324,9.1225188227,Yes,14.4,16.541,Missing,Yes,No,No,Yes,No,No,No,No,9,Yes,No,No,Yes,Yes,No,No,4,12,5.16,29.577,13.332,55.746,65.902,75.271,27.673,16.062,11.611,23.159,No,No,No,No,3.106,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.9,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,707-017,Biologic Naïve,19,Male,34.717838657,6.0533880903,No,16.2,18.073,Missing,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,11,4.185,15.319,44.101,84.674,41.843,21.371,15.532,7.734,7.798,20.348,No,No,No,No,1.389,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.3,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,707-018,Biologic Non-naïve,51,Male,29.700413223,10.130047912,No,14.4,8,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,7,41,14.327,60,56,40,12,4,8,23,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.8,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,707-019,Biologic Naïve,48,Male,33.05785124,1.2922655715,No,10.2,10,Current,No,No,No,Yes,No,No,No,No,1,No,No,Yes,No,No,No,No,3,11,2,18.057,3.676,23.333333333,16,0,11,4,7,23.903,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-8.1,0,0,1,0,0,1,1,1,Y,-7,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,707-020,Biologic Naïve,20,Female,26.037493991,2.2231348392,No,15,15,Never,No,No,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,4,20,6,72,24.7,63.333333333,58,70,15,6,9,22,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.2,0,0,1,0,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,707-021,Biologic Naïve,31,Male,23.148148148,2.3271731691,No,10.2,7,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,4,4,12.261,46.666666667,38,40,11,6,5,23,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.3,0,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,707-022,Biologic Non-naïve,45,Female,41.623309053,6.4120465435,Yes,5.4,9.2,Missing,No,No,No,Yes,No,No,No,No,8,Yes,No,Yes,Yes,Yes,Yes,Yes,3,11,4.255,68.807,15.765,59.628,35.673,76.99,7.551,4.506,3.045,24.49,No,No,No,No,2.212,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.4,0,0,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,707-023,Biologic Naïve,58,Female,31.25,3.0882956879,No,12,9,Never,No,No,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,4,13,6,19,27.779,60,58,50,26,10,16,16,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.2,0,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,707-024,Biologic Non-naïve,46,Male,43.436132179,10.015058179,No,5.2,2,Current,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,9,1,0,33.934,1.6666666667,6,0,6,3,3,24,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.3,0,0,1,1,1,1,1,1,Y,-1,1,Y,1,1,0,0,1,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,707-025,Biologic Naïve,42,Female,26.346494034,10.05338809,No,14.1,15.776,Missing,No,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,15,6.277,68.988,4.921,55.31,53.753,53.417,20.701,12.165,8.536,24.442,No,No,No,Yes,1.28,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,707-026,Biologic Naïve,57,Female,27.755102041,6.3271731691,No,5.1,4,Former,No,Yes,No,Yes,No,No,No,No,9,Yes,No,No,No,No,Yes,No,3,10,4,8,9.412,30,12,0,2,1,1,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,0,0,1,1,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,707-027,Biologic Naïve,69,Male,31.834212415,8.5585215606,No,5.4,12.396,Missing,No,No,No,Yes,No,No,No,No,2,No,No,No,No,Yes,Yes,No,3,9,2.421,10.81,16.21,14.765,7.135,17.105,12.906,8.161,4.745,19.8,No,No,No,No,1.012,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.2,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,707-028,Biologic Non-naïve,62,Male,41.53330285,5.9630390144,No,4.9,3,Never,No,No,No,Yes,No,No,No,No,6,Yes,No,Yes,Yes,Yes,Yes,Yes,3,5,3,38,26.21,43.333333333,24,0,4,1,3,15,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,707,Saudi Arabia,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.7,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,710-001,Biologic Non-naïve,62,Male,27.636054422,14.50513347,Yes,14.6,1.445,Former,No,No,No,Yes,No,No,No,No,3,No,No,No,No,No,No,No,3.2017453799,20,0.463,18.246,36.377,38.641,28.496,18.252,2.604,0.711,1.894,21.038,No,No,No,No,2.476,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,710,Saudi Arabia,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.4,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,710-002,Biologic Non-naïve,52,Female,36.684095126,3.5044490075,Yes,5.4,10,Never,No,No,No,Yes,No,No,No,No,3,Yes,No,No,No,No,Yes,No,2,10,3,0,0.053,18.333333333,12,30,14,8,6,24,No,No,No,No,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,710,Saudi Arabia,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.4,1,1,1,1,1,1,1,1,Y,-10,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,726-001,Biologic Non-naïve,48,Male,23.986870345,30.483230664,No,9.5,8,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,8,1,38.203,61,15,4,0,16.085,7.048,9.037,24.242,Yes,Yes,Yes,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,726,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.5,0,0,0,0,0,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,726-003,Biologic Non-naïve,59,Male,25.864512472,0,No,22.1,3,Current,No,Yes,Yes,Yes,Yes,Yes,No,No,1.5063613232,No,No,No,No,Yes,No,No,3,25,5,0,9.884,45,32,0,0,0,0,25,No,No,Yes,No,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,726,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,-11.3,0,0,0,0,0,0,0,0,Y,0,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,726-004,Biologic Non-naïve,31,Female,21.501886486,25.292265572,No,20.1,8,Current,No,Yes,Yes,Yes,No,No,No,No,1.5063613232,No,No,No,No,No,No,No,4,70,8,60,45.486,83.333333333,68,20,3,3,0,22,Yes,No,Yes,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,726,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.7,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,726-005,Biologic Naïve,44,Female,19.948059769,20.566735113,No,5.8,10,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,5,10,80,16,88.333333333,92,10,8,5,3,24,No,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,726,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-2,0,0,0,0,0,0,1,0,Y,,,N,0,0,0,0,0,0,0,0,0,0,1,0,0,,N,No
1,726-006,Biologic Non-naïve,51,Male,36.592455798,29.924709103,No,10.1,1,Former,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,No,No,3,34,2,16,3,25,22,30,14,4,10,17,No,No,No,No,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,726,Spain,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,1,1,1,1,1,1,1,1,Y,-1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,727-001,Biologic Non-naïve,45,Female,29.73390041,25.319644079,No,4.7,3,Never,Yes,No,No,No,No,No,No,No,2,No,No,No,No,Yes,Yes,No,2,8,2,0,3.031,30,34,0,8,7,1,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,727,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4,0,0,1,1,1,1,1,1,Y,-3,1,Y,1,1,0,0,1,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,727-002,Biologic Naïve,21,Female,17.804967129,14.477754962,No,6.3,11.337,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,67,6.602,25.263,8,57.833,70.776,33.716,8.568,4.813,3.755,19.687,No,No,No,Yes,3.407,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,727,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,727-003,Biologic Non-naïve,33,Male,28.731921488,20.585900068,No,4.5,4.148,Missing,Yes,Yes,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,2,5,3.6,17.443,4.434,32.005,13.158,6.707,11.194,7.611,3.584,24.696,No,No,No,No,1.041,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,727,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,727-004,Biologic Naïve,35,Female,22.038567493,28.605065024,Yes,7.4,17,Current,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,10,9,36,0,78.333333333,80,70,24,14,10,21,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,727,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,727-005,Biologic Naïve,35,Female,30.119401915,19.06091718,No,14,18,Former,Yes,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3.2017453799,30,8,5,0,81.666666667,76,60,8,5,3,25,No,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,727,Spain,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14,1,1,1,1,1,1,1,1,Y,-17,1,Y,,1,,0,1,1,1,1,1,1,1,1,0,Yes,Y,Yes
1,727-006,Biologic Naïve,77,Female,25.593737062,30.822724162,No,6,9.87,Missing,No,Yes,Yes,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3.2017453799,7,6.52,15.223,0,57.357,40.944,39.746,10.897,6.453,4.444,22.671,No,No,Yes,No,0.73,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,727,Spain,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,728-001,Biologic Non-naïve,59,Female,33.044982699,54.042436687,No,8.3,14,Former,Yes,No,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,3,10,3,1,4,55,36,100,28,16,12,25,No,No,Yes,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,728,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.3,1,1,1,1,1,1,1,1,Y,-15,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,728-002,Biologic Non-naïve,41,Male,24.622960911,15.794661191,No,4.8,8,Never,Yes,No,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,4,6,0,0,41.666666667,36,50,8,7,1,25,Yes,Yes,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,728,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.4,0,0,0,0,0,0,1,1,Y,0,0,Y,1,1,1,1,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,728-003,Biologic Non-naïve,55,Female,36.730945822,2.3901437372,No,2.4,12,Former,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,3,5,21,0,50,56,50,26,14,12,25,Yes,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,728,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.4,1,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,728-004,Biologic Non-naïve,43,Female,24.005486968,22.809034908,No,6.2,11,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,3,7,0,0,56.666666667,68,30,14,12,2,25,No,No,No,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,728,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.9,0,1,1,1,1,1,1,1,Y,-11,1,Y,1,1,1,1,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,728-005,Biologic Naïve,28,Female,19.098161168,10.324435318,No,6.8,9,Never,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,4,7,17,0,70,54,50,12,9,3,25,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,728,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,729-001,Biologic Naïve,53,Female,24.973985432,9.9192334018,No,14.6,18,Former,Yes,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,5,4,0,18.61,14.767,15.642,0,9,3,6,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,729,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,1,Y,-2,0,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,731-001,Biologic Naïve,49,Male,31.20719035,9.2128678987,No,7.6,9,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,4,0,0,18.369,46.666666667,20,0,18,12,6,23,No,No,Yes,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,731,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.4,0,0,1,0,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,733-001,Biologic Non-naïve,57,Female,28.025793651,35.386721424,Yes,13.7,13,Former,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,36,4,41,39.511,56.666666667,70,30,14,10,4,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.7,1,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,733-002,Biologic Naïve,25,Female,25.224089005,5.5030800821,Yes,9.6,20,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,18,9,87,15,88.333333333,82,70,22,13,9,20,No,No,No,No,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,1,1,1,1,1,1,1,1,Y,-16,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,733-003,Biologic Non-naïve,56,Male,27.464810711,42.499657769,Yes,9.4,8,Former,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,15,3,15,14,36.666666667,38,10,20,9,11,19,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.9,0,0,0,0,0,0,1,0,Y,2,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,733-004,Biologic Non-naïve,53,Male,26.234567901,37.519507187,Yes,1.8,7,Never,No,Yes,Yes,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,Yes,No,1,1,0,0,2,6.6666666667,6,60,24,12,12,25,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,733-005,Biologic Non-naïve,31,Male,32.15191402,9.5359342916,Yes,8.3,27,Never,Yes,No,No,No,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,3,14,10,99,5,91.666666667,88,50,29,13,16,16,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.3,1,1,1,1,1,1,1,1,Y,-27,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,733-006,Biologic Non-naïve,54,Male,32.78799351,52.654346338,No,10.8,11.77,Missing,Yes,Yes,No,Yes,No,No,No,No,5,No,No,No,Yes,Yes,Yes,No,3,16,6.254,59.782,6,77.796,69.118,32.458,17.633,10.57,7.063,21.862,No,No,No,Yes,1.381,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,733-007,Biologic Naïve,71,Female,30.405292526,11.017111567,No,11.3,11.317,Former,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,10,10,85.861,0,65.185,88.705,8.198,1.125,0.223,0.902,23.563,No,No,No,No,2.817,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,733-008,Biologic Naïve,44,Male,24.391058839,37.689253936,No,9,6,Former,No,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,3,14,7,8,23,53.333333333,24,0,10,5,5,25,No,No,No,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-1.8,0,0,0,0,0,0,0,0,Y,-5,1,N,0,0,0,0,0,0,0,0,0,0,0,1,0,,N,No
1,733-009,Biologic Non-naïve,48,Female,33.968915238,35.882272416,No,4.2,14,Never,No,Yes,Yes,No,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,4,2,41,6,58.333333333,64,80,22,15,7,20,No,No,Yes,No,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.6,0,0,0,0,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,733-010,Biologic Naïve,59,Female,33.462224866,8.9226557153,Yes,0,8.701,Missing,Yes,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,2,0,4.239,14.841,60,68.687,56.69,30.128,4.942,0.999,3.943,23.567,No,No,No,No,1.099,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,,,,1,1,1,1,1,Y,,,Y,1,1,1,1,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,733-011,Biologic Non-naïve,43,Male,31.699070161,21.998631075,No,2.4,5,Never,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,2,3,47,0,40,28,20,3,3,0,24,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.4,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,733-012,Biologic Non-naïve,31,Male,30.24691358,12.073921971,Yes,2,24.008,Missing,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,1,0.5,6.108,58.615,3,53.887,65.567,72.515,24.932,14.787,10.146,23.192,No,No,No,No,1.039,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,733,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,734-001,Biologic Non-naïve,48,Male,32.458412659,29.489390828,Yes,12.6,6,Former,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,No,3.2017453799,28,0,4,1,53.333333333,22,80,2,0,2,25,No,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,734,Spain,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,0,0,0,0,0,0,0,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,734-002,Biologic Naïve,33,Male,26.014568158,12.793976728,No,10.1,7,Never,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,14,5,41,0,36.666666667,36,0,15,8,7,25,Yes,Yes,No,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,734,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.5,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,734-003,Biologic Naïve,39,Male,24.074074074,13.130732375,No,12.4,7,Never,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,16,2,0,2,16.666666667,12,50,15,9,6,25,No,No,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,734,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.5,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,734-004,Biologic Naïve,31,Female,18.442545824,1.4839151266,No,4.5,8,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,2,9,7,59,0,58.333333333,46,0,15,12,3,25,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,734,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.6,0,0,1,1,1,1,1,1,Y,2,0,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,738-001,Biologic Naïve,56,Female,29.031510377,21.826146475,No,10.8,8.246,Former,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,11,7.164,3.824,0,58.311,45.874,7.231,11.562,6.688,4.874,24.23,No,No,No,No,1.054,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,738,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.6,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,739-001,Biologic Naïve,47,Female,43.430595379,5.2292950034,No,8.4,16,Current,No,No,Yes,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,No,No,3,8,8,76,24.825,75,82,60,33,18,15,25,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,739,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,0.2,0,0,0,0,0,0,0,0,N,8,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,739-002,Biologic Naïve,58,Male,36.063163055,22.809034908,No,8,2,Current,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,5,3,4,38.325,26.666666667,16,30,4,3,1,25,No,No,No,Yes,4,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,739,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.4,0,0,0,0,0,0,1,0,Y,1,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,739-003,Biologic Naïve,49,Female,36.448060487,15.79192334,Yes,10.7,4,Former,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,15,2,17,31.124,51.666666667,28,20,22,16,6,25,No,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,739,Spain,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,739-004,Biologic Naïve,37,Male,20.910708155,5.144421629,No,10.2,18,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,15,5,0,18.997,41.666666667,26,50,11,6,5,24,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,739,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.2,1,1,1,1,1,1,1,1,Y,-14,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,739-005,Biologic Naïve,58,Female,41.091387245,1.2977412731,No,16.8,22.933,Missing,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,No,4,20,7.375,82.676,30.469,88.391,75.342,81.007,21.875,14.028,7.847,22.083,No,No,No,Yes,0.495,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,739,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,739-006,Biologic Non-naïve,53,Male,29.9136168,10.116358658,No,12.9,12,Former,No,No,No,No,No,No,No,No,2,No,No,No,No,Yes,No,No,4,9,9,60,22.265,83.333333333,84,80,17,8,9,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,739,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.7,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,739-008,Biologic Non-naïve,46,Female,20.047445621,27.115674196,No,5.2,11,Former,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,3,5,40,32.949,60,56,0,13,10,3,24,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,739,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.2,0,0,0,0,0,0,1,0,Y,-8,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,739-009,Biologic Non-naïve,48,Male,25.661152035,23.849418207,No,3.3,13.827,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,2,3.615,19.945,0,59.188,33.821,46.66,17.228,11.133,6.096,24.605,No,No,No,Yes,3.448,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,739,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.3,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,739-010,Biologic Naïve,46,Female,35.201045144,46.012320329,No,15,2,Never,Yes,No,Yes,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,4,15,2,0,55.697,51.666666667,28,0,14,9,5,15,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,739,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,742-001,Biologic Naïve,37,Female,19.227687871,17.040383299,No,12.4,0,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,24,0,0,4.529,8.3333333333,0,0,20,11,9,23,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,742,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.4,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,743-001,Biologic Naïve,39,Male,27.994736989,7.7180013689,No,10.1,15,Former,No,Yes,Yes,Yes,Yes,No,No,Yes,1,No,No,No,No,Yes,No,No,3,13,6,60,26,58.333333333,52,30,16,9,7,24,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,8.9,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,743-002,Biologic Naïve,21,Male,21.773842357,6.1902806297,No,5,0,Current,Yes,Yes,Yes,No,Yes,Yes,No,No,0,No,No,No,No,No,No,No,2,5,0,0,5.431,30,0,0,5,5,0,25,No,No,Yes,No,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,743-003,Biologic Naïve,57,Male,29.377582645,10.951403149,No,12.6,17,Current,Yes,Yes,No,Yes,Yes,Yes,No,No,3,Yes,No,No,No,Yes,No,No,3,23,0,0,3.56,53.333333333,16,0,17,9,8,23,No,No,No,No,0,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,743-004,Biologic Naïve,48,Male,24.391058839,7.0910335387,No,13.1,21,Never,No,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,19,8,77,0,71.666666667,76,70,11,7,4,23,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.5,0,1,1,1,1,1,1,1,Y,-20,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,743-005,Biologic Naïve,36,Female,26.446280992,8.5338809035,No,12.1,22,Current,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,5,6,8,72,0,83.333333333,62,90,21,11,10,20,No,Yes,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-7.9,0,0,0,0,0,0,1,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,743-006,Biologic Naïve,49,Female,29.319856487,1.1882272416,No,15.9,30,Never,No,Yes,No,Yes,Yes,No,No,Yes,4,Yes,No,No,Yes,Yes,No,No,4,12,8,57,0,55,58,80,14,8,6,24,Yes,No,No,Yes,3,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.9,0,0,1,0,1,1,1,1,Y,-15,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,743-007,Biologic Non-naïve,55,Female,32.912012885,10.102669405,Yes,13.4,21,Current,No,Yes,Yes,Yes,Yes,No,No,Yes,4,Yes,No,No,Yes,Yes,No,No,4,7,10,53,73,91.666666667,94,100,15,9,6,25,No,No,Yes,No,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.8,0,1,1,1,1,1,1,1,Y,-14,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,743-008,Biologic Non-naïve,79,Male,32.604757879,7.6249144422,No,8,0,Never,No,Yes,Yes,No,Yes,Yes,No,Yes,2,No,No,No,Yes,Yes,No,No,2,10,0,0,0,0,0,0,1,1,0,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,743-009,Biologic Non-naïve,61,Female,28.444444444,10.203969884,No,9.2,5,Never,Yes,Yes,Yes,No,Yes,No,No,Yes,2,No,No,No,No,Yes,No,No,3,9,5,28,0,28.333333333,22,0,14,4,10,25,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.6,0,0,0,0,0,0,1,0,Y,6,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,743-010,Biologic Non-naïve,30,Male,30.32334259,8.2929500342,Yes,7.6,10,Current,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,9,3,6,0,41.666666667,28,60,22,12,10,23,No,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,743-011,Biologic Non-naïve,41,Male,42.448979592,19.331964408,No,25.6,1,Never,Yes,Yes,No,No,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,No,3,36,3,31,10,48.333333333,32,0,6,5,1,24,No,No,No,Yes,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.8,0,0,0,0,0,0,0,0,Y,3,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,743-012,Biologic Naïve,54,Male,38.271604938,19.989048597,No,18,21,Current,Yes,Yes,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,Yes,No,4,18,5,60,42,73.333333333,58,80,14,7,7,22,No,Yes,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,3,0,0,0,0,0,0,0,0,N,-2,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,743-013,Biologic Naïve,34,Male,18.518518519,6.4284736482,No,30.3,8,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,45,7,74,47,71.666666667,74,20,18,9,9,17,Yes,Yes,Yes,Yes,3,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-30.3,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,743-014,Biologic Non-naïve,34,Female,32.046146451,11.446954141,No,20.4,18,Current,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,24,9,73,21,65,60,50,27,15,12,21,No,No,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.2,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,743-015,Biologic Naïve,46,Male,37.673130194,8.5037645448,No,4.5,7,Former,Yes,Yes,No,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,Yes,No,3,5,6,70,10.087,68.333333333,54,0,19,11,8,24,Yes,No,No,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.1,0,0,0,0,0,1,1,0,Y,-1,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,743-016,Biologic Naïve,21,Male,26.511804065,8.0301163587,No,9.1,12,Former,Yes,No,No,No,Yes,Yes,No,Yes,1,No,No,No,No,Yes,No,No,3,7,8,61,0,75,70,60,10,9,1,24,Yes,Yes,No,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.5,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,743-017,Biologic Naïve,40,Female,23.951226593,5.0568104038,No,18.8,18,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,22,7,70,9,75,84,70,26,11,15,25,Yes,No,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.6,0,1,1,0,1,1,1,1,Y,-13,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,743-018,Biologic Naïve,45,Female,27.688778134,32.599589322,No,22.7,16.035,Never,Yes,No,No,Yes,Yes,No,No,Yes,1,No,No,No,No,Yes,No,No,3,52,6.608,56.064,3,63.011,69.842,19.171,15.723,8.13,7.593,18.762,Yes,Yes,Yes,Yes,0.418,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.7,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,743-020,Biologic Non-naïve,38,Male,33.515273389,3.6440793977,No,8,3,Current,No,Yes,Yes,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,3,6,1,2,0,16.666666667,10,0,8,5,3,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8,1,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,743-021,Biologic Naïve,42,Male,27.6816609,15.323750856,No,17.9,25,Current,No,No,No,No,Yes,No,No,Yes,1,No,No,No,No,Yes,No,No,4,28,2,81,14,83.333333333,54,60,17,8,9,25,No,No,Yes,Yes,2,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-18,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,743-022,Biologic Naïve,19,Female,23.702422145,10.721423682,No,9.5,6,Never,Yes,No,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,3,14,0,0,0,10,0,0,20,12,8,24,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.9,0,0,1,0,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,743-023,Biologic Non-naïve,53,Female,23.108434579,12.084873374,No,6,0,Current,Yes,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,2,6,0,2,0,0,10,0,2,2,0,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,1,1,1,1,1,1,1,1,Y,0,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,743-024,Biologic Naïve,54,Female,23.951226593,5.6153319644,No,6,6,Current,Yes,No,No,Yes,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,2,8,3,37,0,56.666666667,14,60,18,13,5,19,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,743-025,Biologic Non-naïve,48,Female,44.956733369,17.834360027,No,7,10,Former,Yes,Yes,Yes,Yes,Yes,No,No,Yes,4,Yes,No,No,Yes,Yes,No,No,2,8,0,7,0,53.333333333,44,40,23,13,10,24,No,No,No,No,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.4,0,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,743-026,Biologic Naïve,28,Female,20.202020202,10.406570842,No,11.9,5,Former,Yes,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,14,8,31,0,70,72,40,6,3,3,21,No,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,0,0,1,0,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,743-027,Biologic Naïve,27,Female,22.233115087,14.92128679,No,7.8,9,Never,No,No,No,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,9,8,0,0,48.333333333,60,0,7,6,1,22,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.6,0,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,743-028,Biologic Naïve,48,Male,33.802055165,2.9486652977,No,8.1,8,Former,No,No,No,No,Yes,Yes,No,Yes,2,No,No,No,Yes,Yes,No,No,3,9,6,47,0,63.333333333,62,20,25,14,11,24,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.5,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,743-029,Biologic Naïve,33,Male,24.158817969,11.430527036,No,5.6,3,Current,No,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,2,5.5,0,0,57.452,56.666666667,10,0,7,6,1,25,No,No,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,743-030,Biologic Naïve,24,Female,22.060353798,3.9397672827,No,21,16,Current,No,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,26,9,75,0,78.333333333,84,50,6,6,0,25,No,Yes,Yes,Yes,3,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21,1,1,1,1,1,1,1,1,Y,-6,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,743-031,Biologic Non-naïve,51,Female,55.096418733,38.978781656,No,12.4,19,Current,Yes,Yes,Yes,Yes,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,4,6,8,100,0,96.666666667,84,70,21,11,10,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,0,0,1,0,1,1,1,1,Y,-7,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,743-032,Biologic Naïve,58,Female,22.144274376,15.997262149,No,11.3,15.609,Missing,No,Yes,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,Yes,No,4,8,7.708,57.13,0,46.265,58.274,64.072,8.701,5.385,3.316,23.012,No,No,No,Yes,0.773,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,743-033,Biologic Non-naïve,47,Male,32.140248356,15.515400411,Yes,15,4.087,Former,No,Yes,No,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,No,3,22,2,19.197,13,15,4,0,8.407,5.314,3.094,19.044,No,No,No,Yes,4,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.4,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,743-034,Biologic Naïve,50,Female,24.76756592,22.061601643,Yes,9.6,24,Former,Yes,No,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,7,7,70,0,58.333333333,70,50,6,3,3,24,No,Yes,Yes,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,743,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.4,0,0,1,0,0,1,1,1,Y,-17,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,744-001,Biologic Naïve,52,Female,25.727555214,52.76659822,No,10.3,5,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,9,5,0,39.782,40,54,0,17,9,8,24,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,744,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.7,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,745-001,Biologic Non-naïve,47,Female,36.730945822,18.767967146,No,12,4,Current,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,10,6,1,0,50,34,0,9,8,1,23,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,745-002,Biologic Naïve,48,Male,25.351541374,16.774811773,No,12.6,11,Never,Yes,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,6,76,11.978,76.666666667,66,30,30,17,13,22,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.7,0,1,1,1,1,1,1,1,Y,-11,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,745-003,Biologic Non-naïve,52,Female,35.012779665,19.783709788,No,7.8,3,Never,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,8,5,50,25.112,28.333333333,32,0,13,6,7,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.8,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,745-004,Biologic Non-naïve,56,Male,29.384756657,3.6249144422,No,3.9,14,Former,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,5,5,48,3.71,45,48,80,12,6,6,25,No,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,8.1,0,0,0,0,0,0,0,0,Y,,,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,745-005,Biologic Non-naïve,45,Male,20.745069394,39.808350445,No,24.3,5,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,7,5,60,26.076,36.666666667,36,0,2,2,0,25,Yes,No,Yes,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.9,0,0,1,0,0,0,0,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,745-006,Biologic Naïve,52,Female,22.718974401,9.8069815195,No,6.3,10,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,8,0,9.038,48.333333333,36,50,15,9,6,24,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,0,0,0,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,745-007,Biologic Non-naïve,49,Female,30.46875,16.646132786,No,17.7,7,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,3,17,14.962,56.666666667,30,0,26,14,12,24,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,745-008,Biologic Non-naïve,72,Male,36.730945822,29.859000684,No,13.8,10.006,Missing,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,3,8,2.923,11.42,1.568,50.149,36.707,53.583,13.04,1.92,11.119,22.213,Yes,No,No,No,0.207,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-009,Biologic Non-naïve,29,Male,34.285714286,12.774811773,No,16.2,27,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,10,9,90,2.806,91.666666667,90,90,17,8,9,25,Yes,Yes,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-010,Biologic Non-naïve,48,Male,28.010223732,30.92128679,No,14.4,8,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,21.321860465,6,76,9.929,58.333333333,48,40,16,13,3,23,No,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,745-011,Biologic Naïve,60,Female,28.010223732,9.8507871321,No,27.9,16.271,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,6.088,88.405,5.479,73.336,55.026,34.65,12.29,5.759,6.531,24.064,Yes,No,No,Yes,0.491,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25.2,0,1,1,0,0,1,1,1,Y,,,Y,0,1,0,0,1,1,0,0,0,1,1,0,0,Yes,Y,Yes
1,745-012,Biologic Naïve,27,Female,28.72678773,13.686516085,No,15,9,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,7,8,6,14.761,60,50,10,9,4,5,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.6,0,0,1,0,0,1,1,0,Y,-3,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,745-013,Biologic Naïve,57,Male,25.648917616,17.790554415,No,18,10,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,10,4,43,18.357,51.666666667,36,30,17,12,5,25,No,No,Yes,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,-6,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-014,Biologic Naïve,37,Female,21.203105229,17.456536619,No,18.9,22,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,8,88,17.586,76.666666667,80,60,9,9,0,25,Yes,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.1,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,745-015,Biologic Naïve,49,Male,29.667971216,9.2895277207,No,12,14.83,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,5.191,46.927,0.62,53.536,47.051,21.515,12.432,6.387,6.045,23.197,No,No,No,No,0.897,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-016,Biologic Naïve,62,Female,29.333333333,14.543463381,Yes,13.8,3,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,2,8,41.341,33.333333333,10,0,8,5,3,24,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,745-017,Biologic Naïve,47,Male,26.061679308,16.843258042,No,29.7,17.795,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,14,5.453,50.718,30.919,61.004,60.479,43.082,17.529,12.504,5.025,23.003,No,No,No,Yes,0.526,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-29.7,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-018,Biologic Non-naïve,60,Male,38.567493113,24.413415469,No,20.7,6.804,Missing,Yes,No,No,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,Yes,No,3,15,5.059,33.964,18.955,51.544,26.778,17.662,12.757,7.397,5.36,17.812,No,No,No,No,0.799,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-20.7,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-019,Biologic Non-naïve,45,Female,22.031725685,7.7180013689,No,16.8,19,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,7,52,25.612,60,68,60,27,15,12,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.8,1,1,1,1,1,1,1,1,Y,-3,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-020,Biologic Non-naïve,40,Female,21.755468534,15.561943874,No,21.9,0.482,Missing,Yes,No,No,No,No,No,No,No,4,Yes,Yes,Yes,No,No,No,No,3,10,7.363,22.787,25.766,61.352,45.804,34.043,13.909,6.755,7.153,23.708,No,No,Yes,No,0.431,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-021,Biologic Non-naïve,49,Female,25.816630213,0,No,10.8,1.708,Never,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,10,7.618,4.399,11.523,50.915,40.404,20.268,24.787,14.212,10.575,20.837,No,No,No,No,1.938,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-022,Biologic Naïve,53,Male,30.040816327,17.790554415,No,18,16,Never,Yes,No,No,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,Yes,No,3,10,9,80,8.915,85,82,70,10,8,2,25,No,No,Yes,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,745-023,Biologic Non-naïve,58,Female,27.6816609,19.000684463,No,23.8,23,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,16,9,88,3.248,83.333333333,84,70,16,10,6,22,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.8,1,1,1,1,1,1,1,1,Y,-14,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-024,Biologic Naïve,44,Female,27.6816609,13.746748802,No,30.8,8,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,3,0,22.019,80,24,0,9,6,3,24,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-30.8,1,1,1,1,1,1,1,1,Y,1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-025,Biologic Naïve,36,Male,23.719609251,7.8220396988,No,18,9,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,4,29,10.653,40,32,10,14,8,6,25,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,745-026,Biologic Naïve,74,Male,32.660763536,55.296372348,No,32.7,23,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,8,99,26.943,76.666666667,66,80,26,13,13,25,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-32.7,1,1,1,1,1,1,1,1,Y,-8,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-027,Biologic Naïve,38,Female,27.580200319,19.110198494,No,27,11.879,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,18,0,26.938,18.553,35,10,40.982,25.083,12.892,12.191,22.974,No,No,No,No,3.081,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-028,Biologic Non-naïve,56,Male,32.876887229,28.090349076,No,24.3,5,Former,Yes,No,No,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,16,3,0,21.534,46.666666667,24,0,10,6,4,22,No,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.3,1,1,1,1,1,1,1,1,Y,0,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-029,Biologic Naïve,51,Male,32.449972958,24.991101985,No,15.6,17,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,5,40,40.297,35,24,30,21,12,9,25,No,No,Yes,No,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-15.6,1,1,1,1,1,1,1,1,Y,-10,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,745-030,Biologic Naïve,55,Male,30.64253567,22.907597536,No,18,14,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,12,5,30,6.972,58.333333333,58,60,28,18,10,25,No,No,Yes,No,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,745,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,749-001,Biologic Naïve,33,Female,19.233560749,9.9274469541,No,6.8,4,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,7,7,0,0,5,12,0,17,14,3,25,No,No,No,Yes,2,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,749,Spain,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,749-002,Biologic Naïve,60,Male,34.93877551,0.8898015058,No,28.8,6,Former,No,Yes,No,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,Yes,No,4,38,5,46.848,73.717,65,64,10,1,1,0,21.527,Yes,No,No,No,1,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,749,Spain,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.6,0,0,1,0,0,0,0,0,Y,-6,1,Y,0,0,0,0,1,0,0,0,0,0,0,1,0,No,Y,No
1,749-003,Biologic Naïve,39,Male,23.781212842,1.0075290897,No,14.1,13.556,Missing,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,10,1.946,33.551,37,36.135,28.801,81.443,20.069,9.726,10.344,24.038,No,No,Yes,Yes,1.493,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,749,Spain,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.4,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,749-004,Biologic Naïve,52,Male,29.68495643,0.629705681,No,14.2,7,Former,Yes,Yes,No,Yes,No,No,No,No,7,Yes,No,No,Yes,Yes,No,No,4,10,4,18,22,70,60,0,28,16,12,23,Yes,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,749,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.2,1,1,1,1,1,1,1,1,Y,-6,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,749-005,Biologic Naïve,38,Female,23.148148148,22.603696099,No,16,13,Current,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,Yes,4,16,10,10,0,58.333333333,68,0,28,12,16,18,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,749,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16,1,1,1,1,1,1,1,1,Y,-13,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,749-006,Biologic Naïve,46,Male,41.118421053,31.282683094,No,21,12.353,Missing,No,No,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,33,5.41,53.35,0,60.523,69.654,53.687,12.59,4.693,7.897,22.619,Yes,Yes,No,Yes,1.039,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,749,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,750-001,Biologic Naïve,33,Female,27.168114617,26.877481177,No,7.4,28,Never,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,7.3,9,86,0,93.333333333,92,90,13,6,7,25,No,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,750,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.6,0,0,1,0,1,1,1,1,Y,-17,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,750-002,Biologic Non-naïve,36,Male,20.28008984,13.514031485,No,11.8,5,Former,Yes,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,21,8,16,0,20,34,30,9,7,2,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,750,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10,0,0,1,0,1,1,1,1,Y,-5,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,750-003,Biologic Naïve,38,Male,22.783308885,36.900752909,No,8.4,27,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,21.321860465,8,52,0,66.666666667,78,60,8,7,1,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,750,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,0,0,1,0,1,1,1,1,Y,-13,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,750-004,Biologic Non-naïve,50,Female,21.513858511,14.902121834,No,18.7,8,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,21,0,10,0,28.333333333,10,0,19,11,8,25,Yes,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,750,Spain,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.7,1,1,1,1,1,1,1,1,Y,-7,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,751-001,Biologic Non-naïve,74,Male,25.910684347,35.047227926,No,8.5,13.74,Missing,No,No,No,Yes,No,No,No,No,2,Yes,No,No,No,No,Yes,No,3,6,6.514,14.541,21.287,44.35,48.343,49.083,8.885,7.271,1.614,22.816,No,No,Yes,No,1.522,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,751,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.9,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,751-004,Biologic Naïve,39,Female,23.42209073,9.4893908282,No,11.3,18.538,Missing,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,4,12,1.667,44.743,10.374,59.575,31.046,39.926,18.422,10.256,8.166,21.684,No,No,Yes,No,2.153,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,751,Spain,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,752-001,Biologic Naïve,47,Female,38.09014668,23.438740589,No,8,23,Never,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,7.6,9,89,5.08,83.333333333,76,90,18,11,7,20,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.6,0,0,0,0,0,0,1,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,752-002,Biologic Non-naïve,70,Male,24.221453287,6.4476386037,No,19.1,11,Never,No,No,No,Yes,No,No,No,No,4,No,No,No,No,No,Yes,No,3,3.6,9,90,8.236,60,80,70,23,14,9,23,Yes,No,No,Yes,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-7,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,752-003,Biologic Non-naïve,50,Male,31.633665059,40.492813142,No,6.7,10,Former,No,No,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,3,4,8,86,23.041,53.333333333,74,50,3,3,0,17,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.7,1,1,1,1,1,1,1,1,Y,-10,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,752-004,Biologic Non-naïve,48,Female,37.1334722,27.603011636,No,13.2,17,Never,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,25,9,87,12.927,90,88,80,15,8,7,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-17,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,752-005,Biologic Naïve,51,Female,24.76756592,43.644079398,Yes,5.4,6,Current,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,2,2.8,6,5,28,55,70,80,28,14,14,23,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,N,,,,,,,,,,N,-6,1,N,,0,,0,0,0,0,0,0,0,0,1,0,,N,No
1,752-006,Biologic Naïve,67,Female,36.328125,1.5797399042,No,6,15,Former,Yes,No,No,Yes,No,No,No,No,3,No,No,No,No,No,Yes,Yes,3,2,10,51,2.647,71.666666667,48,70,22,12,10,25,No,No,No,Yes,2,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-14,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,752-007,Biologic Non-naïve,47,Male,24.074074074,26.732375086,No,7.1,5,Former,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,3,10,2.324,33.333333333,36,10,20,6,14,25,Yes,No,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-4,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,752-008,Biologic Naïve,39,Male,26.446280992,4.2737850787,No,5.4,15,Never,No,Yes,No,Yes,No,No,No,No,2,Yes,Yes,No,No,No,No,No,3,4.9,8,0,6,88.333333333,58,0,13,6,7,21,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.4,1,1,1,1,1,1,1,1,Y,-14,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,752-009,Biologic Naïve,58,Female,39.039262344,11.983572895,No,8.8,7,Former,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,3,6.9,10,40,25.423,73.333333333,76,50,6,1,5,23,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-6,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,752-010,Biologic Non-naïve,40,Female,21.773842357,27.206023272,No,9.8,7,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,4,20,5.152,43.333333333,24,10,5,4,1,22,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-7,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,752-011,Biologic Non-naïve,63,Male,35.908484662,25.552361396,No,9.6,5,Former,No,No,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,4,5.7,3,0,20.025,81.666666667,38,0,11,5,6,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-4,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,752-012,Biologic Non-naïve,50,Female,21.875,23.022587269,Yes,6.3,13,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,5.1,10,40,53.893,68.333333333,74,80,12,4,8,25,No,Yes,Yes,No,3,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-11,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,752-013,Biologic Naïve,49,Female,37.520281233,26.702258727,No,14.2,30,Former,No,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,13,9,90,53,95,92,100,12,6,6,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.2,1,1,1,1,1,1,1,1,Y,-26,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,752-014,Biologic Naïve,66,Male,29.410758866,15.635865845,Yes,10.9,2,Former,Yes,Yes,No,Yes,No,No,No,No,5,No,No,No,No,Yes,No,No,4,20,4,20,28,20,16,80,2,1,1,25,No,No,Yes,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,752,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.4,0,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,755-001,Biologic Non-naïve,59,Female,28.125,0.9171800137,Yes,20.4,18,Former,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,4,15,8,80,18.75,81.666666667,78,70,17,10,7,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.5,0,0,1,0,0,1,1,1,Y,-16,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,755-002,Biologic Non-naïve,47,Female,37.577627467,18.913073238,Yes,29.4,27,Never,Yes,No,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,Yes,5,85,7,67,21.335,76.666666667,72,80,17,9,8,25,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-29.4,1,1,1,1,1,1,1,1,Y,-27,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,755-003,Biologic Non-naïve,65,Female,31.644285772,45.768651608,No,7.8,1,Former,Yes,No,No,Yes,No,No,No,No,6,No,No,No,Yes,Yes,Yes,No,3,5,2,0,18.349,38.333333333,16,0,18,11,7,25,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,755-004,Biologic Naïve,55,Male,26.014568158,2.0013689254,Yes,18.1,9,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,7,0,8.127,55,18,20,13,10,3,24,Yes,No,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.3,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,755-005,Biologic Non-naïve,59,Male,25.468471148,25.612594114,No,5.2,6.241,Missing,No,No,No,Yes,No,No,No,No,9,Yes,No,No,No,No,Yes,No,3,8,7.351,68.122,29.851,92.839,94.669,33.677,14.751,5.778,8.973,19.109,No,No,No,No,0.482,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.4,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,755-006,Biologic Non-naïve,73,Male,26.573129252,21.828884326,No,4.2,8.955,Missing,No,No,No,Yes,No,No,No,No,4,Yes,No,No,No,Yes,Yes,No,3,3,6.733,4.677,0.255,47.45,37.69,60.033,16.04,13.395,2.646,23.05,No,Yes,No,No,0.138,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.8,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,755-007,Biologic Non-naïve,43,Male,23.67125363,29.385352498,No,2.2,11.301,Missing,Yes,No,No,Yes,No,No,No,No,4,No,No,No,No,No,No,No,1,1.5,6.705,26.753,12.029,81.217,74.759,10.293,27.21,17.506,9.704,22.001,No,No,No,Yes,1.427,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,755-008,Biologic Naïve,40,Male,27.438271605,0.8432580424,No,10,19,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,Yes,No,3,8,9,83,20.82,81.666666667,80,80,12,8,4,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.8,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,755-009,Biologic Non-naïve,40,Female,21.936347412,27.069130732,Yes,12.3,14.353,Missing,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,35,7.464,76.258,46.086,83.436,71.864,42.084,9.858,3.446,6.412,19.418,No,No,No,Yes,1.464,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,755,Spain,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,755-010,Biologic Naïve,51,Male,25.758881547,11.709787817,No,8.9,19.546,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,3,6.363,42.357,9.121,56.839,51.526,83.565,15.633,10.896,4.737,24.157,No,No,No,Yes,1.042,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,755-011,Biologic Naïve,54,Male,29.410734918,8.887063655,No,8.4,2,Never,Yes,Yes,No,Yes,No,No,No,No,4,No,No,No,No,Yes,Yes,No,3,6,5,10,11.58,25,30,0,17,8,9,22,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-7.2,0,0,1,0,1,1,1,1,Y,0,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,755-012,Biologic Naïve,57,Female,35.670041437,13.87816564,Yes,7,5.944,Missing,No,Yes,No,Yes,No,No,No,No,6,No,No,No,Yes,Yes,Yes,No,3,6,6.957,26.331,0.978,50.793,40.411,23.135,5.991,1.488,4.503,22.838,No,No,Yes,No,1.52,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,755-013,Biologic Naïve,55,Female,24.973985432,11.887748118,No,1.2,24.289,Missing,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,Yes,2,0.6,6.308,77.372,26.318,58.433,70.895,69.091,17.066,10.634,6.432,19.198,No,No,Yes,No,0.365,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,1.2,0,0,0,0,0,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,755-014,Biologic Non-naïve,80,Female,22.77318641,4.7939767283,No,6,14.043,Missing,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,2,3,5.85,6.87,0.707,54.734,50.252,76.488,6.932,4.364,2.568,24.009,No,No,No,No,3.188,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,755,Spain,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,801-001,Biologic Non-naïve,27,Male,21.203105229,9.6919917864,No,23.6,16,Current,Yes,Yes,No,Yes,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,3,43,3,56,26,35,32,40,12,8,4,18,Yes,No,Yes,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,801,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.4,0,1,1,0,1,1,1,1,Y,2,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,802-002,Biologic Non-naïve,62,Male,23.666807131,32.17522245,Yes,10.1,11,Former,No,Yes,Yes,Yes,Yes,Yes,No,Yes,3,No,No,No,No,No,No,Yes,2,10,5,0,48,58.333333333,60,70,8,3,5,25,No,No,Yes,Yes,3,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,802-003,Biologic Non-naïve,43,Male,51.483178305,7.2525667351,No,16.6,3,Never,No,Yes,Yes,No,Yes,Yes,Yes,Yes,3,No,No,No,Yes,Yes,Yes,No,3,30,2,15,5.465,16.666666667,6,50,5,3,2,21,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.4,0,1,1,0,1,1,1,1,Y,-1,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,802-004,Biologic Non-naïve,45,Female,29.744199881,18.874743326,Yes,35.7,17,Never,No,Yes,Yes,Yes,Yes,No,Yes,No,2,No,No,No,Yes,Yes,No,No,5,50,8,65,19,76.666666667,66,60,1,0,1,22,No,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-35.7,1,1,1,1,1,1,1,1,Y,-12,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,802-005,Biologic Non-naïve,28,Female,38.154861686,4.3586584531,Yes,14.6,19,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,15,8,82,11,70,60,100,9,6,3,23,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.6,1,1,1,1,1,1,1,1,Y,-19,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,802-006,Biologic Non-naïve,48,Female,40.565580781,18.54072553,Yes,39.6,11,Never,No,Yes,Yes,No,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,5,70,5,66,32,53.333333333,36,60,14,5,9,25,Yes,Yes,Yes,No,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-29.8,0,0,1,0,0,0,0,0,Y,2,0,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,802-007,Biologic Naïve,49,Male,27.331259293,11.786447639,No,12.3,29,Current,No,Yes,Yes,No,Yes,No,No,Yes,4,No,No,No,No,No,Yes,No,2,15,6,44,16,63.333333333,28,60,19,12,7,14,No,No,Yes,Yes,4,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.7,0,1,1,1,1,1,1,1,Y,-19,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,802-008,Biologic Non-naïve,53,Male,26.431405896,33.826146475,Yes,24,16,Former,No,Yes,No,Yes,Yes,No,No,Yes,5,Yes,No,No,Yes,Yes,Yes,No,4,30,0,0,19,53.333333333,6,100,13,4,9,23,Yes,Yes,Yes,Yes,3,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,802-009,Biologic Naïve,20,Female,27.392257122,1.5386721424,No,22.8,14,Never,No,Yes,Yes,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,4,50,1,9,0,51.666666667,18,40,9,6,3,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.1,0,0,1,0,0,0,1,1,Y,2,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,802-010,Biologic Non-naïve,67,Male,31.053908142,31.206023272,No,17.9,19,Never,Yes,Yes,Yes,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,3,25,5,50,23,65,54,60,18,11,7,18,No,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.9,0,0,1,0,1,1,1,1,Y,-9,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,802-011,Biologic Non-naïve,54,Female,27.34375,33.210130048,Yes,9,20,Never,No,Yes,Yes,Yes,No,No,No,No,5,No,No,No,No,No,Yes,Yes,3,15,8,50,33,76.666666667,58,90,21,15,6,24,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.7,0,1,1,1,1,1,1,1,Y,-13,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,802-012,Biologic Naïve,57,Male,28.408135758,3.3264887064,No,21.4,6,Never,No,Yes,Yes,No,No,No,No,No,1,No,No,No,No,No,No,No,3,65,3,50,0,36.666666667,40,50,6,1,5,16,No,No,No,No,0,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,802,Taiwan,Asia/Pacific,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.7,0,0,0,0,0,0,0,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,804-001,Biologic Naïve,48,Male,27.170631566,20.221765914,No,6.5,27,Current,Yes,Yes,Yes,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,8.2,10,51,1,76.666666667,64,50,11,8,3,25,No,No,No,No,1,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,804,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.3,0,0,0,0,0,1,1,0,Y,-8,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,804-002,Biologic Non-naïve,56,Male,23.7332384,36.462696783,No,21.7,12,Former,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,37,8,0,51,61.666666667,52,40,17,9,8,23,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,804,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.7,0,0,1,0,0,1,1,0,Y,-7,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,804-003,Biologic Naïve,30,Female,23.111111111,13.431895962,No,17.8,13,Never,Yes,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,25,3,25,4,65,26,20,9,6,3,17,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,804,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.2,0,1,1,0,1,1,1,1,Y,-7,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,804-004,Biologic Non-naïve,33,Male,30.842756708,12.969199179,No,12.2,16,Current,Yes,Yes,Yes,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,4,20,7,72,58,50,48,30,7,4,3,18,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,804,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10,0,0,1,0,0,1,1,1,Y,-7,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,804-005,Biologic Non-naïve,40,Male,21.644791987,31.737166324,No,10.3,16,Current,No,Yes,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,4,6.2,3,19,33,38.333333333,16,80,7,5,2,21,Yes,No,Yes,Yes,4,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,804,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.7,0,0,0,0,0,1,1,1,Y,-11,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,804-006,Biologic Non-naïve,44,Male,28.628792385,31.490759754,Yes,13.4,23,Never,Yes,Yes,Yes,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,11,8,68,11,75,82,70,22,13,9,22,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,804,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.1,0,1,1,1,1,1,1,1,Y,-23,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,805-001,Biologic Non-naïve,62,Male,29.053287982,11.463381246,No,11.1,8,Former,No,No,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,3,13,6,0,5,53.333333333,56,20,3,2,1,23,No,No,Yes,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.1,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,805-002,Biologic Non-naïve,31,Male,38.062283737,9.4428473648,No,12.4,5,Former,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,17,1,1,15,21.666666667,2,0,7,2,5,24,Yes,No,No,Yes,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.5,0,0,0,0,0,0,0,0,Y,0,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,805-003,Biologic Non-naïve,40,Male,23.051754908,18.023271732,No,12.9,10,Former,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,12,5,31,40,38.333333333,20,0,16,9,7,20,Yes,No,Yes,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.9,0,0,1,0,0,1,1,0,Y,-7,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,805-004,Biologic Non-naïve,64,Male,22.230987128,22.611909651,No,18.9,17,Former,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,25,9,89,16,76.666666667,82,40,7,3,4,23,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.9,0,0,1,0,0,1,1,0,Y,-14,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,805-005,Biologic Non-naïve,33,Male,29.752066116,17.941136208,No,11.5,5,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,13,4,6,6,28.333333333,12,10,2,1,1,23,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.9,0,0,0,0,0,0,1,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,805-006,Biologic Naïve,38,Male,24.391058839,11.460643395,No,13.2,13,Never,No,Yes,Yes,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,3,22,6,0,23,63.333333333,36,30,10,4,6,25,Yes,No,No,Yes,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,0,1,1,0,1,1,1,1,Y,-12,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,805-007,Biologic Non-naïve,45,Female,25.076193048,13.281314168,Yes,21.7,30,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,39,9,85,70,96.666666667,100,100,20,12,8,22,No,Yes,Yes,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.9,0,0,1,0,0,1,1,0,Y,-7,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,805-008,Biologic Non-naïve,52,Male,26.061679308,10.395619439,No,13.8,27,Former,No,No,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,3,20,2,14,28,26.666666667,14,80,13,6,7,24,No,No,No,Yes,0,Yes,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,19.6,0,0,0,0,0,0,0,0,Y,3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,805-009,Biologic Non-naïve,46,Male,21.967120181,26.978781656,No,36,24,Current,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,83,8,89,19,75,80,80,24,10,14,18,Yes,Yes,Yes,Yes,4,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-31,0,0,1,0,0,0,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,805-010,Biologic Non-naïve,61,Female,25.636917161,43.980835044,Yes,9.1,9,Never,Yes,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,3,9,1,5,11,20,8,10,12,8,4,24,Yes,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.2,0,1,1,1,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,805-011,Biologic Non-naïve,60,Male,25,19.994524298,No,16.7,22,Current,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,18,10,84,40,76.666666667,76,80,19,10,9,15,No,No,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.7,1,1,1,1,1,1,1,1,Y,-18,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,805-012,Biologic Non-naïve,43,Female,21.192742415,26.995208761,Yes,11.2,13,Never,No,No,No,No,No,No,No,No,1,No,No,Yes,No,No,No,No,3,12,7,72,8,83.333333333,64,0,8,5,3,25,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.4,0,0,0,0,0,0,1,0,Y,-6,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,805-013,Biologic Non-naïve,58,Male,28.075042938,27.414099932,No,18,20,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,26,7,52,9,66.666666667,62,50,12,5,7,22,No,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,0,0,1,0,0,0,1,0,Y,-20,1,Y,0,0,0,0,1,0,0,0,0,0,1,1,0,No,Y,No
1,805-015,Biologic Non-naïve,43,Male,28.010223732,24.996577687,No,15.1,10,Former,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,20,3,21,11,51.666666667,40,20,8,4,4,22,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.9,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,805-016,Biologic Non-naïve,49,Male,25.209201358,25.749486653,Yes,14.8,15,Former,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,20,1,0,2,73.333333333,44,60,15,9,6,22,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,1,1,1,1,1,1,1,1,Y,-14,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,805-017,Biologic Non-naïve,37,Male,27.636054422,22.187542779,Yes,13.2,28,Current,No,No,No,Yes,No,No,No,No,1,No,No,Yes,No,No,No,No,3,21,8,100,39,98.333333333,100,80,20,12,8,19,Yes,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.7,0,0,0,0,0,0,1,0,Y,-9,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,805-018,Biologic Non-naïve,49,Female,31.184587125,9.0239561944,No,33,25,Current,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,90,10,100,8,100,100,100,13,8,5,22,No,Yes,Yes,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-33,1,1,1,1,1,1,1,1,Y,-22,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,805-019,Biologic Non-naïve,28,Female,30.859375,9.0239561944,Yes,28.7,29,Never,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,Yes,3,49,10,98,12,96.666666667,100,90,23,16,7,23,Yes,Yes,Yes,Yes,1,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,9,0,0,0,0,0,0,0,0,Y,1,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,805-020,Biologic Naïve,32,Male,31.919307989,14.042436687,No,12.5,7,Never,Yes,Yes,No,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,12,6,16,28,30,12,0,11,5,6,20,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.1,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,805-021,Biologic Naïve,39,Male,28.577960677,25.040383299,No,11.4,13,Never,No,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,Yes,3,10,3,16,18,53.333333333,42,40,12,4,8,23,No,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,1,1,1,1,1,1,1,1,Y,-4,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,805-022,Biologic Non-naïve,45,Male,37.037037037,26.042436687,Yes,12.6,28,Current,No,No,No,Yes,No,No,No,No,4,No,No,No,No,No,Yes,No,3,15,10,58,11,93.333333333,98,100,18,11,7,25,No,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.2,0,0,0,0,0,0,1,0,Y,-23,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,805-023,Biologic Non-naïve,54,Male,31.511501698,19.011635866,Yes,18.8,21,Current,No,No,No,Yes,No,No,No,No,5,No,No,No,Yes,Yes,Yes,No,4,17,8,55,40,75,84,50,12,7,5,18,No,No,No,Yes,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.3,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,805-024,Biologic Naïve,47,Female,23.140495868,14.984257358,Yes,10.8,17,Former,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,12,6,56,0,50,44,80,14,5,9,10,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,1,1,1,1,1,1,1,1,Y,-11,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,805-025,Biologic Non-naïve,48,Female,17.928215425,22.020533881,Yes,15,27,Never,Yes,No,No,Yes,No,No,No,No,2,No,No,Yes,No,No,No,Yes,4,11,1,93,1,88.333333333,84,70,23,13,10,13,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.5,0,0,0,0,0,0,0,0,Y,-9,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,805-026,Biologic Non-naïve,62,Male,24.092970522,25.004791239,No,10.8,21,Current,No,Yes,No,Yes,No,No,No,No,3,No,No,No,No,No,Yes,No,3,20,4,78,24,53.333333333,58,80,32,16,16,25,Yes,No,Yes,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,805,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.8,1,1,1,1,1,1,1,1,Y,-11,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,807-001,Biologic Non-naïve,49,Male,18.870663376,3.8576317591,Yes,14,13,Current,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,14,6,21,50,33.333333333,34,40,14,5,9,21,No,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.1,0,1,1,1,1,1,1,1,Y,-9,0,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,807-002,Biologic Non-naïve,73,Female,37.717643963,23.12936345,Yes,26.7,16,Never,No,No,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,No,Yes,5,58,10,70,37,73.333333333,78,80,20,10,10,24,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.9,0,0,1,0,0,0,1,0,Y,-13,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,807-003,Biologic Non-naïve,59,Male,24.609375,8.9856262834,No,14.4,2,Current,No,No,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,4,24,5,0,62,38.333333333,18,60,14,9,5,23,No,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.5,0,1,1,1,1,1,1,1,Y,1,0,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,807-004,Biologic Naïve,54,Male,28.90625,9.0266940452,No,17.2,13,Current,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,Yes,3,39,5,50,9,53.333333333,46,50,12,7,5,21,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.2,0,0,1,0,0,1,1,1,Y,-12,1,Y,1,1,0,0,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,807-005,Biologic Non-naïve,60,Male,23.225431848,3.6851471595,No,18.6,8,Former,No,No,No,No,No,No,No,No,1,No,No,No,No,No,No,No,4,23,9,85,11,71.666666667,68,0,9,6,3,24,Yes,No,Yes,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.1,0,0,1,0,0,1,1,0,Y,8,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,807-007,Biologic Non-naïve,44,Female,26.577781676,6.6666666667,Yes,24.9,15.728,Missing,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,54,4.224,59.754,3.161,52.122,62.008,76.666,10.356,3.959,6.398,22.049,No,No,Yes,Yes,0.917,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,807-008,Biologic Naïve,30,Female,36.934441367,11.052703628,No,11.7,5,Former,Yes,Yes,Yes,Yes,Yes,Yes,No,Yes,2,Yes,No,No,No,No,No,No,3,38,6,0,8,63.333333333,40,70,18,13,5,23,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.7,0,0,1,0,1,1,1,1,Y,-4,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,807-009,Biologic Naïve,41,Male,29.320987654,5.7741273101,No,19.2,18,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,32,5,0,27,60,54,50,18,7,11,21,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.8,0,0,1,0,0,0,1,0,Y,-8,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,807-010,Biologic Non-naïve,70,Male,24.759564306,8.3093771389,Yes,8.3,10,Former,Yes,No,Yes,Yes,Yes,Yes,No,No,5,Yes,No,No,No,No,Yes,No,2,14,9,60,42,73.333333333,60,60,17,6,11,22,No,No,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.9,0,0,1,0,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,807-011,Biologic Naïve,57,Male,24.744350461,5.4948665298,No,38.4,19,Current,Yes,Yes,Yes,Yes,Yes,Yes,No,No,1,No,No,No,No,No,No,Yes,4,77,10,92,86,81.666666667,78,90,16,6,10,19,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-34.2,0,0,1,0,0,0,1,0,Y,-17,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,807-012,Biologic Naïve,35,Male,38.974765491,4.2902121834,Yes,36.7,5,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,15,0,0,0,56.666666667,36,0,11,2,9,23,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,807,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-30.9,0,0,1,0,0,0,0,0,Y,-5,1,Y,0,0,0,0,1,0,0,0,0,0,0,1,0,No,Y,No
1,808-001,Biologic Naïve,24,Male,36.510560147,6.6228610541,Yes,27,12,Never,No,Yes,Yes,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,50,8,75,10,68.333333333,74,20,21,13,8,18,Yes,No,Yes,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,808,Taiwan,Asia/Pacific,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12,0,0,0,0,0,0,0,0,Y,0,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,809-001,Biologic Non-naïve,35,Female,39.896119538,24.246406571,Yes,72,20,Never,No,Yes,No,Yes,No,No,No,No,3,No,No,No,No,Yes,Yes,No,4,90,10,76,100,85,82,50,5,2,3,23,Yes,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,809,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-57.4,0,0,1,0,0,0,0,0,Y,-10,0,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,810-001,Biologic Non-naïve,34,Female,31.24499279,1.3716632444,Yes,19.2,22,Former,Yes,No,No,No,Yes,No,No,Yes,4,No,No,No,Yes,Yes,No,Yes,3,46,5,14,0,48.333333333,36,80,15,9,6,24,Yes,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,810,Taiwan,Asia/Pacific,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-3.8,0,0,0,0,0,0,0,0,N,0,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,810-002,Biologic Non-naïve,32,Male,36.763418648,5.826146475,No,14.8,25,Never,Yes,No,Yes,Yes,Yes,No,No,Yes,5,Yes,No,No,Yes,Yes,Yes,No,4,30,8,71,13,83.333333333,78,80,11,6,5,23,Yes,Yes,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,810,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.4,0,0,0,0,0,0,0,0,Y,-10,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,810-003,Biologic Naïve,49,Female,34.256055363,20.131416838,No,9.8,9,Never,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,No,3,14,8,80,45,85,84,80,15,4,11,23,No,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,810,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.2,0,0,0,0,0,0,0,0,Y,-3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,810-004,Biologic Naïve,44,Male,28.06642387,5.1745379877,No,8.4,21,Former,Yes,No,Yes,Yes,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,4,9,3,0,64,65,26,90,4,2,2,25,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,810,Taiwan,Asia/Pacific,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3.3,0,0,0,0,0,0,0,0,Y,-13,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,810-005,Biologic Non-naïve,24,Female,29.744199881,17.267624914,No,44,22,Never,No,Yes,Yes,Yes,Yes,Yes,No,Yes,2,No,No,No,Yes,Yes,No,No,5,90,6,60,25,78.333333333,70,80,10,6,4,24,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,810,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.9,0,0,0,0,0,0,0,0,Y,-15,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,810-006,Biologic Naïve,30,Female,37.109375,0.7857631759,No,30.2,20,Never,No,Yes,Yes,No,Yes,Yes,No,Yes,2,No,No,No,Yes,Yes,No,No,4,38,7,64,10,71.666666667,62,80,9,4,5,17,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,810,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-30,0,1,1,1,1,1,1,1,Y,-18,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,810-007,Biologic Non-naïve,45,Female,27.239224483,21.979466119,No,17.6,23,Current,Yes,Yes,Yes,Yes,Yes,Yes,No,Yes,2,No,No,No,Yes,Yes,No,No,3,37,8,23,10,66.666666667,46,90,16,10,6,22,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,810,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-17.3,0,1,1,1,1,1,1,1,Y,-1,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,811-001,Biologic Non-naïve,66,Female,22.939750693,8.090349076,No,12.6,7,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,30,4,43,0,35,24,0,8,4,4,22,No,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,811,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.7,0,0,0,0,0,0,1,0,Y,-1,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,811-002,Biologic Naïve,49,Male,37.874005807,1.1937029432,No,11.7,7,Never,No,No,No,Yes,No,No,No,No,8,Yes,No,No,Yes,Yes,Yes,No,4,50,0,5,23,36.666666667,12,0,9,6,3,20,No,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,811,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.7,0,0,0,0,0,0,0,0,Y,3,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,811-003,Biologic Naïve,42,Male,24.212293388,7.523613963,No,15,13,Current,No,No,No,No,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,50,5,12,35,75,44,50,20,8,12,17,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,811,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,1,1,1,1,1,1,1,1,Y,-7,0,Y,1,1,0,0,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,811-004,Biologic Naïve,23,Male,46.62221834,6.7898699521,No,10.2,18,Never,No,No,No,Yes,No,No,No,No,1.5063613232,No,No,No,No,Yes,No,No,4,60,8,63,7,51.666666667,42,60,15,8,7,20,Yes,No,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,811,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.6,0,0,0,0,0,1,1,0,Y,-17,1,Y,0,0,0,0,0,0,0,0,0,1,1,1,0,No,Y,No
1,811-005,Biologic Naïve,26,Male,24.618103775,17.752224504,No,9,15,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,50,4,59,28,80,64,50,13,8,5,21,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,811,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.8,0,0,1,0,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,811-006,Biologic Naïve,32,Male,33.412409369,9.3360711841,No,11.8,9,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,70,3,9,25,26.666666667,22,10,8,3,5,13,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,811,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-3,0,0,0,0,0,0,0,0,Y,-6,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,811-007,Biologic Naïve,47,Male,26.929037642,3.1156741958,No,19.9,23,Former,No,No,No,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,Yes,No,4,35,8,90,0,86.666666667,82,70,26,14,12,25,Yes,No,Yes,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,811,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.9,0,1,1,1,1,1,1,1,Y,-12,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,811-008,Biologic Naïve,68,Male,25.155895692,10.058863792,No,24,4,Never,No,No,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,4,80,6,29,2,60,42,40,4,0,4,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,811,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.2,0,1,1,0,1,1,1,1,Y,-4,1,Y,0,1,0,0,1,1,0,0,1,1,1,1,0,Yes,Y,Yes
1,811-009,Biologic Naïve,43,Male,31.7417889,15.247091034,No,11.3,10,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,18,2,13,29,15,16,30,9,4,5,23,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,811,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.7,0,0,1,0,1,1,1,0,Y,1,0,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,812-001,Biologic Non-naïve,28,Male,29.337411442,7.7891854894,No,11.3,25,Never,No,Yes,No,No,Yes,No,No,Yes,1,No,No,No,No,No,No,No,4,19,10,89,0,83.333333333,82,100,24,13,11,16,Yes,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,812-002,Biologic Non-naïve,51,Female,26.330876858,5.2840520192,No,11.9,10,Never,No,Yes,Yes,No,Yes,Yes,No,Yes,1,No,No,No,No,Yes,No,No,4,24,5,0,27,50,46,0,12,2,10,25,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.7,0,0,1,0,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,812-003,Biologic Naïve,41,Male,28.429752066,2.6392881588,No,13.2,9,Former,No,Yes,No,No,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,16,7,16,31,41.666666667,34,10,16,6,10,23,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.9,0,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,812-004,Biologic Non-naïve,28,Female,26.839346811,11.641341547,Yes,10.9,11,Never,No,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,14,5,0,12,28.333333333,24,20,5,5,0,19,Yes,Yes,No,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.6,0,0,0,0,0,0,0,0,Y,-6,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,812-005,Biologic Naïve,37,Male,32.368873035,27.830253251,No,15.4,6,Current,No,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,17,6,26,28,45,46,50,16,7,9,20,Yes,Yes,Yes,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.3,0,0,1,0,0,0,1,0,Y,-5,1,Y,0,0,0,0,1,0,0,0,0,0,1,1,0,No,Y,No
1,812-006,Biologic Non-naïve,57,Male,23.507805326,8.9609856263,Yes,14.6,17,Former,No,Yes,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,5,31,6,25,22,60,54,50,11,9,2,20,Yes,Yes,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.2,0,0,1,0,0,1,1,1,Y,-17,1,Y,1,1,0,0,1,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,812-007,Biologic Non-naïve,43,Female,30.621391947,21.067761807,Yes,19,20,Never,No,Yes,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,4,33,9,80,33,81.666666667,90,80,21,11,10,22,Yes,Yes,Yes,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.8,0,0,0,0,0,0,0,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,812-008,Biologic Non-naïve,45,Male,29.726516052,9.2375085558,Yes,25.3,13,Former,No,Yes,No,No,Yes,Yes,No,Yes,2,No,No,No,No,No,No,Yes,5,54,3,20,28,35,24,20,3,0,3,20,Yes,Yes,Yes,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-21.9,0,0,1,0,0,0,1,1,Y,-1,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,812-009,Biologic Non-naïve,42,Female,34.575813797,22.592744695,No,14.9,13,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,21,7,58,2,81.666666667,64,50,12,8,4,17,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,0,0,1,0,0,0,1,1,Y,-6,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,812-010,Biologic Non-naïve,32,Male,24.337479719,8.5201916496,No,11,8,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,17,4,0,47,68.333333333,20,10,13,7,6,19,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.4,0,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,812-011,Biologic Non-naïve,52,Male,35.417153931,8.0136892539,No,18.4,21,Current,No,Yes,No,Yes,No,No,No,No,3,Yes,No,No,No,No,Yes,No,4,18,8,70,14,83.333333333,82,40,12,7,5,23,Yes,Yes,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.3,0,0,1,0,0,1,1,1,Y,-12,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,812-012,Biologic Non-naïve,32,Male,19.031141869,10.015058179,Yes,24.4,30,Former,Yes,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,5,44,10,100,7,96.666666667,90,80,36,18,18,20,Yes,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.2,0,1,1,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,812-013,Biologic Non-naïve,40,Male,26.19618735,18.765229295,No,11.3,20,Never,Yes,Yes,No,No,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,17,6,30,5,70,72,80,7,7,0,21,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11,0,1,1,1,1,1,1,1,Y,-3,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,812-014,Biologic Non-naïve,49,Male,29.402920245,28.292950034,No,13,14,Current,No,Yes,No,Yes,Yes,No,No,Yes,5,Yes,No,No,No,No,Yes,No,4,31,3,13,43,58.333333333,28,40,16,5,11,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.9,0,0,1,0,0,0,1,1,Y,-11,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,812-015,Biologic Non-naïve,36,Male,27.732299776,18.466803559,Yes,18.3,10,Never,No,Yes,No,Yes,Yes,Yes,No,Yes,2,No,No,No,Yes,Yes,No,No,4,42,3,15,49,30,40,60,14,6,8,23,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.3,0,0,0,0,0,0,0,0,Y,-5,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,812-016,Biologic Non-naïve,56,Male,26.19618735,12.906228611,No,12,16,Current,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,16,8,88,8,75,76,60,14,7,7,23,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,0,1,1,1,1,1,1,1,Y,-14,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,812-017,Biologic Non-naïve,43,Female,31.221303949,17.993155373,Yes,17.4,27,Current,No,Yes,Yes,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,4,25,8,91,42,95,92,80,13,5,8,23,No,No,Yes,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.5,0,0,1,0,0,0,1,1,Y,-17,0,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,812-018,Biologic Naïve,58,Male,25.762980579,31.000684463,Yes,16.3,15,Current,Yes,Yes,Yes,Yes,Yes,Yes,No,No,2,No,No,No,No,No,No,No,3,61,3,0,49,25,32,20,12,6,6,20,No,No,No,Yes,3,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.1,0,1,1,1,1,1,1,1,Y,-14,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,812-019,Biologic Non-naïve,55,Female,19.453125,20.049281314,Yes,13.3,28,Never,Yes,Yes,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,3,23,10,90,15,100,100,90,23,14,9,21,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.5,0,0,1,0,1,1,1,1,Y,-11,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,812-020,Biologic Non-naïve,50,Male,40.562466198,12.076659822,Yes,13.7,9,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,13,2,19,52,48.333333333,4,0,15,2,13,25,Yes,No,No,Yes,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.4,0,0,0,0,0,0,0,0,Y,-5,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,812-021,Biologic Non-naïve,35,Female,27.700831025,0,Yes,22.1,29,Never,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,30,10,75,13,80,72,100,19,12,7,15,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.1,1,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,812-022,Biologic Non-naïve,42,Female,24.888888889,20.402464066,Yes,14.4,19,Never,No,Yes,No,Yes,Yes,No,No,Yes,2,Yes,No,No,No,No,No,No,4,17,7,57,6,66.666666667,60,20,19,10,9,24,Yes,No,Yes,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.7,0,0,0,0,0,0,0,0,Y,-10,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,812-023,Biologic Non-naïve,43,Female,28.125,11.575633128,Yes,11,27,Never,No,No,No,Yes,Yes,Yes,No,Yes,3,Yes,No,No,No,No,Yes,No,4,12,10,94,22,91.666666667,90,70,28,18,10,24,Yes,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8,0,0,0,0,0,1,1,0,Y,-9,0,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,812-024,Biologic Non-naïve,45,Male,29.28390291,10.494182067,Yes,31.7,12,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,No,5,60,5,30,17,48.333333333,46,50,8,5,3,25,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-31.5,0,1,1,1,1,1,1,1,Y,-12,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,812-025,Biologic Non-naïve,33,Male,34.626038781,14.562628337,No,12.8,24,Current,No,Yes,No,No,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,14,8,0,47,78.333333333,28,90,9,6,3,17,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.1,0,1,1,1,1,1,1,1,Y,-14,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,812-026,Biologic Non-naïve,41,Male,34.602076125,9.5715263518,No,14.6,8,Never,Yes,Yes,No,No,Yes,Yes,No,No,0,No,No,No,No,No,No,No,4,15,3,62,11,70,34,0,0,0,0,25,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13,0,0,1,0,1,1,1,1,Y,-8,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,812-027,Biologic Non-naïve,30,Male,33.659297052,13.659137577,No,19.5,25,Never,No,Yes,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,4,27,8,78,28,83.333333333,90,80,16,10,6,23,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.5,1,1,1,1,1,1,1,1,Y,-6,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,812-028,Biologic Non-naïve,59,Male,21.258503401,24.676249144,Yes,17.5,14,Never,Yes,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,27,6,80,31,70,70,50,11,6,5,12,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.6,0,1,1,1,1,1,1,1,Y,-12,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,812-029,Biologic Non-naïve,35,Female,25.711662075,17.697467488,Yes,14.8,30,Former,No,Yes,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,4,23,10,98,11,100,100,100,16,11,5,24,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.6,0,1,1,0,1,1,1,1,Y,-25,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,812-030,Biologic Non-naïve,61,Male,26.218820862,10.762491444,No,12.1,29,Current,Yes,Yes,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,3,17,5,69,36,73.333333333,84,80,13,6,7,25,Yes,No,Yes,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,0,0,1,0,1,1,1,1,Y,-28,1,Y,1,1,0,0,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,812-031,Biologic Naïve,24,Female,32.454716898,5.7686516085,No,18.6,8,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,17,7,62,5,63.333333333,46,50,10,5,5,23,No,No,No,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.2,0,0,0,0,0,0,0,0,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,812-032,Biologic Non-naïve,26,Male,30.477966223,8.1642710472,No,14.5,4,Current,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,17,4,0,7,68.333333333,22,0,12,3,9,17,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.7,0,1,1,1,1,1,1,1,Y,0,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,812-033,Biologic Non-naïve,40,Male,38.766984079,13.869952088,No,10.3,3,Never,No,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,13,2,4,11,56.666666667,4,0,4,3,1,23,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.3,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,812-034,Biologic Non-naïve,27,Male,26.218820862,8.887063655,Yes,10.2,11,Never,Yes,Yes,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,3,17,7,56,44,60,44,50,8,6,2,20,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.1,0,0,1,0,0,1,1,0,Y,-6,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,812-035,Biologic Naïve,34,Male,45.725068951,1.492128679,No,11.3,18,Current,No,Yes,Yes,Yes,Yes,Yes,No,Yes,4,Yes,No,No,Yes,Yes,No,No,4,31,4,40,13,43.333333333,6,80,10,5,5,19,Yes,No,No,Yes,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.7,0,0,1,0,1,1,1,1,Y,-10,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,812-036,Biologic Non-naïve,21,Female,32.60588843,6.0095824778,Yes,16.6,21,Former,No,Yes,No,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,4,20,8,61,13,91.666666667,80,70,24,15,9,19,Yes,No,No,Yes,1,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Brodalumab,IL17 RA,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.4,0,0,0,0,0,0,0,0,Y,2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,812-038,Biologic Non-naïve,72,Female,25.333333333,7.0280629706,No,26.5,26,Never,Yes,Yes,No,No,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,5,46,9,100,20,83.333333333,94,100,32,21,11,23,No,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-24.5,0,1,1,0,1,1,1,1,Y,-15,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,812-039,Biologic Naïve,28,Male,21.707923392,13.037645448,Yes,40.9,14,Current,Yes,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,5,75,7,75,46,68.333333333,80,70,0,0,0,22,Yes,Yes,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-35.9,0,0,1,0,0,0,1,0,Y,-7,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,812-040,Biologic Non-naïve,41,Male,29.761904762,22.036960986,Yes,10.5,16,Never,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,14,8,68,7,75,74,30,13,11,2,21,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,812,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.5,0,0,1,0,1,1,1,1,Y,-14,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,813-001,Biologic Naïve,46,Male,29.434840246,5.4976043806,Yes,28.6,12,Never,No,Yes,No,No,No,No,No,No,4,Yes,No,No,No,No,No,Yes,4,80,4,60,31,46.666666667,50,30,18,9,9,25,Yes,No,Yes,No,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,813,Taiwan,Asia/Pacific,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28,0,1,1,1,1,1,1,1,Y,-12,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,813-002,Biologic Non-naïve,43,Male,31.214569161,13.535934292,No,26.2,18,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,No,No,No,No,4,60,7,15,2,93.333333333,70,70,13,5,8,22,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,813,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.8,0,1,1,0,0,1,1,1,Y,-14,0,Y,1,1,0,0,1,1,0,0,0,1,1,0,1,Yes,Y,Yes
1,813-003,Biologic Non-naïve,30,Male,24.833221616,11.635865845,No,14,11,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,30,6,55,5,73.333333333,52,60,19,12,7,21,No,No,No,Yes,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,813,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,0,0,0,0,0,0,1,0,Y,1,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,813-004,Biologic Non-naïve,56,Male,22.704536436,31.107460643,No,11.7,4,Former,No,No,No,Yes,No,No,No,No,3,No,No,No,No,No,Yes,No,3,40,3,6,4,33.333333333,14,0,6,0,6,25,No,No,No,No,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,813,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.3,0,0,0,0,0,0,1,0,Y,-3,1,Y,0,0,0,0,0,0,0,0,0,0,1,1,0,No,Y,No
1,813-005,Biologic Non-naïve,56,Male,23.809516044,8.2162902122,No,41.8,23,Former,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,75,6,6,16,76.666666667,52,80,14,2,12,21,Yes,No,Yes,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,813,Taiwan,Asia/Pacific,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-38.4,0,1,1,0,0,0,1,1,Y,-22,0,Y,0,1,0,0,1,1,0,0,0,0,1,0,0,Yes,Y,Yes
1,814-001,Biologic Naïve,34,Male,35.151515152,2.3518138261,No,28.4,12.441,Never,No,No,Yes,Yes,No,No,No,No,5,No,No,No,Yes,Yes,Yes,No,4,60,7.322,54.018,0,76.848,71.528,75.538,7.432,4.632,2.8,22.054,Yes,Yes,No,Yes,1.589,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,814,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,814-002,Biologic Non-naïve,32,Female,32.893331625,24.446269678,Yes,5.7,5,Never,No,Yes,Yes,Yes,Yes,Yes,No,No,5,No,No,No,Yes,Yes,No,No,3,10,3,0,22,15,14,0,13,4,9,24,Yes,No,Yes,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,814,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-1.9,0,0,0,0,0,0,1,0,Y,1,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,814-003,Biologic Non-naïve,39,Male,32.593495643,19.504449008,No,14.5,28,Never,Yes,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,17,8,82,22,66.666666667,66,80,11,6,5,22,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,814,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.5,0,0,0,0,0,0,0,0,Y,-17,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,814-004,Biologic Non-naïve,38,Male,26.709246625,17.557837098,No,12.8,19,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,13,6,61,14,63.333333333,64,60,20,9,11,23,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,814,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.8,0,0,0,0,0,0,1,0,Y,-10,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,814-005,Biologic Non-naïve,42,Male,26.500811249,25.645448323,Yes,14.4,27,Current,No,Yes,Yes,Yes,No,No,No,No,4,No,No,No,No,Yes,Yes,No,4,14,8,80,12,88.333333333,74,80,20,10,10,25,Yes,No,No,Yes,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,814,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.4,0,0,1,0,1,1,1,1,Y,-25,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,814-006,Biologic Non-naïve,35,Male,34.827008078,11.665982204,No,25.6,15,Never,No,Yes,Yes,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,45,3,80,4,73.333333333,68,10,2,1,1,24,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,814,Taiwan,Asia/Pacific,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.8,0,0,1,0,0,1,1,0,Y,-12,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,826-001,Biologic Non-naïve,43,Male,26.15916955,15.085557837,No,22.8,9,Never,No,No,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,4,35,1,15,11.272,16.666666667,10,0,16,9,7,17,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,826,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18.6,0,0,1,0,0,0,1,,Y,-1,0,Y,,0,,0,1,0,0,0,0,0,1,0,0,,Y,No
1,826-002,Biologic Naïve,35,Female,27.531229454,4.3258042437,No,22.1,13.745,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,23,5.878,37.185,14.315,82.85,72.167,26.05,12.933,4.872,8.061,17.13,No,No,No,Yes,0.43,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,826,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,826-003,Biologic Non-naïve,33,Male,29.012345679,23.085557837,No,18,13.53,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,28,5.342,38.118,1.353,66.865,52.908,62.006,17.023,8.466,8.557,22.481,Yes,No,No,Yes,0.572,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,826,United Arab Emirates,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,833-001,Biologic Non-naïve,24,Female,24.382372979,13.393566051,No,16.8,9,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,32,5,67,6.221,55,38,70,5,3,2,20,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,833,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-16.8,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,833-002,Biologic Non-naïve,59,Male,37.242772377,10.264202601,No,1.2,12.727,Missing,No,No,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,3,10,7.628,66.235,18.057,77.045,65.7,31.62,17.216,6.856,10.36,21.093,No,No,Yes,Yes,0.125,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,833,United Arab Emirates,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,0.9,0,0,0,0,0,1,1,1,Y,,,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,833-003,Biologic Naïve,23,Male,22.491349481,7.0800821355,No,9,21,Current,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,8,3,66,34.827,36.666666667,38,60,14,6,8,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,833,United Arab Emirates,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.4,0,1,1,1,1,1,1,1,Y,,,Y,,1,,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,834-001,Biologic Naïve,22,Female,17.606659729,17.927446954,Yes,12.3,17,Never,No,No,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,Yes,3,20,8,70,11.012,83.333333333,84,90,23,11,12,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.4,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,834-002,Biologic Naïve,23,Male,24.816326531,6.0205338809,No,15,10,Current,Yes,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,30,9,92,38.031,90,90,90,2,1,1,21,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-2.4,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,834-003,Biologic Naïve,29,Female,30.46875,8.0355920602,No,11.6,1,Never,No,No,No,No,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,30,3,23,40.976,41.666666667,40,20,0,0,0,21,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,N,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,834-004,Biologic Naïve,30,Male,27.3046875,7.0663928816,No,13.6,0,Never,No,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,35,0,2,24,6.6666666667,2,0,1,0,1,25,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,834-005,Biologic Non-naïve,55,Male,32.933210219,3.2991101985,No,15.2,25,Former,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,32,8,90,28,95,98,100,4,0,4,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-5.6,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,834-006,Biologic Naïve,29,Female,62.871513489,7.0253251198,No,7,20,Never,Yes,No,No,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,3,19,8,87,27.42,85,82,90,15,9,6,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,N,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,834-007,Biologic Naïve,36,Female,38.293444329,19.96440794,Yes,17.4,8,Never,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,23,7,68,31.751,70,70,20,3,1,2,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-11.5,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,834-008,Biologic Naïve,59,Female,40.582681874,9.6919917864,Yes,23.4,18,Never,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,30,7,81,21.518,71.666666667,72,70,18,9,9,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,N,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,834-009,Biologic Naïve,32,Male,26.753864447,1.8973305955,No,22.8,23,Former,No,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,20,7,20,44.152,71.666666667,48,90,24,11,13,20,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,834-010,Biologic Naïve,43,Female,28.628792385,4.5037645448,No,10.2,7,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,3,76,0,56.666666667,62,60,9,2,7,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,834-011,Biologic Non-naïve,41,Female,31.084762057,20.654346338,No,12,30,Never,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,20,10,69,15,95,96,100,19,10,9,25,No,No,No,Yes,4,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.7,0,0,0,0,0,0,0,1,Y,,,Y,1,1,1,1,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,834-012,Biologic Naïve,45,Female,38.156221218,5.5277207392,Yes,13.8,10,Never,Yes,No,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,Yes,3,20,7,71,10,81.666666667,74,40,5,2,3,21,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-5.5,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,834-013,Biologic Naïve,19,Female,27.147932108,2.1957563313,Yes,12,16,Never,Yes,No,No,No,No,No,No,No,1,No,No,No,No,No,No,Yes,3,30,5,70,0,50,50,50,16,8,8,24,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-3.6,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,834-014,Biologic Non-naïve,32,Male,28.344671202,19.145790554,No,12,1,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,30,2,31,0,36.666666667,14,10,3,0,3,24,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,834,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,0,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,835-001,Biologic Naïve,36,Male,28.06642387,4.977412731,No,20.7,2,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,40,6,16,2.469,53.333333333,40,10,0,0,0,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,835,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,0,0,0,0,0,0,0,,Y,0,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,835-002,Biologic Naïve,62,Female,33.760387812,21.248459959,No,5.8,27,Never,No,No,No,Yes,No,No,No,No,2,Yes,No,No,No,No,Yes,No,3.2017453799,5,8,85,8.85,100,94,90,4,3,1,21,No,No,No,No,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,835,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.8,1,1,1,1,1,1,1,1,Y,-27,1,Y,,1,,0,1,1,1,1,1,1,1,1,0,Yes,Y,Yes
1,835-003,Biologic Non-naïve,48,Female,33.620748627,17.284052019,Yes,19.7,18,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,25,9,83,40.677,100,100,90,16,8,8,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,835,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.7,1,1,1,1,1,1,1,1,Y,-17,1,Y,,1,,0,1,1,1,1,1,1,1,1,0,Yes,Y,Yes
1,835-004,Biologic Naïve,36,Male,33.126014062,2.2861054073,No,14.521901872,14,Never,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3.2017453799,21.321860465,8,89,4.681,83.333333333,78,90,14,5,9,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,835,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,,,,,1,1,1,1,,Y,,,Y,,0,,0,0,0,0,1,1,1,1,0,0,,Y,No
1,835-005,Biologic Naïve,23,Female,19.705532421,6.5133470226,No,5.4,17.894,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,6,5.677,75.635,20.036,84.611,65.229,31.644,10.15,4.356,5.794,19.4,No,No,No,No,2.152,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,835,United Arab Emirates,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.4,1,1,1,1,1,1,1,1,Y,,,Y,,1,,0,1,1,1,1,1,1,1,0,0,Yes,Y,Yes
1,836-001,Biologic Non-naïve,36,Female,30.486657383,24.309377139,No,7.6,3,Never,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,7,5,20,5,20,20,20,1,1,0,19,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.3,0,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,836-002,Biologic Naïve,23,Female,37.421395779,12.227241615,No,8.1,11,Never,No,No,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,10,9,80,10,80,78,10,12,11,1,16,No,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-7.8,0,1,1,1,1,1,1,1,Y,-9,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,836-003,Biologic Non-naïve,40,Female,30.021501886,20.328542094,No,24.6,22.196,Missing,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,30,7.495,45.546,8,51.864,32.232,52.636,17.03,10.961,6.069,21.728,Yes,No,No,Yes,2.541,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,836-004,Biologic Non-naïve,40,Female,23.918830292,17.409993155,Yes,33.3,11.412,Missing,Yes,No,No,Yes,No,No,No,No,4,Yes,No,Yes,No,No,Yes,No,4,90,3.98,46.937,37,58.757,38.336,20.46,19.079,12.207,6.872,23.06,Yes,Yes,No,Yes,0.709,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.6,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,836-007,Biologic Non-naïve,58,Male,38.062283737,30.584531143,No,19.5,8.461,Missing,Yes,No,No,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,Yes,No,4,45,8.717,14.004,20,57.38,64.716,64.058,19.871,10.963,8.909,21.775,Yes,No,No,Yes,1.467,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.5,0,0,1,0,0,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,836-008,Biologic Naïve,58,Male,28.934068902,20.421629021,No,19.2,14,Former,Yes,No,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,40,5,0,19,55,14,10,25,15,10,25,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.2,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,836-009,Biologic Naïve,48,Female,31.957633309,10.625598905,No,6,7.136,Missing,No,No,No,Yes,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,2,5,6.833,18.262,2,49.969,48.055,40.194,5.591,3.669,1.922,24.699,Yes,No,No,Yes,0.44,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.7,0,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,836-010,Biologic Non-naïve,62,Male,30.614821361,10.814510609,No,11.4,1,Former,Yes,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,Yes,No,3,10,7,16,2,15,16,10,4,4,0,25,No,No,No,No,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.5,0,0,0,0,0,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,836-011,Biologic Non-naïve,34,Female,28.196921201,20.911704312,No,7.9,4,Never,Yes,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,8,3,12,4,36.666666667,18,0,8,6,2,19,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.1,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,836-013,Biologic Non-naïve,21,Female,17.928215425,5.7604380561,No,5.9,13,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,10,10,16,4,45,38,70,19,10,9,17,Yes,No,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.9,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,836-014,Biologic Naïve,28,Female,27.181630086,8.8514715948,No,10.2,19,Never,No,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,3,15,9,0,0,98.333333333,94,70,9,5,4,16,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.2,0,0,0,0,0,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,836-015,Biologic Non-naïve,68,Female,47.800067748,5.7796030116,No,18,7,Never,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,50,10,13,7,58.333333333,28,50,15,5,10,24,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.4,0,0,1,0,0,0,1,0,Y,-6,1,Y,0,0,0,0,1,0,0,0,0,0,1,1,0,No,Y,No
1,836-016,Biologic Naïve,45,Male,32.718619869,10.7816564,No,7.2,20,Current,No,No,No,Yes,No,No,No,No,1,Yes,No,No,No,No,No,No,3,12,3,24,1,61.666666667,52,60,15,7,8,20,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,0,1,1,1,1,1,1,1,Y,-20,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,836-017,Biologic Non-naïve,21,Female,27.34375,6.0287474333,No,10.6,23.176,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,15,5.534,39.047,0,96.208,58.244,65.539,19.681,10.716,8.965,17.139,No,Yes,No,Yes,0.37,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.3,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,836-018,Biologic Naïve,45,Female,60.606060606,10.390143737,No,9.8,24,Never,No,No,No,Yes,No,No,No,No,3,Yes,No,No,Yes,Yes,No,No,3,10,6,68,1,46.666666667,46,20,25,14,11,15,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,836-019,Biologic Non-naïve,33,Male,54.143210585,30.234086242,No,14.4,20,Current,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,18,10,57,18,41.666666667,36,50,21,10,11,15,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,836-020,Biologic Naïve,34,Female,28.303850156,19.983572895,No,11.8,29,Never,No,No,No,No,No,No,No,No,2,Yes,No,No,No,Yes,No,No,3,13,9,80,2,91.666666667,78,80,28,15,13,16,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.8,0,0,0,0,0,0,0,0,Y,-6,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,836-021,Biologic Non-naïve,39,Female,29.475842625,31.071868583,Yes,7.6,9.174,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,2,9,2.61,14.002,0,20.357,29.769,5.85,22.231,14.268,7.963,23.129,No,No,Yes,No,0.933,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.8,0,0,1,0,1,1,1,0,Y,,,Y,0,0,0,0,1,0,0,0,1,1,1,0,0,No,Y,No
1,836-023,Biologic Non-naïve,33,Male,27.774423379,8.8733744011,No,27.6,18,Former,Yes,No,No,No,No,No,No,No,2,No,No,No,No,Yes,Yes,No,5,70,8,76,11,85,78,80,19,12,7,14,Yes,No,Yes,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-23.9,0,0,1,0,0,0,1,0,Y,-12,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,836-024,Biologic Naïve,46,Male,22.14532872,11.039014374,No,8.6,7.772,Never,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,2,10,5,4.206,10,55,32,9.152,13.133,9.691,3.442,22.816,Yes,No,No,Yes,1.89,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.5,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,836-025,Biologic Non-naïve,70,Male,24.859073562,20.199863107,No,13.6,21.094,Missing,Yes,No,No,Yes,No,No,No,No,2,Yes,No,No,No,No,Yes,No,4,10,7.402,79.831,21,94.031,81.274,74.138,23.68,14.583,9.097,20.405,No,No,No,Yes,0.055,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.8,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,836-026,Biologic Naïve,25,Male,27.064051589,11.195071869,No,9.4,11,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,4,29,19,38.333333333,34,40,11,7,4,20,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.2,0,0,1,0,1,1,1,1,Y,-10,1,Y,1,1,1,1,1,0,0,0,1,1,1,1,1,Yes,Y,Yes
1,836-027,Biologic Naïve,26,Female,18.195482774,16.20807666,No,5.7,13,Never,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,5,6,62,0,66.666666667,48,80,24,11,13,20,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-5.3,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,836-028,Biologic Non-naïve,36,Female,37.165192875,29.796030116,No,0,0,Current,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,0,0,0,0,0,10,0,0,1,0,1,25,No,No,No,No,4,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,0,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,836-029,Biologic Naïve,24,Male,23.235631701,8.3504449008,No,9.6,9,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,10,68,16,81.666666667,68,90,14,7,7,23,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,836,United Arab Emirates,Middle East,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,851-002,Biologic Naïve,30,Male,20.408163265,2.173853525,Yes,28.8,12,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,21.321860465,5,1,0.915,28.333333333,34,70,20,11,9,23,No,No,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-22.8,0,0,1,0,0,0,0,0,Y,2,0,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,851-003,Biologic Naïve,72,Male,32.213358572,61.210130048,No,18,23,Never,Yes,Yes,No,Yes,Yes,Yes,No,No,2,No,No,No,No,Yes,No,No,4,21.321860465,8,43,24.608,76.666666667,58,70,14,8,6,24,No,No,No,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-17.6,0,1,1,1,1,1,1,1,Y,-16,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,851-004,Biologic Naïve,33,Male,29.031510377,2.6173853525,No,18.1,30,Never,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,21.321860465,10,100,17.624,95,72,100,25,18,7,19,No,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-16.9,0,1,1,0,1,1,1,1,Y,-11,0,Y,,1,,0,1,1,0,0,1,1,1,0,0,Yes,Y,Yes
1,851-005,Biologic Non-naïve,55,Female,25.694142805,49.467488022,No,11.1,6,Never,Yes,No,No,Yes,No,No,No,No,1,No,No,Yes,No,No,No,No,4,21.321860465,7,85,5.493,80,70,10,19,9,10,24,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,3.2,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,851-006,Biologic Naïve,60,Male,41.735586011,27.017111567,Yes,13.4,10,Former,Yes,No,No,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,No,4,21.321860465,8,70,2.11,70,68,40,17,10,7,18,No,No,No,No,3,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-13,0,1,1,1,1,1,1,1,Y,-9,1,Y,,1,,0,1,1,0,1,1,1,1,1,0,Yes,Y,Yes
1,851-007,Biologic Naïve,31,Male,26.526605877,3.3429158111,No,15.3,23.412,Missing,No,Yes,No,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,4,21.321860465,9.365,77.442,29.337,97.606,77.06,77.651,25.563,17.977,7.586,22.963,Yes,Yes,No,No,0.853,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.7,0,1,1,1,1,1,1,1,Y,,,Y,,1,,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,851-008,Biologic Naïve,27,Male,24.897060232,6.6119096509,No,11.2,17,Former,Yes,Yes,No,No,No,No,No,No,1,No,Yes,No,No,No,No,No,4,21.321860465,5,50,4.363,68.333333333,40,50,26,14,12,23,No,Yes,Yes,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-7.9,0,0,0,0,0,0,1,,Y,,,Y,,0,,0,0,0,0,0,0,0,1,0,0,,Y,No
1,851-009,Biologic Naïve,39,Female,19.923065757,10.127310062,No,11.4,9.306,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,21.321860465,4.294,38.63,27.258,39.361,37.07,27.134,25.661,12.622,13.04,21.201,No,No,No,Yes,1.093,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6.2,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,851-010,Biologic Naïve,58,Male,29.016058032,19.849418207,No,13,18,Current,No,No,Yes,Yes,No,No,No,No,3,No,No,No,No,Yes,No,No,4,21.321860465,7,76,4.035,85,74,10,7,5,2,20,No,No,No,Yes,2,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,851-011,Biologic Non-naïve,31,Female,25.970115548,12.052019165,Yes,14.2,12.873,Missing,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,21.321860465,4.629,37.759,33.141,53.876,36.991,49.315,21.294,9.368,11.926,20.432,No,No,No,No,2.299,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,851-012,Biologic Naïve,36,Female,28.174131325,15.874058864,Yes,11.7,6.636,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,21.321860465,3.396,17.746,14.052,32.389,16.519,37.071,9.838,5.988,3.85,20.482,Yes,No,No,Yes,1.862,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,851,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-8.5,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,854-001,Biologic Non-naïve,38,Female,32.492307692,24.594113621,No,18.4,24,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,50,8,75,15,73.333333333,76,70,5,3,2,25,Yes,Yes,Yes,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,854,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-16.8,0,1,1,0,1,1,1,1,Y,-18,0,Y,1,1,1,1,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,854-002,Biologic Naïve,47,Female,51.736111111,44.980150582,No,7.2,10,Never,No,Yes,No,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,21.321860465,6,65,5,60,70,20,5,3,2,25,No,No,No,No,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,854,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6.3,0,0,1,1,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,855-001,Biologic Non-naïve,35,Female,43.484072176,2.4421629021,No,43.2,22,Current,Yes,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,5,32,10,90,0,95,92,80,21,9,12,25,Yes,Yes,No,Yes,4,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,855,United Kingdom,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.8,0,0,0,0,0,0,0,0,Y,-5,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,855-002,Biologic Naïve,56,Male,32,28.887063655,No,8,1,Never,Yes,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,9,1,0,0,13.333333333,6,0,3,0,3,24,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,855,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-4.4,0,0,0,0,0,0,1,1,Y,-1,,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,855-003,Biologic Naïve,49,Male,36.421463014,10.50513347,No,24.3,16,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,60,1,0,23,45,12,50,7,3,4,22,No,No,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,855,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.6,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,855-004,Biologic Naïve,28,Male,22.920604915,17.295003422,No,6.6,3,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,2,4,10,15,6,0,1,1,0,22,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,855,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,855-005,Biologic Naïve,44,Female,43.500892326,31.419575633,No,8.9,11,Former,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,25,7,60,4,55,60,20,17,10,7,22,Yes,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,855,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,0.3,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,855-006,Biologic Naïve,61,Female,27.030041642,35.438740589,No,14.4,13,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,30,6,78,11,70,64,0,20,14,6,21,No,No,No,Yes,1,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,855,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.2,0,0,0,0,0,0,1,1,Y,3,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,856-001,Biologic Naïve,40,Male,32.00617284,0.5694729637,No,26.7,20,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,80,5.782,87,9,76.666666667,44,10,5,3,2,24,Yes,No,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-26.7,1,1,1,1,1,1,1,1,Y,-20,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,856-002,Biologic Naïve,51,Male,30.930438076,20.930869268,No,14.1,22,Former,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,3,52,8.143,79,12,68.333333333,58,30,24,15,9,24,Yes,Yes,Yes,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.1,1,1,1,1,1,1,1,1,Y,-21,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,856-003,Biologic Naïve,32,Male,29.402273298,17.9137577,No,10.1,20,Never,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,40,6.524,73,17,83.333333333,66,50,25,12,13,24,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,Anti TNFs,Etanercept,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-4.5,0,0,0,0,0,0,0,0,N,-8,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,856-004,Biologic Non-naïve,55,Female,31.360076605,5.9739904175,No,10.7,14,Current,No,No,No,No,No,No,No,No,1,No,No,No,No,No,Yes,No,3,25,8.927,50,14,75,96,0,17,10,7,24,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6.7,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,856-005,Biologic Naïve,61,Female,48.72497203,26.64476386,Yes,21.4,19,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,41,8,22,27,68.333333333,52,30,28,13,15,24,Yes,Yes,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-21.4,1,1,1,1,1,1,1,1,Y,-19,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,856-006,Biologic Naïve,40,Male,27.343513075,22.997946612,No,18.1,7,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,46,7,71,36,65,44,20,9,7,2,24,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-16.3,0,1,1,0,1,1,1,1,Y,-7,1,Y,1,1,0,0,1,1,0,0,1,1,1,1,1,Yes,Y,Yes
1,856-007,Biologic Naïve,48,Male,26.043473234,25.01026694,No,15.5,12,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,33,8,58,3,86.666666667,80,40,4,3,1,23,Yes,Yes,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-15.5,1,1,1,1,1,1,1,1,Y,-12,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,856-008,Biologic Naïve,27,Male,28.384784368,9.2539356605,No,15.1,23,Current,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,32,10,74,10,83.333333333,76,70,25,15,10,19,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-15.1,1,1,1,1,1,1,1,1,Y,-19,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,856-009,Biologic Naïve,50,Male,36.889391325,12.010951403,No,20.6,19,Former,No,Yes,No,No,No,No,No,No,1,No,No,No,No,No,No,No,4,43,8,80,3,73.333333333,64,50,22,13,9,25,Yes,Yes,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-18.5,0,0,1,0,0,1,1,1,Y,-12,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,856-010,Biologic Naïve,49,Female,21.093491124,31.482546201,No,24,18,Former,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,54,4,40,8,80,40,0,5,4,1,25,No,Yes,No,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-15.1,0,0,0,0,0,0,0,0,Y,-14,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,856-011,Biologic Non-naïve,61,Male,27.296181176,39.028062971,Yes,11.1,24,Never,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,29,9,11,8,83.333333333,72,80,15,8,7,24,Yes,No,No,Yes,2,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-9.9,0,0,1,0,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,856-012,Biologic Naïve,37,Male,25.454545455,5.4674880219,No,18.4,22,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,58,5,64,6,46.666666667,50,60,20,11,9,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-16.5,0,0,1,0,1,1,1,1,Y,-15,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,856-013,Biologic Naïve,32,Female,27.763429752,15.852156057,No,11.8,27,Current,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,No,No,No,No,3,32,10,92,0,90,90,80,31,17,14,21,Yes,Yes,No,Yes,1,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-9.4,0,0,1,0,0,1,1,1,Y,-4,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,856-014,Biologic Naïve,39,Female,18.671875,21.604380561,No,10.6,16.119,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,41,6.478,34.372,4,81.771,52.014,70.137,12.89,7.319,5.571,24.018,Yes,No,No,Yes,2.609,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-10.4,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,856-015,Biologic Naïve,31,Male,22.801501786,24.090349076,No,16.5,1,Never,Yes,Yes,No,No,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,55,1,7.434,7,6.6666666667,6,10,8.526,5.992,2.534,23.549,Yes,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-15.6,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,856-016,Biologic Non-naïve,43,Female,18.671875,21.850787132,No,17.2,12.76,Missing,No,No,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,40,5.851,7.666,14,85.308,85.922,81.529,20.961,14.372,6.589,22.55,No,No,No,Yes,0.045,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-17.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,856-017,Biologic Naïve,49,Male,28.367523664,29.221081451,No,20,18,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,37,10,0,13,100,96,100,26,9,17,25,No,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-11.5,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,856-018,Biologic Naïve,66,Male,41.481481481,10.351813826,No,30.5,12,Former,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,Yes,5,58,10,70,4,88.333333333,72,30,5,1,4,22,Yes,No,No,Yes,3,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-26.9,0,0,1,0,0,0,1,1,Y,-11,1,Y,1,1,0,0,1,0,0,0,0,0,1,1,1,Yes,Y,Yes
1,856-020,Biologic Non-naïve,31,Male,38.4,7.3867214237,Yes,27.4,30,Never,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,56,8,79,7,80,74,90,32,15,17,21,Yes,No,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.4,0,0,0,0,0,0,0,0,Y,-15,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,856-021,Biologic Non-naïve,40,Male,35.895061728,17.297741273,Yes,18.3,19,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,40,8,79,6,85,82,30,10,6,4,25,Yes,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,7.4,0,0,0,0,0,0,0,0,Y,,,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,856-022,Biologic Naïve,46,Female,38.721149659,20.34770705,Yes,10.9,19,Never,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,18,8,77,3,81.666666667,76,60,19,12,7,22,Yes,No,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-10.9,1,1,1,1,1,1,1,1,Y,-17,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,856-023,Biologic Naïve,52,Female,33.061573803,11.241615332,Yes,20.8,30,Never,No,Yes,No,Yes,Yes,Yes,No,No,1,Yes,No,No,No,No,No,No,4,57,10,72,27.318,100,100,90,26,16,10,22,Yes,Yes,No,Yes,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,N,,,,,,,,,,Y,,,N,,0,,0,0,0,0,0,0,0,0,0,0,,N,No
1,856-024,Biologic Naïve,68,Male,28.405504356,48.963723477,Yes,17.3,5,Former,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,36,1,4,4,30,4,0,14,5,9,25,No,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,856,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-17.3,1,1,1,1,1,1,1,1,Y,-4,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,857-001,Biologic Naïve,58,Male,21.27284184,23.449691992,No,11.4,14,Current,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,8.5,3,10,80,26.666666667,18,20,26,17,9,24,Yes,Yes,No,No,2,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.5,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,857-002,Biologic Naïve,42,Male,30.89791205,6.5735797399,No,22.9,16.517,Former,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,30,6.524,47.615,0,59.74,51.567,37.489,7.422,5.512,1.91,22.47,No,No,No,Yes,0.536,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-19.6,0,0,1,0,0,0,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,857-003,Biologic Non-naïve,58,Female,31.331496786,25.552361396,No,3.2,7.505,Missing,No,No,No,Yes,No,No,No,No,3,No,Yes,No,No,No,Yes,No,2,30,5.614,35.078,19.238,44.457,45.359,34.456,19.639,10.188,9.451,24.584,No,No,No,No,1.801,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-3.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,857-004,Biologic Non-naïve,42,Male,29.383916172,28.525667351,Yes,18,9,Former,No,Yes,No,Yes,Yes,Yes,No,No,1,Yes,No,No,No,No,No,No,4,21.321860465,1,17,24,40,22,20,18,8,10,23,No,No,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-3.8,0,0,0,0,0,0,0,0,Y,0,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,857-005,Biologic Non-naïve,41,Female,38.296800202,16.616016427,Yes,14.7,15,Current,No,No,No,No,No,No,No,No,1,No,No,No,No,No,No,No,4,40,8,78,40,58.333333333,66,40,11,4,7,24,Yes,Yes,No,Yes,3,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,0,0,0,0,0,0,1,Y,-14,1,Y,1,1,0,0,0,0,0,0,0,0,0,1,1,Yes,Y,Yes
1,857-006,Biologic Non-naïve,34,Male,30.378357438,15.676933607,Yes,9.6,20,Never,Yes,No,No,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,3,21.321860465,8,100,10,75,86,100,30,15,15,19,No,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-9.2,0,1,1,1,1,1,1,1,Y,-3,0,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,857-007,Biologic Naïve,36,Female,22.012182315,16.917180014,No,10,25,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,20,7,75,30,73.333333333,72,60,22,14,8,19,No,No,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-10,1,1,1,1,1,1,1,1,Y,-4,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,857-008,Biologic Naïve,60,Male,28.448460059,0.1232032854,No,32.1,17.958,Never,No,Yes,No,Yes,No,No,No,No,5,Yes,No,No,No,No,No,No,4,70,8.768,64.537,18,86.144,79.751,83.271,16.093,7.251,8.842,23.396,No,Yes,No,Yes,1.034,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,857-009,Biologic Naïve,21,Female,31.965706156,2.2915811088,No,10.4,14,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,30,7,71,20,65,52,50,17,10,7,23,Yes,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,1.6,0,0,0,0,0,0,0,0,Y,10,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,857-010,Biologic Naïve,55,Male,38.530612245,38.135523614,Yes,22.1,19,Never,No,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,3,80,7,52,3,50,50,70,5,0,5,23,No,Yes,No,Yes,2,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-12,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,857-011,Biologic Naïve,35,Male,30.463050578,20.079397673,Yes,13.5,25,Former,No,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,30,8,79,37,85,80,30,29,11,18,25,Yes,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,857,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,858-002,Biologic Non-naïve,54,Female,35.379577703,33.11430527,Yes,34.8,21,Former,Yes,Yes,Yes,Yes,Yes,Yes,No,Yes,3,No,No,No,Yes,Yes,No,Yes,3,95,7,59,43,58.333333333,58,70,6,4,2,23,Yes,Yes,Yes,Yes,3,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,858,United Kingdom,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,-4.6,0,0,0,0,0,0,0,0,N,-12,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,858-003,Biologic Naïve,60,Female,32.265625,31.93155373,No,9.1,13,Never,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,3,35,7,36,12,51.666666667,38,0,4,4,0,25,No,No,No,Yes,3,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,858,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,,Y,1,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,859-001,Biologic Naïve,28,Male,36.965871252,15.718001369,No,45.1,21,Former,Yes,Yes,Yes,No,No,No,No,No,3,No,No,No,Yes,Yes,Yes,No,5,80,9,31,57,76.666666667,64,50,25,11,14,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,859,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-42.4,0,1,1,0,0,1,1,1,Y,-17,0,Y,0,1,0,0,1,1,0,0,0,1,1,0,0,Yes,Y,Yes
1,859-002,Biologic Naïve,47,Male,26.730371901,47.567419576,No,3.9,18,Former,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,4,21.321860465,7,39,19.732,66.666666667,54,60,20,12,8,25,Yes,Yes,Yes,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,859,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-2.5,0,0,0,0,1,1,1,1,Y,-11,0,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,859-003,Biologic Non-naïve,50,Female,29.031510377,34.924024641,No,6.6,16,Former,Yes,No,No,Yes,Yes,Yes,No,No,1.5063613232,No,No,No,No,Yes,No,No,3,21.321860465,6,7,2.836,53.333333333,40,70,21,8,13,24,Yes,Yes,No,No,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,859,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-2.1,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,859-004,Biologic Non-naïve,39,Male,29.031510377,21.927446954,No,14,24,Never,Yes,No,No,No,No,No,No,No,1.5063613232,No,No,No,No,Yes,No,No,4,21.321860465,8,79,40.084,51.666666667,54,70,18,10,8,24,Yes,No,No,No,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,859,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-10.6,0,0,1,0,0,0,1,0,Y,-14,0,Y,0,0,0,0,1,0,0,0,0,0,1,0,0,No,Y,No
1,859-005,Biologic Naïve,44,Female,29.031510377,16.31211499,No,22.2,10.777,Missing,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,5,21.321860465,6.536,78.531,42.44,78.07,62.841,35.75,20.669,10.679,9.99,17.765,Yes,Yes,No,No,2.151,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,859,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,859-006,Biologic Non-naïve,44,Female,29.031510377,32.158795346,No,5.2,17,Former,Yes,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,3,21.321860465,3,64,34.979,78.333333333,50,10,7,3,4,25,Yes,Yes,No,No,3,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,859,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,860-001,Biologic Non-naïve,30,Female,42.176013443,17.815195072,Yes,12.8,22,Current,No,Yes,No,Yes,No,No,No,No,6,No,No,Yes,Yes,Yes,No,No,3,30,10,85,28.005,66.666666667,74,80,32,15,17,20,No,Yes,No,No,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,860,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,0,0,0,0,0,0,0,0,0,Y,-11,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,860-002,Biologic Naïve,43,Female,33.988721232,37.533196441,No,14,27,Former,No,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,20,7,61,22,65,50,30,28,15,13,25,No,Yes,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,860,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-13.8,0,1,1,1,1,1,1,1,Y,-24,0,Y,1,1,1,1,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,860-003,Biologic Non-naïve,64,Female,32.879220611,52.648870637,No,31,24,Former,Yes,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,30,10,96,3.714,100,100,90,3,1,2,24,Yes,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,860,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,Y,Y,-25.8,0,0,1,0,0,0,0,0,Y,-20,0,Y,0,0,0,0,1,0,0,0,0,0,0,0,0,No,Y,No
1,860-004,Biologic Naïve,40,Female,47.402201585,24.238193018,No,12.6,24,Former,No,No,No,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,No,3,40,9,85,2,80,86,70,25,13,12,25,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,860,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-12.6,1,1,1,1,1,1,1,1,Y,-24,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,860-005,Biologic Naïve,30,Male,23.160901949,19.619438741,Yes,10.2,12,Current,Yes,Yes,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,4,30,8,68,10,58.333333333,74,0,7,7,0,20,No,No,No,Yes,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,860,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-0.1,0,0,0,0,0,0,0,0,Y,8,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,860-006,Biologic Naïve,35,Female,33.645546373,13.987679671,No,10,21,Former,Yes,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,25,6,8,0.67,36.666666667,38,40,22,13,9,25,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,860,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-9.8,0,1,1,1,1,1,1,1,Y,-21,1,Y,1,1,1,1,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,860-008,Biologic Naïve,32,Female,29.031510377,18.770704997,Yes,10.7,26,Former,No,Yes,No,Yes,Yes,Yes,No,Yes,0,No,No,No,No,No,No,No,3,10,9,78,0,68.333333333,56,70,10,4,6,25,Yes,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,860,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-26,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,860-009,Biologic Naïve,48,Female,27.290303391,5.2511978097,No,11,14.835,Missing,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,Yes,3,15,5.814,11.856,2,54.905,32.885,61.567,5.77,4.217,1.553,18.929,Yes,No,Yes,Yes,0.528,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,860,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,863-001,Biologic Non-naïve,42,Male,47.020408163,15.041752225,Yes,32.7,11,Never,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,75,7,75,10.33,53.333333333,46,20,10,4,6,25,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,863,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.1,0,0,0,0,0,0,0,0,Y,-7,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,863-003,Biologic Naïve,38,Female,43.234049286,18.080766598,Yes,10.2,7,Former,Yes,Yes,Yes,Yes,Yes,Yes,No,No,2,No,No,No,Yes,Yes,No,No,2,40,6,63,11.467,61.666666667,66,30,17,10,7,23,Yes,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,863,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-1.5,0,0,0,0,0,0,0,0,Y,0,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,863-004,Biologic Naïve,55,Male,25.62671792,34.655715264,No,27.6,1.297,Missing,No,Yes,Yes,Yes,No,No,No,No,2,Yes,No,No,No,No,Yes,No,3,70,4.488,31.614,34.666,38.509,50.831,33.023,11.415,5.939,5.476,21.782,No,No,No,No,2.204,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,863,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,863-005,Biologic Naïve,39,Male,31.025567366,36.090349076,No,13.6,9,Current,Yes,Yes,Yes,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,2,40,6,9,35.522,70,56,20,20,11,9,25,Yes,Yes,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,863,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,863-006,Biologic Naïve,43,Female,45.419905502,26.168377823,No,23.8,11,Never,No,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,70,0,4,15.869,13.333333333,2,50,14,7,7,24,Yes,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,863,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-10,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,863-007,Biologic Naïve,63,Female,40.105193951,32.268309377,No,9.9,8,Former,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,40,10,80,32.453,95,80,50,26,12,14,24,Yes,Yes,No,Yes,4,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,863,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,2,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,864-001,Biologic Naïve,35,Male,31.322332855,10.058863792,No,24.9,29,Former,Yes,No,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,5,75,8,95,0,83.333333333,90,80,19,13,6,25,No,No,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,864,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-24,0,1,1,1,1,1,1,1,Y,-28,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,864-002,Biologic Non-naïve,61,Male,36.524058685,21.993155373,No,13.3,13,Never,Yes,No,No,Yes,No,No,No,No,6,Yes,No,No,Yes,Yes,Yes,No,3,70,5,49,35.784,56.666666667,34,10,15,7,8,23,Yes,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,864,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-9,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,866-001,Biologic Naïve,45,Female,31.108276644,35.594798084,No,2.2,11,Never,Yes,Yes,No,No,Yes,Yes,No,No,2,No,No,No,Yes,Yes,No,No,2,10,7,36,30.503,73.333333333,56,10,16,10,6,24,No,No,No,No,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,866,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-0.3,0,0,0,0,1,1,1,1,Y,-7,0,Y,1,1,0,0,0,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,866-003,Biologic Non-naïve,52,Male,28.563312713,26.937713895,Yes,20.4,16,Former,Yes,No,No,No,No,No,No,No,1,No,No,No,No,No,No,No,4,40,8,80,22.074,60,88,70,8,4,4,25,Yes,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,866,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,Y,N,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,866-005,Biologic Naïve,44,Female,47.649281935,5.8234086242,No,10.2,16,Current,Yes,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,Yes,3,20,8,77,2,71.666666667,80,70,21,10,11,25,No,No,Yes,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,866,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-7,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,867-001,Biologic Naïve,50,Male,59.299023127,16.440793977,No,42.8,18,Former,No,No,No,Yes,Yes,No,No,Yes,3,No,No,No,Yes,Yes,No,No,3.2017453799,1.2,8,65,10.498,80,24,70,17,4,13,22,Yes,No,No,Yes,1,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,867,United Kingdom,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-41.6,0,1,1,0,1,1,1,1,Y,-17,1,Y,,1,,0,1,1,0,0,1,1,1,1,0,Yes,Y,Yes
1,867-002,Biologic Naïve,29,Female,32.192904936,5.8179329227,Yes,0,24,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,0,0,9,83,0,78.333333333,60,70,24,12,12,24,No,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,867,United Kingdom,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,0,,,,1,1,1,1,,Y,-23,1,Y,,0,,0,0,0,0,1,1,1,1,1,0,,Y,No
1,867-003,Biologic Naïve,31,Female,36.2109375,21.045859001,Yes,13.5,14,Current,No,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3.2017453799,2,7,66,26.831,53.333333333,66,40,24,16,8,22,No,No,No,No,2,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,867,United Kingdom,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-12.6,0,1,1,1,1,1,1,1,Y,,,Y,,1,,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,867-004,Biologic Naïve,20,Male,23.936998061,18.406570842,No,12.8,15.325,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3.2017453799,1.2,3.409,67.377,11.383,57.279,27.559,31.861,30.364,20.569,9.795,20.863,No,No,No,Yes,0.023,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,867,United Kingdom,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,868-001,Biologic Non-naïve,39,Female,45.411552943,19.310061602,No,11,17,Former,No,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,30,8,87,0,66.666666667,66,60,8,6,2,25,No,Yes,Yes,Yes,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,868,United Kingdom,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6.6,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,868-002,Biologic Non-naïve,38,Male,31.038217271,9.1006160164,No,31.1,0,Never,No,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,4,80,0,0,21,5,0,0,2,2,0,25,Yes,Yes,No,Yes,0,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,868,United Kingdom,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,869-001,Biologic Naïve,65,Female,29.752066116,53.07871321,Yes,15.6,7,Former,Yes,Yes,No,Yes,Yes,No,No,Yes,1,No,No,No,No,No,No,No,3,30,4,5,36,33.333333333,40,0,6,1,5,24,No,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,869,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-3,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,871-001,Biologic Naïve,49,Female,37.32244898,33.160848734,No,12.8,23,Never,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,12,5,0,13.927,46.666666667,30,50,18,10,8,23,No,No,Yes,Yes,3,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,871,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-23,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,871-003,Biologic Naïve,51,Male,28.010223732,34.53798768,No,10.7,19,Never,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,25,8,36,46.953,65,62,40,6,3,3,25,No,No,No,No,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,871,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-10.7,1,1,1,1,1,1,1,1,Y,-19,1,Y,,1,,0,1,1,1,1,1,1,1,1,0,Yes,Y,Yes
1,872-001,Biologic Non-naïve,38,Female,37.475015189,27.813826146,No,17.4,11,Never,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,54,7.299,51,26.129,48.333333333,50,0,24,12,12,24,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,872,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-16.2,0,1,1,0,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,872-002,Biologic Naïve,67,Male,29.757785467,36.183436003,No,11.1,18,Former,No,Yes,No,Yes,No,No,No,No,5,No,No,No,No,Yes,Yes,No,3,34,8,79,9,80,74,60,11,7,4,25,No,No,Yes,Yes,1,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,872,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,N,4.3,0,0,0,0,0,0,0,1,N,12,0,N,1,1,0,0,0,0,0,0,0,0,0,0,1,,N,No
1,872-003,Biologic Non-naïve,56,Male,35.579413876,5.2484599589,No,16.6,20,Never,No,No,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,3,21,8,72,0,80,66,20,15,9,6,25,No,No,No,Yes,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,872,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-9,0,0,0,0,0,0,0,0,Y,2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,872-004,Biologic Naïve,57,Male,34.602076125,6.8062970568,No,10.2,9,Never,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,No,3,18,5,47,45,83.333333333,74,0,2,1,1,25,No,No,No,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,872,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-8.1,0,0,1,0,0,1,1,1,Y,-7,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,872-005,Biologic Non-naïve,31,Female,20.549886621,9.2676249144,No,19.4,30,Former,Yes,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,22,10,66,0,100,100,100,12,5,7,25,No,No,No,No,0,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,872,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,872-006,Biologic Non-naïve,70,Female,33.535353535,13.626283368,Yes,11.1,13,Former,No,No,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,4,17,9,54,30,91.666666667,78,30,18,12,6,22,No,Yes,No,No,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,872,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-7.8,0,0,0,0,0,0,1,1,Y,-8,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,872-007,Biologic Naïve,26,Male,23.570600655,19.378507871,No,10.5,16,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,40,8,85,0,70,74,50,21,12,9,25,Yes,No,No,Yes,2,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,872,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-10.5,1,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,872-008,Biologic Non-naïve,39,Female,42.96875,18.182067077,No,15.9,1,Current,No,No,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,30,3,15,9,23.333333333,18,0,3,2,1,24,No,No,Yes,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,872,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-13.5,0,0,1,0,0,1,1,1,Y,0,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,872-009,Biologic Naïve,65,Male,37.983976507,30.828199863,No,10.1,5,Never,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,No,3,25,5,16,19,25,20,0,3,2,1,23,No,No,No,Yes,3,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,872,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-7.3,0,0,0,0,0,1,1,1,Y,-4,1,Y,1,1,0,0,0,0,0,0,0,1,1,1,1,Yes,Y,Yes
1,872-010,Biologic Naïve,46,Male,27.272555489,25.735797399,No,11.9,19,Former,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,3,17,6,70,31,63.333333333,42,60,22,12,10,25,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,872,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.5,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,873-001,Biologic Naïve,50,Male,34.772521503,25.686516085,No,23.2,13,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,40,6,41,4,53.333333333,52,50,12,3,9,24,Yes,No,No,No,3,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,873,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.8,0,0,0,0,0,0,0,0,Y,-9,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,873-002,Biologic Non-naïve,39,Female,29.691043084,20.07118412,Yes,12.8,9,Never,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,No,Yes,3,50,7,16,8,51.666666667,40,50,21,12,9,23,Yes,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,873,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,,Y,N,N,Y,Y,N,,,,,,,,,,N,-4,0,N,,0,,0,0,0,0,0,0,0,0,0,0,,N,No
1,873-003,Biologic Naïve,45,Female,31.588613407,23.767282683,Yes,28.7,23,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,60,10,82,41,81.666666667,100,100,26,12,14,25,Yes,Yes,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,873,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,,,,,,,,,1,Y,,,Y,1,1,1,1,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,873-004,Biologic Non-naïve,61,Male,25.872930527,39.112936345,No,6.4,3,Current,Yes,Yes,No,Yes,No,No,No,No,5,Yes,No,No,No,No,Yes,No,4,10,3,4,10,41.666666667,20,0,15,7,8,25,No,No,No,No,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,873,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-3,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,,Y,No
1,875-001,Biologic Naïve,43,Female,55.463728191,13.919233402,No,13.7,17,Never,No,Yes,No,Yes,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,3,20,10,70,0,78.333333333,66,50,27,14,13,24,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,875,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-11,0,0,1,0,0,1,1,0,Y,-11,0,Y,0,0,0,0,1,0,0,0,0,1,1,0,0,No,Y,No
1,875-002,Biologic Non-naïve,41,Female,40.913277878,31.353867214,Yes,3.6,16.206,Missing,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,2,6,5.923,52.766,1.941,45.985,41.928,48.014,5.741,4.267,1.474,19.428,No,No,No,Yes,1.377,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,875,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,875-003,Biologic Non-naïve,55,Female,23.490863264,36.402464066,Yes,6.2,7.227,Missing,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,2,8,7.832,21.899,21.866,53.818,40.72,46.813,10.374,7.572,2.802,21.024,No,No,No,No,1.959,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,875,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,875-004,Biologic Naïve,37,Female,37.96875,14.453114305,No,23.4,22,Former,Yes,Yes,Yes,Yes,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,4,26,9,86,32,88.333333333,84,70,24,15,9,24,Yes,Yes,Yes,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,875,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-22.1,0,1,1,0,1,1,1,1,Y,-16,0,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,875-005,Biologic Naïve,35,Female,31.453287197,15.192334018,No,6.9,20.762,Missing,No,Yes,Yes,Yes,Yes,Yes,No,No,0,No,No,No,No,No,No,No,3,11,6.415,29.136,11,71.856,43.952,64.004,15.539,9.623,5.915,24.239,Yes,No,Yes,Yes,0.229,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,875,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,N,-0.5,0,0,0,0,0,0,0,0,Y,,,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,878-001,Biologic Naïve,32,Female,17.915615943,6.3956194387,No,16.3,14,Current,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,30,6,58,0,45,32,10,7,6,1,24,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,878,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-15.5,0,1,1,1,1,1,1,1,Y,-11,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,878-002,Biologic Naïve,35,Female,38.424270774,20.183436003,No,11.2,29,Former,Yes,Yes,Yes,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,15,7,60,0,76.666666667,68,80,24,10,14,22,Yes,No,Yes,Yes,0,No,Other Biologics,,,,,,,,,Brodalumab,,,,,,Brodalumab,Brodalumab,ADOUT,I1F-MC-B007,878,United Kingdom,Europe,Other Biologics,,Brodalumab,IL17 RA,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-10.4,0,1,1,1,1,1,1,1,Y,,,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,878-003,Biologic Naïve,47,Female,45.362171578,6.4558521561,No,14.3,7.954,Missing,No,Yes,No,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,4,35,2.57,13.647,2.875,51.425,28.457,27.62,11.584,2.969,8.616,21.333,No,No,No,Yes,0.866,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,878,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,4.9,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,878-004,Biologic Non-naïve,31,Male,22.093170054,14.335386721,Yes,4.7,8,Current,Yes,Yes,No,No,No,No,No,No,1,No,No,Yes,No,No,No,No,3,2,5,49,7.037,33.333333333,30,30,17,11,6,23,No,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,878,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-4,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,,Y,No
1,878-005,Biologic Non-naïve,33,Female,23.378392915,27.463381246,No,4.2,6,Former,No,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,7,8,58,15,65,52,10,9,5,4,25,No,No,Yes,No,2,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,878,United Kingdom,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-2,0,0,0,0,0,1,1,1,Y,-4,0,Y,1,1,0,0,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,878-006,Biologic Naïve,47,Male,24.419279021,20.509240246,No,13.4,11,Never,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,12,7,14,11,61.666666667,36,10,6,3,3,22,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,878,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-11.2,0,0,1,0,0,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,878-007,Biologic Naïve,63,Female,31.120867769,51.258042437,No,17.2,2.842,Missing,No,Yes,Yes,Yes,No,No,No,No,7,No,No,No,Yes,Yes,No,Yes,3,20,6.933,13.718,44.01,34.908,32.351,24.019,9.869,1.939,7.929,23.412,No,No,No,No,0.469,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,878,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,878-008,Biologic Naïve,46,Male,36.737785633,14.973305955,No,16.1,21,Current,No,Yes,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,No,No,3.2017453799,20,8,79,17.161,86.666666667,82,70,11,7,4,25,Yes,No,No,Yes,3,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,878,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-6.2,0,0,0,0,0,0,0,0,Y,-12,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,878-009,Biologic Naïve,72,Female,31.000918274,20.862422998,No,12.9,14.508,Missing,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,3,40,7.046,28.541,17.854,57.925,43.785,63.175,12.049,3.632,8.418,21.986,No,No,No,Yes,0.571,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,878,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,N,6.4,0,0,0,0,0,0,0,0,Y,,,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,879-001,Biologic Naïve,58,Male,29.102099021,38.789869952,No,12.1,16,Never,Yes,Yes,Yes,Yes,No,No,No,No,3,No,Yes,No,No,No,No,No,4,20,6,5,43,63.333333333,26,0,13,11,2,22,Yes,No,No,Yes,0,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,879,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-11.9,0,1,1,1,1,1,1,1,Y,-16,1,Y,1,1,0,0,1,1,0,1,1,1,1,1,1,Yes,Y,Yes
1,879-002,Biologic Naïve,58,Male,36.567420074,4.8843258042,No,17.1,7,Never,No,Yes,No,Yes,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,30,7,49,18,76.666666667,68,50,24,12,12,25,Yes,No,No,Yes,3,Yes,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,879,United Kingdom,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.3,0,0,1,0,0,1,1,0,Y,-7,1,Y,0,0,0,0,1,0,0,0,0,1,1,1,0,No,Y,No
1,879-003,Biologic Naïve,37,Female,22.283737024,4.5941136208,No,12.8,28.54,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,8.355,76.863,8,74.695,72.048,79.778,25.65,13.274,12.376,22.89,No,No,Yes,Yes,3.785,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,879,United Kingdom,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,879-004,Biologic Non-naïve,49,Male,35.72023605,21.94934976,No,15.9,13.568,Missing,Yes,Yes,Yes,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,4,25,8.345,96.32,0,83.369,85.437,33.382,16.457,7.139,9.318,22.759,No,No,No,Yes,0.298,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,879,United Kingdom,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.9,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,879-005,Biologic Naïve,47,Female,31.467221644,12.328542094,No,20.2,30,Current,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,35,10,91,0,100,92,100,25,17,8,25,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,879,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-20.2,1,1,1,1,1,1,1,1,Y,-22,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,879-006,Biologic Naïve,36,Male,34.795987959,5.2484599589,No,17.4,13,Former,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,25,8,83,0,71.666666667,74,50,18,8,10,24,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,879,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-15.6,0,0,1,0,1,1,1,1,Y,-5,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,879-007,Biologic Naïve,44,Female,44.567474048,26.809034908,Yes,20.8,24,Never,No,Yes,No,Yes,No,No,No,No,5,Yes,No,No,Yes,Yes,Yes,No,4,40,8,84,0,80,78,80,25,16,9,24,Yes,No,No,Yes,0,Yes,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,879,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.9,0,0,0,0,0,0,0,1,Y,,,Y,1,1,0,0,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,879-008,Biologic Naïve,39,Male,24.691358025,28.481861739,No,14.7,13,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,33,7,51,0,66.666666667,62,20,17,10,7,24,Yes,Yes,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,879,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-13.1,0,0,1,0,1,1,1,1,Y,-8,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,879-009,Biologic Non-naïve,44,Female,37.178204868,11.091033539,Yes,33.1,3,Never,Yes,Yes,Yes,Yes,No,No,No,No,2,Yes,No,No,No,No,No,No,4,60,4,0,5,16.666666667,22,0,12,8,4,21,No,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,879,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-33.1,1,1,1,1,1,1,1,1,Y,-1,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,879-010,Biologic Non-naïve,44,Female,34.195431109,26.806297057,Yes,20.7,18,Former,Yes,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,30,7,63,1,66.666666667,54,40,6,3,3,23,Yes,Yes,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,879,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-19.9,0,1,1,1,1,1,1,1,Y,-16,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,880-001,Biologic Naïve,34,Female,26.753864447,12.657084189,No,0.6,0,Former,Yes,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,1,0,0,4,0,0,0,0,9,9,0,24,No,No,No,No,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,880,United Kingdom,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,0,0,0,1,1,1,1,1,Y,4,,Y,1,1,0,0,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,880-002,Biologic Non-naïve,50,Male,34.528073385,31.854893908,No,11.5,14,Current,No,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,0,8,70,0,76.666666667,62,60,7,3,4,23,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,880,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-5.8,0,0,0,0,0,0,0,0,Y,-10,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,880-003,Biologic Naïve,23,Female,19.333729923,2.0506502396,No,0.3,2,Never,No,Yes,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,0,3,0,0,23.333333333,14,0,9,7,2,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,880,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0,0,0,0,1,1,1,1,1,Y,-2,1,Y,1,1,0,0,0,0,0,1,1,1,1,1,1,Yes,Y,Yes
1,880-004,Biologic Naïve,62,Female,27.770888875,44.438056126,Yes,13.1,24,Current,Yes,Yes,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,3,0,9,81,10,78.333333333,70,60,29,14,15,22,Yes,Yes,Yes,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,880,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-13,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,880-005,Biologic Naïve,24,Female,33.949307511,12.246406571,No,1.8,13,Never,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,0,10,94,0,88.333333333,82,60,20,13,7,24,No,No,No,Yes,1,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,880,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,1.3,0,0,0,0,0,0,1,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,880-006,Biologic Non-naïve,42,Female,48.336624913,27.383983573,No,4.2,19,Former,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,2,0,7,78,5,61.666666667,46,50,21,15,6,25,Yes,No,Yes,Yes,3,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,880,United Kingdom,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-1.8,0,0,0,0,0,1,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,1,1,0,0,No,Y,No
1,880-007,Biologic Naïve,36,Male,39.070846433,12.490075291,Yes,4.2,18,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,0,6,23,1,66.666666667,36,10,15,7,8,24,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,880,United Kingdom,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-3.5,0,0,1,1,1,1,1,1,Y,-14,0,Y,1,1,0,0,1,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,881-001,Biologic Naïve,32,Female,26.145568598,10.184804928,Yes,12.6,22,Former,Yes,Yes,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,30,4,49,0,61.666666667,40,70,17,10,7,23,Yes,Yes,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,Adalimumab,,,,,,Adalimumab,,,,Adalimumab,ADOUT,I1F-MC-B007,881,United Kingdom,Europe,Other Biologics,Anti TNFs,Adalimumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,,,,,,,,,,Y,-17,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,881-002,Biologic Naïve,68,Female,31.446227945,39.58110883,No,29.8,13,Former,Yes,Yes,Yes,Yes,No,No,No,No,7,No,No,No,Yes,Yes,Yes,No,5,90,10,100,27,82.091,92.444,100,18,12,6,23,Yes,No,No,Yes,2,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,881,United Kingdom,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,N,Y,Y,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,881-003,Biologic Naïve,27,Female,47.064028067,9.1197809719,Yes,31.7,20,Current,Yes,Yes,Yes,Yes,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,90,10,0,16,73.333333333,74,90,17,8,9,24,Yes,No,No,Yes,0,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,881,United Kingdom,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,N,Y,N,Y,N,,,,,,,,,,Y,,,N,,0,,0,0,0,0,0,0,0,0,0,0,,N,No
1,901-001,Biologic Naïve,32,Male,28.905075731,17.924709103,No,12.8,14,Current,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,7,10,37,24,43.333333333,38,50,16,9,7,25,No,Yes,No,No,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,901,Austria,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.5,0,0,0,0,0,0,0,0,Y,-10,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,901-002,Biologic Naïve,32,Male,44.820538564,2.2012320329,No,18.3,13.641,Missing,No,No,No,Yes,No,No,No,No,4,No,No,No,Yes,Yes,Yes,No,4,35,4.597,9.794,14,50.373,25.869,54.847,7.39,6.668,0.722,19.788,Yes,No,No,Yes,0.829,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,901,Austria,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.8,0,1,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,901-003,Biologic Naïve,65,Female,22.14532872,47.321013005,Yes,3.4,0.086,Former,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,5,0,0.012,29,52.949,14.27,6.831,17.827,6.439,11.388,17.352,No,Yes,No,No,1.584,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,901,Austria,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.4,0,0,0,1,1,1,1,1,Y,,,Y,1,1,0,0,0,0,0,1,1,1,1,0,1,Yes,Y,Yes
1,902-001,Biologic Naïve,37,Male,29.761904762,4.5859000684,No,18.6,3.115,Missing,Yes,No,No,Yes,Yes,No,No,Yes,2,No,No,No,No,Yes,Yes,No,3,70,1.511,42.986,14.869,36.994,40.824,4.547,9.666,6.634,3.032,23.9,Yes,Yes,Yes,Yes,1.617,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,902,Austria,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,N,N,Y,-17.3,0,1,1,0,1,1,1,1,Y,,,Y,1,1,1,1,1,1,0,0,1,1,1,0,1,Yes,Y,Yes
1,902-002,Biologic Naïve,54,Male,32.846606348,0.0191649555,No,17.7,14.731,Missing,No,No,Yes,Yes,No,No,No,No,4,Yes,No,No,Yes,Yes,No,No,4,80,8.452,75.565,24.551,83.607,79.129,40.531,21.035,11.211,9.823,24.177,No,No,No,No,1.276,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,902,Austria,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,Y,N,Y,Y,-17.7,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,902-003,Biologic Naïve,39,Male,22.598140496,32.314852841,No,13.2,15.511,Missing,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,1,40,1.47,22.496,80,73.897,42.376,67.743,18.557,9.966,8.591,23.962,No,No,No,No,1.376,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,902,Austria,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,902-004,Biologic Naïve,66,Female,23.423557406,1.3278576318,No,28.2,21.175,Missing,No,Yes,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3,80,7.305,62.949,49.404,63.053,74.77,86.24,15.088,7.301,7.788,21.57,Yes,Yes,No,Yes,0.589,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,902,Austria,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-28.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,904-001,Biologic Non-naïve,44,Female,18.556773222,32.725530459,No,2.7,3,Never,Yes,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,1,5,1,10,38.715,1.6666666667,10,10,6,5,1,25,No,No,No,No,0,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,904,Austria,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.7,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,904-002,Biologic Non-naïve,41,Female,28.256989887,30.825462012,Yes,2.7,12,Current,No,No,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,4,3,7,63,0,71.666666667,60,20,4,4,0,23,No,No,No,Yes,1,No,Other Biologics,,,,,,,Ustekinumab,,,,,,Ustekinumab,,,Ustekinumab,ADOUT,I1F-MC-B007,904,Austria,Europe,Other Biologics,,Ustekinumab,IL12/23,,IL12/23,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.7,0,0,0,0,0,0,1,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,1,0,0,No,Y,No
1,904-003,Biologic Naïve,33,Male,28.086419753,2.1902806297,No,21,21,Current,No,No,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,4,20,9,100,0,95,90,80,19,8,11,25,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,904,Austria,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,4.6,0,0,0,0,0,0,0,0,Y,-17,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,904-004,Biologic Non-naïve,63,Male,20.987654321,9.5770020534,No,8.1,9.076,Missing,No,Yes,Yes,Yes,No,No,No,No,5,Yes,No,No,No,No,No,No,3,7,5.98,17.035,0,69.652,49.55,31.103,10.717,8.263,2.454,23.933,No,No,No,No,0.097,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,904,Austria,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.1,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,904-005,Biologic Naïve,30,Female,29.270994027,2.2286105407,No,16.1,21,Current,Yes,No,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,15,9,80,0,95,84,20,5,2,3,24,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,904,Austria,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-16.1,1,1,1,1,1,1,1,1,Y,-15,0,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,906-002,Biologic Non-naïve,27,Female,23.836734694,2.340862423,Yes,5.3,8,Current,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,5,9,46,0,63.333333333,44,30,15,9,6,21,No,Yes,No,Yes,3,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,906,Austria,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-5,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,906-003,Biologic Naïve,69,Male,34.478096268,7.4305270363,No,10.6,2,Former,No,No,No,No,No,No,No,No,2,No,No,No,No,Yes,No,No,3,24,5,9,0,41.666666667,46,20,15,6,9,24,No,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,906,Austria,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-2,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,906-004,Biologic Naïve,37,Male,26.85546875,7.0800821355,No,5,1,Current,No,No,Yes,No,No,No,No,No,1,No,No,No,No,Yes,No,No,2,7,4,31,0,21.666666667,26,20,11,5,6,24,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,906,Austria,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-5,1,1,1,1,1,1,1,1,Y,-1,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,907-001,Biologic Naïve,60,Male,27.08415907,32.292950034,Yes,11.4,23.389,Missing,No,No,No,Yes,No,No,No,No,2,No,No,No,No,No,No,No,3.2017453799,15,3.598,61.184,80,71.054,52.445,48.753,23.16,13.143,10.017,23.366,No,No,No,No,1.049,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,907,Austria,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,1,1,1,1,1,1,1,1,Y,,,Y,,1,,0,1,1,1,1,1,1,1,0,0,Yes,Y,Yes
1,907-002,Biologic Naïve,47,Female,19.721036968,1.7631759069,Yes,11,17,Current,No,Yes,No,No,No,No,No,No,1.5063613232,No,No,No,No,No,No,No,4,7,8,75,12,90,76,40,23,15,8,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,907,Austria,Europe,Other Biologics,,Risankizumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,-7.6,0,0,0,0,0,0,1,1,Y,-11,0,Y,1,1,0,0,0,0,0,0,0,0,1,0,1,Yes,Y,Yes
1,907-003,Biologic Naïve,59,Male,36.111111111,2.5571526352,No,14.6,0.513,Missing,No,No,No,Yes,No,No,No,No,1,No,No,No,No,No,No,No,3.2017453799,7,3.06,16.744,7,36.76,14.125,39.662,9.669,3.835,5.834,24.577,Yes,No,Yes,Yes,0.488,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,907,Austria,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Rest,,,Y,Y,Y,N,N,Y,-14,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,927-001,Biologic Naïve,40,Female,23.384353741,8.9336071184,No,12.2,12,Never,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,3,10,25.013,68.333333333,38,20,19,12,7,25,Yes,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9.8,0,0,1,0,0,1,1,1,Y,-9,0,Y,1,1,1,1,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,927-002,Biologic Naïve,34,Male,28.596757128,15.978097194,No,20.5,11,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,8,39,0.282,86.666666667,62,30,7,5,2,23,No,No,No,Yes,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-7.4,0,0,0,0,0,0,0,0,Y,-1,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,927-003,Biologic Naïve,38,Female,36.753650306,19.140314853,No,38,2,Current,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,Yes,No,No,5,50,0,0,33.827,13.333333333,2,10,4,2,2,22,No,Yes,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-38,1,1,1,1,1,1,1,1,Y,-2,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,927-004,Biologic Naïve,25,Female,19.486961451,13.051334702,No,14.4,8,Never,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,20,4,10,13.588,46.666666667,14,10,9,8,1,23,No,Yes,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-14.4,1,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,927-005,Biologic Naïve,67,Female,23.233456177,62.132785763,No,22.8,8,Never,No,Yes,Yes,Yes,No,No,No,No,2,No,No,No,No,No,Yes,No,4,30,0,37,29.089,61.666666667,22,40,0,0,0,20,No,No,No,Yes,0,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-22.8,1,1,1,1,1,1,1,1,Y,-8,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,927-006,Biologic Naïve,30,Male,28.196921201,10.135523614,No,15.4,2,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,20,0,10,3.95,26.666666667,22,0,6,2,4,24,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.4,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,927-007,Biologic Non-naïve,42,Female,26.365603029,7.2388774812,No,15,0,Former,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,10,0,0,13.333,1.6666666667,0,0,2,2,0,25,No,No,No,No,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,927-008,Biologic Naïve,37,Male,24.858365129,5.0759753593,No,11.2,14,Current,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,0,10,5,64,0,65,52,70,4,3,1,25,No,No,No,No,1,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.2,0,0,0,0,0,1,1,1,Y,-10,0,Y,1,1,1,1,0,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,927-009,Biologic Non-naïve,61,Male,26.588750913,13.63449692,No,15.6,14,Former,No,No,No,Yes,No,No,No,No,4,No,No,No,No,No,Yes,No,4,15,6,47,20,63.333333333,42,20,13,8,5,24,No,Yes,Yes,Yes,0,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.4,0,0,0,0,0,0,0,0,Y,-2,0,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,927-010,Biologic Naïve,58,Male,31.481481481,5.6728268309,No,5.9,25,Never,No,Yes,Yes,Yes,No,No,No,No,7,No,No,No,Yes,Yes,Yes,No,4,7,4,11,0,90,52,60,2,1,1,25,No,No,No,No,1,Yes,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,0.1,0,0,0,0,0,0,0,0,Y,-24,1,Y,0,0,0,0,0,0,0,0,0,0,0,1,0,No,Y,No
1,927-011,Biologic Non-naïve,39,Female,28.405337561,15.92881588,No,17.4,28,Current,No,Yes,No,No,No,No,No,No,2,No,No,No,Yes,Yes,No,No,4,30,10,100,0,100,100,100,8,5,3,25,No,Yes,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,927,Switzerland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15.6,0,0,1,0,1,1,1,1,Y,,,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,929-001,Biologic Naïve,29,Male,26.729927495,5.0239561944,No,19.4,16.824,Current,No,No,No,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,4,15,5.499,54.437,36.117,46.412,48.773,40.816,18.986,5.739,13.247,24.299,Yes,Yes,Yes,Yes,0.888,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,929,Switzerland,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-12.5,0,0,0,0,0,0,0,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,929-002,Biologic Naïve,64,Male,31.141868512,40.167008898,No,15,2,Current,No,No,No,Yes,Yes,No,No,Yes,6,No,No,No,Yes,Yes,Yes,No,4,11,5,0,60,50,14,0,0,0,0,25,No,Yes,No,Yes,1,Yes,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,929,Switzerland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-12.8,0,0,1,0,0,1,1,,Y,0,0,Y,,0,,0,1,0,0,0,0,1,1,0,0,,Y,No
1,930-001,Biologic Naïve,41,Male,23.765432099,16.616016427,Yes,4.4,15,Current,Yes,Yes,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,3.5,3,11,20,26.666666667,18,20,9,7,2,21,No,No,No,Yes,3,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Secukinumab,,,,,,,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,Secukinumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Anti IL 17,Anti IL 17,Secukinumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-2.6,0,0,0,0,1,1,1,0,Y,-11,0,Y,0,0,0,0,0,0,0,0,1,1,1,0,0,No,Y,No
1,930-002,Biologic Non-naïve,51,Male,26.365603029,37.675564682,No,27.2,5,Never,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,58,4,27,50,45,26,0,9,7,2,25,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-27.2,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,930-003,Biologic Naïve,28,Male,19.731762418,13.675564682,No,10.8,8,Never,Yes,No,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3,12,7,46,0,63.333333333,50,70,9,7,2,25,No,No,No,Yes,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.6,0,1,1,1,1,1,1,1,Y,-2,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,930-004,Biologic Naïve,51,Male,30.717399921,32.741957563,Yes,13.6,3,Never,Yes,Yes,Yes,No,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,3,10,2,18,14,55,18,0,5,3,2,18,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-13.6,1,1,1,1,1,1,1,1,Y,-3,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,930-005,Biologic Naïve,24,Male,33.208549692,6.0616016427,No,9.6,23,Never,No,Yes,No,Yes,Yes,Yes,No,No,2,No,No,No,Yes,Yes,No,No,4,10,3,59,2,73.333333333,40,30,15,8,7,25,No,No,No,Yes,1,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-9,0,1,1,1,1,1,1,1,Y,-15,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,930-006,Biologic Naïve,22,Female,21.612811791,2.7980835044,No,5.5,17,Never,No,Yes,No,Yes,No,No,No,No,0,No,No,No,No,No,No,No,5,7,7,61,0,51.666666667,48,40,14,9,5,24,No,No,No,Yes,0,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,N,2.9,0,0,0,0,0,0,0,0,N,4,0,N,0,0,0,0,0,0,0,0,0,0,0,0,0,,N,No
1,930-007,Biologic Naïve,34,Male,25.992438563,10.81724846,No,10.5,1,Former,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,0,0,30,21.666666667,0,0,2,2,0,25,Yes,Yes,No,Yes,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.2,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,930-009,Biologic Naïve,52,Female,29.744199881,20.922655715,No,5.8,10.441,Missing,Yes,No,Yes,No,Yes,No,No,Yes,1,No,No,No,No,Yes,No,No,2,8.7,7.781,62.715,35,69.306,65.067,58.089,13.213,10.016,3.197,22.743,Yes,Yes,No,Yes,0.382,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,,,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,930-010,Biologic Non-naïve,20,Male,26.234567901,13.960301164,No,8.8,13.324,Missing,No,Yes,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,3,8,6.063,71.378,0,68.759,49.99,16.269,17.91,6.952,10.957,21.143,Yes,No,No,Yes,0.929,No,Other Biologics,,IL-23,,,,,,Tildrakizumab,,,,,,Tildrakizumab,,Tildrakizumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Other Biologics,,Tildrakizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-8.2,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,930-011,Biologic Naïve,54,Male,33.443817373,30.965092402,No,12.2,7,Former,No,No,Yes,Yes,Yes,No,No,Yes,4,No,No,No,Yes,Yes,No,Yes,4,8.6,8,3,12,30,22,10,28,12,16,24,Yes,Yes,Yes,Yes,2,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-10.1,0,0,1,0,0,1,1,1,Y,4,0,Y,1,1,0,0,1,0,0,0,0,1,1,0,1,Yes,Y,Yes
1,930-012,Biologic Non-naïve,19,Male,18.078512397,5.0047912389,No,0.6,16.223,Missing,No,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,1,0.2,3.504,54.704,4,65.51,38.217,9.764,7.459,5.806,1.653,22.967,No,No,No,No,2.194,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-0.6,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,930-013,Biologic Naïve,31,Female,22.647376961,24.021902806,No,6,6,Never,Yes,Yes,Yes,No,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3.2017453799,6,3,5,0,23.333333333,16,10,9,7,2,23,Yes,No,No,Yes,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-6,1,Y,,0,,0,0,0,0,0,0,0,0,1,0,,Y,No
1,930-014,Biologic Naïve,33,Female,22.206330686,18.026009582,No,7.2,22,Former,Yes,No,Yes,Yes,Yes,No,No,Yes,0,No,No,No,No,No,No,No,3.2017453799,5.1,6,31,0,71.666666667,34,30,12,7,5,25,No,No,No,Yes,1,No,Other Biologics,Anti-TNFs,,,,,,,,,,,,,,,,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Other Biologics,Anti TNFs,Certolizumab,Anti TNF,,,No Psoriatic Arthritis,mNAPSI at baseline = 0,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.9,0,1,1,1,1,1,1,1,Y,-20,0,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,930-015,Biologic Naïve,53,Male,25.102391333,16.024640657,No,12.6,21,Current,No,No,Yes,Yes,Yes,No,No,Yes,4,No,No,No,No,Yes,No,No,3.2017453799,9.3,3,54,42,60,30,50,5,2,3,24,No,Yes,No,Yes,1,Yes,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,930,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,,Y,Y,Y,N,N,Y,,,,,,,,,,Y,-17,0,Y,,0,,0,0,0,0,0,0,0,0,0,0,,Y,No
1,932-001,Biologic Naïve,48,Male,25.102391333,25.875427789,No,15.8,15,Current,No,No,Yes,Yes,No,No,No,No,0,No,No,No,No,No,No,No,3,11,8,79,30.849,73.333333333,64,20,3,1,2,25,No,No,No,No,1,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,932,Switzerland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-15,0,1,1,1,1,1,1,1,Y,-12,0,Y,0,1,0,0,1,1,0,1,1,1,1,0,0,Yes,Y,Yes
1,932-002,Biologic Naïve,20,Male,46.09375,7.2498288843,No,14.4,28.036,Current,No,Yes,Yes,Yes,Yes,No,No,Yes,2,No,No,No,Yes,Yes,No,No,3,5,2.583,89.362,23.367,48.806,37.393,64.638,25.4,13.657,11.743,21.664,No,No,No,No,1.079,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,932,Switzerland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,4.8,0,0,0,0,0,0,0,0,Y,,,Y,0,0,0,0,0,0,0,0,0,0,0,0,0,No,Y,No
1,932-003,Biologic Naïve,52,Male,27.968016064,13.503080082,No,8,13,Former,No,No,No,No,No,No,No,No,0,No,No,No,No,No,No,No,3,6.4,5,45,12.803,56.666666667,40,10,12,6,6,22,No,No,No,Yes,0,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,932,Switzerland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-6.6,0,0,1,0,1,1,1,1,Y,-4,0,Y,1,1,0,0,1,0,0,0,1,1,1,0,1,Yes,Y,Yes
1,932-004,Biologic Naïve,50,Male,35.908484662,20.583162218,No,5.6,0,Current,Yes,Yes,No,Yes,No,No,No,No,4,Yes,No,No,No,Yes,Yes,No,3,3,4,5,26.005,21.666666667,12,0,7,5,2,24,No,No,No,Yes,1,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,932,Switzerland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,,,,,,,,,1,Y,0,,Y,1,1,1,1,0,0,0,0,0,0,0,0,1,Yes,Y,Yes
1,932-005,Biologic Naïve,54,Female,46.712802768,1.3661875428,No,25.6,2,Current,Yes,Yes,Yes,No,No,No,No,No,3,No,No,No,Yes,Yes,No,No,4,12,6,7,20.03,41.666666667,34,0,1,1,0,25,No,No,No,Yes,0,Yes,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,932,Switzerland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-25.6,1,1,1,1,1,1,1,1,Y,-1,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
1,935-001,Biologic Non-naïve,54,Female,29.031510377,31.775496235,Yes,12.3,6.423,Missing,Yes,Yes,No,Yes,No,No,No,No,1,No,No,No,No,Yes,No,No,4,14,5.621,46.17,15.006,49.451,56.781,20.604,14.041,9.069,4.972,23.668,No,Yes,No,Yes,0.31,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,935,Switzerland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,,Rest,Antidepressants Taken at Baseline,Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-11.4,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,935-002,Biologic Naïve,66,Male,21.224489796,31.753593429,Yes,15.4,21.894,Missing,No,No,Yes,No,No,No,No,No,0,No,No,No,No,No,No,No,4,13,1.67,39.831,5,76.291,59.934,43.137,24.851,14.2,10.651,23.509,Yes,No,No,Yes,0.689,No,Other Biologics,,IL-23,,Guselkumab,,,,,,Guselkumab,,,,,,Guselkumab,ADOUT,I1F-MC-B007,935,Switzerland,Europe,Other Biologics,,Guselkumab,IL23,IL23,,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-14.6,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,935-003,Biologic Naïve,45,Male,33.967391304,21.735797399,Yes,17.1,9.769,Missing,No,Yes,No,Yes,No,No,No,No,2,Yes,No,No,No,Yes,No,No,4,12,3.033,9.704,35,34.289,26.981,7.565,7.834,3.519,4.315,23.12,Yes,No,No,Yes,1.62,No,Anti-IL-17A,Anti-IL-17A,Anti-IL-17A,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,Ixekizumab,,,,,,,Ixekizumab,ADOUT,I1F-MC-B007,935,Switzerland,Europe,Anti IL 17,Anti IL 17,Ixekizumab,IL17A,Anti IL 17,Anti IL 17,Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,N,N,Y,Y,Y,-16.8,0,1,1,1,1,1,1,1,Y,,,Y,1,1,0,0,1,1,0,1,1,1,1,0,1,Yes,Y,Yes
1,935-004,Biologic Naïve,31,Male,32.871972318,27.950718686,No,18,2,Current,Yes,Yes,No,No,No,No,No,No,0,No,No,No,No,No,No,No,4,12,2,3,15,21.666666667,36,0,19,12,7,21,Yes,No,No,Yes,2,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,935,Switzerland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,mNAPSI at baseline >= 1,Nails,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-18,1,1,1,1,1,1,1,1,Y,,,Y,1,1,1,1,1,1,1,1,1,1,1,0,1,Yes,Y,Yes
1,935-005,Biologic Naïve,52,Male,29.031510377,40.008213552,No,28.3,5,Former,No,Yes,No,No,No,No,No,No,1,No,No,No,No,Yes,No,No,5,35,2,1,21.22,11.666666667,10,10,1,0,1,25,No,Yes,Yes,No,0,No,Other Biologics,,IL-23,,,Risankizumab,,,,,,Risankizumab,,,,,Risankizumab,ADOUT,I1F-MC-B007,935,Switzerland,Europe,Other Biologics,,Risankizumab,IL23,IL23,,No Psoriatic Arthritis,,Rest,No Antidepressants Taken at Baseline,No Antidepressants Taken at at least one Visit after Baseline,Y,Y,Y,N,N,Y,-28.3,1,1,1,1,1,1,1,1,Y,-5,1,Y,1,1,1,1,1,1,1,1,1,1,1,1,1,Yes,Y,Yes
